<SEC-DOCUMENT>0001493152-26-018351.txt : 20260421
<SEC-HEADER>0001493152-26-018351.hdr.sgml : 20260421
<ACCEPTANCE-DATETIME>20260421171613
ACCESSION NUMBER:		0001493152-26-018351
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20260421
FILED AS OF DATE:		20260421
DATE AS OF CHANGE:		20260421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stardust Power Inc.
		CENTRAL INDEX KEY:			0001831979
		STANDARD INDUSTRIAL CLASSIFICATION:	PRIMARY SMELTING & REFINING OF NONFERROUS METALS [3330]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39875
		FILM NUMBER:		26880562

	BUSINESS ADDRESS:	
		STREET 1:		9112 N. KELLEY AVE
		STREET 2:		SUITE C
		CITY:			OKLAHOMA CITY
		STATE:			OK
		ZIP:			73131
		BUSINESS PHONE:		(646) 585-8975

	MAIL ADDRESS:	
		STREET 1:		6608 N. WESTERN AVE
		STREET 2:		SUITE 466
		CITY:			NICHOLS HILLS
		STATE:			OK
		ZIP:			73116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Global Partner Acquisition Corp II
		DATE OF NAME CHANGE:	20201110
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:SDST="http://stardust-power.com/20251231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_ECD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_SDST_stardust%2Dpower.com_20251231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250101_20251231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001831979 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001831979</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0010" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sdst-20251231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2025-01-01to2025-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001831979</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">UNITED
STATES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Washington,
D.C. 20549</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_904_edei--DocumentType_dxL_c20250101__20251231_zlUXrTYZztWa" title="::XDX::DEF%2014A" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE
14A</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">INFORMATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant to Section 14(a)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the Securities Exchange Act of 1934</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Amendment
No. &#160;&#160;&#160;&#160;&#160;&#160;)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Preliminary Proxy Statement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;
Definitive Proxy Statement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Definitive Additional Materials</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Soliciting Material under &#167; 240.14a-12</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_90C_edei--EntityRegistrantName_c20250101__20251231_zHHLUB2THHQk" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000011" name="dei:EntityRegistrantName">STARDUST
POWER INC.</ix:nonNumeric></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name
of Registrant as Specified in Its Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check all boxes that apply):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;
No fee required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Fee paid previously with preliminary materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><img src="formdef14a_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>STARDUST
POWER INC.<br/>
15 E. Putnam Ave., Suite 378<br/>
Greenwich, CT 06830</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
    OF 2026 ANNUAL MEETING OF STOCKHOLDERS</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2026
ANNUAL MEETING OF STOCKHOLDERS OF STARDUST POWER INC. TO BE HELD ON JUNE 2, 2026</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN of the 2026 Annual Meeting of Stockholders of Stardust Power Inc. (the &#8220;<b><i>Company</i></b>,&#8221; &#8220;<b><i>we</i></b><i>,</i>&#8221;
&#8220;<b><i>us</i></b><i>,</i>&#8221; or &#8220;<b><i>our</i></b>&#8221;) to be held on June 2, 2026 at 11:00 AM Eastern Time (the &#8220;<b><i>Meeting</i></b>&#8221;).
We have adopted a virtual format for our Meeting to provide a convenient experience to all stockholders regardless of location. You may
attend, vote and submit questions during the Meeting via the Internet at <i>www.virtualshareholdermeeting.com/SDST2026</i>. You may also
vote ahead of the Meeting through the designated website. The Meeting will be held for the following purposes, as
more fully described in the accompanying proxy statement (the &#8220;<b><i>Proxy Statement</i></b>&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            elect the following six director nominees, each to serve a one-year term expiring at the
                                            2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified:
                                            Roshan Pujari, Anupam Agarwal, Charlotte Nangolo, Mark Rankin, Michael Earl Cornett Sr. and
                                            Sudhindra Kankanwadi&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            ratify the selection of KNAV CPA LLP as the Company&#8217;s independent registered public
                                            accounting firm for the fiscal year ending December 31, 2026&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of shares
                                            of Common Stock to Lind Global Asset Management XIII LLC;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            approve an amendment of the Company&#8217;s Certificate of Incorporation to clarify the director
                                            removal provision;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            approve an amendment and restatement of the Company&#8217;s 2024 Equity Incentive Plan; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            transact such other business as may properly come before the Meeting or any adjournment or
                                            postponement thereof.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Board of Directors (the &#8220;<b><i>Board</i></b>&#8221;) has fixed the close of business on April 6, 2026 as the record
date for determining stockholders entitled to notice of, and to vote at, the Meeting or any adjournments or postponements thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has carefully reviewed and considered the foregoing proposals and has concluded that each proposal is in the best interests of
the Company and its stockholders. Our Board recommends that you vote <span style="text-decoration: underline">FOR</span> each director
nominee listed in Proposal 1 and <span style="text-decoration: underline">FOR</span> Proposals 2 through 5.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I
M P O R T A N T</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend the Meeting virtually. Your vote is important no matter how large or small your holdings in the Company
may be. After reading the enclosed Proxy Statement, you are urged to cast your vote via the Internet, or, if you requested a printed
copy of the proxy materials, by telephone or by using the proxy card or voting instruction form provided with the printed proxy materials.
Whether or not you expect to participate in the virtual Meeting, please vote as promptly as possible in order to ensure your representation
at the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instructions
for accessing the virtual Meeting are provided in the Proxy Statement. Unless otherwise announced differently at the Meeting or on the
Meeting website, in the event of a technical malfunction or other situation that the Meeting chair determines may affect the ability
of the Meeting to satisfy the requirements for a meeting of stockholders to be held by means of remote communication under the Delaware
General Corporation Law, or that otherwise makes it advisable to adjourn the Meeting, the Meeting chair or secretary will convene the
meeting at 12:00 PM Eastern Time on the date specified above and at the Company&#8217;s address specified above solely for the purpose
of adjourning the Meeting to reconvene at a date, time and physical or virtual location announced by the Meeting chair or secretary.
Under either of the foregoing circumstances, we will post information regarding the announcement on the Investors page of the Company&#8217;s
website at <i>https://investors.stardust-power.com/</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
Order of the Board,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1pt solid; width: 50%"><span style="font-family: Times New Roman, Times, Serif"><i>/s/
  Roshan Pujari</i></span></td>
  <td style="padding-bottom: 1pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Roshan Pujari</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder and Chief Executive Officer</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greenwich,
Connecticut</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
21, 2026</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMPORTANT
    NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 2, 2026</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice of the Annual Meeting of Stockholders, the Proxy Statement and our 2025 Annual Report on Form 10-K are available on our website
at <i>https://investors.stardust-power.com/financial-information/sec-filings</i>. Additionally, in accordance with Securities and Exchange
Commission (&#8220;<b><i>SEC</i></b>&#8221;) rules, you may access our proxy materials at <i>www.proxyvote.com</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Legal
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination. </i></b>On July 8, 2024 (the &#8220;<b><i>Closing Date</i></b>&#8221;), Stardust Power Operating Inc. (f/k/a Stardust Power
Inc. prior to the consummation of the Business Combination (as defined below), or &#8220;<b><i>Legacy Stardust Power</i></b>&#8221;)
consummated the business combination contemplated by the Business Combination Agreement, dated as of November 21, 2023 (as amended, the
&#8220;<b><i>Business Combination Agreement</i></b>&#8221;), by and among Global Partner Acquisition Corp. II, a Cayman Islands exempted
company (&#8220;<b><i>GPAC II</i></b>&#8221;), Strike Merger Sub I, Inc., a Delaware corporation and direct wholly owned subsidiary of
GPAC II (&#8220;<b><i>First Merger Sub</i></b>&#8221;), Strike Merger Sub II, LLC, a Delaware limited liability company and a direct
wholly owned subsidiary of GPAC II (&#8220;<b><i>Second Merger Sub</i></b>&#8221;), and Legacy Stardust Power (the &#8220;<b><i>Business
Combination</i></b>&#8221;). Pursuant to the Business Combination Agreement, First Merger Sub merged into Legacy Stardust Power, with
Legacy Stardust Power being the surviving corporation. Legacy Stardust Power then merged into Second Merger Sub, with Second Merger Sub
being the surviving entity. Upon the completion of the Business Combination, GPAC II was renamed Stardust Power Inc. Unless the context
otherwise requires, any reference in this Proxy Statement to the &#8220;<b><i>Company</i></b>,&#8221; &#8220;<b><i>we</i></b>,&#8221;
&#8220;<b><i>us</i></b>,&#8221; &#8220;<b><i>our</i></b>,&#8221; or &#8220;<b><i>Stardust Power</i></b>&#8221; refers to Stardust Power
Inc. and its consolidated subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse
Stock Split. </i></b>Effective September 8, 2025, the Company effected a reverse stock split of all outstanding shares of the Company&#8217;s
Common Stock at a ratio of 1-for-10. Unless otherwise specified, all share amounts and related figures (as applicable) reported in this
Proxy Statement are presented on a post-split basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Forward-Looking
Statements. </i></b>The Proxy Statement may contain &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221;
provisions of the Private Securities Litigation Reform Act of 1995, which statements are subject to substantial risks and uncertainties
and are based on estimates and assumptions. All statements other than statements of historical fact included in the Proxy Statement,
including statements about the Board, corporate governance practices, executive compensation program and equity compensation utilization,
are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;might,&#8221;
&#8220;will,&#8221; &#8220;objective,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221;
&#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221;
&#8220;plan&#8221; or the negative of these terms, and similar expressions intended to identify forward-looking statements. These statements
involve known and unknown risks, uncertainties and other factors that could cause our actual results or outcomes to differ materially
from the forward-looking statements expressed or implied in the Proxy Statement. Such risks, uncertainties and other factors include
those risks described in &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and
Results of Operations&#8221; in the Company&#8217;s most recent Annual Report on Form 10-K filed with the SEC and other subsequent documents
we file with the SEC. The Company expressly disclaims any obligation to update or alter any statements whether as a result of new information,
future events or otherwise, except as required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Website
References.</i></b> Website references throughout this document are inactive textual references and provided for convenience only, and
the content on the referenced websites is not incorporated herein by reference and does not constitute a part of the Proxy Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Trademarks.</i></b> Stardust Power is the trademark of Stardust Power Inc. Other names and brands may be claimed as the property of
others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><img src="formdef14a_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STARDUST
POWER INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15
E. Putnam Ave., Suite 378</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Greenwich,
CT 06830</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROXY
    STATEMENT FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON <span style="text-transform: uppercase">June 2, 2026 at 1<span style="font-weight: normal">1</span>:00
    AM Eastern Time</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement (the &#8220;<b><i>Proxy Statement</i></b>&#8221;) is being furnished in connection with the solicitation of proxies by
the Board of Directors (the &#8220;<b><i>Board</i></b>&#8221;) of Stardust Power Inc. (the &#8220;<b><i>Company</i></b>,&#8221; &#8220;<b><i>we</i></b><i>,</i>&#8221;
&#8220;<b><i>us</i></b><i>,</i>&#8221; or &#8220;<b><i>our</i></b>&#8221;) for use at the 2026 Annual Meeting of Stockholders of the
Company (the &#8220;<b><i>Meeting</i></b>&#8221; or the &#8220;<b><i>2026 Annual Meeting</i></b>&#8221;) to be held on June 2, 2026 at
11:00 AM Eastern Time, or at any other time following adjournment or postponement thereof. The proxy materials will be made available
to our stockholders on or about April 21, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are invited to participate in the Meeting and to vote on the proposals described in this Proxy Statement. You may attend, vote and
submit questions during the Meeting via the Internet at <i>www.virtualshareholdermeeting.com/SDST2026</i>. You may also vote ahead
of the Meeting through the designated website. We believe that the virtual format allows us to communicate more effectively with
stockholders. We recommend that you log in to the Meeting at <i>www.virtualshareholdermeeting.com/SDST2026</i> a few minutes before
the scheduled meeting time on June 2, 2026 to ensure you are logged in when the Meeting starts. For further information about the
virtual Meeting, please see &#8220;Questions And Answers Regarding This Solicitation&#8221; beginning on page 2 of this Proxy
Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board selected Roshan Pujari and Bruce Czachor to serve as the holders of proxies for the Meeting. The shares of the Company&#8217;s
Common Stock, par value $0.0001 per share (the &#8220;<b><i>Common Stock</i></b>&#8221;), represented by each executed and returned proxy
will be voted by Messrs. Pujari and Czachor in accordance with the directions indicated on the proxy card. The proxy card also confers
the proxies with discretionary authority to vote the shares authorized by such proxies on any other matter that may properly be presented
for action at the Meeting or at any adjournments or postponements thereof, but, as of the date of filing this Proxy Statement, the Board
knows of no other matters to be presented at the Meeting. It is the intention of the proxies to vote on such other matters, if any, in
accordance with their best judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay the costs associated with the solicitation of proxies, including the preparation, assembly, printing and mailing of the proxy
materials. We may also reimburse brokers, fiduciaries or custodians for the cost of forwarding proxy materials to beneficial owners of
shares of common stock held in &#8220;street name.&#8221; Our directors, officers and employees may solicit proxies by Internet, telephone,
facsimile or personal solicitation. We will not pay additional compensation for any of these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUESTIONS
    AND ANSWERS REGARDING THIS SOLICITATION</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEN
                                            IS THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
                                            2, 2026 at 11:00 AM Eastern Time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
                                            DO I ATTEND THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a virtual format for our Meeting to provide a convenient experience to all stockholders regardless of location. You may
attend, vote and submit questions during the Meeting via the Internet at <i>www.virtualshareholdermeeting.com/SDST2026</i>. We will be
holding a virtual-only meeting for a few reasons. First, we value innovation, and we welcome the expanded access, improved communication
and cost savings for our stockholders and the Company afforded by the virtual format. We believe that hosting a virtual meeting enables
increased stockholder attendance and participation from locations around the world, which provides for a more meaningful forum.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recommend that you log in to the Meeting at <i>www.virtualshareholdermeeting.com/SDST2026</i> a few minutes before the scheduled meeting
time on June 2, 2026 to ensure you are logged in when the Meeting starts. You will need to use the control number included on your Notice
of Internet Availability of Proxy Materials, proxy card or voting instruction form to log in. Beneficial owners who do not have a control
number may gain access to the Meeting by contacting their bank, broker or other nominee (preferably at least five days before the Meeting)
and obtaining a &#8220;legal proxy&#8221; in order to be able to attend, participate in or vote at the Meeting. We will have technicians
ready to assist you with any technical difficulties you may have accessing the Meeting website. If you encounter any difficulties accessing
the Meeting, please call the technical support number that will be posted on the Meeting webpage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WILL
                                            THERE BE A Q&amp;A SESSION DURING THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the Meeting, we will hold a live Q&amp;A session during which we intend to answer questions submitted online during the Meeting that comply with the Meeting rules of conduct and as time permits. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
stockholder may submit no more than one question. Questions should be succinct and only cover a single topic. We reserve the right to
edit profanity or other inappropriate language and to exclude questions regarding topics that are not pertinent to Meeting matters or
Company business. If we receive substantially similar questions, we may group such questions together and provide a single response to
avoid repetition. We encourage you to review the Meeting rules of conduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Why
                                            Did I Receive a Notice of Internet Availability?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            permitted by U.S. Securities and Exchange Commission (the &#8220;<b><i>SEC</i></b>&#8221;)
                                            rules, we are making this Proxy Statement and our Annual Report on Form 10-K for the fiscal
                                            year ended December 31, 2025 (the &#8220;<b><i>Annual Report</i></b>&#8221;) available to
                                            our stockholders primarily electronically via the Internet instead of mailing printed copies.
                                            This process allows us to expedite our stockholders&#8217; receipt of proxy materials, lower
                                            the costs of printing and mailing the proxy materials and reduce the environmental impact
                                            of our Meeting. The Notice of Internet Availability of Proxy Materials contains instructions
                                            on how to access the proxy materials for the Meeting via the Internet, how to request a printed
                                            set of proxy materials and how to vote your shares. If you received a Notice of Internet
                                            Availability of Proxy Materials, you will not receive a printed copy of the proxy materials
                                            unless specifically requested.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHO
                                            IS ENTITLED TO VOTE AT THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
                                            stockholders of record at the close of business on April 6, 2026 (the &#8220;<b><i>Record
                                            Date</i></b>&#8221;) are entitled to notice of and to vote at the Meeting and any postponements
                                            or adjournments thereof. At the close of business on the Record Date, 9,990,130 shares of
                                            the Company&#8217;s Common Stock were issued and outstanding.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of shares of Common Stock are entitled to one vote for each share on each proposal to be voted on at the Meeting. The holders of Common
Stock shall vote together as a single class on all proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
                                            MANY SHARES MUST BE PRESENT TO CONDUCT BUSINESS?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            presence of the holders of a majority of the voting power of the shares of Common Stock issued
                                            and outstanding and entitled to vote at the Meeting, present or represented by proxy, will
                                            constitute a quorum for the transaction of business. A quorum is required to conduct business
                                            at the Meeting and any adjournments or postponements thereof. Your shares will be counted
                                            toward the quorum only if you submit a valid proxy (or a valid proxy is submitted on your
                                            behalf by your broker, fiduciary or custodian) or if you attend the Meeting virtually and
                                            vote. Abstentions and broker non-votes will be counted toward the quorum requirement. If
                                            there is no quorum, the Meeting chair or, if directed to be voted on by the Meeting chair,
                                            the holders of a majority of the voting power of the shares entitled to vote who are present
                                            or represented by proxy at the Meeting may adjourn the Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHAT
                                            WILL BE VOTED ON AT THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            following table sets forth the proposals scheduled for a vote at the 2026 Annual Meeting,
                                            the vote required for such proposals to be approved and the Board&#8217;s voting recommendation:</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 28%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 37%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VOTES
    REQUIRED</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VOTING
    OPTIONS</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOARD
    RECOMMENDATION</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    1</b>: To elect the following six director nominees, each to serve a one-year term expiring at the 2027 Annual Meeting of Stockholders
    or until their successors are duly elected and qualified: Roshan Pujari, Anupam Agarwal, Charlotte Nangolo, Mark Rankin, Michael
    Earl Cornett Sr. and Sudhindra Kankanwadi. </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            nominee will be elected as a director at the Meeting if the nominee receives a plurality
                                            of the votes cast. This means that the six nominees receiving the highest number of votes
                                            cast &#8220;FOR&#8221; will be elected as directors.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withheld
    votes and broker non-votes, if any, will have no effect on the outcome of the election. Stockholders do not have cumulative voting
    rights for the election of directors.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
    or &#8220;WITHHOLD&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;
    all nominees </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    2</b>: To ratify the selection of KNAV CPA LLP as the Company&#8217;s independent registered public accounting firm for the fiscal
    year ending December 31, 2026. </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
                                            requires the affirmative vote of a majority of the votes cast.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
    and broker non-votes, if any, will have no effect on the outcome of the proposal.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR,&#8221;
    &#8220;AGAINST&#8221; or &#8220;ABSTAIN&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
                                            3</b>: To approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance
                                            of shares of Common Stock to Lind Global Asset Management XIII LLC.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
                                            requires the affirmative vote of a majority of the votes cast.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
    and broker non-votes, if any, will have no effect on the outcome of the proposal.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#8220;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR,&#8221;
    &#8220;AGAINST&#8221; or &#8220;ABSTAIN&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    4</b>: To approve an amendment of the Company&#8217;s Certificate of Incorporation to clarify the director removal provision. </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
                                            requires the affirmative vote of at least a majority of the shares of Common Stock outstanding.</span></p>
                                                                              <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
                                                                              <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
                                            and broker non-votes, if any, will have the same effect as a vote &#8220;AGAINST&#8221; the
                                            proposal. </span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR,&#8221;
    &#8220;AGAINST&#8221; or &#8220;ABSTAIN&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    5</b>: To approve an amendment and restatement of the Company&#8217;s 2024 Equity Incentive Plan.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
                                            requires the affirmative vote of a majority of the votes cast.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abstentions
    and broker non-votes, if any, will have no effect on the outcome of the proposal.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR,&#8221;
    &#8220;AGAINST&#8221; or &#8220;ABSTAIN&#8221;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOR&#8221;</span></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHAT
                                            SHARES CAN I VOTE AT THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may vote all shares of Common Stock owned by you as of the Record Date, including (i) shares
                                            held directly in your name as the stockholder of record and (ii) shares held for you as the
                                            beneficial owner through a broker, trustee or other nominee, such as a bank.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHAT
                                            SHOULD I DO IF I RECEIVE MORE THAN ONE SET OF PROXY MATERIALS?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you receive more than one set of proxy materials, your shares may be registered in more than
                                            one name or held in different accounts. Please follow the instructions on each set of proxy
                                            materials you receive and vote each set of proxy materials you receive to ensure that all
                                            of your shares are voted.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHAT
                                            IS THE DIFFERENCE BETWEEN HOLDING SHARES AS A REGISTERED STOCKHOLDER AND AS A BENEFICIAL
                                            OWNER?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            summarized below, there are some distinctions between registered shares and those owned beneficially.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registered
Stockholders</i>. If your shares are registered directly in your name with our transfer agent, Continental Stock Transfer &amp; Trust
Company, you are considered to be, with respect to those shares, the registered stockholder, and the proxy materials are being sent directly
to you by us. As the registered stockholder, you have the right to attend and vote at the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Beneficial
Owner</i>. If your shares are held in a brokerage account or by another nominee, you are considered the beneficial owner of shares held
in &#8220;street name,&#8221; and these proxy materials, together with a voting instruction card, are being forwarded to you by or on
behalf of that entity. As the beneficial owner, you have the right to direct your broker, bank or other nominee how to vote on your behalf
and are also invited to attend the 2026 Annual Meeting. If your voting instruction form or Notice of Internet Availability of Proxy Materials
indicates that you may vote those shares through <i>www.proxyvote.com</i>, then you may access, participate in and vote at the Meeting
with the 16-digit access code indicated on that voting instruction form or Notice of Internet Availability of Proxy Materials. Otherwise,
beneficial owners should contact their bank, broker or other nominee (preferably at least five days before the Meeting) and obtain a
&#8220;legal proxy&#8221; in order to be able to attend, participate in or vote at the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
                                            CAN I VOTE MY SHARES PRIOR TO THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
                                            if you plan to attend the Meeting, we recommend that you also submit your vote as early as
                                            possible in advance so that your vote will be counted if you later decide not to, or are
                                            unable to, virtually attend the Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a registered stockholder, you may vote by proxy in advance of the Meeting by Internet (at <i>www.proxyvote.com</i>) or, if you
requested paper copies of the proxy materials, by completing and mailing a proxy card or by telephone (at 800-690-6903).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
owners may cause their shares to be voted by proxy in accordance with the instructions provided by their broker, bank or other nominee.
In most instances, beneficial owners are able to do this over the Internet, by telephone or by mail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
                                            CAN I VOTE MY SHARES AT THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a registered stockholder, you may attend and vote during the Meeting at <i>www.virtualshareholdermeeting.com/SDST2026</i>.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
owners may attend and vote during the Meeting by following the instructions under &#8220;What is the difference between holding shares
as a registered stockholder and as a beneficial owner?&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHAT
                                            HAPPENS IF I DO NOT VOTE? WHAT IS A &#8220;BROKER NON-VOTE&#8221;?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are the registered stockholder and do not vote in one of the ways described above, your
                                            shares will not be voted at the Meeting and will not be counted toward the quorum requirement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are the beneficial owner and do not direct your broker, fiduciary or custodian how to vote your shares, your broker, fiduciary or
custodian will only be able to vote your shares with respect to proposals considered to be &#8220;routine.&#8221; Your broker, fiduciary
or custodian is not entitled to vote your shares with respect to &#8220;non-routine&#8221; proposals, which we refer to as a &#8220;broker
non-vote.&#8221; Whether a proposal is considered routine or non-routine is subject to stock exchange rules and final determination by
the stock exchange. Even with respect to routine matters, some brokers choose not to exercise their discretionary voting authority. As
a result, we urge you to direct your broker, fiduciary or custodian how to vote your shares on all proposals to ensure that your vote
is counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">What
                                            If I Sign and Return a Proxy Card or Otherwise Vote but Do Not Indicate Specific Choices</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a registered stockholder, the shares represented by each signed and returned proxy
                                            will be voted at the Meeting by the persons named as proxies in the proxy card in accordance
                                            with the instructions indicated on the proxy card. However, if you are the registered stockholder
                                            and sign and return your proxy card without giving specific instructions, the persons named
                                            as proxies in the proxy card will vote your shares in accordance with the recommendations
                                            of the Board. Your shares will be counted toward the quorum requirement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are the beneficial owner and do not direct your broker, fiduciary or custodian how to vote your shares, your broker, fiduciary or
custodian will only be able to vote your shares with respect to proposals considered to be &#8220;routine.&#8221; Your broker, fiduciary
or custodian is not entitled to vote your shares with respect to &#8220;non-routine&#8221; proposals, resulting in a broker non-vote
with respect to such proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAN
                                            I CHANGE MY MIND AFTER I RETURN MY PROXY?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
                                            You may change your vote at any time before your proxy is voted at the Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a registered stockholder, you can revoke your proxy by (i) giving timely written notice to the Company&#8217;s Secretary at the
address set forth on the first page of this Proxy Statement, (ii) submitting another proxy with a later date by mail, Internet or telephone
or (iii) attending the Meeting and voting virtually. However, your virtual attendance at the Annual Meeting will not, by itself, revoke
your proxy. Your last submitted vote is the one that will be counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a beneficial owner, you should consult with your bank, broker or other nominee regarding that entity&#8217;s procedures for revoking
your voting instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IS
                                            THERE A LIST OF STOCKHOLDERS ENTITLED TO VOTE AT THE MEETING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            list of stockholders entitled to vote at the Meeting will be available during ordinary business
                                            hours for at least 10 days prior to the Meeting at our principal executive offices at Stardust
                                            Power Inc., 15 E. Putnam Ave, Suite 378, Greenwich, CT 06830, by contacting our Director
                                            of Investor Relations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
                                            CAN I FIND OUT THE RESULTS OF THE VOTING?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            intend to announce preliminary voting results at the Meeting and publish the final results
                                            in a Current Report on Form 8-K within four business days following the Meeting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHOM
                                            SHOULD I CONTACT IF I HAVE QUESTIONS?</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you have any additional questions about the Meeting or the proposals presented in this Proxy
                                            Statement, you should contact our Investor Relations department at our principal executive
                                            offices as follows:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stardust
Power Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15
E. Putnam Ave., Suite 378</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greenwich,
CT 06830</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800-742-3095</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
investor.relations@stardust-power.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
1: ELECTION OF DIRECTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
NOMINATION PROCESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee of the Board (the &#8220;<b><i>Governance Committee</i></b>&#8221;) is charged with making
recommendations to the Board regarding qualified candidates to serve as members of the Board. The Governance Committee&#8217;s goal is
to assemble a Board with the skills and characteristics that, taken as a whole, help create a strong Board with experience and expertise
in different aspects of corporate governance. Accordingly, the Governance Committee believes that candidates for director should have
certain minimum qualifications, including strength of character, mature judgment, familiarity with the Company&#8217;s business and industry,
independence of thought and an ability to work collegially. In evaluating director nominees, the Governance Committee considers the following
factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            appropriate size of the Board&#894;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&#8217;s needs with respect to the particular talents and experience of its directors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            ability of a potential director to serve on committees of the Board&#894; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            knowledge, skills and experience of nominees, including experience in business, finance,
                                            engineering, mining, energy, technology, administration and/or public service.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than the foregoing, there is no stated minimum criteria for director nominees, although the Governance Committee also considers such
other factors as it deems to be in the Company&#8217;s and its stockholders&#8217; best interests, such as the independence requirements
for Board and committee membership under the Nasdaq Stock Market (the &#8220;<b><i>Nasdaq</i></b>&#8221;) listing standards and the requirement
for at least one member of the Board to meet the criteria for an &#8220;audit committee financial expert,&#8221; as defined by SEC rules.
The Governance Committee also believes it is appropriate for our Chief Executive Officer to serve on the Board. In addition, the Governance
Committee and the Board also generally consider a potential director candidate&#8217;s ability to contribute to the diversity of skills,
experiences, perspectives, tenures and backgrounds on the Board. The Governance Committee and the Board seek to assemble a group that
can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment. The Governance
Committee assesses its effectiveness in balancing these considerations in connection with its annual evaluation of the composition of
the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a stockholder agreement by and between the Company, Global Partner Sponsor II LLC, a Delaware limited liability company (the &#8220;<b><i>Sponsor</i></b>&#8221;),
and Roshen Pujari (hereinafter, Roshan Pujari) and his affiliates, the Sponsor has the right to designate one nominee to the Board (the
&#8220;<b><i>Designation Right</i></b>&#8221;) as long as certain criteria are satisfied. In December 2024, the Sponsor designated Martyn
Buttenshaw as its designated director. Mr. Buttenshaw resigned from the Board in June 2025, and the Board reduced its size from seven
to six directors. The Governance Committee recommends to the Board the nominees for election to the Board at each annual meeting subject
to the Designation Right. See &#8220;Certain Relationships and Related Transactions&#8211;Related-Party Transactions&#8211;Stockholder
Agreement.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Governance Committee identifies nominees by first evaluating the current members of the Board willing to continue in service. Current
members of the Board with skills and experience that are relevant to our business and who are willing to continue in service are considered
for re-nomination, but the Governance Committee also seeks to balance the value of continuity of service by existing members of the Board
with that of obtaining new perspectives. The Governance Committee identifies the desired skills and experience of a new nominee and then
uses its network and external resources to solicit and compile a list of eligible candidates, including, from time to time, third-party
search firms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Governance Committee will consider stockholder recommendations of nominees for director to the Board that are properly submitted by a
stockholder. The committee considers candidates recommended by our stockholders in the same manner as a candidate recommended by other
sources. Stockholders wishing to recommend a candidate may do so by sending a written notice to Stardust Power Inc., 15 E. Putnam Ave.,
Suite 378, Greenwich, CT 06830, Attention: Secretary, naming the proposed candidate and providing the same biographical and other information
regarding such proposed candidate as required under our bylaws for nominating a director. See &#8220;Stockholder Proposals for Next Year&#8217;s
Annual Meeting&#8221; for further information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
potential director candidates are identified, the committee, with the assistance of management, undertakes a vetting process that considers
each candidate&#8217;s background, independence and fit with the Board&#8217;s priorities. As part of this vetting process, the committee,
as well as other members of the Board and the CEO, may conduct interviews with the candidates. If the committee determines that a potential
candidate meets the needs of the Board and has the desired qualifications, it recommends the candidate to the full Board for appointment
or nomination and to the stockholders for election at the annual meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
ABOUT OUR DIRECTOR NOMINEES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with our bylaws, the Board has fixed the number of directors constituting the Board at six. Directors are elected annually
for a one-year term. The Governance Committee has recommended, and the Board has nominated, each of the six nominees named below, each
of whom was most recently elected by stockholders at the 2025 Annual Meeting of Stockholders, to be elected as a director for a one-year
term expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified, subject
to prior death, resignation, disqualification or removal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
director nominees have indicated that they are willing and able to serve as directors. However, if any of them becomes unable or, for
good cause, unwilling to serve, proxies may be voted for the election of such other person as shall be designated by our Board, or the
Board may decrease the size of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than the Designation Right, there are no arrangements or understandings to our knowledge between any of our directors, nominees for directors
or officers and any other person pursuant to which any director, nominee for director or officer was or is to be selected as a director,
nominee or officer, as applicable. There currently are no legal proceedings, and during the past ten years there have been no legal proceedings,
that are material to the evaluation of the ability or integrity of any of our directors or director nominees. There are no material proceedings
to which any director, officer, affiliate or owner of record or beneficially of more than 5% of any class of voting securities of the
Company, or any associates of any such persons, is a party adverse to the Company or any of our subsidiaries, and none of such persons
has a material interest adverse to the Company or any of its subsidiaries. Other than as disclosed below, during the last five years,
none of our directors held any other directorships in any company with a class of securities registered pursuant to Section 12 of the
Securities Exchange Act of 1934, as amended (the &#8220;<b><i>Exchange Act</i></b>&#8221;), or subject to the requirements of Section
15(d) of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Biographical
and other information regarding our director nominees, including the primary skills and experiences considered by our Governance Committee
in determining to recommend them as nominees, is set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAME</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGE</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(as
    of April 21)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POSITION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anupam
    Agarwal</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and VP Finance</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charlotte
    Nangolo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Rankin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Earl Cornett Sr.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sudhindra
    Kankanwadi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1.3in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Roshan
    Pujari</span></td>
    <td style="width: 0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Roshan
                                            Pujari has served as Chairman of the Board and as our Chief Executive Officer since the consummation
                                            of the Business Combination in July 2024. Prior to the Business Combination, Mr. Pujari co-founded
                                            Legacy Stardust Power and served as Chief Executive Officer of Legacy Stardust Power from
                                            its inception in March 2023 until the Business Combination. In his role as Chief Executive
                                            Officer of Stardust Power, he is responsible for developing and executing strategy, operations,
                                            key hires and financing. Mr. Pujari is a highly seasoned chief executive officer. Mr. Pujari
                                            has over 20 years of experience in investments and transactions and has demonstrated expertise
                                            and deep domain knowledge in new company formation and fund raising. He is highly skilled
                                            in dealmaking, identifying niche opportunities and leading them to successful ventures. Prior
                                            to co-founding Legacy Stardust Power, Mr. Pujari founded VIKASA Capital LLC in 2012, which
                                            reorganized as VIKASA Capital Inc. in 2021, a diversified investment firm investing into
                                            global markets and clean energy. Mr. Pujari led the firm&#8217;s clean energy practice until
                                            2023 where he developed a deep understanding of lithium. He is also a philanthropist, having
                                            founded the Pujari Foundation, a 501(c)(3) non-profit organization, to promote the interests
                                            of education, arts, and community around the globe. Mr. Pujari has served on numerous philanthropic
                                            boards and served as a Governor&#8217;s appointee to the Oklahoma Arts Council. He served
                                            as trustee for the Heritage Hall School from 2017 to 2021, his alma mater. Mr. Pujari attended
                                            the University of Redlands in California, where he majored in both History and Government,
                                            and was in the honor society in both majors. Mr. Pujari also has a diploma from Heritage
                                            Hall, Oklahoma, where he was awarded &#8220;Top Speaker&#8221; in the National Tournament
                                            in 1995.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe that Mr. Pujari is qualified to serve on the Board because of his extensive experience in strategic, financial and transaction
    advisory roles, industry knowledge in clean energy as well as his senior leadership experience.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Anupam
    Agarwal</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Anupam
                                            Agarwal has served as a member of the Board and our VP Finance since the consummation of
                                            the Business Combination in July 2024. Prior to the Business Combination, Mr. Agarwal served
                                            as Legacy Stardust Power&#8217;s Senior Director of Finance and Accounts from its inception
                                            in March 2023. He brings over two decades of experience in advising multinational corporations
                                            on strategic matters and assisting organizations in their growth initiatives. Mr. Agarwal
                                            worked for VIKASA Capital Inc., an investment firm, as Director, Finance from 2019 to 2023.
                                            He began his career as a Project Manager at Gammon India, where he served from 2004 to 2007,
                                            executing various infrastructure and renewable projects, and later worked with EY (UAE),
                                            Edelweiss (Investment Banking) and KPMG, advising global clients and government agencies
                                            on due diligence, M&amp;A, fundraising and strategic and deal advisory. While at KPMG, his
                                            notable experiences include advising on project bidding for a large independent power producer
                                            company and providing buy-side advisory services for large transactions, including acquisitions
                                            by large construction companies and airport operators. At Edelweiss, he advised on sell-side
                                            projects for infrastructure transportation and solar engineering, procurement and construction.
                                            Later as an independent advisor, he advised on strategic growth for an educational technology
                                            company and also served as a board advisor to an infrastructure company. Mr. Agarwal holds
                                            a Master&#8217;s in Management Studies (MMS) from Mumbai University.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe that Mr. Agarwal is qualified to serve on the Board because of his extensive experience in infrastructure and renewable projects
    as well as his finance and accounting experience.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Charlotte
    Nangolo</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Charlotte
                                            Nangolo has served as a member of the Board since the consummation of the Business Combination
                                            in July 2024. Ms. Nangolo is a mining engineer with over 20 years of experience in the mining
                                            and metals industry, spanning operations, consulting, business improvement, cost estimation,
                                            and financial modeling of mining projects. She also has financial markets experience as a
                                            mining research analyst, focusing on financial modeling and research. Ms. Nangolo began her
                                            career as a Graduate Mining Engineer/Short Term Planning Engineer at AngloGold Ashanti from
                                            January 2005 to January 2008, followed by her role as a Mining Engineer at Rio Tinto in Australia
                                            from February 2008 to December 2009. She then served as an Associate Lecturer/Postgraduate
                                            Student at the University of the Witwatersrand from January 2010 to June 2011, before joining
                                            XSTRACT Consultants as a Mining Consultant from July 2011 to June 2012. She subsequently
                                            worked as Senior Mining Engineer at SIMEC Mining from June 2012 to April 2016 and as Senior
                                            Mining Engineer at AMC Consultants from February 2018 to September 2020. She then served
                                            as Senior Consultant (Mining) at SRK Consulting from September 2020 to November 2021 and
                                            has been a Senior Consultant (Mining Technical/Corporate) at CSA Global since November 2021,
                                            focusing on critical mineral projects worldwide, particularly lithium. Ms. Nangolo is the
                                            founder of Minerals of Africa Pty Ltd (&#8220;<b><i>MOAPL</i></b>&#8221;), a mining company
                                            focused on exploration activities of critical minerals in Africa, and has served as Founder
                                            &amp; CEO since June 2022. MOAPL is currently focused on lithium in Namibia with a strategy
                                            to expand into West Africa. She has served as an advisory board member to Pamwe Royalties
                                            &amp; Streaming (Pty) Ltd. (&#8220;<b><i>Pamwe</i></b>&#8221;) since October 2021, focusing
                                            on the medium- to small-scale royalty space in the mining industry. Pamwe is Africa&#8217;s
                                            only metals royalty and streaming company headquartered in Namibia. Ms. Nangolo also serves
                                            as an Advisory Board member and Investment Committee member of AFA, a Mauritius-registered
                                            fund focused on Africa&#8217;s mining sector, since January 2025. Ms. Nangolo actively supports
                                            the industry through an informal mentorship program for young mining professionals and mining
                                            students in Africa. She earned her Master of Science and Bachelor of Science degrees in Mining
                                            Engineering and Mineral Economics from the University of the Witwatersrand, South Africa.</p></td></tr>
</table>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 1.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
    believe that Ms. Nangolo is qualified to serve on the Board because of her extensive experience in lithium, mining and mining technology
    as well as financial consulting and research in the mining space.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Mark
    Rankin</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Mark
                                            Rankin has served as a member of the Board since the consummation of the Business Combination
                                            in July 2024. Mr. Rankin currently serves as a part-time Assistant Controller at RKI Energy
                                            Resources, LLC, an oil and natural gas exploration and production company in Oklahoma City,
                                            where he previously worked as the Assistant Controller from June 2017 to December 2021 and
                                            completed project-based work. Prior to RKI he worked at WPX Energy as an Operations Accounting
                                            Manager and at RKI Exploration &amp; Production, LLC in roles ranging from Senior Staff Accountant
                                            to Operations Accounting Manager. Mr. Rankin&#8217;s responsibilities have included financial
                                            statement preparation, income and expense analysis, cost accrual and managing payable/receivable
                                            systems. Additionally, he served as an Accounting Supervisor/Office Manager at I-35 Auto
                                            mall/Dealers Finance, further refining his skills in accounts receivable, payroll and financial
                                            review. Mr. Rankin received his Bachelor of Business Administration in Accounting from Oklahoma
                                            Christian University, where he graduated with honors.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe that Mr. Rankin is qualified to serve on the Board because of his extensive experience in accounting and financial management.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Michael
    Earl Cornett Sr.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Michael
                                            Earl Cornett Sr. has served as a member of the Board since the consummation of the Business
                                            Combination in July 2024. He is a distinguished American public servant and business consultant.
                                            Mr. Cornett has dedicated his life to journalism, education, business and public service.
                                            Starting his professional journey as a journalist, Mr. Cornett worked in the field from 1980
                                            to 1999. After nearly two decades in journalism, he transitioned into academia, serving as
                                            a full-time college professor at the University of Oklahoma from 1999 to 2000. In 1999, Mr.
                                            Cornett founded Mick Cornett Inc., a business consulting firm, where he serves as President.
                                            His commitment to public service is evident through his tenure as a member of the City Council
                                            of Oklahoma City from 2001 to 2004. He was then elected as the Mayor of Oklahoma City, a
                                            position he held from 2004 to 2018. During his time as mayor, Mr. Cornett played a pivotal
                                            role in the city&#8217;s development and transformation, earning recognition for his leadership
                                            and vision. Since 2019, he has been a board member of IBC Bank, and in 2023, he joined the
                                            board of Rees Architecture. Mr. Cornett earned his bachelor&#8217;s degree in journalism
                                            from the University of Oklahoma in 1981 and obtained an MBA from New York University in 2011.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe that Mr. Cornett is qualified to serve on the Board because of his extensive public service and experience in business consulting.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Sudhindra
    Kankanwadi</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Sudhindra
                                            (&#8220;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sujit</i><span style="font-weight: normal">&#8221;)
                                            Kankanwadi has served as a member of the Board since the consummation of the Business Combination
                                            in July 2024. Mr. Kankanwadi has served as Senior Vice President Finance and Chief Accounting
                                            Officer at Synopsys, Inc., an electronic design automation company, since 2015. In his role
                                            at Synopsys, Mr. Kankanwadi has scaled his organization by expanding the shared services
                                            team, implementing new financial technology platforms and leading the digital finance strategy
                                            and implementation for the organization. He was also a member of the AICPA task force for
                                            the software industry, contributing to the development of implementation guides for new revenue
                                            rules. Earlier in his career, Mr. Kankanwadi worked with KPMG, serving various large multinational
                                            companies in the United States and India. He led audit and advisory teams for IPO listings
                                            and spent time at the Global Center developing worldwide audit methodologies. Mr. Kankanwadi
                                            holds a Bachelor of Commerce from Karnataka University and is a Fellow Chartered Accountant,
                                            accredited by the Institute of Chartered Accountants of India. He is also a Certified Public
                                            Accountant (CPA) with an active license from the California Board of Accountancy. He also
                                            serves as a lecturer teaching advanced accounting at the University of California, Santa
                                            Cruz.</span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe that Mr. Kankanwadi is qualified to serve on the Board because of his extensive financial background and advisory experience.</span></p></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
REQUIRED AND RECOMMENDATION OF THE BOARD</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
nominee will be elected as a director at the Meeting if the nominee receives a plurality of the votes cast. This means that the six nominees
receiving the highest number of votes cast &#8220;FOR&#8221; will be elected as directors. Withheld votes and broker non-votes, if any,
will have no effect on the outcome of the election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; ALL THE NOMINEES UNDER PROPOSAL 1.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt"><b>&#160;</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL
    2: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of the Board (the &#8220;<b><i>Audit Committee</i></b>&#8221;) has selected KNAV CPA LLP (&#8220;<b><i>KNAV</i></b>&#8221;)
as our independent registered public accounting firm for the fiscal year ending December 31, 2026 and has further directed that we submit
the selection of the independent registered accounting firm for ratification by our stockholders at the 2026 Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
ratification of the selection of KNAV as the Company&#8217;s independent auditor is not required by law or our bylaws. However, the Audit
Committee considers the selection of our independent registered public accounting firm to be an important matter of stockholder concern
and considers the proposal an opportunity for stockholders to provide direct feedback to the Board on an important issue of corporate
governance. If our stockholders do not ratify this selection, the Audit Committee will reconsider its selection of KNAV. Even if the
selection is ratified, the Audit Committee may, in its sole discretion, determine to appoint a different independent registered public
accounting firm at any time during the year if it determines that such a change would be in our and our stockholders&#8217; best interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNAV
audited Stardust Power&#8217;s consolidated financial statements for the fiscal years ended December 31, 2025 and 2024. We expect representatives
from KNAV to be present at the Meeting. They will have an opportunity to make a statement if they so desire and are expected to be available
to respond to appropriate questions from stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM&#8217;S FEES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the audit fees billed and expected to be billed by KNAV for the indicated fiscal years and the fees billed
by KNAV for all other services rendered during the indicated fiscal years. All fees described below were pre-approved by the Audit Committee
in accordance with the &#8220;Pre-Approval Policies and Procedures&#8221; described below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">FEE
    CATEGORY</span></td><td style="font-weight: bold; text-transform: uppercase; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-transform: uppercase; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Year
                                            Ended</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">December
                                            31, 2025</span></p></td><td style="padding-bottom: 1pt; font-weight: bold; text-transform: uppercase"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-transform: uppercase; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-transform: uppercase; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Year
                                            Ended</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">December
                                            31, 2024</span></p></td><td style="padding-bottom: 1pt; font-weight: bold; text-transform: uppercase"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: normal; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Audit
    Fees<sup>(1)</sup></span></td><td style="width: 2%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: normal; text-align: right"><p style="margin: 0">156,598</p></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,400</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Audit-Related
    Fees<sup>(2)</sup></span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><p style="margin: 0">90,830</p></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,920</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Tax
    Fees</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><p style="margin: 0">-</p></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">All
    Other Fees</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><p style="margin: 0">-</p></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total
    Fees</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><p style="margin: 0">247,428</p></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">73,320</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
                                            fees consist of amounts billed for professional services for audit and quarterly reviews
                                            of our financial statements, and other statutory and regulatory filings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related
                                            fees consist of amounts billed for auditor comfort letters and consents for filing registration
                                            statements.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CHANGE
IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Board approved the dismissal of WithumSmith+Brown, PC (&#8220;<b><i>Withum</i></b>&#8221;) as the Company&#8217;s
independent registered public accounting firm on the recommendation of the Audit Committee. Withum had served as the Company&#8217;s
independent registered public accounting firm since the Business Combination and, prior to the consummation of the Business Combination,
of GPAC II since 2020. Also on September 17, 2024, the Board approved the engagement of KNAV as the Company&#8217;s independent registered
public accounting firm on the recommendation of the Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reports of Withum on GPAC II&#8217;s consolidated financial statements as of and for the fiscal years ended December 31, 2023 and 2022
did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting
principles, with the exception of providing a qualification as to GPAC II&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended December 31, 2023 and 2022 and the subsequent interim period through September 17, 2024, there were no disagreements
with Withum on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which
disagreement(s), if not resolved to the satisfaction of Withum, would have caused it to make reference to the subject matter of the disagreement(s)
in connection with its report. During the fiscal years ended December 31, 2023 and 2022 and the subsequent interim period through September
17, 2024, there were no reportable events of the type described in Item 304(a)(1)(v) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provided Withum with a copy of the disclosures regarding its dismissal reproduced in this Proxy Statement and received a letter
from Withum addressed to the SEC stating that it agreed with the above statements. The letter was filed as Exhibit 16.1 to our Current
Report on Form 8-K filed with the SEC on September 20, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended December 31, 2023 and 2022 and the subsequent interim period through September 17, 2024, neither GPAC II (prior
to the consummation of the Business Combination) nor the Company (after the consummation of the Business Combination) consulted with
KNAV regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of
audit opinion that might be rendered on the Company&#8217;s consolidated financial statements, and neither a written report nor oral
advice was provided that KNAV concluded was an important factor considered by the Company in reaching a decision as to an accounting,
auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv)
of Regulation S-K and its related instructions) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRE-APPROVAL
POLICIES AND PROCEDURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee has established policies and procedures for the pre-approval of permitted services performed by our independent auditor
in compliance with applicable SEC rules and reviews such policies and procedures at least quarterly. Under these procedures, the Audit
Committee must pre-approve all audit and permitted non-audit services (including the fees and terms thereof) to be performed for the
Company by its independent registered public accounting firm, subject to and in accordance with the Exchange Act, and the Audit Committee&#8217;s
pre-approval policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
REQUIRED AND RECOMMENDATION OF THE BOARD</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
requires the affirmative vote of a majority of the votes cast. Abstentions and broker non-votes, if any, will have no effect on the outcome
of the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE RATIFICATION OF THE SELECTION OF KNAV AS THE COMPANY&#8217;S INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL
    3: APPROVAL OF THE ISSUANCE OF SHARES OF COMMON STOCK IN ACCORDANCE WITH NASDAQ LISTING RULES</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more fully described below, we are submitting this Proposal 3 to stockholders in order to obtain stockholder approval under Nasdaq Listing
Rule 5635 for the issuance of shares of our Common Stock pursuant to the transactions contemplated by the Securities Purchase Agreement,
dated December 23, 2025 (the &#8220;<b><i>Stock Purchase Agreement</i></b>&#8221;), with Lind Global Asset Management XIII LLC (&#8220;<b><i>Lind</i></b>&#8221;),
including approval of the issuance of shares of Common Stock (i) upon conversion of one or more senior secured convertible promissory
notes with original principal amount of up to $15 million (the &#8220;<b><i>Convertible Notes</i></b>&#8221;) to be issued pursuant to
the Stock Purchase Agreement (the &#8220;<b><i>Conversion Shares</i></b>&#8221;) and (ii) upon exercise of warrants (&#8220;<b><i>Warrants</i></b>&#8221;)
to be issued pursuant to the Stock Purchase Agreement (the &#8220;<b><i>Warrant Shares</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BACKGROUND
AND SUMMARY OF THE STOCK PURCHASE AGREEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed in our Current Report on Form 8-K, filed December 31, 2025, we entered into the Stock Purchase Agreement with Lind.
An initial closing occurred on December 23, 2025, as a result of which an initial tranche of Convertible Notes were issued with a principal
amount of $4.8 million and Warrants were issued for the purchase of approximately 411,245 Warrant Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Stock Purchase Agreement provides for additional issuances of Convertible Notes and Warrants, subject to closing conditions. The proceeds
of the financing can be used for general corporate purposes and for certain early design and engineering services, infrastructure improvement,
procurement activities and other expenses for our project in Muskogee, Oklahoma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHY
WE NEED STOCKHOLDER APPROVAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on Nasdaq, and as a result, we are subject to Nasdaq&#8217;s Listing Rules. We are seeking stockholder approval
to comply with Nasdaq Listing Rule 5635 and to satisfy our obligations under the Stock Purchase Agreement, the Convertible Notes and
the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rule
5635(d)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
Listing Rule 5635(d) requires stockholder approval prior to the issuance of securities in connection with a transaction, other than a
public offering, involving the sale, issuance or potential issuance by us of Common Stock (or securities convertible into or exercisable
or exchangeable for our Common Stock, such as the Convertible Notes and Warrants) equal to 20% or more of our Common Stock or voting
power outstanding before the issuance, unless sold at a price equal to or greater than the Minimum Price (as defined in the Rule).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Stock Purchase Agreement provides for the issuance of Convertible Notes with an aggregate principal amount of up to $15 million. The
principal amount of each Convertible Note, along with all interest and other amounts that come due under such Convertible Notes, may
be converted by the holder currently at a conversion price of $5.837 per share (subject to adjustment as provided in the Convertible
Notes).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we decide to prepay any Convertible Notes, the holder will have the right to convert up to one-third of the amounts owing
under such note at the lower of the (i) conversion price and (ii) 90% of the average of the daily volume-weighted stock price for our
Common Stock, over a consecutive five-day period selected by the holder of the Convertible Note from within the 20 trading days prior
to the issuance of such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Assuming the issuance of $15
million of Convertible Notes, the payment of all interest in shares through maturity and conversion of the Convertible Notes at
maturity, we estimate that 2,700,000 shares of common stock would be issuable under the arrangement. In addition, in such
circumstances we would issue warrants for the purchase of up to 1,592,000 shares of common stock, assuming a volume-weighted stock
price of $5.84. We will be obligated to issue additional shares of our common stock upon the occurrence of certain events, including
if we incur late payment fees or early payment fees.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Stock Purchase Agreement, each time we issue Convertible Notes to Lind, we also will issue Lind with warrants for the purchase of
a number of shares equal to 35% of the dollar amount funded under the Convertible Notes divided by the volume-weighted stock price of
our Common Stock on the day prior to the applicable issuance date. The exercise price for each share of Common Stock under the warrants
will be $5.837 per share (subject to adjustment as provided in the Warrants).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Approval
Requested</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of Common Stock issuable in these transactions may exceed 20% or more of the shares of our Common Stock that were outstanding
prior to signing the Stock Purchase Agreement. As a result, the Company is seeking stockholder approval of the issuances for purposes
of complying with Nasdaq Rule 5635(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rule
5635(b)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
Listing Rule 5635(b) requires us to obtain stockholder approval prior to an issuance of securities when such issuance would result in
a change of control. Pursuant to applicable Nasdaq guidance, a change of control may generally be deemed to occur when an investor or
a group would own or have the right to acquire 20% or more of the outstanding shares of Common Stock or voting power and such ownership
or voting power would be the largest ownership position of the issuer. However, in determining if a change of control has occurred (and
stockholder approval is required), Nasdaq will consider all circumstances concerning the transaction and may determine that a change
of control has occurred even if the number of shares of Common Stock or voting power that an investor or a group has a right to acquire
is less than 20%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the terms of the Convertible Notes and Warrants contemplate that the holder cannot convert the Convertible Notes or exercise the Warrants
if, as a result, they would own in excess of 4.99% of our Common Stock or, in certain cases, 9.99% of our Common Stock, we cannot be
certain that Nasdaq will calculate beneficial ownership in the same manner contemplated by the transaction documents or this limitation
could be waived by us in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we do not know whether one or more of the issuances of Common Stock contemplated by the Stock Purchase Agreement may be deemed to be
a change in control under Nasdaq Listing Rule 5635(b), the Company is seeking stockholder approval for purposes of complying with Nasdaq
Rule 5635(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSEQUENCES
OF NOT APPROVING THIS PROPOSAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is not seeking the approval of our stockholders to authorize our entry into the Stock Purchase Agreement. The Stock Purchase Agreement
has already been executed. However, the Company has agreed to seek the stockholder approval contemplated by this Proposal 3 within one
year of the issuance date of the Convertible Notes. If stockholder approval is not obtained, the Company may be limited in its ability
to issue stock pursuant to the Convertible Notes or Warrants and may be required to use cash to pay obligations due under the Convertible
Notes or Warrants. Using cash to fulfill such obligations could adversely impair our liquidity and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we cannot obtain stockholder approval of this Proposal 3, we may be unable to borrow additional amounts under the Stock
Purchase Agreement, even in circumstances where such exercise would benefit us or our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REASONS
FOR TRANSACTION AND POTENTIAL EFFECTS ON CURRENT STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of our entry into the Stock Purchase Agreement, our Board determined that the Stock Purchase Agreement was in the best interests
of the Company and its stockholders. We are seeking approval of the transactions so that we can secure prior and future funding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock issued pursuant to the transactions contemplated by the Stock Purchase Agreement will have the same rights and privileges
as the shares of our currently authorized and outstanding Common Stock. The issuance of such shares will not affect the rights of the
holders of our outstanding Common Stock, but such issuances will have a dilutive effect on the existing stockholders, including on the
voting power and economic rights of the existing stockholders, and may result in a decline in the price of our Common Stock or in greater
price volatility. If our stockholders approve Proposal 3, such shares, if issued, could constitute 20% or more of our outstanding shares
of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ADDITIONAL
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Stock Purchase Agreement is attached hereto as <span style="text-decoration: underline">Appendix A</span>, the form of Senior Secured
Convertible Promissory Note is attached hereto as <span style="text-decoration: underline">Appendix B</span> and the form of warrant
is attached hereto as <span style="text-decoration: underline">Appendix C</span>. The above summaries of each of these documents are
qualified in their entirety by reference to the full text of such documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
REQUIRED AND RECOMMENDATION OF THE BOARD</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
requires the affirmative vote of a majority of the votes cast. Abstentions and broker non-votes, if any, will have no effect on the outcome
of the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE ISSUANCE OF SHARES OF COMMON STOCK IN ACCORDANCE WITH NASDAQ LISTING
RULES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
4: APPROVAL OF AN AMENDMENT OF THE COMPANY&#8217;S CERTIFICATE OF INCORPORATION TO CLARIFY THE DIRECTOR REMOVAL PROVISION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are submitting to our stockholders a vote to adopt an amendment of our current Certificate of Incorporation, as amended (the &#8220;<b><i>Certificate</i></b>&#8221;),
to update the director removal provision in Article V, Section 4 to clarify that directors may be removed with or without cause (the
&#8220;<b><i>Certificate Amendment</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUMMARY
OF THE CERTIFICATE AMENDMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the proposed Certificate Amendment, which is qualified in its entirety by reference to the full text of the
Certificate Amendment, as set forth in <span style="text-decoration: underline">Appendix D</span> (with additions shown as double underlined
and deletions shown as struck through).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate currently provides that, subject to the rights of any preferred stockholders, directors may only be removed from office for
cause and by the affirmative vote of the holders of at least two-thirds (2/3) of the voting power of the then-outstanding shares of capital
stock of the Company entitled to vote generally in the election of directors voting together as a single class. The Board has approved
and declared advisable the Certificate Amendment, subject to its approval by stockholders at the Meeting, which would update this provision
solely to clarify that directors may be removed from office either with or without cause. The provision would otherwise remain unchanged,
and director removal would continue to require a supermajority stockholder vote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the Certificate Amendment is in the best interests of the Company and its stockholders as it removes a legacy provision
that was adopted prior to the Board&#8217;s declassification. As the Board became declassified in April 2025 when we ceased to be a controlled
company under Nasdaq rules, with all directors now serving for one-year terms and standing for election annually, this provision is no
longer applicable per the Delaware General Corporation Law. If our stockholders do not approve the Certificate Amendment, Article V,
Section 4 would remain unchanged; however, the enforceability of such a provision is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
approved by stockholders, the Certificate Amendment will become effective upon filing of such Amendment with the Secretary of State of
the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
REQUIRED AND RECOMMENDATION OF THE BOARD</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has unanimously approved the Certificate Amendment. As such, approval of this proposal requires the affirmative vote of at least
a majority of the shares of Common Stock outstanding. Abstentions and broker non-votes, if any, will have the same effect as a vote &#8220;AGAINST&#8221;
the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; AN AMENDMENT TO THE COMPANY&#8217;S CERTIFICATE OF INCORPORATION TO CLARIFY
THE DIRECTOR REMOVAL PROVISION.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
5: APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY&#8217;S 2024 EQUITY INCENTIVE PLAN</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A&amp;R
2024 Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is seeking stockholder approval of amending and restating the Stardust Power Inc. 2024 Equity Incentive Plan (as amended, the
&#8220;<b><i>A&amp;R 2024 Plan</i></b>&#8221;). The only changes proposed in the A&amp;R 2024 Plan are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorizing
                                            2,600,000 additional shares for issuance under the A&amp;R 2024 Plan; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extending
                                            the term of the A&amp;R 2024 Plan.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, the Board adopted, and the stockholders of the Company approved, the Stardust Power Inc. 2024
Equity Incentive Plan (the &#8220;<b><i>2024 Plan</i></b>&#8221;) in September 2024. The Board adopted the A&amp;R 2024 Plan on April
8, 2026 to further the Company&#8217;s goal of attracting, incentivizing and retaining top talent and continuing to offer our key personnel
compensation opportunities that are market competitive. If stockholders do not approve the A&amp;R 2024 Plan, we will continue to grant
equity incentive awards under the existing share reserve under the 2024 Plan until it expires or there is no remaining capacity left
under such plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that equity-based compensation plans, such as the A&amp;R 2024 Plan, benefit the interests of our stockholders by effectively
linking employee compensation to the performance of the stock price of our Common Stock. Approval of the A&amp;R 2024 Plan will enable
the Compensation Committee to design and implement compensation programs that retain our key employees, compensate those employees based
on the performance of the Company and other individual performance factors, and enhance stockholder alignment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on current projections, the Company will not have sufficient share capacity under the 2024 Plan to continue granting equity incentive
compensation awards through 2026, and the Board and the Compensation Committee wish to ensure that there is sufficient capacity available
to make grants in subsequent years as well as any necessary off-cycle grants without any delay. If the A&amp;R 2024 Plan is not approved
and we are not able to make equity grants in subsequent years, we will be at a significant disadvantage in attracting and retaining talented
employees, consultants and non-employee directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our stockholders approve the A&amp;R 2024 Plan, we will file with the SEC a registration statement on Form S-8, as soon as reasonably
practicable after the approval, to register the shares available for issuance under the A&amp;R 2024 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 7, 2026:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">There were 9,996,218 shares
    issued and outstanding.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">There were no outstanding stock
    options. </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">There was a total of 21,742
    shares of restricted stock outstanding, 117,860 RSUs outstanding and 50,658 PSUs outstanding (assuming maximum level of performance
    payout).</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">There was a total of 74,550
    shares available for future awards under the 2024 Plan. As described more fully below, upon approval of the A&amp;R 2024 Plan, we
    will have 2,674,550 shares in the aggregate available for grant under the A&amp;R 2024 Plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">On
April 8, 2026, the closing price of the stock price of our Common Stock as reported on the Nasdaq Capital Market was $2.78 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Summary
of the A&amp;R 2024 Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of the A&amp;R 2024 Plan is not intended to be complete and is qualified in its entirety by the complete text of
the A&amp;R 2024 Plan, a copy of which is attached as <span style="text-decoration: underline">Appendix E</span> to this Proxy Statement.
Stockholders are urged to read the A&amp;R 2024 Plan in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
A&amp;R 2024 Plan provides for the grant of incentive stock options (&#8220;<b><i>ISOs</i></b>&#8221;), within the meaning of Section
422 of the Internal Revenue Code (the &#8220;<b><i>Code</i></b>&#8221;), to employees, including employees of any parent or subsidiary,
and for the grant of non statutory share options (&#8220;<b><i>NSOs</i></b>&#8221;), share appreciation rights (&#8220;<b><i>SARs</i></b>&#8221;),
restricted shares, restricted share units (&#8220;<b><i>RSUs</i></b>&#8221;), other share and cash-based awards (including performance
awards), and dividend equivalents (collectively, the &#8220;<b><i>Awards</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility</i>.
Any individual who is an employee of the Company or any of its affiliates, or any person who provides services to the Company or its
affiliates, including consultants and members of the Board (other than consultants whose services are provided in connection with the
offer or sale of securities in a capital-raising transaction or who promote or maintain a market for the Company&#8217;s securities),
is eligible to receive awards under the A&amp;R 2024 Plan at the discretion of the plan administrator, as defined below. If this proposal
is approved by the stockholders, then all of the Company&#8217;s employees, directors and permitted consultants will be eligible to receive
awards as of our 2026 Annual Meeting. As of our 2026 Annual Meeting, the Company is expected to have approximately 12 employees, 4 non-employee
directors, and 3 consultants who may be eligible to receive awards under the A&amp;R 2024 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Employee
Director Compensation Limits</i>. The fair value of any awards granted under the A&amp;R 2024 Plan to a non-employee director as compensation
for services on the Board, during any one fiscal year, taken together with any cash fees paid to such non-employee director during such
period in respect of the non-employee director&#8217;s services as a member of the Board during such year, may not exceed $750,000, provided
that the Board can make exceptions to this limit so long as the applicable non-employee director does not participate in the decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Authorized
Shares</i>. The maximum number of shares of Common Stock that may be issued under the A&amp;R 2024 Plan is equal to 3,799,526 shares
(the &#8220;<b><i>Share Pool</i></b>&#8221;), representing the initial share reserve and subsequent automatic increases on January 1,
2025 and January 1, 2026, in each case, adjusted to reflect the 1-for-10 reverse stock split, and the additional shares of 2,600,000
being requested hereunder. The Share Pool will be automatically increased on each January 1 through January 1, 2034 in an amount equal
to 5% of the total number of shares of Common Stock outstanding on December 31 of the immediately preceding fiscal year. The maximum
number of shares of Common Stock that may be issued on the exercise of ISOs under the A&amp;R 2024 Plan is equal to 3,799,526.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
shares of Common Stock subject to an Award that are forfeited, cancelled, exchanged or surrendered, or if an Award otherwise terminates
or expires without a distribution of such shares or is settled in cash, shares of Common Stock with respect to such Awards shall again
be available for grant under the A&amp;R 2024 Plan. Shares of Common Stock used to pay the exercise price of an Award or to satisfy the
tax withholding obligations related to an Award will become available for future grant or sale under the A&amp;R 2024 Plan. Further,
Awards issued under the A&amp;R 2024 Plan in connection with a corporate transaction in substitution for outstanding equity awards issued
by another company or entity will not result in reducing the number of shares available for issuance under the A&amp;R 2024 Plan, except
as otherwise required by the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
Administration</i>. A committee of the Board duly authorized by the Board, or if no such committee, the Board, will administer the A&amp;R
2024 Plan and is referred to as the &#8220;plan administrator&#8221; herein. Under the A&amp;R 2024 Plan, the plan administrator has
broad authority, subject to the provisions of the A&amp;R 2024 Plan, to administer and interpret the A&amp;R 2024 Plan and Awards granted
thereunder. The Board may delegate to a committee of one or more directors or one or more officers of the Company the authority to grant
or amend awards or to take other administrative actions, provided that in no event shall an officer of the Company be delegated the authority
to grant awards to, or amend awards held by, the following individuals: (i) individuals who are subject to Section 16 of the Exchange
Act; or (ii) officers of the Company (or directors) to whom authority to grant or amend awards has been delegated under the A&amp;R 2024
Plan. The plan administrator may set restrictions on the delegation and may rescind the authority delegated at any time or may appoint
a new delegate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Types
of Awards</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Options</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
ISOs and NSOs are granted under award agreements adopted by the plan administrator. The plan administrator determines the exercise price
for share options, within the terms and conditions of the A&amp;R 2024 Plan, but, for ISOs, the exercise shall not be less than 100%
of the fair market value of a share of Common Stock on the grant date (or 110% of fair market value if the optionholder is a 10% stockholder).
Share options granted under the A&amp;R 2024 Plan vest at the rate specified in the award agreement as determined by the plan administrator.
The plan administrator determines the term of share options granted under the A&amp;R 2024 Plan, up to a maximum of ten years (or, in
the case of an ISO granted to a 10% stockholder, five years). Share options may be exercised in whole or in part by giving written notice
of exercise under the A&amp;R 2024 Plan and the award agreement, and by complying with other required deliverables thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SARs</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
SARs generally entitle the holder, upon exercise, to receive payment in an amount determined by multiplying (i) the excess of the fair
market value of a share of Common Stock on the date of exercise over the exercise price established for such SAR on its grant date, by
(ii) the number of shares as to which such SAR is being exercised. SARs are granted under award agreements adopted by the plan administrator.
The plan administrator determines the exercise price for a SAR. A SAR granted under the A&amp;R 2024 Plan vests at the rate specified
in the award agreement as determined by the plan administrator. SARs may be settled in cash or shares of Common Stock or in some combination
thereof, as determined by the plan administrator and specified in the award agreement. The grant price of a SAR cannot be less than 100%
of the fair market value of a share of Common Stock on the date on which the SAR is granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Share Awards</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Restricted shares are granted under award agreements adopted by the plan administrator. The plan administrator determines the terms and
conditions of restricted share awards, including vesting and forfeiture terms. Unless the plan administrator determines otherwise, the
Company will hold restricted shares in escrow until the restrictions on such restricted shares have lapsed. Unless otherwise determined
by the plan administrator and specified in the applicable award agreement, the holder of a restricted share award has rights as a shareholder,
including the right to vote the shares of Common Stock subject to the restricted share award or to receive dividends on the shares of
Common Stock subject to the restricted share award during the restriction period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Share Unit Awards</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
RSUs are granted under award agreements adopted by the plan administrator. The plan administrator determines the terms and conditions
of RSUs, including vesting and forfeiture terms. RSUs may be settled in cash, by delivery of shares of Common Stock, by a combination
of cash and shares of Common Stock as determined by the plan administrator, or in any other form of consideration set forth in the award
agreement. The plan administrator may determine that a grant of RSUs will provide a participant a right to receive dividend equivalents,
which entitles the participant to receive the equivalent value (in cash or shares of Common Stock) of dividends paid on the underlying
shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Share-Based Awards</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
In addition to the Awards described above, the plan administrator may issue other forms of awards that may be denominated or payable
in shares of Common Stock. Subject to the provisions of the A&amp;R 2024 Plan, the plan administrator may determine the individuals to
whom, and the times at which, such other share-based awards shall be granted, the number of shares to be granted pursuant to such other
share-based awards, the manner in which such other share-based awards shall be settled (e.g., in shares, cash or other property), the
conditions to the vesting and/or payment of such other share-based awards, and all other terms and conditions of such other share-based
awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Cash-Based Awards</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
The plan administrator may grant Awards that are denominated in or payable solely in cash, subject to the terms, conditions, restrictions
and limitations determined by the plan administrator, in its sole discretion. Cash-based awards may be granted on a free-standing basis
or as an element of, a supplement to, or in lieu of any other award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Equivalents</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
The plan administrator may, in its sole discretion, grant dividend equivalents, which represent the right to receive the value of dividends,
if any, paid by in respect of the number of shares of Common Stock underlying an Award, under the A&amp;R 2024 Plan, either alone or
in tandem with another Award. Dividend equivalents with respect to an award that are based on dividends paid prior to the vesting of
the award will only be paid to the participant to the extent that the vesting or performance conditions for such award are satisfied.
Dividend equivalent rights may be settled in cash, shares or other property, or a combination thereof as determined by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Substitute
Awards</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Awards may be granted under the A&amp;R 2024 Plan in substitution for similar awards held for individuals who become participants as
a result of a merger, consolidation or acquisition of another entity by or with Stardust Power or one of its affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
to Capital Structure</i>. In the event there is a specified type of change in the capital structure of the Company, such as a stock split,
reverse stock split or recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange
of shares or other securities of the Company, or another equity restructuring or change in the corporate structure of the Company affecting
shares occurs, the plan administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to
be made available under the A&amp;R 2024 Plan, shall make appropriate adjustments to (i) the class and maximum number of shares reserved
for issuance under the A&amp;R 2024 Plan, (ii) the number and grant or exercise price of shares covered by each outstanding share award,
and (iii) the terms and conditions of any outstanding share awards (including, without limitation, any applicable performance criteria
and performance goals with respect thereto).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in Control</i>. In the event of a change in control (as defined under the A&amp;R 2024 Plan), an outstanding award will be treated as
the plan administrator determines in its sole discretion, which may include having the successor entity assume or substitute for the
award, terminating the award, accelerating the vesting of or waiving restrictions on the award in whole or in part (including deeming
any performance targets to have been achieved at the greater of actual performance or target levels), terminating the award in exchange
for cash and/or property, or any combination of permissible actions. In taking such actions, the plan administrator is not obligated
to treat all awards similarly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dissolution
or Liquidation</i>. In the event that the Company winds up, dissolves or liquidates, the plan administrator will notify each participant
of such proposed transaction. To the extent that an award has not been previously exercised, the award will terminate immediately prior
to the consummation of such proposed action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i>.
Unless the plan administrator provides otherwise, share options generally are not transferable except by will or the laws of descent
and distribution. Subject to approval of the plan administrator or a duly authorized officer, an option may be transferred pursuant to
a domestic relations order. Otherwise, until an Award has been exercised or the underlying shares have been issued, no Award under the
A&amp;R 2024 Plan may be transferred, except as provided in an award agreement or with prior written consent of the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clawback</i>.
Awards under the A&amp;R 2024 Plan are subject to the recoupment in accordance with any clawback policy adopted by the Company, including
the Clawback Policy (or any successor clawback policy adopted by the Company) to the extent applicable to the participant and the award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
Amendment or Termination</i>. The Board has the authority to amend, suspend or terminate the A&amp;R 2024 Plan at any time, provided
that such action does not impair the existing rights of any award recipient without such recipient&#8217;s written consent, unless otherwise
permitted by the terms of the A&amp;R 2024 Plan. Certain material amendments also require approval of the Company&#8217;s stockholders.
No share Awards may be granted under the A&amp;R 2024 Plan while it is suspended or after it is terminated. Also, no Awards may be granted
after April 8, 2036.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
U.S. Federal Income Tax Considerations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the U.S. federal income tax treatment applicable to the Company and the participants who receive Awards under
the A&amp;R 2024 Plan based on the federal income tax laws in effect on the date of this Proxy Statement. This summary is not intended
to be exhaustive and does not address all matters relevant to a particular participant based on their specific circumstances. The summary
expressly does not discuss the income tax laws of any state, municipality, or non-U.S. taxing jurisdiction, or the gift, estate, excise
(including the rules applicable to deferred compensation under Section 409A of the Code), or tax laws other than U.S. federal income
tax law. Because individual circumstances may vary, each participant is urged to consult their own tax advisor concerning the tax implications
of Awards granted under the A&amp;R 2024 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Incentive
Stock Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
granted under the A&amp;R 2024 Plan may be either incentive stock options, which are intended to satisfy the requirements of Section
422 of the Code, or non-qualified stock options, which are not intended to meet such requirements. No taxable income is recognized by
the optionee at the time of the option grant, and no taxable income is recognized for ordinary income tax purposes at the time the option
is exercised, although taxable income may arise at that time for alternative minimum tax purposes. Unless there is a &#8220;disqualifying
disposition&#8221;, as described below, the optionee will recognize long-term capital gain in an amount equal to the excess of (i) the
amount realized upon the sale or other disposition of the purchased shares over (ii) the exercise price paid for the shares. A disqualifying
disposition occurs if the disposition is less than two years after the date of grant or less than one year after the exercise date. If
there is a disqualifying disposition of the shares, then the excess of (i) the fair market value of those shares on the exercise date
or (if less) the amount realized upon such sale or disposition over (ii) the exercise price paid for the shares will be taxable as ordinary
income to the optionee. Any additional gain or loss recognized upon the disposition will be a capital gain or loss. If the optionee makes
a disqualifying disposition of the purchased shares, then the Company will be entitled to an income tax deduction for the taxable year
in which such disposition occurs equal to the amount of ordinary income recognized by the optionee as a result of the disposition. The
Company will not be entitled to any income tax deduction if the optionee makes a qualifying disposition of the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nonqualified
Stock Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
taxable income is recognized by an optionee upon the grant of a non-qualified stock option. The optionee in general will recognize ordinary
income, in the year in which the option is exercised, equal to the excess of the fair market value of the purchased shares on the exercise
date over the exercise price paid for the shares, and the optionee will be required to satisfy the tax withholding requirements applicable
to such income. The Company will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the optionee
with respect to the exercised non-qualified stock option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
taxable income is recognized upon receipt of a SAR. The participant will recognize ordinary income in the year in which the SAR is exercised,
in an amount equal to the excess of the fair market value of the underlying shares of Common Stock on the exercise date over the base
price in effect for the exercised right, and the participant will be required to satisfy the tax withholding requirements applicable
to such income. The Company will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant
in connection with the exercise of the SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant who receives unvested shares of Common Stock will not recognize any taxable income at the time those shares are granted but
will have to report as ordinary income, as and when those shares subsequently vest, an amount equal to the excess of (i) the fair market
value of the shares on the vesting date over (ii) the cash consideration (if any) paid for the shares. The participant may, however,
elect under Section 83(b) of the Code to include as ordinary income in the year the unvested shares are issued an amount equal to the
excess of (a) the fair market value of those shares on the issue date over (b) the cash consideration (if any) paid for such shares.
If the Section 83(b) election is made, the participant will not recognize any additional income as and when the shares subsequently vest.
The Company will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant at the time
such ordinary income is recognized by the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Share Units, Other Share-Based Awards, Other Cash-Based Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
no taxable income is recognized upon the grant of RSUs, other share-based awards or other cash-based awards. The participant will recognize
ordinary income in the year in which the award is settled in shares or cash. The amount of that income will be equal to the fair market
value of the shares on the date of issuance or the amount of the cash paid in settlement of the award, and the participant will be required
to satisfy the tax withholding requirements applicable to the income. The Company will be entitled to an income tax deduction equal to
the amount of ordinary income recognized by the participant at the time the shares are issued or the cash amount is paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deductibility
of Executive Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
162(m) of the Code limits the deductibility for federal income tax purposes of certain compensation paid to any &#8220;covered employee&#8221;
in excess of $1 million. It is expected that compensation deductions for any covered employee with respect to awards granted under the
A&amp;R 2024 Plan will be subject to the $1 million annual deduction limitation. The administrator of the A&amp;R 2024 Plan may grant
Awards under the A&amp;R 2024 Plan or otherwise that are or may become non-deductible when it believes doing so is in the best interests
of the Company and its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
Plan Benefits Under the A&amp;R 2024 Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described above, the selection of participants who will receive Awards under the A&amp;R 2024 Plan and the size and types of Awards will
be determined by the Compensation Committee in its discretion. As such, the number or value of Awards that will be granted under the
A&amp;R 2024 following the Meeting is not yet determinable, and it is not possible to predict the benefits or amounts that will be received
by, or allocated to, particular individuals or groups of employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Awards
Granted Under the 2024 Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Awards made under the 2024 Plan prior to the date of the Meeting were granted subject to stockholder approval of the A&amp;R 2024 Plan.
The following table sets forth information with respect to Awards that have been granted under the 2024 Plan to the named executive
officers (&#8220;<b><i>NEOs</i></b>&#8221;), the director nominees, recipients of more than 5% of all awards under the 2024 Plan, and the specified
groups set forth below as of April 7, 2026 (even if not currently outstanding), with the PSUs based on achievement of target performance.
No associates of any director, executive officer or director nominee have received any Awards under the 2024 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name &amp; Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number
    of Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number
    of RSUs and PSUs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari, <i>Chief Executive Officer</i></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">304,379</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pablo
    Cortegoso, <i>Chief Technical Officer</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,723</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris
    Edward Celano, <i>Chief Operating Officer</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">132,507</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All current executive officers as a group (5 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">820,557</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Anupam Agarwal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,138</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Charlotte Nangolo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mark Rankin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael Earl Cornett Sr.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sudhindra Kankanwadi</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All current directors who are not executive officers (5 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,906</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">All employees, including all current officers who are not executive
    officers, as a group (6 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">104,419</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VOTE
REQUIRED AND RECOMMENDATION OF THE BOARD</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
requires the affirmative vote of a majority of the votes cast. Abstentions and broker non-votes, if any, will have no effect on the outcome
of the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE AMENDMENT AND RESTATEMENT OF THE COMPANY&#8217;S 2024 EQUITY INCENTIVE
PLAN.</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOARD
    MATTERS AND CORPORATE GOVERNANCE</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOARD
AND STOCKHOLDER MEETINGS AND ATTENDANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has responsibility for managing the business and affairs of the Company. The primary responsibility of the Board is to oversee
the management of the Company and, in doing so, serve the best interests of the Company and its stockholders. The entire Board selects,
evaluates and provides for the succession of executive officers and, subject to stockholder election, directors. It reviews and approves
corporate objectives and strategies and evaluates significant policies and proposed major commitments of corporate resources. The Board
also participates in decisions that have a potential major economic impact on the Company. Management keeps the directors informed of
Company activity through regular communication, including written reports and presentations at Board and committee meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2025, the Board met eight times, the Audit Committee met seven times, the Governance Committee met four times and the Compensation Committee
of the Board (the &#8220;<b><i>Compensation Committee</i></b>&#8221;) met four times. All of our directors then-serving on the Board
attended 75% or more of the total number of meetings of the Board and meetings of any committee of the Board on which such director served
during the period in which he or she was on the Board or committee. Directors are expected to attend annual meetings of stockholders.
All of our directors then serving on the Board attended the 2025 Annual Meeting of Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOARD
COMPOSITION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
listing rules require that a majority of the members of the Board be independent. Under the rules of the Nasdaq, a director will only
qualify as an &#8220;independent director&#8221; if, in the opinion of that company&#8217;s board of directors, that person does not
have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.
Based on information requested from and provided by each director concerning his or her background, employment and affiliations, including
family relationships, the Board has determined that each of Ms. Nangolo, Mr. Cornett, Mr. Kankanwadi and Mr. Rankin are &#8220;independent&#8221;
as that term is defined under the Nasdaq listing rules. Former director Mr. Martyn Buttenshaw was &#8220;independent&#8221; under the
Nasdaq listing rules during the period he served on our Board. In addition, there are no family relationships among any of our directors
or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Time Commitments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
Board members benefit from service on the boards of other companies and such service is encouraged, under the Board&#8217;s Corporate
Governance Guidelines, directors are expected to limit the number of other boards on which they serve so as not to interfere with their
service as a director of the Company. In this regard, the Company has adopted specific limits on the number of other public company boards
upon which a director may sit. Ordinarily, directors may not serve on the boards of more than four public companies and the CEO and directors
who are executive officers of public companies may not serve on the board of more than three public companies. As part of the annual
director nomination process, the Governance Committee considers directors&#8217; adherence to these expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has established three standing committees - the Audit Committee, the Compensation Committee and the Governance Committee - each
of which operates under a written charter that has been approved by our Board. The following table provides information regarding the
current membership for each of the committees of the Board:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAME</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 34%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">POSITION</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT
    COMMITTEE</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPENSATION
    COMMITTEE</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GOVERNANCE
    COMMITTEE</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Roshan
    Pujari</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Chairman
    of the Board and Chief Executive Officer </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Charlotte
    Nangolo</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Independent
    Director</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">*</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">*</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Michael
    Earl Cornett Sr.</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Independent
    Director</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">C</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Sudhindra
    Kankanwadi</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Independent
    Director</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">C</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Anupam
    Agarwal</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Director
    and VP Finance </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Mark
    Rankin</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Independent
    Director</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">*</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">C</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C
    = Chair</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
    = Member</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
Committee</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee consists of Mr. Kankanwadi, Ms. Nangolo and Mr. Rankin, with Mr. Kankanwadi serving as Chair of the Audit Committee.
Each member of the Audit Committee: (i) is independent under the Nasdaq listing rules, (ii) satisfies the additional independence criteria
applicable to directors on such committee under the Nasdaq listing rules and the established by the SEC and (iii) is financially literate
under Nasdaq listing rules. In addition, the Board has determined that Mr. Kankanwadi qualifies as an &#8220;audit committee financial
expert&#8221; as defined in applicable SEC rules. The Audit Committee&#8217;s primary responsibility is to oversee the Company&#8217;s
accounting and financial reporting practices and the audits of the Company on behalf of the Board and report the results of its activities
to the Board. The Audit Committee&#8217;s other responsibilities include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing,
                                            compensating, retaining, evaluating, terminating and overseeing the Company&#8217;s independent
                                            accountants;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving
                                            all audit and permitted non-audit services (including the fees and terms thereof) to be performed
                                            by the Company&#8217;s independent accountants;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing the quality and integrity of the Company&#8217;s financial statements and
                                            accounting and financial reporting with the Company&#8217;s management and independent accountants;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            any significant issues that arise regarding the Company&#8217;s financial statements with
                                            the full Board;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
                                            with management and the independent accountants the adequacy and effectiveness of the Company&#8217;s
                                            accounting and financial controls, including the Company&#8217;s system to monitor financial
                                            risk, and its legal and ethical compliance programs;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            procedures for the receipt, retention and treatment of complaints and concerns received by
                                            the Company regarding accounting, internal accounting controls or auditing or related matters
                                            and the confidential, anonymous submission by employees of the Company of concerns regarding
                                            questionable accounting or auditing matters;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preparing
                                            the audit committee report included in the Company&#8217;s annual proxy statement and any
                                            other reports or disclosures required by the rules of the SEC;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing the functions of the Company&#8217;s internal audit department with the independent
                                            accountants and approving said functions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
                                            approving and overseeing related party transactions; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually
                                            reviewing and evaluating the performance of the Audit Committee and periodically reviewing
                                            the adequacy of the Audit Committee&#8217;s charter.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose and responsibilities of our Audit Committee are set forth in the Audit Committee Charter, which is available on the Company&#8217;s
website at <i>https://investors.stardust-power.com/corporate-governance/governance-overview</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Report
of the Audit Committee of the Board of Directors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee oversees the Company&#8217;s financial reporting process on behalf of our Board. Management has the primary responsibility
for the financial statements and the reporting process, including the systems of internal controls. In fulfilling its oversight responsibilities,
the Audit Committee reviewed and discussed the audited financial statements for the year ended December 31, 2025 with management and
the Company&#8217;s independent registered public accounting firm, including a discussion of any significant changes in the selection
or application of accounting principles, the reasonableness of significant judgments, the clarity of disclosures in the financial statements
and the effect of any new accounting pronouncements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee discussed with the Company&#8217;s independent registered public accounting firm, which is responsible for expressing
opinions on the conformity of the Company&#8217;s audited financial statements with generally accepted accounting principles, its judgments
as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to
be discussed under the applicable requirements of the Public Company Accounting Oversight Board (&#8220;<b><i>PCAOB</i></b>&#8221;) and
the SEC. In addition, the Audit Committee has discussed with the Company&#8217;s independent registered public accounting firm its independence
from management and the Company, has received from the Company&#8217;s independent registered public accounting firm the written disclosures
and the letter required by applicable requirements of the PCAOB regarding the independent registered public accounting firm&#8217;s communications
with the Audit Committee concerning independence and has considered the compatibility of non-audit services with the auditor&#8217;s
independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee met with the Company&#8217;s independent registered public accounting firm to discuss the overall scope of its services,
the results of its audit and reviews and the overall quality of the Company&#8217;s financial reporting. The Company&#8217;s independent
registered public accounting firm also periodically updates the Audit Committee about new accounting developments and their potential
impact on the Company&#8217;s reporting. The Audit Committee&#8217;s meetings with the Company&#8217;s independent registered public
accounting firm were held both with and without management present. The Audit Committee relies, without independent verification, on
the accuracy and integrity of the information provided and representations made by management and the Company&#8217;s independent registered
public accounting firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the audited financial statements
of the Company be included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 for filing with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Respectfully
submitted,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of the Board of Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sudhindra
Kankanwadi (Chair)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charlotte
Nangolo</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
Rankin</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
report of the Audit Committee is not &#8220;soliciting material,&#8221; shall not be deemed &#8220;filed&#8221; with the SEC and shall
not be incorporated by reference by any general statement incorporating by reference this Proxy Statement into any filing under the Securities
Act of 1933, as amended (the &#8220;<b>Securities Act</b>&#8221;), or the Exchange Act whether made before or after the date hereof and
irrespective of any general incorporation language in any such filing, except to the extent that we specifically incorporate this information
by reference.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
Committee</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee currently consists of Mr. Rankin and Ms. Nangolo, with Mr. Rankin serving as Chair of the Compensation Committee.
Each member of the Compensation Committee (i) qualifies as an independent director under the Nasdaq listing rules, (ii) satisfies the
additional independence criteria applicable to directors on such committee under Nasdaq listing rules and the rules established by the
SEC and (iii) qualifies as a &#8220;non-employee director&#8221; as defined in Rule 16b-3 promulgated under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee reviews and approves, or recommends that our Board approve, the compensation of the Company&#8217;s Chief Executive
Officer, reviews and recommends to the Board the compensation of the Company&#8217;s non-employee directors, reviews and approves, or
recommends that the Board approve, the terms and compensatory arrangements of the Company&#8217;s executive officers, administers the
Company&#8217;s incentive compensation and benefit plans, and assesses whether any of the Company&#8217;s compensation policies and programs
has the potential to encourage excessive risk-taking.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may form and delegate authority to subcommittees from time to time as it sees fit, provided that the subcommittees
are composed entirely of directors who satisfy the applicable independence requirements of the Exchange Act, the Company&#8217;s corporate
governance guidelines and the Nasdaq listing rules. The Compensation Committee also may, at its sole discretion, retain a compensation
consultant, independent legal counsel or other advisors to assist the Compensation Committee in its responsibilities. The Chair of the
Compensation Committee may request that any officer, employee or advisor of the Company attend a meeting of the Compensation Committee
or otherwise respond to Compensation Committee requests. However, the Compensation Committee meets regularly without such individuals
present, and the CEO and other executive officers may not be present at meetings of the Compensation Committee at which their compensation
or performance is discussed or determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose and responsibilities of our Compensation Committee are set forth in the Compensation Committee Charter, which is available on
the Company&#8217;s website at <i>https://investors.stardust-power.com/corporate-governance/governance-overview</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
Committee Interlocks and Insider Participation.</i> None of the members of our Compensation Committee has at any time during the prior
three years been one of our officers or employees. None of our executive officers currently serves, or in the past fiscal year has served,
as a member of the board or compensation committee of any entity that has one or more executive officers serving on our Board or Compensation
Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">Governance
Committee</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Governance Committee currently consists of Mr. Cornett and Mr. Kankanwadi, with Mr. Cornett serving as Chair of the Governance Committee.
Each member of the Governance Committee qualifies as an independent director under the Nasdaq listing rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Governance Committee identifies, evaluates and recommends qualified nominees to serve on the Board, considers and makes recommendations
to the Board regarding the composition of the Board and its committees, oversees the Company&#8217;s internal corporate governance processes,
maintains a management succession plan and oversees an annual evaluation of the Board&#8217;s performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose and responsibilities of our Governance Committee are set forth in the Governance Committee Charter, which is available on the
Company&#8217;s website at <i>https://investors.stardust-power.com/corporate-governance/governance-overview</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOARD
LEADERSHIP STRUCTURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a policy regarding whether the role of the Chairperson of the Board and Chief Executive Officer should be separate or combined,
and the Board maintains the flexibility to select the Chairperson of the Board and Chief Executive Officer and reorganize the leadership
structure, from time to time, based on criteria that are in the best interests of the Company and its stockholders. Our Board believes
that there is no single, generally accepted board leadership structure that is appropriate across all circumstances, and that the right
structure may vary as circumstances change. As such, the Board periodically reviews its leadership structure to evaluate whether the
structure remains appropriate for the Company, and may modify this structure from time to time as and when appropriate to best address
the Company&#8217;s unique circumstances and advance the best interests of all stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
our Chief Executive Officer, Roshan Pujari, also serves as Chairman of the Board. The Board believes that Mr. Pujari&#8217;s familiarity
with the Company and extensive knowledge of the metals and mining industry qualify him to serve as the Chairman of the Board and that
combining the roles of Chief Executive Officer and Chairman of the Board enables Mr. Pujari to drive strategy and agenda setting at the
Board level while maintaining responsibility for executing on that strategy by also serving as Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that the Board may, in its discretion, elect a lead independent director from among its members. The independent directors
currently have not selected a lead independent director. The independent directors have the opportunity to meet in executive sessions
without management present at every regular Board meeting and at such other times as may be determined appropriate. The purpose of these
executive sessions is to encourage and enhance communication among the independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that its programs for overseeing risk, as described under &#8220;Board&#8217;s Role in Risk Management,&#8221; would be
effective under a variety of leadership frameworks. Accordingly, the Board&#8217;s risk oversight function did not significantly impact
its selection of the current leadership structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOARD&#8217;S
ROLE IN RISK MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote
a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses strategic
and operational risks at regular management meetings and conducts specific strategic planning and review sessions during the year that
include focused discussions and analysis of the risks facing us. Our Board does not have a standing risk management committee, but rather
administers this oversight function directly through the Board as a whole, as well as through the committees of the Board that oversee
risks inherent in their respective areas of oversight. Our management is responsible for day-to-day management of risk. The Board regularly
discusses with management our major risk exposures, their potential impact on our business and the steps we take to manage them. Through
the risk oversight process, the Board receives regular reports from Board committees and members of senior management to enable it to
understand the Company&#8217;s risk identification, risk management and risk mitigation strategies with respect to areas of potential
material risk, including commodity price, global demand, insurance and strategic risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee oversees the Company&#8217;s major financial and compliance risks. As part of this process, the Audit Committee regularly
reviews the adequacy and effectiveness of the Company&#8217;s accounting financial controls and reviews recommendations for the improvement
of internal control procedures or particular areas where new or more detailed controls or procedures could be desirable. The Audit Committee
also reviews any significant deficiencies or material weaknesses in internal control over financial reporting that could adversely affect
the Company&#8217;s ability to report accurate financial information. The Audit Committee also considers and approves or disapproves
any related party transactions when required under the Company&#8217;s policy regarding related party transactions. Periodically, the
Audit Committee reviews our policies with respect to risk assessment, risk management and regulatory compliance. Oversight by the Audit
Committee includes direct communication with our external auditors and discussions with management regarding significant risk exposures
and the actions management has taken to limit, monitor or control such exposures. The Compensation Committee assesses the material risks
associated with our executive compensation structure, policies and programs to determine whether they encourage excessive risk-taking
and to evaluate compensation policies and practices that could mitigate such risks. The Governance Committee oversees risks related to
our corporate governance practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has delegated the primary responsibility of overseeing cybersecurity risks to the Audit Committee. The Audit Committee receives
periodic updates on cybersecurity, including prompt notification of any material cybersecurity events, information technology matters
and related risk exposures, from management. The Board also receives updates from management and the Audit Committee on cybersecurity
risks. Our Chief Financial Officer plays the primary role in informing the Audit Committee about cybersecurity risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board is regularly
informed through committee reports and by members of our management team about such risks. Matters of significant strategic risk and
enterprise-wide risk exposures are considered by our Board as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMUNICATIONS
WITH OUR BOARD OF DIRECTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
and other interested parties may communicate with the Board, any individual member or our independent directors, by sending a letter
to Stardust Power Inc., c/o Bruce Czachor, Secretary, Stardust Power Inc., 15 E. Putnam Ave., Suite 378, Greenwich, CT 06830, and specifying
to whom the correspondence should be directed. All communications should include (i) the address, telephone number and e-mail address
(if any) of the person submitting the communication&#894; (ii) if the person submitting the communication is a stockholder, a statement
of the number of shares of our Common Stock that the person holds&#894; (iii) if the person submitting the communication is not a stockholder,
the nature of the person&#8217;s interest in the Company&#894; (iv) any special interest of the person submitting the communication in
the subject matter of the communication&#894; and (v) whether the communication is directed to the Board as a whole or to a specific
director or our independent directors (and, if so, the name or names of such director(s)). The Secretary will review all correspondence
and regularly forward to the Board (or a specified director(s), as applicable) copies of all correspondence (together with a summary
thereof) that, in the opinion of the Secretary, relates to the functions of the Board or its committees or that otherwise requires the
attention of any member or committee of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
enable the Company to speak with a single voice, as a general matter, senior management serves as the primary spokesperson for the Company
and is responsible for communicating with various constituencies, including stockholders, on behalf of the Company. Directors may participate
in discussions with stockholders and other constituencies on issues where Board-level involvement is appropriate. In addition, the Board
is kept informed by senior management of the Company&#8217;s stockholder engagement efforts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CORPORATE
GOVERNANCE GUIDELINES AND CODE OF BUSINESS CONDUCT AND ETHICS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted Corporate Governance Guidelines that address items such as the qualifications and responsibilities of our directors and
director candidates, limits on outside board membership by our directors and corporate governance policies and standards applicable to
us in general. In addition, we have adopted a Code of Business Conduct and Ethics that establishes the standards of ethical conduct applicable
to all of our directors, officers, employees, independent contractors and consultants. It addresses, among other matters, compliance
with laws and policies, conflicts of interest, corporate opportunities, regulatory reporting, external communications, confidentiality
requirements, insider trading, proper use of assets and how to report compliance concerns. Our Corporate Governance Guidelines and Code
of Business Conduct and Ethics are each available on our website at <i>https://investors.stardust-power.com/corporate-governance/governance-overview</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CLAWBACK
POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Section 10D-1 of the Exchange Act and the requirements of Nasdaq Listing Standard 5608 implementing Rule 10D-1, the Board
has adopted a Clawback Policy. The Clawback Policy applies to individuals who are or were formerly designated as &#8220;officers&#8221;
of the Company under Section 16 of the Exchange Act and is administered by the Compensation Committee. In the event the Company is required
to prepare an accounting restatement to correct material noncompliance with any financial reporting requirement under U.S. federal securities
laws, including restatements that correct an error in previously issued financial statements that is material to the previously issued
financial statements or that would result in a material misstatement if the error were corrected in the current period or left uncorrected
in the current period, it is our policy to recover erroneously awarded incentive-based compensation received by the Company&#8217;s executive
officers. The recovery of such compensation applies regardless of whether an executive officer engaged in misconduct or otherwise caused
or contributed to the requirement for a restatement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INSIDER
TRADING POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted an <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_" id="xdx_902_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20250101__20251231_zS7gtFQNlyHi"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000012" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">Insider
Trading Policy</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">governing the purchase,
sale and other transactions in Company securities by the Company&#8217;s directors, officers and employees, as well as certain contractors
and consultants, that we believe are reasonably designed to promote compliance with insider trading laws, rules and regulations and Nasdaq
listing rules. The Insider Trading Policy prohibits certain transactions, such as hedging or monetization transactions or similar arrangements
with respect to the Company&#8217;s securities that hedge or offset, or are designed to hedge or offset, any decrease in the market value
of the Company&#8217;s securities. It also prohibits (a) short-term trading, (b) short sales and (c) transactions involving publicly
traded options or other derivatives, such as trading in puts or calls with respect to Company securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, from time to time, the Company may engage in transactions in its own securities, including share issuances and repurchases.
The Company&#8217;s practices with respect to share issuances and repurchases, which are overseen by the Finance and Legal Departments
(and, if appropriate, approved by the Board or appropriate committee), are designed to promote compliance with applicable insider trading
and other securities laws, rules, regulations and listing standards. Transactions pursuant to equity-based compensation arrangements
are conducted in accordance with the terms of the plans and agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
                                            COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify">During
2025, the Company provided non-employee members of the Board with the following cash retainers; however, Ms. Nangolo does not receive
the annual cash retainer:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: justify">Annual Cash Retainer:</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">25,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify">Audit Committee Retainers:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify; padding-left: 12.65pt">Chair</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify; padding-left: 12.65pt">Non-Chair Member</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,500</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify">Compensation Committee Retainers:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify; padding-left: 12.65pt">Chair</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,500</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify; padding-left: 12.65pt">Non-Chair Member</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">5,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify">Governance Committee Retainers:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: justify; padding-left: 12.65pt">Chair</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,500</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: justify; padding-left: 12.65pt">Non-Chair Member</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">5,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in">The
Company also generally reimburses non-employee directors for reasonable and necessary out-of-pocket expenses incurred in connection with
attending Board and committee meetings or performing other services in their capacities as non-employee directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following
table sets forth information regarding the compensation awarded to, earned by, or paid to our non-employee directors who served on the
Board for the fiscal year ended December 31, 2025. Roshan Pujari, our CEO, who served on the Board as Chairman during 2025, did not receive additional compensation for such service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees Earned or Paid in Cash ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-Equity Incentive Plan Compensation
    ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other Compensation ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Sudhindra Kankanwadi</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">40,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">40,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Mark Rankin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Michael Earl Cornett Sr.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Charlotte Nangolo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martyn Buttenshaw<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anupam Agarwal</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,489</td><td style="text-align: left"><sup>(2)</sup>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,000</td><td style="text-align: left"><sup>(3)</sup>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: right">177,489</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Buttenshaw resigned from the Board in June 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    amount represents Mr. Agarwal&#8217;s incentive bonus earned, which was paid on March 20, 2026 in
    11,220 fully vested RSUs that will be settled in shares of Common Stock of the Company within 60 days, with a grant date value calculated
    in accordance with Topic 718 based on the closing price of the Common Stock on the date of grant ($2.45).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Agarwal is a consultant of the Company, and thus, does not receive additional compensation for his 2025-2026 board service. This
    amount represents Mr. Agarwal&#8217;s consulting fees, which are paid on his behalf to Peregrine Advisory Partners LLP.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 30.95pt; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE
    COMPENSATION AND OTHER INFORMATION </span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the names, ages and positions of Stardust Power&#8217;s executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAME</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGE</span></p>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">(as
    of April 21)</span></p></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 57%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">POSITION</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Roshan
    Pujari</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">48</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Chairman
    of the Board and Chief Executive Officer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Pablo
    Cortegoso</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">43</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Chief
    Technical Officer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Udaychandra
    Devasper</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">44</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Chief
    Financial Officer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Chris
    Edward Celano</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">56</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Chief
    Operating Officer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Bruce
    Czachor</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">64</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">General
    Counsel, Chief Compliance Officer and Secretary</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below are brief descriptions of the background and business experience of our executive officers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Roshan
Pujari</i></b> is our Chairman of the Board and Chief Executive Officer. A description of Mr. Pujari&#8217;s background and business
experience is provided under &#8220;Proposal 1: Election of Directors.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pablo
Cortegoso</i></b> has served as the Chief Technical Officer of Stardust Power since February 2024. In this role, he is responsible for
all operations aspects of exploration, mining, extraction and production. Mr. Cortegoso has over 13 years of experience in civil and
mining projects, specializing in lithium projects. His skills include the development of hydrogeological field programs, with an emphasis
on lithium brine deposits, including well designs, packer testing, aquifer tests, brine standards preparation, sampling protocols and
drilling oversight, with expertise in solar pond evaporation design, modeling and operation for lithium and potassium brine projects.
He has extensive experience in performing fatal flaw analysis; risk and investment analysis; technical due diligence, including on battery
metals; design and implementation of field programs; data collection and analysis for hydrogeological and geotechnical studies; and completing
technical reports (Mineral Resource and Reserve Statements, PEA, PFS, FS) in accordance with international guidelines for lithium brine
and hard rock projects throughout Argentina, Australia, Brazil, Bolivia, Canada, Chile, Mexico, the United States, Europe, the United
Kingdom and Botswana. Prior to co-founding Stardust Power, from April 2023 to February 2024, Mr. Cortegoso was engaged in independent
consulting through his wholly owned company, Florentino Energy LLC, where he advised clients on lithium and mining projects, including
technical due diligence, project evaluation, and development strategy. Prior to this, he served at Aurora Lithium (Galp/Northvolt), a
lithium refining project, as Vice President, Sourcing, in Lisbon, Portugal from April 2022 to March 2023, where he was responsible for
identifying, evaluating and advancing lithium raw material supply opportunities for the company&#8217;s refining strategy. Prior to Aurora
Lithium, he served at SRK Consulting (U.S.), Inc., a consulting firm, in various positions including as Senior Consultant from January
2018 to February 2022, and as Consultant from September 2010 to December 2017. Prior to SRK, he served at Trine University as a Graduate
Researcher and Teaching Assistant from August 2009 to May 2010. Prior to Trine University, Mr. Cortegoso served at Jose Cartellone Construcciones
Civiles, in Buenos Aires, Argentina as a Management and Budget Control Analyst in 2007. He is a published author in prestigious industry
magazines and has presented in conferences and workshops globally in his field of expertise on lithium. Mr. Cortegoso has industry affiliations,
including as a Registered Member of the Society for Mining, Metallurgy, and Exploration, Inc.; a Qualified Person under the guidelines
of National Instrument 43-101 in Canada; and a Competent Person in accordance with the JORC Code in Australia. Mr. Cortegoso earned his
master&#8217;s degree in civil engineering from Trine University, and an undergraduate degree in civil engineering from the Universidad
Nacional de Cuyo in Argentina.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Udaychandra
Devasper</i></b> has served as the Chief Financial Officer of Stardust Power since December 2023. In this role, Mr. Devasper is responsible
for leading and developing the finance and accounting functions of the Company, as well as assisting the Chief Executive Officer in executing
strategy, operations, key hires and financing functions. He is a highly seasoned finance professional, with over 20 years of experience
in finance and accounting and has demonstrated expertise and deep domain knowledge in leading projects and assisting companies through
multiple transactions. Mr. Devasper&#8217;s skills include building and managing large teams; operational and technical accounting expertise
in key accounting areas such as revenues, mergers and acquisitions; and end-to-end project management for de-SPAC and IPO transactions.
Prior to joining Stardust Power, Mr. Devasper was part of the initial founding team as a partner at Effectus Group, LLC, a boutique national
accounting advisory firm, where he was involved in developing the business, hiring and resource management, as well as leading the firm&#8217;s
nationwide Technology practice (which included the clean energy industry) for all technical accounting and strategic projects, from October
2014 to September 2022. During his time at Effectus, he gained domain, industry and transactional expertise through the multiple projects
he led for companies in the cleantech, renewable energy and alternative energy sectors. Further, during his term at Effectus, Mr. Devasper
led multiple de-SPAC/IPO transactions in the cleantech and renewable energy sectors, including end-to-end project management and overall
reporting assistance. Prior to his term at Effectus, Mr. Devasper served as a Director, Technical Accounting at Echelon Corporation from
July 2012 to August 2014, and as a Senior Manager, Technical Accounting at Synopsys, Inc., from March 2011 to July 2012. Prior to Echelon
and Synopsys, he worked in the public accounting sector at KPMG LLP, progressing to Senior Manager, Assurance. Mr. Devasper is a licensed
CPA (inactive) in California, and a licensed Chartered Accountant from the Institute of Chartered Accountants of India. He earned his
bachelor&#8217;s degree in commerce from Mumbai University in India.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Chris
Edward Celano </i></b>has served as the Chief Operating Officer of Stardust Power since January 2025. In this role, Mr. Celano oversees
the Company&#8217;s upstream lithium supply initiatives and processing operations, including sourcing and site development. He plays
a key role in driving the Company&#8217;s operational efficiency, advancing the timely delivery of high-quality lithium products and
strengthening relationships with customers and stakeholders. His deep experience in renewables, cleantech and drilling will be pivotal
to the Company&#8217;s long-term success as it works to meet growing demand for critical minerals. Mr. Celano brings over 20 years of
executive leadership experience, combining a strong background as a Chief Executive Officer, practicing securities attorney and graduate
of the Massachusetts Institute of Technology. His diverse expertise spans the energy sector, drilling, engineering, procurement and construction
fields, along with deep legal knowledge, from which he is uniquely equipped to drive Stardust Power&#8217;s strategic and operational
goals during this critical phase of the Company&#8217;s growth. Prior to joining Stardust Power, he served as President and Chief Executive
Officer of IHI E&amp;C International Corporation, an engineering and construction company, beginning in January 2017, prior to which
he served as General Counsel and Senior Vice President of Business Administration beginning in February 2013. Prior to his time at IHI,
Mr. Celano served as Vice President and General Counsel at Vantage Drilling Company from May 2008 to May 2011. He started his career
at the law firms Olshan Frome Wolosky LLP, Graham &amp; James LLP and Elenoff Grossman &amp; Schole LLP. Mr. Celano has a bachelor&#8217;s
degree in economics from Vanderbilt University, a J.D. from Boston College Law School, an LLM from New York University School of Law
and a master&#8217;s degree in engineering from the Massachusetts Institute of Technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bruce
Czachor </i></b>has served as the General Counsel, Chief Compliance Officer and Secretary of Stardust Power since January 2026. In this
role, Mr. Czachor is responsible for leading and developing the legal and compliance functions of the Company, as well as assisting the
Chief Executive Officer in executing strategy, operations and key hires. He brings over 35 years of legal and corporate experience, and
has served in executive and legal leadership roles at public companies and international law firms. Prior to joining Stardust Power,
Mr. Czachor served as Executive Vice President &#8211; Chief Legal Officer and Secretary of Piedmont Lithium Inc., a U.S. public mining
and chemical company, and its predecessor Australian company since December 2018. Prior to that, he served as a partner and associate
in major international law firms in New York, Toronto, and Silicon Valley from 1988 through 2017. Mr. Czachor holds a Juris Doctorate
degree from New York Law School, and a Bachelor of Arts degree in Political Science from Binghamton University. Mr. Czachor is also a
director of Vinland Lithium Inc., a public company listed on the TSXV under the symbol &#8220;VLD&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OVERVIEW</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently considered an &#8220;emerging growth company&#8221; within the meaning of the Securities Act for purposes of the SEC&#8217;s
executive compensation disclosure rules. Accordingly, we are required to provide a Summary Compensation Table and an Outstanding Equity
Awards at Fiscal Year End Table, as well as limited narrative disclosures regarding executive compensation for our last completed fiscal
year. Further, our reporting obligations extend only to &#8220;named executive officers,&#8221; who are the individuals who served as
our principal executive officers and the next two most highly compensated executive officers at the end of the most recent fiscal year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari, Chairman of the Board and Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pablo
    Cortegoso, Chief Technical Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris
    Edward Celano, Chief Operating Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUMMARY
COMPENSATION TABLE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the compensation of the Company&#8217;s named executive officers for the years ended
December 31, 2025, and December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Name
    and Principal Position</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Salary
    ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Bonus
    ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    Awards<sup>(1)</sup> ($)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity
    Incentive Plan Compensation<sup>(2)</sup> ($)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Other Compensation<sup>(3)</sup> ($)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Roshan Pujari</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">647,452</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">595,637</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,243,146</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief
    Executive Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">437,423</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,621,597</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">650,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,525</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,723,545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pablo
    Cortegoso</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">498,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">57</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">819,135</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief
    Technical Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">442,033</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,513,504</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">306,967</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">121</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,312,625</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris
    Edward Celano<sup>(4)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">349,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">192,748</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">224,508</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">766,882</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief
    Operating Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27.35pt; padding: 0pt; text-align: justify; text-indent: -9.35pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27.35pt; padding: 0pt; text-align: justify; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
  required by applicable SEC rules, this column reflects the aggregate grant date fair value of time-based RSUs, fully vested shares
  of Common Stock and performance stock units (&#8220;<b><i>PSUs</i></b>&#8221;) granted to our named executive officers in the applicable
  year under the 2024 Plan, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic
  718 (&#8220;<b><i>Topic 718</i></b>&#8221;). The grant date fair value of the PSUs was based on the probable outcome of the applicable
  performance conditions as of the date of grant. For a discussion of the assumptions that we used to value the time-based RSUs and PSUs
  for financial accounting purposes, please refer to &#8220;Note 8&#8221; in the notes to our consolidated financial statements contained
  in our Annual Report on Form 10-K for the year ended December 31, 2025.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts reported for
  the year 2025 represent incentive bonuses earned pursuant to our 2025 bonus plan, which were paid on March 20, 2026 in fully vested
  RSUs that will be settled in shares of Common Stock of the Company within 60 days, in each case, with a grant date value
  equal to the amount shown for each NEO calculated in accordance with Topic 718 based on the closing price of the Common Stock on the
  date of grant ($2.45). For more information, see &#8220;Narrative Disclosure to Summary Compensation Table&#8212;Executive Short-Term
  Incentive Bonus Plan&#8221; below.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
  payment by the Company of life insurance premiums for executive officers.</span></td></tr>

<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
  Celano began his employment in January 2025.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27pt; padding: 0pt; text-align: justify; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NARRATIVE
DISCLOSURE TO SUMMARY COMPENSATION TABLE</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has implemented an executive compensation program that is designed to align the executive officer&#8217;s compensation with the
Company&#8217;s business objectives and the creation of stockholder value, while enabling the Company to attract, retain, incentivize
and reward individuals who contribute to the long-term success of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">Employment
Agreement with Roshan Pujari</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2023, the Company entered into an At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement
with Roshan Pujari, its Chief Executive Officer (the &#8220;<b><i>Pujari Agreement</i></b>&#8221;), which provided for at-will employment,
an initial annual base salary and participation in benefits programs available to U.S. employees as provided from time to time. Effective
September 16, 2024, the Company and Mr. Pujari entered into an employment addendum agreement to the Pujari Agreement which provides for
an annual base salary of $650,000, of which up to $100,000 may be payable in fully vested RSUs issued under the 2024 Plan solely at the
option of the Company. The Pujari Agreement also contains a customary confidentiality clause, a conflict-of-interest provision, a non-compete
provision and one-year post-termination non-solicitation clauses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">Employment
Agreement with Pablo Cortegoso</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2024, the Company entered into an At-Will, Employment, Confidential Information, Invention Assignment and Arbitration Agreement
with Pablo Cortegoso, its Chief Technical Officer (the &#8220;<b><i>Cortegoso Agreement</i></b>&#8221;). Details of the Cortegoso Agreement
are as follows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Salary.
    </i>Mr. Cortegoso&#8217;s annual base salary is $500,000, with a one-time sign on bonus of $50,000, which was paid in 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Benefits</i>.
    Mr. Cortegoso is participating in all retirement and welfare benefit plans, programs, arrangements and receives other benefits that
    are customarily available to senior executives of the Company, as these plans exist and become adopted, subject to eligibility requirements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cortegoso Agreement also contains a customary confidentiality clause, a conflict-of-interest provision, a noncompete provision and one-year
post termination non-solicitation clauses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">Employment
Agreement with Chris Celano</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2025, Stardust Power entered into an At-Will, Employment, Confidential Information, Invention Assignment and Arbitration Agreement
with Chris Celano, its Chief Operating Officer (the &#8220;<b><i>Celano Agreement</i></b>&#8221;). Details of the Celano Agreement are
as follows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Salary.
    </i>Mr. Celano&#8217;s annual base salary is $350,000.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Benefits</i>.
    Mr. Celano is participating in all retirement and welfare benefit plans, programs, arrangements and receives other benefits that
    are customarily available to senior executives of the Company, as these plans exist and become adopted, subject to eligibility requirements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Celano Agreement also contains a customary confidentiality clause, a conflict of interest provision, a noncompete provision and one-year
post termination non-solicitation clauses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Short-Term Incentive Bonus Plan</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted a short-term annual incentive bonus plan for its executive officers. The executive officers are eligible to receive
annual bonuses based on the executive officers&#8217; achievement of key performance indicators (&#8220;<b><i>KPI</i></b>&#8221;). The
participant&#8217;s target award is a percentage of such participant&#8217;s annual base salary as of the end of the performance period
as detailed in the table below. To be eligible to receive a bonus under the anticipated executive incentive bonus plan, a participant
must be employed by the Company on the date the bonus is paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NAME</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TARGET
                                            BONUS </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%
                                            OF BASE SALARY)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Roshan Pujari</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pablo Cortegoso</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">70</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chris Edward Celano</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">70</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">For
2025, the Compensation Committee determined that each named executive officer was entitled to the annual bonuses set forth below based
on achievement of the following KPI: (i) for Mr. Pujari, overall leadership of the Company, investor outreach and capital raising efforts,
as well as engagement in strategic transaction discussions and government affairs initiatives, (ii) for Mr. Cortegoso, delivering potential
feed stock options and exploration of partnerships with various Direct Lithium Extraction technology providers, and (iii) for Mr. Celano,
completion of the front end loading &#8211; 3 (FEL-3) study, securing necessary construction permits and drafting of EPC contracts. The
earned bonuses were settled in a number of fully vested RSUs calculated based on a five-day volume-weighted average price of the Common
Stock, as set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NAME</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2025
    SHORT-TERM INCENTIVE BONUS</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2025
    BONUS RSUs</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Roshan Pujari</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 34%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">650,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">243,117</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pablo Cortegoso</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">350,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">130,909</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chris Edward Celano</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">245,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">91,636</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
Incentive Awards</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2025, in connection with his appointment, Mr. Celano was granted 2,000 shares of Common Stock and 38,871 RSUs (in each case,
adjusted to reflect the 1-for-10 reverse stock split on September 8, 2025) under the 2024 Plan. The RSUs vest as to 25% on March 15,
2026 and quarterly over three years following March 31, 2026, subject to the applicable named executive officer&#8217;s continued employment.
In the event of a change in control, all then-unvested RSUs will accelerate and become vested as set forth in detail in the &#8220;Potential
Payments Upon Termination or Change in Control&#8221; section below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OUTSTANDING
EQUITY AWARDS AT 2025 FISCAL YEAR-END</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the outstanding RSU and PSU awards held by the named executive officers as of December
31, 2025. The amount set forth below reflect the Company&#8217;s 1-for-10 reverse stock split on September 8, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Stock
    Awards</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>or
                                            Units of Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>That
                                            Have Not</b></span></p>
                                                                   <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
                                            Value of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
                                            or Units</b></span></p>
                                                                                                                                                                                                                                                                                                         <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
                                            That</b></span></p>
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Have
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
                                            Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
                                            Incentive </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
                                            Awards: </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unearned
                                            Shares, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units
                                            or Other </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights
                                            That Have </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
                                            Vested (#)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive
                                            Plan </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards:
                                            Market </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                            Payout Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Unearned </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares,
                                            Units, or </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
                                            Rights </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>That
                                            Have Not </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Roshan
    Pujari</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,869</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,679</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,631</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(2)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">93,731</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pablo Cortegoso</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,811</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,722</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,246</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,233</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Chris Edward Celano</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">38,871</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(3)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">118,945</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    RSUs approved and granted by the Board on September 16, 2024. The RSUs vest quarterly over three years following the date of grant,
    subject to the named executive officer&#8217;s continued employment. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    PSU represents a contingent right to receive one share of Common Stock upon the named executive officer&#8217;s continued employment
    until the third anniversary of the date of grant, subject to the Common Stock achieving a $120.00 volume weighted average price for
    a period of 20 trading days during any 30 trading day period during the three year vesting period ending on September 15, 2027.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%
    of the RSUs vested on March 15, 2026 and the remaining RSUs vest quarterly over three years following March 31, 2026, subject to
    the named executive officer&#8217;s continued employment.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; padding: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL
NARRATIVE DISCLOSURE</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retirement
Plans</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stardust
Power sponsors a Section 401(k) retirement plan (the &#8220;<b><i>401(k) Plan</i></b>&#8221;), that provides eligible employees, including
our named executive officers, with an opportunity to save for retirement on a tax-advantaged basis. U.S. employees who have attained
at least 18 years of age are generally eligible to participate in the 401(k) Plan as of the first day of the calendar month. Participants
may make pre-tax or post-tax contributions to the 401(k) Plan, subject to the statutorily prescribed annual limits on contributions under
the Code. Currently, the Company does not make any matching contributions to participants&#8217; contributions to the 401(k) Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
Payments Upon Termination or Change in Control</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
named executive officers are not entitled to receive any potential payments upon termination of employment. The RSU and PSU award agreements,
as applicable, for each named executive officer provide that, upon a change in control, all outstanding RSUs and PSUs will accelerate
and become vested in full. Upon a change in control occurring on December 31, 2025, each of the named executive officers would have been
entitled to full vesting acceleration of their then-unvested RSUs and PSUs, which would be valued at $148,410 for Mr. Pujari, $39,955
for Mr. Cortegoso and $118,945 for Mr. Celano, based upon the closing price of our Common Stock as of December 31, 2025 ($3.06 per share).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Practices
on Timing of Equity Awards</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p id="xdx_98A_eecd--AwardTmgMnpiDiscTextBlock_c20250101__20251231_zEAAIsbDbKv" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000013" name="ecd:AwardTmgMnpiDiscTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any program, plan or obligation that requires us to grant equity awards on specified dates. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20250101__20251231_zTx7MiLM4c7g" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000014" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock">We
also do <span id="xdx_908_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_z76eRhlGWiV8" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000015" name="ecd:AwardTmgMnpiCnsdrdFlag">no</ix:nonNumeric></span>t
have any program, plan or practice to time award dates of stock option grants to our executive officers in coordination with the release
of material nonpublic information and typically aim to make equity grants during an open trading window.</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
awards may occasionally be granted following a significant change in job responsibilities or to meet special retention or performance
objectives. During 2025, we did </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eecd--MnpiDiscTimedForCompValFlag_dbF_c20250101__20251231_zUHKmKOhzhKj" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000016" name="ecd:MnpiDiscTimedForCompValFlag">no</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t
time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation, and no stock
options were granted to any named executive officer.</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Equity
Compensation PLAN INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information about the Common Stock that may be issued under the Company&#8217;s equity compensation plans
as of December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN
    CATEGORY</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NUMBER
    OF SECURITIES TO BE ISSUED UPON EXERCISE OF OUTSTANDING OPTIONS, WARRANTS AND RIGHTS<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WEIGHTED-AVERAGE
    PRICE OF SECURITIES TO BE ISSUED UPON EXERCISE OF OUTSTANDING OPTIONS, WARRANTS AND RIGHTS<sup>(2)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NUMBER
    OF SECURITIES REMAINING AVAILABLE FOR FUTURE ISSUANCE UNDER EQUITY COMPENSATION PLANS<sup>(3)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plans approved by stockholders</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><p style="margin: 0">194,366</p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><p style="margin: 0">263,126</p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plans not approved by stockholders</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">194,366</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">263,126</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    outstanding RSUs and PSUs granted under the 2024 Plan and outstanding RSUs under the 2023 equity incentive plan.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
    and PSUs reflected in column (A) are not included in this column as they do not have an exercise price.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    the shares of Common Stock available for issuance under the 2024 Plan. The number of shares of Common Stock available for issuance
    under the 2024 Plan will be subject to an annual increase on the first day of each fiscal year of the Company in an amount equal
    to 5% of the number of outstanding shares on the last day of the immediately preceding fiscal year. Accordingly, on January 1, 2026,
    the number of shares of Common Stock available for issuance under the 2024 Plan was increased by 493,478 shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; padding: 0pt; text-align: left; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; padding: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<div style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY
                                            OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the beneficial ownership of shares of our Common Stock as of April 1, 2026 (except as
otherwise indicated in the footnotes to the table) by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person and entity known by us as of such date to be a beneficial owner of more than 5% of our Common Stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors and nominees;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our named executive officers; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our current executive officers and directors as a group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security
if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently
exercisable or exercisable within 60 days as of the date of the table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
table is based upon information supplied by officers, directors, and principal stockholders and Schedules 13G or 13D filed with the SEC.
Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, we believe that all
persons and entities named in the table have sole voting and investment power with respect to all shares of our Common Stock beneficially
owned by them (plus any shares that such person or entity has the right to acquire within 60 days after the date of this table). Applicable
percentages are based on 9,966,473 shares of Common Stock issued and outstanding as of April 1, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Name
    and Address of Beneficial Owners</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of Shares of</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Common
                                            Stock</span></p></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ownership
    Percentage</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Five
    percent holders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entities
    affiliated with Endurance Antarctica Partners II, LLC<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">563,054</span></td><td style="width: 1%; text-align: left"/><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><p style="margin: 0">5.39</p></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari<sup>(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,330,357</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">23.38</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pablo Cortegoso</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">626,916</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">6.29</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors
    and named executive officers</i></b><sup>(3)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari<sup>(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,330,357</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">23.38</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Pablo Cortegoso</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">626,916</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">6.29</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chris Edward Celano</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">99,209</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right">1.00</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mark Rankin</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,941</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sudhindra Kankanwadi</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">942</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Michael Earl Cornett
    Sr.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">942</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Anupam Agarwal</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,171</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Charlotte Nangolo</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,002</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    directors and executive officers as a group (10 individuals)</b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,493,321</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">34.51</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; padding: 0pt; text-align: justify; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&#160;&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Represents
    beneficial ownership of less than one percent.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Antarctica
    Endurance Manager, LLC is the general partner of Endurance Antarctica Partners II, LLC and shares voting and dispositive power with
    respect to these securities. Includes 85,000 shares of Common Stock subject to vesting based on earnout conditions and 478,054 shares
    of Common Stock underlying warrants to purchase shares of Common Stock. The business address of the entities listed above is 200
    Park Avenue, 32nd Floor, New York, NY 10166.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    amount includes 589,882 shares of Common Stock held directly by Mr. Pujari, 465,286 shares of Common Stock held by Energy Transition
    Investors LLC, 1,087,279 shares of Common Stock held by 7636 Holdings LLC, 141,888 shares of Common Stock held by VIKASA Clean Energy
    I LP and 46,022 shares of Common Stock held by Roshan Pujari&#8217;s spouse, Maggie Clayton. The business address of Energy Transition
    Investors LLC, 7636 Holdings LLC and VIKASA Clean Energy I LP is 6608 N. Western Ave., Suite 466, Nichols Hills, OK 73116. The business
    address of Mr. Pujari and Ms. Clayton is 15 E. Putnam Ave., Suite 378, Greenwich, CT 06830.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise noted, the business address of each of our executive officers and directors is 15 E. Putnam Ave., Suite 378, Greenwich,
    CT 06830.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; padding: 0pt; text-align: justify; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; padding: 0pt; text-align: justify; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DELINQUENT
SECTION 16(A) REPORTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; padding: 0pt; text-align: justify; text-indent: -0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our directors, officers and persons who beneficially own more than 10% of a registered class of our
equity securities to file with the SEC initial reports of ownership and reports of changes in ownership of our Common Stock and other
equity securities. To our knowledge, based solely on our review of Forms 3, 4 and 5 filed with the SEC, or written representations that
no Form 5 was required, during the year ended December 31, 2025, we believe that our directors, officers and persons who beneficially
own more than 10% of a registered class of our equity securities timely filed all reports required under Section 16(a) of the Exchange
Act, except that, due to administrative error, one Form 3 for Mr. Celano, one Form 3 for Paramita Das and one Form 4 reporting one transaction
for Mr. Agarwal were filed late.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="font-size: 10pt">&#160;</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 0in"></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS</b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of transactions or agreements since January 1, 2024, or any currently proposed transaction, to which the Company
was or is a party, in which the amount involved exceeded or will exceed $120,000 and in which any of the Company&#8217;s executive officers,
directors (including nominees for election as directors of the Company) or beneficial owners of more than 5% of the Common Stock, or
an affiliate or immediate family member thereof, had or will have a direct or indirect material interest, other than equity and other
compensation, termination, change in control and other similar arrangements, which are described above under &#8220;Executive Compensation
and Other Information.&#8221; Beneficial ownership of securities is determined in accordance with the rules of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RELATED-PARTY
TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administrative
Support Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2021, in connection with its initial public offering, GPAC II entered into an administrative support agreement (the &#8220;<b><i>Administrative
Support Agreement</i></b>&#8221;) with the Sponsor, a greater than 5% holder of GPAC II. The Administrative Support Agreement provided
that GPAC II would pay the Sponsor $25,000 per month for office space, investment support services, utilities and secretarial and administrative
support. In June 2024, the Sponsor waived the administrative fees payable. The Administrative Support Agreement terminated upon the consummation
of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2021, simultaneously with the closing of the initial public offering, GPAC II completed the private sale of an aggregate of 5,566,667
private warrants (the &#8220;<b><i>Private Warrants</i></b>&#8221;) to the Sponsor at a purchase price of $1.50 per Private Warrant,
generating gross proceeds to GPAC II of $8,350,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
10 Private Warrants is exercisable for one share of Common Stock at a price of $115.00 per share, subject to adjustment. The Private
Warrants are non-redeemable for cash when our price per share equals or exceeds $180.00 and exercisable on a cashless basis so long as
they are held by the Sponsor or its permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sponsor
Earnout Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the closing of the Business Combination, the Company issued 100,000 shares to the Sponsor. These shares are subject to vesting
(or forfeiture) based on the Company&#8217;s achievement of certain trading price thresholds following the closing of the Business Combination
(the &#8220;<b><i>Sponsor Earnout Shares</i></b>&#8221;). Fifty percent of the Sponsor Earnout Shares will vest when the volume-weighted
average price (&#8220;<b><i>VWAP</i></b>&#8221;) of the Common Stock equals or exceeds $120.00 per share for a period of 20 trading days
in a 30 trading day period, and the remaining fifty percent of the Sponsor Earnout Shares will vest when the VWAP of the Common Stock
equals or exceeds $140.00 per share for a period of 20 trading days in a 30 trading day period. Upon the occurrence of a change in control,
any remaining unvested Sponsor Earnout Shares will become vested. Unvested Sponsor Earnout Shares will be forfeited if vesting does not
occur prior to the eighth anniversary of the closing of the Business Combination. The Company assesses the fair value of expected earnout
consideration at each reporting period using the Monte Carlo Method, which is consistent with the initial measurement of the expected
earnout consideration. As of December 31, 2025, the fair value of Sponsor Earnout Shares amounted to $4,700.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amended
and Restated Registration Rights Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GPAC
II, the Sponsor and certain equity holders of Legacy Stardust Power are party to an Amended and Restated Registration Rights Agreement,
pursuant to which, among other things, the parties thereto have been granted customary registration rights with respect to shares of
Common Stock and warrants. Pursuant to the Amended and Restated Registration Rights Agreement, the Company agreed to file with the SEC
(at the Company&#8217;s sole cost and expense) a shelf registration statement registering the resale of certain shares of Common Stock
and warrants from time to time, and the Company agreed to use commercially reasonable efforts to have such resale registration statement
declared effective after the Closing Date in accordance with the Amended and Restated Registration Rights Agreement. The certain equity
holders of the Company party to the Amended and Restated Registration Rights Agreement are entitled to customary piggyback rights and
may demand underwritten offerings, including block trades, of their registrable securities by the Company from time to time, subject
to the terms and conditions of the Amended and Restated Registration Rights Agreement. Such registration statement was filed with the
SEC on August 10, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholder
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, the Company entered into a stockholder agreement (the &#8220;<b><i>Stockholder Agreement</i></b>&#8221;) with the Sponsor
and Mr. Pujari, our Chairman of the Board and Chief Executive Officer, and his affiliates. The Stockholder Agreement provides the Sponsor
with the right to designate one nominee to the Company&#8217;s Board until the date upon which the Sponsor&#8217;s and its affiliates&#8217;
aggregate ownership interest of the issued and outstanding Common Stock decreases to one-half of their aggregate initial ownership interest
as of the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Notes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the Company entered into unsecured notes payable with three related parties. The notes payable provided the Company with
the ability to draw up to $1 million in aggregate: $160,000 until December 31, 2023 and $840,000 until December 31, 2025. VIKASA Capital
Partners LLC (&#8220;<b><i>VCP</i></b>&#8221;), an entity affiliated with Mr. Pujari, facilitated the initial funding of the notes obtained
on behalf of the additional related parties, Roshan Pujari, Vikasa Clean Energy I LP (an entity affiliated with Mr. Pujari) and Energy
Transition Investors LLC (an entity affiliated with Mr. Pujari). These loan facilities accrue interest, compounding semi-annually, at
the long-term semiannual Applicable Federal Rate, as established by the Internal Revenue Service, which effectively was 4.71% as of June
30, 2025. No borrowings were made in fiscal 2024.  In June 2025, the Company drew $250,000 from Energy Transition Investors LLC and repaid
the amount in full during the same month. As of December 31, 2025, $422 in interest was due to Energy Transition Investors LLC, which
has been paid subsequently.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loan
with Endurance Antarctica Partners II, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2024, the Company entered into a term sheet (the &#8220;<b><i>Endurance Term Sheet</i></b>&#8221;) with Endurance Antarctica
Partners II, LLC (&#8220;<b><i>Endurance</i></b>&#8221;), a greater than 5% holder of the Company, which provided for a loan in the aggregate
principal amount of $1,750,000 and bore interest at a rate of 15% per year (the &#8220;<b><i>Endurance Loan</i></b>&#8221;). The Endurance
Loan matured in March 2025 (the &#8220;<b><i>Endurance Maturity Date</i></b>&#8221;). The Endurance Term Sheet contained customary representations
and warranties and customary events of default. Pursuant to the Endurance Term Sheet, 550,000 shares of Company&#8217;s Common Stock,
owned by Mr. Pujari were pledged as collateral. In addition, the Company agreed to issue to Endurance $3,500,000 in Common Stock as an
equity kicker (the &#8220;<b><i>Equity Kicker</i></b>&#8221;). In addition, Endurance will receive warrants representing the right, exercisable
within five years of the closing date, to receive up to 50% of Common Stock issued as the Equity Kicker, with 10 warrants exercisable
for one share of Common Stock at an exercise price of $115.00, in accordance with the private placement terms. During the year ended
December 31, 2025, the Company repaid the principal amount of $1,750,000 along with the accrued interest of $70,000 and issued 97,765
shares of Common Stock and 488,826 warrants to Endurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreements
with DRE Chicago LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2024, the Company entered into a consulting agreement in the aggregate principal amount of $41,667 per month with DRE Chicago
LLC (&#8220;<b><i>DRE Chicago</i></b>&#8221;), whose principal is Paramita Das, an executive officer of the Company between January 2025
and March 2025. Ms. Das&#8217; employment with the Company ended in November 2025 and she is no longer considered a related party as
of December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2024, the Company entered into a binding term sheet with DRE Chicago, which provided for a loan in the principal amount of $250,000
and bore interest at a rate of 15% per year. The loan matured in March 2025. Pursuant to the term sheet for the loan, an aggregate of
approximately 47,000 shares of Company&#8217;s Common Stock owned by Mr. Pujari was pledged as collateral. In addition, the Company agreed
to issue to DRE Chicago an aggregate of $375,000 in Common Stock as an Equity Kicker. In addition, DRE Chicago will receive warrants
representing the right, exercisable within five years of the closing date, to receive up to 50% of Common Stock issued as the Equity
Kicker, with 10 warrants exercisable for one share of Common Stock at an exercise price of $115.00 in accordance with the private placement
terms. During the year ended December 31, 2025, the Company repaid the principal amount of $250,000 along with the accrued interest of
$9,166 and issued 10,474 shares of Common Stock and 52,374 warrants to DRE Chicago. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
and Officer Indemnification Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stardust
Power&#8217;s Certificate and bylaws provide for indemnification and advancement of expenses for its directors and officers to the fullest
extent permitted by the Delaware General Corporation Law, subject to certain limited exceptions. The Company has entered into separate
indemnification agreements with each of its directors and executive officers in addition to the indemnification provided for in our organizational
documents. These agreements, among other things, require us to indemnify our directors and executive officers for certain costs, charges
and expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts, reasonably incurred by a director or executive
officer in any action or proceeding because of their association with us or any of our subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POLICIES
AND PROCEDURES REGARDING RELATED-PARTY TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a written related person transaction policy that sets forth policies and procedures for the review and approval or ratification
of related person transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purpose of our policy, a &#8220;Related Party Transaction&#8221; is a transaction, arrangement or relationship in which we or any of
our subsidiaries was, is or will be a participant, the amount involved exceeds $120,000, and in which any related person had, has or
will have a direct or indirect material interest. A &#8220;Related Party&#8221; or &#8220;Related Parties&#8221; means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">any person who is,
  or at any time since the beginning of the Company&#8217;s last fiscal year was, a director or executive officer of the Company or a
  nominee to become a director of the Company;</span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif">any
                                  person or entity known to be the beneficial owner of more than 5% of any class of the Company&#8217;s
                                  voting securities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>

</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">any immediate family
  member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law,
  son-in-law, daughter-in-law, brother-in-law or sister-in-law of the director, executive officer, nominee or more than 5% beneficial
  owner, and any person (other than domestic employees) sharing the household of such director, executive officer, nominee or more than
  5% beneficial owner; and</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
  firm, corporation or other entity in which any of the foregoing persons is employed or is a general partner or principal or in a similar
  position or in which such person has a 5% or greater beneficial ownership interest.</span></td>
  </tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the policy, if a transaction has been identified as a related person transaction, our Audit Committee must review the material facts
and either approve or disapprove of the entry into the transaction. In addition, under our Code of Business Conduct and Ethics, our employees
and directors have an affirmative responsibility to avoid activities that create or give the appearance of a conflict of interest, and
directors must consult and seek prior approval of potential conflicts of interest from the Audit Committee. In considering related party
transactions, our Audit Committee will take into account the relevant available facts and circumstances including, but not limited to,
whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third-party under the same or
similar circumstances and the extent of the related party&#8217;s interest in the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the related party transactions described above were consummated prior to our adoption of the formal, written policy described above
in July 2024, and, accordingly, the foregoing policies and procedures were not followed with respect to these transactions. However,
we believe that the terms obtained or consideration that we paid or received, as applicable, in connection with the transactions described
below were comparable to terms available or the amounts that would be paid or received, as applicable, in arm&#8217;s-length transactions
at such time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">STOCKHOLDER
    PROPOSALS FOR NEXT YEAR&#8217;S ANNUAL MEETING</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
may submit proposals on matters appropriate for stockholder action at our annual meetings consistent with Rule 14a-8 promulgated under
the Exchange Act. For such proposals to be considered in the proxy statement and proxy relating to the 2027 annual meeting of stockholders,
they must be received by us no later than the close of business (6:00 p.m. Eastern Time) on December 22, 2026. Such proposals
should be directed to Stardust Power Inc., 15 E. Putnam Ave., Suite 378, Greenwich, CT 06830, Attn: Bruce Czachor, Secretary. A proposal
may be included in next year&#8217;s proxy materials only if such proposal complies with the rules and regulations promulgated by the
SEC. Nothing in this section shall be deemed to require us to include in our proxy statement or our proxy relating to any meeting any
stockholder proposal that does not meet all of the requirements for inclusion established by the SEC. The chair of the annual meeting
may exclude matters that are not properly presented in accordance with these requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that stockholders seeking to bring business before an annual meeting of stockholders (other than pursuant to Rule 14a-8
under the Exchange Act), or to nominate candidates for election as directors at an annual meeting of stockholders, must provide timely
notice of their intent in writing (which includes the timing and information required under Rule 14a-19 of the Exchange Act). Unless
our 2027 Annual Meeting is held more than 30 days before or more than 60 days after the anniversary of our 2026 Annual Meeting, to be
considered timely under our bylaws, a stockholder&#8217;s notice must be received not earlier than the close of business (6:00 p.m. Eastern
Time) on February 2, 2027 (120 days prior to the anniversary of the 2026 Annual Meeting) and not later than close of business (6:00 p.m.
Eastern Time) on March 4, 2027 (90 days prior to the anniversary of the 2026 Annual Meeting). Our bylaws specify certain requirements
as to the form and content of stockholders&#8217; notices. If a stockholder fails to meet these deadlines and fails to satisfy the requirements
of Rule 14a-4 of the Exchange Act, we may exercise discretionary voting authority under proxies we solicit to vote on any such proposal
as we determine appropriate. We reserve the right to reject, rule out of order or take other appropriate action with respect to any nomination
or proposal that does not comply with these and other applicable requirements. The foregoing bylaw provisions do not affect a stockholder&#8217;s
ability to request inclusion of a proposal in our proxy statement within the procedures and deadlines set forth in Rule 14a-8 of the
SEC&#8217;s proxy rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
    BUSINESS</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board knows of no matters other than those described herein that will be presented for consideration at the 2026 Annual Meeting. However,
should any other matters properly come before the 2026 Annual Meeting or any adjournments or postponements thereof, it is the intention
of the person(s) named in the accompanying proxy to vote in accordance with their best judgment in the best interests of the Company
and its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOUSEHOLDING
    OF PROXY MATERIALS</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that permit companies and intermediaries such as brokers to satisfy delivery requirements for proxy statements
with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders.
This process, which is commonly referred to as &#8220;householding,&#8221; potentially provides extra convenience for stockholders and
cost savings for companies. The Company and some brokers householding proxy materials may deliver a single proxy statement, Annual Report
on Form 10-K and/or Notice of Internet Availability of Proxy Materials to multiple stockholders sharing an address unless contrary instructions
have been received from the affected stockholders. Once you have received notice from your broker or the Company that they or the Company
will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your
consent. If, at any time, you no longer wish to participate in householding and would prefer to receive separate copies of the proxy
materials, please notify your broker if you are a beneficial holder or the Company if you are a registered stockholder. We will promptly
deliver a separate copy of the proxy materials to any stockholder upon written or oral request. Similarly, stockholders who have previously
received multiple copies of the proxy materials may notify their broker or the Company (as applicable) to request delivery of a single
copy of these materials in the future. You can notify the Company by sending a written request to Stardust Power Inc., 15 E. Putnam Ave.,
Suite 378, Greenwich, CT 06830, Attn: Bruce Czachor&#894; by registered, certified or express mail&#894; or by calling the Company at
(800) 742-3095.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOW
    YOU CAN OBTAIN A COPY OF OUR ANNUAL REPORT AND OTHER INFORMATION</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and current reports&#894; proxy statements&#894; and other information with the SEC. The SEC maintains a website
at <i>http://www.sec.gov</i> that contains reports, proxy and information statements and other information regarding issuers that file
electronically with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
2025 Annual Report is being mailed with this Proxy Statement to those stockholders that have requested a paper copy of the proxy materials.
For those stockholders that received the Notice of Internet Availability of Proxy Materials, this Proxy Statement and our 2025 Annual
Report are available on our website at <i>https://investors.stardust-power.com/financial-information/sec-filings</i>. Additionally, and
in accordance with SEC rules, you may access our Proxy Statement and Annual Report at <i>www.virtualshareholdermeeting.com/SDST2026</i>.
<b>A copy of the Company&#8217;s Annual Report on Form 10-K filed with the SEC will be provided to stockholders without charge upon written
or oral request.</b> Stockholders are directed to contact our Secretary at Stardust Power Inc., 15 E. Putnam Ave, Suite 378, Greenwich,
CT 06830, Attn: Bruce Czachor or by calling the Company at (800) 742-3095. The Company&#8217;s copying costs will be charged if exhibits
to the 2025 Annual Report on Form 10-K are requested. The Company makes available on or through its website free of charge its Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to such reports filed pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    21, 2026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</span></td>
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
                                            Roshan Pujari </i></span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
                                            of the Board of Directors and Chief Executive Officer</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Appendix
A</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this &#8220;<b>Agreement</b>&#8221;)
is entered into as of December 23, 2025, by and between Stardust Power Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;),
and Lind Global Asset Management XIII LLC, a Delaware limited liability company (the &#8220;<b>Investor</b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BACKGROUND</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The board of directors (the &#8220;<b>Board of Directors</b>&#8221;) of the Company has authorized the issuance to Investor of the Notes
and the Warrants (each as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B
The Investor desires to purchase the Notes and Warrants on the terms and conditions set forth in this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW
THEREFORE, in consideration of the foregoing recitals and the covenants and agreements set forth herein, and intending hereby to be legally
bound, the Company and the Investor hereby agree as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.
</span><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DEFINITIONS</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
As used in this Agreement, the following terms shall have the following meanings specified or indicated below, and such meanings shall
be equally applicable to the singular and plural forms of such defined terms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>1933
Act</b>&#8221; means the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>1934
Act</b>&#8221; means the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Affiliate</b>&#8221;
means a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control
with, the Person specified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Agreement</b>&#8221;
has the meaning set forth in the preamble.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>ATM
Agreement</b>&#8221; means the Common Stock Purchase Agreement, dated October 7, 2024 by and between the Company and B. Riley Principal
Capital II, LLC, and any additional agreement regarding a similar transaction between such parties or a registered at-the-market offering
by the Company in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Blue
Sky Application</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 9.3(a)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Board
of Directors</b>&#8221; has the meaning set forth in the recitals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Business
Day</b>&#8221; means any day other than a Saturday, Sunday or any other day on which banks are permitted or required to be closed in
New York City.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Capital
Stock</b>&#8221; means the Common Stock, the Preferred Stock and any other classes of shares in the capital stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Certificate
of Incorporation and Bylaws</b>&#8221; means the Certificate of Incorporation of the Company, as amended and/or restated from time to
time, together with its Bylaws, each as in effect on the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Change
of Control</b>&#8221; means, with respect to the Company, on or after the date of this Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            change in the composition of the Board of Directors of the Company at a single shareholder
                                            meeting where a majority of the individuals that were directors of the Company immediately
                                            prior to the start of such shareholder meeting are no longer directors at the conclusion
                                            of such meeting, without prior written consent of the Investor;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            change, without prior written consent of the Investor, in the composition of the Board of
                                            Directors of the Company prior to the termination of this Agreement where a majority of the
                                            individuals that were directors as of the date of this Agreement cease to be directors of
                                            the Company prior to the termination of this Agreement;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                            than a shareholder that holds such a position at the date of this Agreement, if a Person
                                            comes to have beneficial ownership, control or direction over more than fifty percent (50%)
                                            of the voting rights attached to any class of voting securities of the Company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            consummation of a merger, consolidation, or similar transaction resulting in the holders
                                            of fifty percent (50%) of the voting rights attached to any class of voting securities of
                                            the Company immediately prior to such merger, consolidation, or similar transaction ceasing
                                            to hold fifty percent (50%) of the voting rights attached to any class of voting securities;
                                            or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sale or other disposition by the Company or any of its Subsidiaries in a single transaction,
                                            or in a series of transactions, of all or substantially all of their respective assets.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.9pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Closing</b>&#8221;
has the meaning set forth in <span style="text-decoration: underline">Section 2.2(b)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Closing
Date</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 2.2(b)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Commitment
Fee</b>&#8221; means in respect of any Closing an amount equal to two and one-half percent (2.5%) of the applicable Funding Amount in
respect of such Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Common
Stock</b>&#8221; means the common stock of the Company, par value per share $0.0001.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Company</b>&#8221;
has the meaning set forth in the preamble.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Conversion
Shares</b>&#8221; means the Common Stock issuable upon the full or any partial conversion of the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Disclosure
Letter</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 3</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Effectiveness
Period</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 9.2(a)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Equity
Assets</b>&#8221; means: (i) any Equity Interest in any Person which becomes a Subsidiary of the Company to the extent the purchase of
such Equity Interest was paid for with the proceeds of a Permitted Acquisition Arrangement; or (ii) any group of assets acquired by the
Company that constitute a &#8220;business&#8221; within the meaning of Rule 11-01(d) under Regulation S-X (&#8220;<span style="text-decoration: underline">Business
Assets</span>&#8221;), to the extent that: (a) the purchase of such assets was paid for with the proceeds of a Permitted Acquisition
Arrangement; and (b) all of such assets are acquired by, and held within, a newly-created and wholly-owned Subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Equity
Interests</b>&#8221; means and includes capital stock, membership interests and other similar equity securities, and shall also include
warrants or options to purchase capital stock, membership interests or other equity interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Event</b>&#8221;
means any event, change, development, effect, condition, circumstance, matter, occurrence or state of facts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Event
of Default</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 7.1</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Exempted
Securities</b>&#8221; means (a) Common Stock or options to employees, officers or directors of the Company pursuant to any stock or option
plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members
of a committee of non-employee directors established for such purpose for services rendered to the Company (&#8220;<b>Equity Plan</b>&#8221;),
(b) securities issued upon the exercise or exchange of or conversion of any Securities issued hereunder, other securities exercisable
or exchangeable for or convertible into Common Stock issued and outstanding on the date of this Agreement, provided that such securities
have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company; provided that such securities are issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith, and provided that any such
issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company
or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits
in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for
the purpose of raising capital or to an entity whose primary business is investing in securities, (d) Common Stock issued under the ATM
Agreement, and (e) Common Stock issued or issuable in respect of any equity line of credit, stand-by equity distribution agreements or
similar transaction with the Investor or any affiliate thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Form
8-K&#8221;</b> has the meaning set forth in <span style="text-decoration: underline">Section 5.10</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Funding
Amount&#8221;</b> means an amount equal to up to Fifteen Million and Zero/100 United States Dollars ($15,000,000.00).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>GAAP</b>&#8221;
means United States generally accepted accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>HSR
Act</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 5.15</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Indebtedness</b>&#8221;
has the meaning set forth in the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Investor</b>&#8221;
has the meaning set forth in the preamble.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Investor
Group</b>&#8221; shall mean the Investor plus any other Person with which the Investor is considered to be part of a group under Section
13 of the 1934 Act or with which the Investor otherwise files reports under Sections 13 and/or 16 of the 1934 Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Investor
Party</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 5.11.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Investor
Shares</b>&#8221; means the Conversion Shares, the Warrant Shares and any other shares issued or issuable to the Investor pursuant to
this Agreement, any Note or any Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>IP
Rights</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 3.10</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Law</b>&#8221;
means any law, rule, regulation, order, judgment or decree, including, without limitation, any federal and state securities Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Legend
Removal Date</b>&#8221; shall have the meaning set forth in <span style="text-decoration: underline">Section 5.1(c)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Lien</b>&#8221;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Material
Adverse Effect</b>&#8221; means any material adverse effect on (i) the businesses, properties, assets, prospects, operations, results
of operations or financial condition of the Company, or the Company and the Subsidiaries, taken as a whole, or (ii) the ability of the
Company to consummate the transactions contemplated by this Agreement or to perform its obligations hereunder or under the Security Agreement,
the Note or the Warrant; <i>provided, however</i>, that none of the following shall be deemed either alone or in combination to constitute,
and none of the following shall be taken into account in determining whether there has been or would be, a Material Adverse Effect: (a)
any adverse effect resulting from or arising out of general economic conditions; (b) any adverse effect resulting from or arising out
of general conditions in the industries in which the Company and the Subsidiaries operate; (c) any adverse effect resulting from any
changes to applicable Law; or (d) any adverse effect resulting from or arising out of any natural disaster or any acts of terrorism,
sabotage, military action or war or any escalation or worsening thereof; <i>provided</i>, <i>further</i>, that any event, occurrence,
fact, condition or change referred to in clauses (a) through (d) immediately above shall be taken into account in determining whether
a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition
or change has a disproportionate effect on the Company and/or the Subsidiaries compared to other participants in the industries in which
the Company and the Subsidiaries operate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Maximum
Percentage</b>&#8221; means 4.99%; <i>provided</i>, that if at any time after the date hereof the Investor Group beneficially owns in
excess of 4.99% of any class of Equity Interests in the Company that is registered under the 1934 Act or exempt from the registration
and qualification requirements under the 1933 Act, then the Maximum Percentage shall automatically increase to 9.99% so long as the Investor
Group owns in excess of 4.99% of such class of Equity Interests (and shall, for the avoidance of doubt, automatically decrease to 4.99%
upon the Investor Group ceasing to own in excess of 4.99% of such class of Equity Interests).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Money
Laundering Laws</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 3.25</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Note</b>&#8221;
has the meaning set forth in <span style="text-decoration: underline">Section 2.1</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Notice
Termination Time&#8221;</b> has the meaning set forth in <span style="text-decoration: underline">Section 10.2</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>OFAC</b>&#8221;
has the meaning set forth in <span style="text-decoration: underline">Section 3.23</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Outstanding
Principal Amount</b>&#8221; shall have the meaning set forth in the Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Person</b>&#8221;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Permitted
Acquisition Arrangement</b>&#8221; means Indebtedness incurred after the date hereof from one or more lenders so long as (a) the proceeds
thereof are used by the Company solely for the purchase of Equity Interests in an unaffiliated Person which becomes a Subsidiary or Business
Assets of an unaffiliated Person so long as such assets are acquired by, and held within, a newly-created and wholly-owned Subsidiary
of the Company; (b) at the time of incurring such Indebtedness, no Event of Default has occurred and is continuing under any Transaction
Document; (c) the terms and conditions contained in any agreement or document relating to such Indebtedness do not contain any covenants
or defaults more onerous to the Company or any Subsidiary than those contained in the Transaction Documents and do not contain any covenant
or provision which would cause the Company to violate or otherwise contravene the terms of any Transaction Document; (d) to the extent
any security interest is granted to secure the Company&#8217;s or any such newly-created and wholly-owned Subsidiary&#8217;s obligations
with respect to such Indebtedness, such security interest is limited solely to a security interest on the Equity Assets of the Person
so acquired or the Business Assets so acquired, and the provider of such Indebtedness shall have no other recourse to any other assets
or recourse to the Company or any other Subsidiary (other than the Subsidiary so acquired); and (e) the provider of such Indebtedness,
the Investor and the Company (and to the extent applicable, the applicable Subsidiary) have entered into a Subordination Agreement with
respect to the security interest in the applicable Excluded Assets so acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Permitted
Senior Indebtedness</b>&#8221; means any future Indebtedness, the proceeds of which are used to finance the construction of the Company&#8217;s
refinery project in Muskogee and related capital/ operating expenditures, of no less than $20,000,000 (in aggregate or in tranches; provided
that such tranches are part of a committed single financing facility of no less than $20,000,000).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Permitted
Indebtedness</b>&#8221; means (a) the Company&#8217;s obligations under this Agreement and the other Transaction Documents; (b) Indebtedness
existing on the Closing Date which is shown on the Disclosure Letter; (c) Indebtedness subordinated to the Company&#8217;s obligations
under the Notes on terms reasonable acceptable to the Investor and in connection with which the counterparty shall have entered into
a subordination agreement acceptable to the Investor in its sole discretion; (d) Indebtedness obtained by the Company to acquire capital
equipment, capital leases, or operating leases, (e) Indebtedness secured by Permitted Liens or unsecured but as described in clauses
(iv) and (v) of the definition of Permitted Liens, (f) Liens with respect to the Permitted Senior Indebtedness and (g) Indebtedness obtained
pursuant to an Permitted Acquisition Arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.8pt"></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Permitted
Indebtedness Repayments</b>&#8221; shall mean cash payments the Company is required to make pursuant to the express terms of Indebtedness
existing on the date hereof but not including bonus payments or other compensation owing to directors or members of management of the
Company or any Subsidiary or other amounts owing to any creditor of the Company that is directly or indirectly owned or controlled by
any director or member of management of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Permitted
Liens</b>&#8221; means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for
which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business
by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as
materialmen&#8217;s liens, mechanics&#8217; liens and other similar liens, arising in the ordinary course of business with respect to
a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens incurred
in connection with Permitted Indebtedness under clauses (a), (c), (d), (e), (f), and (g) thereunder, (v) Liens incurred in connection
with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above, provided
that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount
of the Indebtedness being extended, renewed or refinanced does not increase, (vi) Liens in favor of customs and revenue authorities arising
as a matter of law to secure payments of custom duties in connection with the importation of goods, (vii) Liens arising from judgments,
decrees or attachments in circumstances not constituting an Event of Default, (viii) Liens on accounts receivable and inventory to secure
the Permitted Indebtedness to the extent permitted by the applicable intercreditor agreement, (ix) second priority or junior Liens that
are subordinate to the Liens created by any security interest established in connection with the Purchase Agreement and its related documents,
and (x) any Liens required to ensure compliance with applicable laws or regulations governing wells, land leases, mineral rights, or
similar obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Prepayment
Amount</b>&#8221; means an amount in cash owing to the Investor equal to the one hundred and five percent (105%) of the Outstanding Principal
Amount together with any other amounts owing under the Notes then outstanding and the other Transaction Documents as of the applicable
date of prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Prepayment
Notice</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 1.4</span> of the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Prepayment
Right</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 2.4</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Prepayment
Right Date</b>&#8221; in respect of any Note, means the Trading Day following such date as the Conversion Shares issuable in respect
of such Note and the Warrant Shares issuable in respect of the Warrant issued to the holder of such Note, may be offered or sold pursuant
to an effective Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Press
Release&#8221;</b> has the meaning set forth in <span style="text-decoration: underline">Section 5.8</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Principal
Amount</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 2.1</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Preferred
Stock</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 3.4</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Proceedings</b>&#8221;
has the meaning set forth in <span style="text-decoration: underline">Section 3.6</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Prohibited
Transaction</b>&#8221; means a transaction with a third party or third parties in which the Company issues or sells (or arranges or agrees
to issue or sell):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any debt, equity or equity-linked securities (including options or warrants) that are convertible into, exchangeable or exercisable for,
or include the right to receive shares of the Company&#8217;s Capital Stock:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
at a conversion, repayment, exercise or exchange rate or other price that is based on, and/or varies with, a discount to the future trading
prices of, or quotations for, Common Stock (which shall not encompass standard anti-dilution provisions in otherwise fixed price instruments;
provided that for the avoidance of doubt any provisions resulting in such instrument &#8220;exploding&#8221; or otherwise resulting in
the increase of the number of shares issuable under a fixed priced instrument shall result in the transaction in which such instrument
was issued being deemed a Prohibited Transaction); or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
at a conversion, repayment, exercise or exchange rate or other price that is subject to being reset at some future date after the initial
issuance of such debt, equity or equity-linked security or upon the occurrence of specified or contingent events (other than warrants
that may be repriced by the Company); or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any securities in a capital or debt raising transaction or series of related transactions which grant to an investor the right to receive
additional securities based upon future transactions of the Company on terms more favorable than those granted to such investor in such
first transaction or series of related transactions;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
are deemed to include transactions generally referred to as equity lines of credit and stand-by equity distribution agreements, and convertible
securities and loans having a similar effect but shall not include transactions generally referred to as at-the-market transaction (ATM)
or an equity line of credit, stand-by equity distribution agreement or similar transaction; provided that the ATM Agreement shall not
be deemed a Prohibited Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Prospectus</b>&#8221;
means the prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement, with respect to
the terms of the offering of any portion of the Investor Shares covered by such Registration Statement and by all other amendments and
supplements to the prospectus, including post-effective amendments and all material incorporated by reference in such prospectus, and
any &#8220;free writing prospectus&#8221; as defined in Rule 405 under the 1933 Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>register</b>,&#8221;
&#8220;<b>registered</b>&#8221; and &#8220;<b>registration</b>&#8221; refer to a registration made by preparing and filing a Registration
Statement or similar document in compliance with the 1933 Act (as defined below), and the declaration or ordering of effectiveness of
such Registration Statement or document.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Registration
Statement</b>&#8221; means any registration statement of the Company filed under the 1933 Act that covers the resale of any of the Investor
Shares pursuant to the provisions of this Agreement, including the Prospectus and amendments and supplements to such Registration Statement,
and including post-effective amendments, all exhibits and all material incorporated by reference in such Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Required
Minimum</b>&#8221; means, as of any date, 150% of the maximum aggregate a sufficient number of shares of Common Stock then issued or
potentially issuable in the future pursuant to any outstanding Notes or Warrants, ignoring any conversion or exercise limits set forth
therein. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>SEC</b>&#8221;
means the United States Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>SEC
Documents</b>&#8221; has the meaning set forth in <span style="text-decoration: underline">Section 3.5(a)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Securities</b>&#8221;
means the Notes, the Warrants, and the Investor Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Securities
Termination Event</b>&#8221; means either of the following has occurred:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
trading in securities generally in the United States has been suspended or limited for a consecutive period of greater than three (3)
Business Days; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
a banking moratorium has been declared by the United States or the New York State authorities and is continuing for a consecutive period
of greater than three (3) Business Days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Security
Agreement</b>&#8221; means that certain Security Agreement in the form attached hereto as <span style="text-decoration: underline"><b>Exhibit
C.</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Shareholder
Approval</b>&#8221; shall mean the approval of the holders of a majority of the Company&#8217;s outstanding voting Common Stock: (a)
to ratify and approve all of the transactions contemplated by the Transaction Documents, including the issuance of all of the Investor
Shares (as such term is defined in each of such documents) issued and potentially issuable to the Investor thereunder, all as may be
required by the applicable rules and regulations of the Trading Market (or any successor entity) and if required under the Transaction
Documents or (b) otherwise legally required, to amend the Company&#8217;s Certificate of Incorporation and Bylaws to increase the number
of authorized shares of Common Stock by at least the number of shares equal to the number of shares of Common Stock issuable under the
Transaction Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Subsidiaries</b>&#8221;
and &#8220;<b>Subsidiary</b>&#8221; have the meaning set forth in <span style="text-decoration: underline">Section 3.4(b)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Subsidiary
Guaranty</b>&#8221; means that certain Guaranty in the form attached hereto as <span style="text-decoration: underline"><b>Exhibit D.</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Trading
Day&#8221;</b> means a day on which the Common Stock is traded on a Trading Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Trading
Market</b>&#8221; means whichever of the New York Stock Exchange, NYSE American, or the Nasdaq Stock Market (including the Nasdaq Capital
Market), on which the Common Stock is listed or quoted for trading on the date in question.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Transaction
Documents</b>&#8221; means this Agreement, the Notes, the Security Agreement, the Subsidiary Guaranty, the Transfer Agent Instruction
Letter and any other documents or agreements executed or delivered in connection with the transactions contemplated hereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Transfer
Agent</b>&#8221; shall mean Continental Stock Transfer &amp; Trust Company, having its address at 1 State St 30th floor, New York, New
York 10004, Attention: Vito Cirone, email: vcirone@continentalstock.com.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Transfer
Agent Instruction Letter</b>&#8221; shall mean a letter of irrevocable instructions addressed by the Company to the Transfer Agent, acceptable
to the Investor in its sole discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>VWAP&#8221;</b>
means, as of any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of one share of Common Stock trading in the ordinary course of
business at the applicable Trading Price for such date (or the nearest preceding date) on such Trading Market as reported by Bloomberg
Financial L.P.; (b) if the Common Stock is not then listed on a Trading Market and if the Common Stock is traded in the over-the-counter
market, as reported by the OTCQX or OTCQB Markets, the volume weighted average price of one share of Common Stock for such date (or the
nearest preceding date) on the OTCQX or OTCQB Markets, as reported by Bloomberg Financial L.P.; (c) if the Common Stock is not then listed
or quoted on a Trading Market or on the OTCQX or OTCQB Markets and if prices for the Common Stock are then reported in the &#8220;Pink
Sheets&#8221; published by the OTC Markets Group (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price of one share of Common Stock so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases,
the fair market value of one share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and
reasonably acceptable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Warrants</b>&#8221;
has the meaning set forth in Section 2.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Warrant
Share Amount</b>&#8221; means in respect of any Warrant issued in a Closing the initial amount of Common Stock into which such Warrant
may be exercised and which shall be equal to the applicable Funding Amount for such Closing multiplied by thirty-five percent (35%) and
divided by the VWAP of the Common Stock on the Trading Day immediately preceding the applicable Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Warrant
Shares</b>&#8221; means the shares of Common Stock issuable upon exercise of the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>2.</b></span><b>
<span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE AND SALE OF THE INVESTOR
SHARES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.1
</b><span style="text-decoration: underline">Purchase and Sale of the Notes and the Warrants</span>. Subject to the terms and conditions
set forth herein at the applicable closing (each, a &#8220;<b>Closing</b>&#8221;, and the date each Closing is consummated being a <b>&#8220;Closing
Date</b>&#8221;) as more particularly set forth in Section 2.2, the Company may issue and sell to the Investor, and the Investor may
purchase from the Company, for an amount not to exceed the aggregate Funding Amount (a) senior secured convertible promissory notes,
in the form attached hereto as <span style="text-decoration: underline"><b>Exhibit A</b></span> (each, a <b>&#8220;Note</b>&#8221;),
in an aggregate principal amount not to exceed Fifteen Million and Zero/100 United States Dollars ($15,000,000.00) (the &#8220;<b>Principal
Amount</b>&#8221;), and (b) Common Stock purchase warrants, in the form attached hereto as <span style="text-decoration: underline"><b>Exhibit
B</b></span> (each, a <b>&#8220;Warrant&#8221;</b>), registered in the name of the Investor, pursuant to which the Investor shall have
the right to acquire shares of Common Stock in accordance with the terms thereof in the applicable Warrant Share Amount..</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.2
</b><span style="text-decoration: underline">Closings</span>. Subject to satisfaction or waiver of the conditions set forth in <span style="text-decoration: underline">Section
6</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the initial Closing of the offer and sale of (i) Notes in the aggregate principal amount of up to Four Million Eight Hundred Thousand
and Zero/100 United States Dollars ($4,800,000.00) and (ii) Warrants to purchase an amount of shares of Common Stock equal to the applicable
Warrant Share Amount, for a purchase price of Four Million and Zero/100 United States Dollars ($4,000,000.00), shall take place remotely
via the exchange of documents and signatures and shall occur no later than ten (10) Business Days following the execution and delivery
of this Agreement) at such time as the Company and the Investor agree upon, orally or in writing; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any subsequent Closing shall occur upon the mutual consent of the Company and the Investor for Note(s) in such principal amount(s) and
at such time and place as the Company and the Investor agree upon, orally or in writing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.3
</b><span style="text-decoration: underline">Commitment Fee</span>. At each Closing, as applicable, the Company shall pay to the Investor
the Commitment Fee payable in respect of such Closing, in United States dollars and in immediately available funds. The Commitment Fee
shall be paid by being offset against the applicable Funding Amount payable by the Investor at such Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.4
</b><span style="text-decoration: underline">Prepayment Right.</span> As set forth in the Notes, at any time following the Prepayment
Right Date and upon giving the prior written notice set forth in each Note, the Company will have the right to pre-pay such Note at any
time in accordance with the terms thereof by paying the applicable Prepayment Amount (the &#8220;<b>Prepayment Right</b>&#8221;); <i>provided</i>,
that in the event that the Company elects to exercise its Prepayment Right, the Investor will have the option to convert up to one-third
(1/3) of the amounts owing under such Note, at a price per share equal to the lesser of the Conversion Price and the Repayment Share
Price (as defined in such Note).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.5
</b><span style="text-decoration: underline">Senior Obligation</span>. As an inducement for the Investor to enter into this Agreement
and to purchase the Notes and Warrants, all obligations of the Company pursuant to this Agreement and the Notes shall be senior to all
other existing Indebtedness and equity of the Company, other than Permitted Indebtedness secured by Permitted Liens that may be issued
after the date hereof. Notwithstanding the foregoing, to the extent after the date hereof, (a) the Company incurs Permitted Indebtedness
to be secured by a Permitted Lien , upon the execution and delivery of the subordination agreement(s), the Investor&#8217;s security
interest on the Company&#8217;s assets be subordinated to the security interest(s) granted to the creditor(s) in the transaction; and
(b) the Company enters into a transaction to acquire Equity Assets, upon the execution and delivery of the subordination agreement(s),
the Investor&#8217;s security interest in the Equity Assets shall be subordinated to the security interest(s) granted to the creditor(s)
in the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>3.</b></span><b>
<span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS AND WARRANTIES
OF THE COMPANY</span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company represents and warrants
to the Investor and covenants with the Investor that as of the Closing Date, except as is set forth in the Disclosure Letter being delivered
to the Investor as of the date hereof, as applicable (the <b>&#8220;Disclosure Letter&#8221;</b>), the following representations and
warranties are true and correct:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.1</b>
<span style="text-decoration: underline">Organization and Qualification</span>. The Company is a corporation duly organized and validly
existing in good standing under the Laws of the State of Delaware and has the requisite corporate power and authority to own its properties
and to carry on its business as now being conducted. The Company is duly qualified to do business and is in good standing (if a good
standing concept exists in such jurisdiction) in every jurisdiction in which the ownership of its property or the nature of the business
conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would
not have a Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.2</b>
<span style="text-decoration: underline">Authorization; Enforcement; Compliance with Other Instruments</span>. The Company has the requisite
corporate power and authority to execute the Transaction Documents, to issue and sell the Notes, the Warrants and the Investor Shares
issuable pursuant thereto, and to perform its obligations under the Transaction Documents, including issuing the Investor Shares on the
terms set forth in this Agreement. The execution and delivery of the Transaction Documents by the Company and the issuance and sale of
the Securities pursuant hereto, including without limitation the reservation of the Conversion Shares, and the Warrant Shares for future
issuance, have been duly and validly authorized by the Company&#8217;s Board of Directors and no further consent or authorization is
required by the Company, its Board of Directors, its shareholders or any other Person in connection therewith. The Transaction Documents
have been duly and validly executed and delivered by the Company and constitute valid and binding obligations of the Company, enforceable
against the Company in accordance with their respective terms, except as such enforceability may be limited by general principles of
equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar Laws relating to, or affecting generally,
the enforcement of creditors&#8217; rights and remedies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.3</b>
<span style="text-decoration: underline">No Conflicts</span>. Except as set forth on <span style="text-decoration: underline">Schedule
3.3</span>, the execution, delivery and performance of the Transaction Documents by the Company and the issuance and sale of the Notes,
the Warrants and of the Investor Shares issuable in respect thereof will not (a) conflict with or result in a violation of the Company&#8217;s
Certificate of Incorporation and Bylaws, (b) conflict with, or constitute a material default (or an event which, with notice or lapse
of time or both, would become a material default) under, or give to others any right of termination, amendment, acceleration or cancellation
of, any material agreement to which the Company or any of the Subsidiaries is a party, or (c) subject to the making of the filings referred
to in <span style="text-decoration: underline">Section 5</span>, violate in any material respect any Law or any rule or regulation of
the Trading Market applicable to the Company or any of the Subsidiaries or by which any of their properties or assets are bound or affected.
Assuming the accuracy of the Investor&#8217;s representations in <span style="text-decoration: underline">Section 4</span> and subject
to the making of the filings referred to in <span style="text-decoration: underline">Section 5</span>, (i) no approval or authorization
will be required from any governmental authority or agency, regulatory or self-regulatory agency or other third party (including the
Trading Market) in connection with the issuance of the Notes, the Warrants, or the Investor Shares or the other transactions contemplated
by this Agreement (including the issuance of the Conversion Shares upon conversion of the Notes and the Warrant Shares upon exercise
of the Warrants) and (ii) the issuance of the Notes, the Warrants, the issuance of the Conversion Shares upon the conversion of a Note
and the issuance of the Warrants Shares upon exercise of a Warrant will be exempt from the registration and qualification requirements
under the 1933 Act and all applicable state securities Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.4</b>
<span style="text-decoration: underline">Capitalization and Subsidiaries</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The authorized Capital Stock of the Company consists of 700,000,000 shares of Common Stock and 100,000,000 shares of preferred stock
to be designated by the Board of Directors (the &#8220;Preferred Stock&#8221;). As of the close of business on September 30, 2025, 8,910,204
shares of Common Stock were issued and outstanding and zero shares of preferred stock were issued and outstanding. Since September 30,
2025, and through the date of this Agreement, the Company has issued 959,354 additional shares of Common Stock and zero shares of preferred
stock. As of September 30, 2025, (i) an aggregate of 220,796 shares of Common Stock are reserved for future issuance under the Stardust
Power Inc, Equity Incentive plan and (ii) 1,136,102 shares of Common Stock are reserved for issuance upon exercise of outstanding warrants
with exercise prices $115 per share. The Company has duly reserved up to 12,185,615 shares of Common Stock for issuance upon conversion
of the Notes and exercise of the Warrants. The Conversion Shares and Warrant Shares, when issued upon conversion of the Notes or exercise
of the Warrants, in accordance with their respective terms, will be validly issued, fully paid and non-assessable and free from all taxes,
liens and charges with respect to the issuance thereof. No shares of the Company&#8217;s Capital Stock are subject to preemptive rights
or any other similar rights or any liens or encumbrances suffered or permitted by the Company. The Company&#8217;s Certificate of Incorporation
and Bylaws on file on the SEC&#8217;s EDGAR website are true and correct copies of the Company&#8217;s Certificate of Incorporation and
Bylaws as in effect as of the Closing Date. The Company is not in violation of any provision of its Certificate of Incorporation and
Bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Schedule 3.4(b)</span> lists each direct and indirect subsidiary of the Company (each, a &#8220;<b>Subsidiary</b>&#8221;
and collectively, the &#8220;<b>Subsidiaries</b>&#8221;). The Company owns, directly or indirectly, all of the capital stock or other
equity interests of each Subsidiary. No Subsidiary has any outstanding stock options, warrants or other instruments pursuant to which
such Subsidiary may at any time or under any circumstances be obligated to issue any shares of its capital stock or other Equity Interests.
Each Subsidiary is duly organized and validly existing in good standing under the laws of its jurisdiction of formation (if a good standing
concept exists in such jurisdiction) and has all requisite power and authority to own its properties and to carry on its business as
now being conducted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Except as set forth on <span style="text-decoration: underline">Schedule 3.4(c)</span>, neither the Company nor any Subsidiary is bound
by any agreement or arrangement pursuant to which it is obligated to register the sale of any securities under the 1933 Act. There are
no outstanding securities of the Company or any of the Subsidiaries which contain any redemption or similar provisions, and there are
no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem or
purchase any security of the Company or any Subsidiary. There are no outstanding securities or instruments containing anti-dilution or
similar provisions that will be triggered by the issuance of the Notes, the Warrants or the Investor Shares. Neither the Company nor
any Subsidiary has any stock appreciation rights or &#8220;phantom stock&#8221; plans or agreements or any similar plan or agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The issuance and sale of any of the Securities will not obligate the Company to issue shares of Common Stock or other securities, or
to satisfy any related contractual obligations, to any other Person and will not result in the adjustment of the exercise, conversion,
exchange, or reset price of any outstanding securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
As of the date of this Agreement, the Company has capacity under the rules and regulations of the Trading Market to issue up to 1,965,778
shares of Common Stock (or securities convertible into or exercisable for shares of Common Stock) without obtaining Shareholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.5</b>
<span style="text-decoration: underline">SEC Documents; Financial Statements</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as set forth on <span style="text-decoration: underline">Schedule 3.5(a</span>), as of the Closing Date, the Company has filed
all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements
of the 1934 Act for the two years preceding the Closing Date (or such shorter period as the Company was required by law or regulation
to file such material) (all of the foregoing filed prior to the Closing Date and all exhibits included therein and financial statements
and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &#8220;<b>SEC Documents</b>&#8221;).
As of their respective filing dates and subject to amendments thereto filed with the SEC, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC
Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As of their respective dates, the financial statements of the Company included in the SEC Documents complied as to form in all material
respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial
statements have been prepared in accordance with GAAP, and audited by a firm that is a member of the Public Companies Accounting Oversight
Board consistently applied, during the periods involved (except as may be otherwise indicated in such financial statements or the notes
thereto, or, in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements)
and fairly present in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated
results of its operations and consolidated cash flows for the periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments). No other written information provided by or on behalf of the Company to the Investor in connection with
the Investor&#8217;s purchase of the Notes or the Warrants which is not included in the SEC Documents contains any untrue statement of
a material fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstance under
which they are or were made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Except as set forth on Schedule 3.5(c), the Company and each of the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (iii) reasonable controls to safeguard assets are in place and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.6</b>
<span style="text-decoration: underline">Litigation and Regulatory Proceedings</span>. Except as set forth on Schedule 3.6, there are
no material actions, causes of action, suits, claims, proceedings, inquiries or investigations (collectively, &#8220;<b>Proceedings</b>&#8221;)
before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive
officers of Company or any of the Subsidiaries, threatened against or affecting the Company or any of the Subsidiaries, the Common Stock
or any other class of issued and outstanding shares of the Company&#8217;s Capital Stock, or any of the Company&#8217;s or the Subsidiaries&#8217;
officers or directors in their capacities as such and, to the knowledge of the executive officers of the Company, there is no reason
to believe that there is any basis for any such Proceeding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.7</b>
<span style="text-decoration: underline">No Undisclosed Events, Liabilities or Developments</span>. No event, development or circumstance
has occurred or exists, or to the knowledge of the executive officers of the Company is reasonably anticipated to occur or exist that
(a) would reasonably be anticipated to have a Material Adverse Effect or (b) would be required to be disclosed by the Company under applicable
securities Laws on a registration statement filed with the SEC relating to an issuance and sale by the Company of its Common Stock and
which has not been publicly announced.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.8</b>
<span style="text-decoration: underline">Compliance with Law</span>. Except as set forth on Schedule 3.8 conducted and are conducting
their respective businesses in compliance in all material respects with all applicable Laws and are in compliance in all material respects
with the rules and regulations of the Trading Market. The Company is not aware of any facts which could reasonably be anticipated to
lead to have the effect of, delisting the of the Common Stock from the Trading Market, nor has the Company received any notification
that the Trading Market is currently contemplating terminating such listing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.9</b>
<span style="text-decoration: underline">Employee Relations</span>. Neither the Company nor any Subsidiary is involved in any union labor
dispute nor, to the knowledge of the Company, is any such dispute threatened. Neither the Company nor any Subsidiary is a party to any
collective bargaining agreement. No executive officer (as defined in Rule 501(f) of the 1933 Act) has notified the Company that such
officer intends to leave the Company&#8217;s employ or otherwise terminate such officer&#8217;s employment with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.10</b>
<span style="text-decoration: underline">Intellectual Property Rights</span>. The Company and each Subsidiary owns or possesses adequate
rights or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights,
copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights (collectively,
&#8220;<b>IP Rights</b>&#8221;) necessary to conduct their respective businesses as now conducted. None of the material IP Rights of
the Company or any of the Subsidiaries are expected to expire or terminate within three (3) years from the date of this Agreement. Neither
the Company nor any Subsidiary is infringing, misappropriating or otherwise violating any IP Rights of any other Person. No claim has
been asserted, and no Proceeding is pending, against the Company or any Subsidiary alleging that the Company or any Subsidiary is infringing,
misappropriating or otherwise violating the IP Rights of any other Person, and, to the Company&#8217;s knowledge, no such claim or Proceeding
is threatened, and the Company is not aware of any facts or circumstances which might give rise to any such claim or Proceeding. The
Company and the Subsidiaries have taken commercially reasonable security measures to protect the secrecy, confidentiality and value of
all of their material IP Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.11</b>
<span style="text-decoration: underline">Environmental Laws</span>. Except, in each case, as would not be reasonably anticipated to have
a Material Adverse Effect, the Company and the Subsidiaries (a) are in compliance with any and all applicable Laws relating to the protection
of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants, (b) have received
and hold all permits, licenses or other approvals required of them under all such Laws to conduct their respective businesses and (c)
are in compliance with all terms and conditions of any such permit, license or approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.12</b>
<span style="text-decoration: underline">Title to Assets</span>. The Company and the Subsidiaries have good and marketable title to all
personal property owned by them which is material to their respective businesses, in each case free and clear of all liens, encumbrances
and defects, except for Permitted Liens. Any real property and facilities held under lease by the Company or any Subsidiary are held
under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed
to be made of such property and buildings by the Company and the Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.13</b>
<span style="text-decoration: underline">Insurance</span>. The Company and each of the Subsidiaries are insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as management of the Company reasonably believes to be prudent
and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor any of the Subsidiaries
has been refused any insurance coverage sought or applied for, and the Company has no reason to believe that it will not be able to renew
all existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.14</b>
<span style="text-decoration: underline">Regulatory Permits</span>. The Company and the Subsidiaries have in full force and effect all
certificates, approvals, authorizations and permits from all regulatory authorities and agencies necessary to own, lease or operate their
respective properties and assets and conduct their respective businesses, and neither the Company nor any Subsidiary has received any
notice of Proceedings relating to the revocation or modification of any such certificate, approval, authorization or permit, except for
such certificates, approvals, authorizations or permits with respect to which the failure to hold would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.15</b>
<span style="text-decoration: underline">No Materially Adverse Contracts, Etc</span>. Neither the Company nor any of the Subsidiaries
is (a) subject to any charter, corporate or other legal restriction, or any judgment, decree or order which in the judgment of the Company&#8217;s
officers has or is expected in the future to have a Material Adverse Effect or (b) a party to any contract or agreement which in the
judgment of the Company&#8217;s management has or would reasonably be anticipated to have a Material Adverse Effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.16</b>
<span style="text-decoration: underline">Taxes</span>. The Company and the Subsidiaries each has made or filed, or caused to be made
or filed, all United States federal and other material tax returns, reports and declarations required by any jurisdiction to which it
is subject and has paid all taxes and other governmental assessments and charges that are material in amount, required to be paid by
it, regardless of whether such amounts are shown or determined to be due on such returns, reports and declarations, except those being
contested in good faith by appropriate proceedings and for which it has set aside on its books provision reasonably adequate for the
payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.17
</b><span style="text-decoration: underline">Solvency</span>. Excluding the Indebtedness set forth on Schedule 3.17, after giving effect
to the receipt by the Company of the proceeds from the transactions contemplated by this Agreement (a) the Company&#8217;s fair saleable
value of its assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other
liabilities (including known contingent liabilities) as they mature; and (b) the current cash flow of the Company, together with the
proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash,
would be sufficient to pay all amounts on or in respect of its debt when such amounts are required to be paid. The Company does not intend
to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file
for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.18
</b><span style="text-decoration: underline">Investment Company</span>. The Company is not, and is not an Affiliate of, an &#8220;investment
company&#8221; within the meaning of the Investment Company Act of 1940, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.19</b>
<span style="text-decoration: underline">Certain Transactions</span>. Other than as disclosed in the SEC Documents, there are no contracts,
transactions, arrangements or understandings between the Company or any of its Subsidiaries, on the one hand, and any director, officer
or employee thereof on the other hand, that would be required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the
SEC in the Company&#8217;s Annual Report on Form 10-K or proxy statement pertaining to an annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.20</b>
<span style="text-decoration: underline">No General Solicitation</span>. Neither the Company, nor any of its Affiliates, nor any person
acting on its behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in
connection with the offer or sale of the Notes, the Warrants or the Investor Shares pursuant to this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.21</b>
<span style="text-decoration: underline">Acknowledgment Regarding the Investor&#8217;s Purchase of the Notes and the Warrants</span>.
The Company&#8217;s Board of Directors has approved the execution of the Transaction Documents and the issuance and sale of the Notes
and the Warrants, based on its own independent evaluation and determination that the terms of the Transaction Documents are reasonable
and fair to the Company and in the best interests of the Company and its stockholders. The Company is entering into this Agreement and
is issuing and selling the Notes and the Warrants voluntarily and without economic duress. The Company has had independent legal counsel
of its own choosing review the Transaction Documents and advise the Company with respect thereto. The Company acknowledges and agrees
that the Investor is acting solely in the capacity of an arm&#8217;s length purchaser with respect to the Notes and the Warrants and
the transactions contemplated hereby and that neither the Investor nor any person affiliated with the Investor is acting as a financial
advisor to, or a fiduciary of, the Company (or in any similar capacity) with respect to execution of the Transaction Documents or the
issuance of the Notes and the Warrants or any other transaction contemplated hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.22</b>
<span style="text-decoration: underline">Brokers&#8217;, Finders&#8217; or Other Advisory Fees or Commissions</span>. Except as set forth
in the Disclosure Letter, no brokers, finders or other similar advisory fees or commissions will be payable by the Company or any Subsidiary
or by any of their respective agents with respect to the issuance of the Notes or any of the other transactions contemplated by this
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.23
</b><span style="text-decoration: underline">OFAC</span>. None of the Company nor any of the Subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee, affiliate or person acting on behalf of the Company and/or any Subsidiary has been or
is currently subject to any United States sanctions administered by the Office of Foreign Assets Control of the United States Department
of the Treasury (&#8220;<b>OFAC</b>&#8221;); and the Company will not directly or indirectly use any proceeds received from the Investor,
or lend, contribute or otherwise make available such proceeds to its Subsidiaries or to any affiliated entity, joint venture partner
or other person or entity, to finance any investments in, or make any payments to, any country or person currently subject to any of
the sanctions of the United States administered by OFAC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.24
</b><span style="text-decoration: underline">No Foreign Corrupt Practices</span>. None of the Company or any of the Subsidiaries has,
directly or indirectly: (a) made or authorized any contribution, payment or gift of funds or property to any official, employee or agent
of any governmental authority of any jurisdiction except as otherwise permitted under applicable Law; or (b) made any contribution to
any candidate for public office, in either case, where either the payment or the purpose of such contribution, payment or gift was, is,
or would be prohibited under the Foreign Corrupt Practices Act or the rules and regulations promulgated thereunder or under any other
legislation of any relevant jurisdiction covering a similar subject matter applicable to the Company or its Subsidiaries and their respective
operations and the Company has instituted and maintained policies and procedures designed to ensure, and which are reasonably expected
to continue to ensure, continued compliance with such legislation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.25
</b><span style="text-decoration: underline">Anti-Money Laundering</span>. The operations of each of the Company and the Subsidiaries
are and have been conducted at all times in compliance with all applicable anti-money laundering laws, regulations, rules and guidelines
in its jurisdiction of incorporation and in each other jurisdiction in which such entity, as the case may be, conducts business (collectively,
the &#8220;<b>Money Laundering Laws</b>&#8221;) and no action, suit or proceeding by or before any court or governmental authority involving
the Company or its Subsidiaries with respect to any of the Money Laundering Laws is, to the knowledge of the Company, pending, threatened
or contemplated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.26
</b><span style="text-decoration: underline">Disclosure</span>. The Company confirms that neither it, nor to its knowledge, any other
Person acting on its behalf has provided the Investor or its agents or counsel with any information that the Company believes constitutes
material, non-public information. The Company understands and confirms that the Investor will rely on the foregoing representations and
covenants in effecting transactions in securities of the Company. All disclosures provided to the Investor regarding the Company, its
business and the transactions contemplated hereby, furnished by or on behalf of the Company (including the Company&#8217;s representations
and warranties set forth in this Agreement) are true and correct in all material respects and do not contain any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances
under which they were made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>4.</b></span><b>
<span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS AND WARRANTIES
OF THE INVESTOR</span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Investor represents and warrants
to the Company as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.1</b>
<span style="text-decoration: underline">Organization and Qualification</span>. The Investor is a limited liability company, duly formed
and validly existing in good standing under the laws of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.2</b>
<span style="text-decoration: underline">Authorization; Enforcement; Compliance with Other Instruments</span>. The Investor has the requisite
power and authority to enter into this Agreement and the Security Agreement, to purchase the Notes, the Warrants and the Investor Shares
and to perform its obligations under the Transaction Documents. The execution and delivery of the Transaction Documents to which it is
a party have been duly and validly authorized by the Investor&#8217;s governing body and no further consent or authorization is required.
The Transaction Documents to which it is a party have been duly and validly executed and delivered by the Investor and constitute valid
and binding obligations of the Investor, enforceable against the Investor in accordance with their terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally, the enforcement of creditors&#8217; rights and remedies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.3</b>
<span style="text-decoration: underline">No Conflicts</span>. The execution, delivery and performance of the Transaction Documents to
which it is a party by the Investor and the purchase of the Notes, the Warrants, and the Investor Shares by the Investor will not (a)
conflict with or result in a violation of the Investor&#8217;s organizational documents, (b) conflict with, or constitute a material
default (or an event which, with notice or lapse of time or both, would become a material default) under, or give to others any rights
of termination, amendment, acceleration or cancellation of, any material agreement, contract, indenture mortgage, indebtedness or instrument
to which the Investor is a party, or (c) violate in any material respect any Law applicable to the Investor or by which any of the Investor&#8217;s
properties or assets are bound or affected. No approval or authorization will be required from any governmental authority or agency,
regulatory or self-regulatory agency or other third party in connection with the purchase of the Notes, the Warrants and the Investor
Shares and the other transactions contemplated by this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.4</b>
<span style="text-decoration: underline">Investment Intent; Accredited Investor</span>. The Investor is purchasing the Notes, the Warrants
and the Investor Shares for its own account, for investment purposes, and not with a view towards distribution. The Investor is an &#8220;accredited
investor&#8221; as such term is defined in Rule 501(a) of Regulation D of the 1933 Act. The Investor has, by reason of its business and
financial experience, such knowledge, sophistication and experience in financial and business matters and in making investment decisions
of this type that it is capable of (a) evaluating the merits and risks of an investment in the Notes, the Warrants and the Investor Shares
and making an informed investment decision, (b) protecting its own interests and (c) bearing the economic risk of such investment for
an indefinite period of time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.5
</b><span style="text-decoration: underline">Certain Trading Activities</span>. The Investor has not directly or indirectly, nor has
any Person acting on behalf of or pursuant to any understanding with the Investor, engaged in any transactions in the securities of the
Company (including, without limitation, any Short Sales (as such term is defined in Rule 200 of Regulation SHO of the 1934 Act) involving
the Company&#8217;s securities) during the period commencing on September 30, 2025 and ending immediately prior to the execution of this
Agreement by such Investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.6</b>
<span style="text-decoration: underline">No Other Representations.</span> Except for the representations and warranties set forth in
this Agreement and in other Transaction Documents, the Investor makes no other representations or warranties to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>5.</b></span><b>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER AGREEMENTS OF THE PARTIES</span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.1
</b><span style="text-decoration: underline">Legends, etc</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities may only be disposed of pursuant to an effective registration statement under the 1933 Act, to the Company or pursuant
to an available exemption from or in a transaction not subject to the registration requirements of the 1933 Act, and in compliance with
any applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Certificates evidencing the Securities will contain the following legend, so long as is required by this <span style="text-decoration: underline">Section
5.1(b)</span> or <span style="text-decoration: underline">Section 5.1(c)</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER
THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON CONVERSION OF THESE SECURITIES HAVE BEEN REGISTERED] [THESE SECURITIES HAVE NOT BEEN
REGISTERED] WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR
SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN
A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE
TO THE COMPANY. _THESE SECURITIES AND THE SECURITIES ISSUABLE UPON CONVERSION OF THESE SECURITIES] [THESE SECURITIES] MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the Investor may from time to time pledge, and/or grant a security interest in some or all of the
Securities, in accordance with applicable securities laws, pursuant to a bona fide margin agreement in connection with a bona fide margin
account and, if required under the terms of such agreement or account, the Investor may transfer pledged or secured Securities to the
pledgees or secured parties. Such a pledge or transfer would not be subject to approval or consent of the Company and no legal opinion
of legal counsel to the pledgee, secured party or pledgor shall be required in connection with the pledge, but such legal opinion may
be required in connection with a subsequent transfer following default by the Investor transferee of the pledge. No notice shall be required
of such pledge. At the Company&#8217;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured
party of Securities may reasonably request in connection with a pledge or transfer of the Securities including the preparation and filing
of any required prospectus supplement under Rule 424(b)(3) of the 1933 Act or other applicable provision of the 1933 Act to appropriately
amend the list of selling stockholders thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Investor Shares shall not contain any legend (including the legend set forth in <span style="text-decoration: underline">Section
5.1(b)</span>): (i) while a Registration Statement is effective under the 1933 Act, (ii) following any sale of such Investor Shares pursuant
to Rule 144, (iii) while such Investor Shares are eligible for sale without restriction under Rule 144(k), or (iv) if such legend is
not required under applicable requirements of the 1933 Act (including judicial interpretations and pronouncements issued by the Staff
of the SEC). The Company shall cause its counsel to issue any legal opinion or instruction required by the Company&#8217;s transfer agent
to comply with the requirements set forth in this Section. At such time as a legend is no longer required for the Investor Shares under
this <span style="text-decoration: underline">Section 5.1(c)</span>, the Company will, no later than two (2) Business Day following the
delivery by the Investor to the Company or the Company&#8217;s transfer agent of a certificate representing Investor Shares containing
a restrictive legend (such third Business Day, the &#8220;<b>Legend Removal Date</b>&#8221;), deliver or cause to be delivered to the
Investor a book entry statement representing such Investor Shares that is free from all restrictive and other legends. In addition to
any other remedies available to the Investor, the Company shall pay to the Investor, in cash, as partial liquidated damages and not as
a penalty, for each $1,000 of Investor Shares (based on the VWAP of the Common Stock on the date such Investor Shares are submitted to
the Company or the Company&#8217;s transfer agent) delivered for removal of the restrictive or other legend, $5 per Trading Day for each
Trading Day after the Legend Removal Date until such Investor Shares are delivered without a legend. The Company may not make any notation
on its records or give instructions to any transfer agent of the Company that enlarge the restrictions on transfer set forth in this
Section except as it may reasonably determine are necessary or appropriate to comply or to ensure compliance with those applicable laws
that are enacted or modified after the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.2
</b><span style="text-decoration: underline">Furnishing of Information</span>. As long as the Investor owns the Securities, the Company
covenants to use commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to the 1934 Act. As long as the Investor
owns the Securities, if the Company is not required to file reports pursuant to such laws, it will prepare and furnish to the Investor
and make publicly available in accordance with Rule 144(c) such information as is required for the Investor to sell the Investor Shares
under Rule 144. The Company further covenants that it will take such further action as any holder of the Securities may reasonably request,
all to the extent required from time to time to enable such Person to sell such Investor Shares without registration under the 1933 Act
within the limitation of the exemptions provided by Rule 144 or other applicable exemptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.3
</b><span style="text-decoration: underline">Integration</span>. The Company shall not, and shall use its commercially reasonable efforts
to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of
any security (as defined in Section 2 of the 1933 Act) that will be integrated with the offer or sale of the Securities in a manner that
would require the registration under the 1933 Act of the sale of the Securities to the Investor, or that will be integrated with the
offer or sale of the Securities for purposes of the rules and regulations of any Trading Market that would require, under the rules of
the Trading Market, the Shareholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.4
</b><span style="text-decoration: underline">Notification of Certain Events</span>. The Company shall give prompt written notice to the
Investor of (a) the occurrence or non-occurrence of any Event, the occurrence or non-occurrence of which would render any representation
or warranty of the Company contained in this Agreement or any other Transaction Documents, if made on or immediately following the date
of such Event, untrue or inaccurate in any material respect, (b) the occurrence of any Event that, individually or in combination with
any other Events, has had or could reasonably be expected to have a Material Adverse Effect, (c) any failure of the Company to comply
with or satisfy any covenant or agreement to be complied with or satisfied by it hereunder or any Event that would otherwise result in
the nonfulfillment of any of the conditions to the Investor&#8217;s obligations hereunder, (d) any written notice or other written communication
from any Person alleging that the consent of such Person is or may be required in connection with the consummation of the transactions
contemplated by this Agreement or any other Transaction Documents, or (e) any Proceeding pending or, to the Company&#8217;s knowledge,
threatened against a party relating to the transactions contemplated by this Agreement or any other Transaction Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.5</b>
<span style="text-decoration: underline">Available Stock</span>. The Company shall at all times keep authorized and reserved and available
for issuance, free of preemptive rights, such number of shares of Common Stock as are issuable upon repayment or conversion in full of
the Notes and exercise in full of the Warrants at any time. If the Company determines at any time that it does not have a sufficient
number of authorized shares of Common Stock to reserve and keep available for issuance as described in this <span style="text-decoration: underline">Section
5.5</span>, the Company shall use all commercially reasonable efforts to increase the number of authorized shares of Common Stock by
seeking Shareholder Approval for the authorization of such additional shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.6</b>
<span style="text-decoration: underline">Use of Proceeds</span>. The Company will use the proceeds from the sale of the Notes and Warrants
for general working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.7
</b><span style="text-decoration: underline">Repayment of Indebtedness</span>. The Company shall not make any voluntary cash prepayments
on any Indebtedness other than in respect of the Notes and, so long as no Event of Default has occurred, in respect of Permitted Indebtedness
Repayments, at any time while any amounts are owing under the Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.8
</b><span style="text-decoration: underline">Subordination in Connection with Project Finance</span>. If in connection with the incurrence
of Permitted Senior Indebtedness by the Company or a Subsidiary in a single financing resulting in proceeds to the Company or a Subsidiary
of no less than twenty-million dollars ($20,000,000.00) to be applied towards project finance, the party providing such financing requires
the Investor to subordinate the obligations of the Company in respect of the Notes, to the obligations of the Company to such party in
respect of such financing, then the Investor agrees that it shall enter into a subordination or intercreditor agreement providing for
such subordination provided that such subordination or intercreditor agreement is acceptable to Investor in its reasonable discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.9
</b><span style="text-decoration: underline">Prohibited Transactions; Equity and Indebtedness Issuances</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.10
</b>The Company hereby covenants and agrees not to enter into any Prohibited Transactions without the Investor&#8217;s prior written
consent, until thirty (30) days after such time as the Notes have been repaid in full, as applicable, and/or have been converted into
Conversion Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Notwithstanding any other provisions set forth in the Transaction Documents, except for Exempted Securities and Permitted Indebtedness,
the Company hereby covenants and agrees not to issue any equity or debt securities, or otherwise incur any Indebtedness for period beginning
on the date hereof and ending on the date that is forty-five (45) days following the date the Investor Shares issuable in respect of
the Notes and Warrants issued in the initial Closing may be offered or sold pursuant to an effective Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.11
</b><span style="text-decoration: underline">Securities Laws Disclosure; Publicity</span>. The Company shall, by 9:00 a.m. (New York
City time) on the Trading Day immediately following the date hereof, issue a press release disclosing the material terms of the transactions
contemplated hereby (the <b>&#8220;Press Release&#8221;</b>), and shall, within four (4) days following the date hereof, file a Current
Report on Form 8-K (the <b>&#8220;Form 8-K&#8221;</b>) disclosing the material terms of the transactions contemplated hereby and including
this Agreement as an exhibit thereto; provided, that the Company may not issue the Press Release without the Investor&#8217;s prior written
consent. The Company shall provide a copy of the draft Form 8-K to the Investor for review prior to release and the Company shall incorporate
the Investor&#8217;s reasonable comments. The Company shall not issue any press release nor otherwise make any such public statement
regarding the Investor or the Transaction Documents without the prior written consent of the Investor, except if such disclosure is made
in a manner consistent with the Press Release or Form 8-K, or is required by law, in which case the Company shall (a) ensure that such
disclosure is restricted and limited in content and scope to the maximum extent permitted by Law to meet the relevant disclosure requirement
and (b) provide a copy of the proposed disclosure to the Investor for review prior to release and the Company shall incorporate the Investor&#8217;s
reasonable comments. Following the execution of this Agreement, the Investor and its Affiliates and/or advisors may place announcements
on their respective corporate websites and in financial and other newspapers and publications (including, without limitation, customary
&#8220;tombstone&#8221; advertisements) describing the Investor&#8217;s relationship with the Company under this Agreement in a manner
consistent with the Press Release or Form 8-K and including the name and corporate logo of the Company. Notwithstanding anything herein
to the contrary, to comply with United States Treasury Regulations Section 1.6011-4(b)(3)(i), each of the Company and the Investor, and
each employee, representative or other agent of the Company or the Investor, may disclose to any and all persons, without limitation
of any kind, the U.S. federal and state income tax treatment, and the U.S. federal and state income tax structure, of the transactions
contemplated hereby and all materials of any kind (including opinions or other tax analyses) that are provided to such party relating
to such tax treatment and tax structure insofar as such treatment and/or structure relates to a U.S. federal or state income tax strategy
provided to such recipient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.12
</b><span style="text-decoration: underline">Indemnification of the Investor</span>. Subject to the provisions of this Section 5.11,
the Company will indemnify and hold the Investor and its directors, officers, shareholders, members, partners, employees and agents (and
any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other
title), each Person who controls the Investor (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;<b>Investor
Party</b>&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including
all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such
Investor Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents, (b) any action instituted against the Investor
Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of
such Investor Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely
based upon a material breach of such Investor Party&#8217;s of any agreements or understandings such Investor Party may have with any
such stockholder), (c) any misrepresentation made by the Company in any Transaction Documents or in any SEC Document, (d) any omission
to state any material fact necessary in order to make the statements made in any SEC Document, in light of the circumstances under which
they were made, not misleading, or (e) any Proceeding before or by any court, public board, government agency, self-regulatory organization
or body based upon, or resulting from the execution, delivery, performance or enforcement of any of the Transaction Documents or the
consummation of the transactions contemplated thereby, and whether or not an Investor Party is party thereto by claim, counterclaim,
crossclaim, as a defendant or otherwise, or if such Proceeding is based upon, or results from, any of the items set forth in clauses
(a) through (e) above. If any action shall be brought against any Investor Party in respect of which indemnity may be sought pursuant
to this Agreement, such Investor Party shall promptly notify the Company in writing, and the Company shall have the right to assume the
defense thereof with counsel of its own choosing reasonably acceptable to the Investor Party. Any Investor Party shall have the right
to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall
be at the expense of such Investor Party except to the extent that (i) the employment thereof has been specifically authorized by the
Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii)
in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the
Company and the position of such Investor Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Investor Party under this Agreement (y) for any settlement
by an Investor Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed;
or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Investor Party&#8217;s breach
of any of the representations, warranties, covenants or agreements made by such Investor Party in this Agreement or in the other Transaction
Documents. The indemnification required by this <span style="text-decoration: underline">Section 5.11</span> shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The
indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Investor Party against the
Company or others and any liabilities the Company may be subject to pursuant to law. The provisions of this <span style="text-decoration: underline">Section
5.12</span> shall survive the termination or expiration of this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.13
</b><span style="text-decoration: underline">Non-Public Information</span>. the Company covenants and agrees that neither it nor any
other Person acting on its behalf will provide the Investor or its agents or counsel with any information that the Company believes constitutes
material, non-public information. To the extent the Company provides the Investor with material, non-public information, the Company
shall publicly disclose such information by thirty (30) minutes prior to the opening of trading on the next succeeding Trading Day; provided,
however, in the event that such material non-public information is provided to Investor pursuant to <span style="text-decoration: underline">Section
10</span>, the Company shall publicly disclose such information within two (2) Business Days of providing the information to the Investor.
The Company understands and confirms that the Investor shall be relying on the foregoing representation in effecting transactions in
securities of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.14
</b><span style="text-decoration: underline">Shareholder Approval</span>. If required by each Trading Market on which the Common Stock
is listed, to fulfill its obligations under the Transaction Documents, the Company shall at its next annual meeting of shareholders seek
Shareholder Approval, with the recommendation of the Board of Directors that such proposal be approved, and the Company shall solicit
proxies from its shareholders in connection therewith in the same manner as all other management proposals in such proxy statement and
all management-appointed proxyholders shall vote their proxies in favor of such proposal. If the Company does not obtain Shareholder
Approval at the first meeting, the Company shall call a meeting every four months thereafter to seek Shareholder Approval until the date
the Shareholder Approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.15
</b><span style="text-decoration: underline">Listing of Securities</span>. The Company shall use its commercially reasonable efforts
to: (a) in the time and manner required by each Trading Market on which the Common Stock is listed, prepare and file with such Trading
Market a listing of additional shares form or equivalent document covering the Investor Shares, (b) take all steps necessary to cause
such shares to be approved for listing on each Trading Market on which the Common Stock is listed as soon as possible thereafter, (c)
provide to the Investor evidence of such Trading Market&#8217;s completion of review of the listing of additional shares form, and (d)
maintain the listing of such shares on each such Trading Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.16
</b><span style="text-decoration: underline">Antitrust Notification</span>. If the Investor determines, in its sole judgment and upon
the advice of counsel, that the issuance of the Notes, the Warrants and the Investor Shares pursuant to the terms hereof would be subject
to the provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;<b>HSR Act</b>&#8221;), the Company
shall file as soon as practicable after the date on which the Company receives notice from the Investor of the applicability of the HSR
Act and a request to so file with the United States Federal Trade Commission and the United States Department of Justice the notification
and report form required to be filed by it pursuant to the HSR Act in connection with such issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.17
</b><span style="text-decoration: underline">Share Transfer Agent</span>. The Company has informed the Investor of the name of its share
transfer agent and represents and warrants that the transfer agent participates in the Depository Trust Company Fast Automated Securities
Transfer program. The Company shall not change its share transfer agent without the prior written consent of the Investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.18
</b><span style="text-decoration: underline">Set-Off</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Investor may set off any of its obligations to the Company (whether or not due for payment), against any of the Company&#8217;s obligations
to the Investor (whether or not due for payment) under this Agreement and/or any other Transaction Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Investor may do anything necessary to effect any set-off undertaken in accordance with this <span style="text-decoration: underline">Section
5.18</span> (including varying the date for payment of any amount payable by the Investor to the Company).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.19
</b><span style="text-decoration: underline">No Short Sales</span>. The Investor covenants that from and after the date hereof through
and ending when the Note no longer remain outstanding (the &#8220;<b>Restricted Period</b>&#8221;), neither the Investor nor any of its
officers, or any entity managed or controlled by the Investor, or an affiliate (collectively, the &#8220;<b>Restricted Persons</b>&#8221;
and each of the foregoing is referred to herein as a &#8220;Restricted Person&#8221;) shall, directly or indirectly, engage in any &#8220;short
sale&#8221; of the Common Stock, either for its own principal account or for the principal account of any other Restricted Person. For
purposes of this Section, &#8220;short selling&#8221; shall include, without limitation, any sale of shares of the Company&#8217;s Common
Stock that the Investor does not own or has not borrowed, or any derivative or other transaction involving shares or warrants that have
the same impact as a short sale defined herewith. Any violation of this provision will be considered a material breach of this Agreement.
For the avoidance of doubt to extent that the Investor has submitted a Conversion Notice (as defined in the Notes) in accordance with
the terms of the Notes the Investor shall not be deemed to have a net short position in respect of the Investor Shares issuable in respect
of such Conversion Notice nor shall the Investor be deemed to have a short position in any Repayment Shares (as defined in the Notes)
payable in respect of any Monthly Payment following such date as the Investor shall notified the Company of the Repayment Share Price
relating to such Repayment Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>6.
</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLOSING CONDITIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.1
</b><span style="text-decoration: underline">Conditions Precedent to the Obligations of the Investor</span>. The obligations of the Investor
to fund the Notes and Warrants at each Closing are subject to the satisfaction or waiver by the Investor, at or before the Closing of
each of the following conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Required Documentation</span>. The Company must have delivered to the Investor: (i) a duly executed
certificate of an officer of the Company and each Subsidiary appending thereto (A) copies of duly executed resolutions or consents, of
the directors, members or manager, as applicable, approving and consenting to such party&#8217;s execution, performance of its obligations
under the Transaction Documents and the transaction contemplated thereby, (B) a certificate of good standing or equivalent document dated
no more than five days prior to the date hereof, in respect of such party, (C) true and correct copies of the organizational documents
of such party, and (D) incumbency signatures of such party; and (ii) copies of each Transaction Document, duly executed by the Company,
the Subsidiaries, the Transfer Agent and any other party thereto that is not the Investor, as applicable;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Consents and Permits</span>. The Company must have obtained and delivered to the Investor copies
of all necessary permits, approvals, and registrations necessary to effect this Agreement, the Transaction Documents and any of the transactions
contemplated hereby or thereby, including pursuant to <span style="text-decoration: underline">Section 3.14</span> of this Agreement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Trading Market Approval</span>. The Company shall have either (i) submitted a listing of additional
shares form with the Trading Market relating to the issuance of the Notes, the Warrants, and, upon conversion of the Notes, the Conversion
Shares, and upon exercise of the Warrants, the Warrant Shares, and if, required by the rules and regulations of the Trading Market, or
(ii) obtained and delivered to the Investor copies of all necessary Trading Market approvals for the issuance of the Notes, the Warrants,
and, upon the conversion of the Notes, the Conversion Shares, and upon exercise of the Warrants, the Warrant Shares;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">No Event(s) of Default</span>. The Investor must be of the reasonable opinion that no Event
of Default has occurred and no Event of Default would result from the execution of this Agreement or any of the Transaction Documents
or the transactions contemplated hereby or thereby;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Representations and Warranties</span>. The representations and warranties of the Company contained
herein shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made on and as
of such date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">Performance</span>. The Company shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with
by it at or prior to the Closing;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<span style="text-decoration: underline">No Injunction</span>. No statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits
the consummation of any of the transactions contemplated by the Transaction Documents;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<span style="text-decoration: underline">No Suspensions of Trading in the Common Stock; Listing</span>. Trading in the shares of Common
Stock shall not have been suspended by the SEC or any Trading Market (except for any suspensions of trading of not more than one day
on which the Trading Market is open solely to permit dissemination of material information regarding the Company) at any time since the
date of execution of this Agreement, and the Common Stock shall have been at all times since such date listed for trading on a Trading
Market;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<span style="text-decoration: underline">Limitation on Beneficial Ownership</span>. The issuance of the Notes and the Warrants shall
not cause the Investor Group to become, directly or indirectly, a &#8220;beneficial owner&#8221; (within the meaning of Section 13(d)
of the 1934 Act and the rules and regulations promulgated thereunder) of a number of Equity Interests of a class that is registered under
the 1934 Act which exceeds the Maximum Percentage of the Equity Interests of such class that are outstanding at such time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<span style="text-decoration: underline">Funds Flow Request</span>. The Company shall have delivered to the Investor a flow of funds
request, substantially in the form set out in <span style="text-decoration: underline"><b>Exhibit E</b></span>;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<span style="text-decoration: underline">Opinion of Counsel</span><b>. </b>The Investor shall have received opinions of counsel to the
Company and its Subsidiaries, acceptable to the Investor in its sole discretion; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<span style="text-decoration: underline">Voting Support Agreements</span>. The Company shall have delivered duly executed voting support
agreements executed by those shareholders holding in excess of 5% of the outstanding authorized Common Stock as of the date hereof, in
a form acceptable to the Investor, providing for the signatory to agree to vote for the Shareholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.2
</b><span style="text-decoration: underline">Conditions Precedent to the Obligations of the Company</span>. The obligations of the Company
to issue the Notes and the Warrants are subject to the satisfaction or waiver by the Company, at or before the applicable Closing, of
each of the following conditions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Representations and Warranties</span>. The representations and warranties of the Investor contained
herein shall be true and correct in all material respects as of the date when made and as of the applicable Closing Date as though made
on and as of such date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Performance</span>. The Investor shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with
by the Investor at or prior to the applicable Closing; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">No Injunction</span>. No statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits
the consummation of any of the transactions contemplated by the Transaction Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>7.
</b></span><b><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">EVENTS OF DEFAULT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.1
</b><span style="text-decoration: underline">Events of Default</span>. The occurrence of any of the following events shall be an &#8220;<b>Event
of Default</b>&#8221; under this Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
an Event of Default (as defined in the Notes);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any of the representations or warranties made by the Company or any of its agents, officers, directors, employees or representatives
in any Transaction Documents or public filing being inaccurate, false or misleading in any material respect, as of the date as of which
it is made or deemed to be made, including as of the Closing Date, or any certificate or financial or other written statements furnished
by or on behalf of the Company to the Investor or any of its representatives, is inaccurate, false or misleading, in any material respect,
as of the date as of which it is made or deemed to be made, including as of the Closing Date; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
a failure by the Company to comply with any of its covenants or agreements set forth in this Agreement, including those set forth in
<span style="text-decoration: underline">Section 9</span> and such failure continues for a period of five (5) Business Days after the
Company receives written notice from the Investor to comply with such covenant or agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.2
</b><span style="text-decoration: underline">Investor Right to Investigate an Event of Default</span>. If in the Investor&#8217;s reasonable
opinion, an Event of Default has occurred, or is or may be continuing:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the Investor may notify the Company that is wishes to investigate such purported Event of Default;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the Company shall cooperate with the Investor in such investigation;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
the Company shall comply with all reasonable requests made by the Investor to the Company in connection with any investigation by the
Investor and shall (i) provide all information requested by the Investor in relation to the Event of Default to the Investor; provided
that the Investor agrees that any materially price sensitive information and/or non-public information will be subject to confidentiality,
and (ii) provide all such requested information within three (3) Business Days of such request; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
the Company shall pay all reasonable costs incurred by the Investor in connection with any such investigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.3
</b><span style="text-decoration: underline">Remedies Upon an Event of Default</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If an Event of Default occurs pursuant to <span style="text-decoration: underline">Section 7.1(a)</span>, the Investor shall have such
remedies as are set forth in the Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If an Event of Default occurs pursuant to <span style="text-decoration: underline">Section 7.1(b)</span> or <span style="text-decoration: underline">Section
7.1(c)</span> and is not remedied within (i) five (5) Business Days for an Event of Default occurring by the Company&#8217;s failure
to comply with <span style="text-decoration: underline">Section 7.1(c)</span>, or (ii) ten (10) Business Days for an Event of Default
occurring pursuant to <span style="text-decoration: underline">Section 7.1(b)</span>, the Investor may declare, by notice to the Company,
effective immediately, all outstanding obligations by the Company under the Transaction Documents to be immediately due and payable in
immediately available funds and the Investor shall have no obligation to consummate a Closing or to accept the conversion of the Notes
into Conversion Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>8.
</b></span><b><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">TERMINATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.1
</b><span style="text-decoration: underline">Events of Termination</span>. This Agreement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
may be terminated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
by the Investor on the occurrence or existence of a Securities Termination Event or a Change of Control; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
by the mutual written consent of the Company and the Investor, at any time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
by either Party, by written notice to the other Party, effective immediately, if the initial Closing has not occurred by December 31,
2025 or such later date as the Company and the Investor agree in writing, provided that the right to terminate this Agreement under this
<span style="text-decoration: underline">Section 8.1(a)(ii)</span> is not available to any party that is in material breach of or material
default under this Agreement or whose failure to fulfill any obligation under this Agreement has been the principal cause of, or has
resulted in the failure of the Closing to occur; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
by the Investor, in accordance with <span style="text-decoration: underline">Section 7.3(b)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.2
</b><span style="text-decoration: underline">Effect of Termination</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to <span style="text-decoration: underline">Section 8.2(b)</span>, each party&#8217;s right of termination under <span style="text-decoration: underline">Section
8.1</span> is in addition to any other rights it may have under this Agreement or otherwise, and the exercise of a right of termination
will not be an election of remedies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If the Investor terminates this Agreement under <span style="text-decoration: underline">Section 8.1(a)(i)</span>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Investor may declare, by notice to the Company, all outstanding obligations by the Company under the Transaction Documents to be
due and payable without presentment, demand, protest or any other notice of any kind all of which are expressly waived by the Company,
anything to the contrary contained in this Agreement or in any other Transaction Documents notwithstanding; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Nothing in this Agreement will be deemed to release the Purchaser from any liability for any breach by such party of the terms and provisions
of this Agreement or to impair the right of any party to compel specific performance by any other Party of its obligations under this
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>9.
</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION RIGHTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.1
</b><span style="text-decoration: underline">Registration</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Registration Statement</span>. Promptly, but in any event no later than forty-five (45) days
from each Closing Date, the Company shall prepare and file with the SEC a Registration Statement or a prospectus supplement, as applicable,
covering the resale of all of the Investor Shares issuable in respect of the Notes and Warrants in such Closing, which such Registration
Statement may include shares of Common Stock issued or issuable to B. Riley Principal Capital II, LLC that have not yet been registered.
The foregoing Registration Statement shall be filed on Form S-1 (or Form S-3, if applicable) or any successor forms thereto. Each Registration
Statement (and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided to
the Investor and its counsel at least five (5) Business Days prior to its filing or other submission and the Company shall incorporate
all reasonable comments provided by the Investor or its counsel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Expenses</span>. Except as otherwise expressly provided herein, the Company will pay all fees
and expenses incident to the performance of or compliance with this <span style="text-decoration: underline">Section 9</span>, including
all fees and expenses associated with effecting the registration of the Investor Shares, including all filing and printing fees, the
Company&#8217;s counsel and accounting fees and expenses, costs associated with clearing Investor Shares for sale under applicable state
securities laws, listing fees, fees and expenses of one counsel to the Investor and the Investor&#8217;s reasonable expenses in connection
with the registration, but excluding discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar securities
industry professionals with respect to the Investor Shares being sold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Effectiveness</span>. The Company shall use its commercially reasonable efforts to have each
Registration Statement declared effective as soon as practicable after filing thereof but in no event later than the date that is ninety
(90) days following the applicable Closing Date, or as soon as practicable thereafter. The Company shall notify the Investor by e-mail
as promptly as practicable, and in any event, within twenty-four (24) hours, after such Registration Statement is declared effective
and shall simultaneously provide the Investor with copies of any related Prospectus to be used in connection with the sale or other disposition
of the securities covered thereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Piggyback Registration Rights</span>. If the Company at any time determines to file a registration
statement under the 1933 Act to register the offer and sale, by the Company, of shares of Common Stock (other than (x) on Form S-4 or
Form S-8 under the 1933 Act or any successor forms thereto, (y) an at-the-market offering, or (z) a registration of securities solely
relating to an offering and sale to employees or directors of the Company pursuant to any employee stock plan or other employee benefit
plan arrangement), the Company shall, as soon as reasonably practicable, give written notice to the Investor of its intention to so register
the offer and sale of shares of Common Stock and, upon the written request, given within five (5) Business Days after delivery of any
such notice by the Company, of the Investor to include in such registration the Investor Shares (which request shall specify the number
of Investor Shares proposed to be included in such registration), the Company shall cause all such Investor Shares to be included in
such registration statement on the same terms and conditions as the shares of Common Stock otherwise being sold pursuant to such registered
offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.2
</b><span style="text-decoration: underline">Company Obligations</span>. The Company will use its commercially reasonable efforts to
effect the registration of Investor Shares in accordance with the terms hereof, and pursuant thereto the Company will, as expeditiously
as possible:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
cause each Registration Statement to become effective and to remain continuously effective for a period that will terminate upon the
first date on which all Investor Shares issuable in respect of the Notes or Warrants issued in connection with applicable Closing have
been sold by the Investor (the &#8220;<b>Effectiveness Period</b>&#8221;) and advise the Investor in writing when the Effectiveness Period
has expired;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
prepare and file with the SEC such amendments and post-effective amendments and supplements to each Registration Statement and the Prospectus
as may be necessary to keep such Registration Statement effective for the Effectiveness Period and to comply with the provisions of the
1933 Act and the 1934 Act with respect to the distribution of all of the Investor Shares covered thereby;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
provide copies to and permit counsel designated by the Investor to review all amendments and supplements to a Registration Statement
no fewer than three (3) Business Days prior to its filing with the SEC and not file any document to which such counsel reasonably objects;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
furnish to the Investor and its legal counsel, without charge, (i) promptly after the same is prepared and publicly distributed, filed
with the SEC, or received by the Company (but not later than two (2) Business Days after the filing date, receipt date or sending date,
as the case may be) one copy of each Registration Statement and any amendment thereto, each preliminary prospectus and Prospectus and
each amendment or supplement thereto, and each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and
each item of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement (other than any
portion of any thereof which contains information for which the Company has sought confidential treatment), and (ii) such number of copies
of a Prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other documents as the Investor
may reasonably request in order to facilitate the disposition of the Investor Shares that are covered by the related Registration Statement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
immediately notify the Investor of any request by the SEC for the amending or supplementing of a Registration Statement or Prospectus
or for additional information;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
use its commercially reasonable efforts prevent the issuance of any stop order or other suspension of effectiveness and, if such order
is issued, obtain the withdrawal of any such order at the earliest possible moment and notify the Company of the issuance of any such
order and the resolution thereof, or its receipt of notice of the initiation or threat of any proceeding for such purpose;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
prior to any public offering of Investor Shares, to register or qualify or cooperate with the Investor and its counsel in connection
with the registration or qualification of such Investor Shares for offer and sale under the securities or blue sky laws of such jurisdictions
requested by the Investor and do any and all other commercially reasonable acts or things necessary or advisable to enable the distribution
in such jurisdictions of the Investor Shares covered by a Registration Statement and the Company shall promptly notify the Investor of
any notification with respect to the suspension of the registration or qualification of any of such Investor Shares for sale under the
securities or blue sky laws of such jurisdictions or its receipt of notice of the initiation or threat of any proceeding for such purpose;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
immediately notify the Investor, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening
of any event as a result of which, a Registration Statement or Prospectus includes an untrue statement of a material fact or omits to
state any material fact required to be stated therein or necessary to make the statements therein not misleading (in the case of the
Prospectus, in light of the circumstances in which they were made), and promptly prepare, file with the SEC and furnish to such holder
a supplement to or an amendment of such Registration Statement or Prospectus as may be necessary so that such Registration Statement
or Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading (in the case of such Prospectus, in light of the circumstances in which they
were made);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
to comply with all applicable rules and regulations of the SEC under the 1933 Act and the 1934 Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i) disclosure of
such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to
complete a Registration Statement or to avoid or correct a misstatement or omission in such Registration Statement, (iii) the release
of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent
jurisdiction, or (iv) such information has been made generally available to the public other than by disclosure in violation of this
Agreement or any other agreement, and upon learning that disclosure of such information concerning the Investor is sought in or by a
court or governmental body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the
Investor, at the Investor&#8217;s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order
for, such information; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of all Investor Shares pursuant to
each Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.3
</b><span style="text-decoration: underline">Indemnification</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Indemnification by the Company</span>. The Company will indemnify and hold harmless the Investor
Parties, from and against any losses to which they may become subject under the 1933 Act or otherwise, arising out of, relating to or
based upon: (i) any untrue statement or alleged untrue statement of any material fact contained in any Registration Statement, any preliminary
Prospectus, final Prospectus or other document, including any Blue Sky Application (as defined below), or any amendment or supplement
thereof or any omission or alleged omission of a material fact required to be stated therein or, in the case of the Registration Statement,
necessary to make the statements therein not misleading or, in the case of any preliminary Prospectus, final Prospectus or other document,
necessary to make the statements therein, in light of the circumstances in which they were made, not misleading; (ii) any Blue Sky Application
or other document executed by the Company specifically for that purpose or based upon written information furnished by the Company filed
in any state or other jurisdiction in order to qualify any or all of the Investor Shares under the securities laws thereof (any such
application, document or information herein called a &#8220;<b>Blue Sky Application</b>&#8221;); (iii) any violation or alleged violation
by the Company or its agents of the 1933 Act, the 1934 Act or any similar federal or state law or any rule or regulation promulgated
thereunder applicable to the Company or its agents and relating to any action or inaction required of the Company in connection with
the registration or the offer or sale of the Investor Shares pursuant to any Registration Statement; or (iv) any failure to register
or qualify the Investor Shares included in any such Registration Statement in any state where the Company or its agents has affirmatively
undertaken or agreed in writing that the Company will undertake such registration or qualification on the Investor&#8217;s behalf and
will reimburse the Investor Indemnified Parties for any legal or other expenses reasonably incurred by them in connection with investigating,
preparing or defending any such losses; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>,
that the Company will not be liable in any such case if and to the extent, but only to the extent, that any such losses arise out of
or are based upon an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information
furnished by the Investor or any such controlling Person in writing specifically for use in such Registration Statement or Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Conduct of Indemnification Proceedings</span>. Any Person entitled to indemnification hereunder
shall (i) give prompt notice to the indemnifying party of any claim, action, suit or proceeding with respect to which it seeks indemnification
following such Person&#8217;s receipt of, or such Person otherwise become aware of, the commencement of such claim, action, suit or proceeding
and (ii) permit such indemnifying party to assume the defense of such claim, action, suit or proceeding with counsel reasonably satisfactory
to the indemnified party; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>,
that any Person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense
of such claim, but the fees and expenses of such counsel shall be at the expense of such Person unless (A) the indemnifying party has
agreed to pay such fees or expenses, (B) the indemnifying party shall have failed to assume the defense of such claim and employ counsel
reasonably satisfactory to such Person or (C) in the reasonable judgment of any such Person, based upon written advice of its counsel,
a conflict of interest exists between such Person and the indemnifying party with respect to such claims (in which case, if the Person
notifies the indemnifying party in writing that such Person elects to employ separate counsel at the expense of the indemnifying party,
the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person); and <span style="text-decoration: underline">provided</span>,
<span style="text-decoration: underline">further</span>, that the failure or delay of any indemnified party to give notice as provided
herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure or delay to give
notice shall materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that
the indemnifying party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more
than one separate firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent
of the indemnified party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such claim or
litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Contribution</span>. If for any reason the indemnification provided for in the preceding paragraph
(a) is unavailable to an indemnified party or insufficient to hold it harmless, other than as expressly specified therein, the indemnifying
party shall contribute to the amount paid or payable by the indemnified party as a result of such losses in such proportion as is appropriate
to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant equitable considerations.
No Person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the 1933 Act shall be entitled to contribution
from any Person not guilty of such fraudulent misrepresentation. The indemnity and contribution agreements contained in this Section
are in addition to any other rights or remedies that any indemnified party may have under applicable law, by separate agreement or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.4
</b><span style="text-decoration: underline">Effect of Failure to File and Maintain Effectiveness of any Registration Statement</span>.
In addition to any other remedies provided under the Transaction Documents, if (i) a Registration Statement covering the resale of all
of the Investor Shares required to be covered thereby and required to be filed by the Company pursuant to Section 9.1 is not filed with
the SEC on or before the Filing Deadline (a &#8220;<b>Filing Failure</b>&#8221;), (ii) on any day after the effective date of a Registration
Statement sales of all of the Registrable Securities required to be included on such Registration Statement cannot be made pursuant to
such Registration Statement (including, without limitation, because of a failure to keep such Registration Statement effective, a failure
to disclose such information as is necessary for sales to be made pursuant to such Registration Statement, a suspension or delisting
of (or a failure to timely list) the Common Stock on a Trading Market, or a failure to register a sufficient number of shares of Common
Stock or by reason of a stop order) or the prospectus contained therein is not available for use for any reason (a &#8220;<b>Maintenance
Failure</b>&#8221;), other than the period of time where the Registration Statement is not effective due to a post-effective amendment
filing to the Registration Statement after an Annual Report on Form 10-K is filed, or (iii) if the Company fails to file with the SEC
any required reports under Section 13 or 15(d) of the 1934 Act such that it is not in compliance with Rule 144(c)(1) (or Rule 144(i)(2),
if applicable) (a &#8220;Current Public Information Failure&#8221;) as a result of which the Investor is unable to sell those Investor
Shares included in such Registration Statement without restriction under Rule 144 (including, without limitation, volume restrictions),
then, as partial relief for the damages to any holder by reason of any such delay in, or reduction of, its ability to sell the underlying
shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity), the Company shall pay
to each holder of Investor Shares relating to such Registration Statement an amount in cash equal to one and one half percent (1.5%)
of the Outstanding Principal Amount of all of all outstanding Notes (I) on the date of such Filing Failure, Maintenance Failure or Current
Public Information Failure, as applicable, and (2) on every thirty (30) day anniversary of (I) a Filing Failure until such Filing Failure
is cured; (II) a Maintenance Failure until such Maintenance Failure is cured; and (III) a Current Public Information Failure until the
earlier of (i) the date such Current Public Information Failure is cured and (ii) such time that such public information is no longer
required pursuant to Rule 144 (in each case, pro rated for periods totaling less than thirty (30) days). The payments to which a holder
of Investor Shares shall be entitled pursuant to this Section 9.4 are referred to herein as &#8220;<b>Registration Delay Payments</b>.&#8221;
Following the initial Registration Delay Payment for any particular event or failure (which shall be paid on the date of such event or
failure, as set forth above), without limiting the foregoing, if an event or failure giving rise to the Registration Delay Payments is
cured prior to any thirty (30) day anniversary of such event or failure, then such Registration Delay Payment shall be made on the third
(3rd) Trading Day after such cure. Notwithstanding the foregoing, (i) no single event or failure with respect to a particular Registration
Statement shall give rise to more than one type of Registration Delay Payment with respect to such Registration Statement, (ii) no Registration
Delay Payments shall be owed to the Investor (with respect to any period during which all of Investor Shares may be sold by the Investor
without restriction under Rule 144 (including, without limitation, volume restrictions) and without the need for current public information
required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable), and (iii) with respect to any Investor Shares excluded from a Registration
Statement by election of the Investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>10.
</b></span><b><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL PROVISIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.1</b>
<span style="text-decoration: underline">Fees and Expenses</span>. At the Closing, the Company shall reimburse the Investor up to $35,000
of due diligence costs and reasonable fees and disbursements of Lucosky Brookman LLP and Morgan, Lewis &amp; Bockius LLP in connection
with the preparation of the Transaction Documents, it being understood that neither Lucosky Brookman LLP nor Morgan, Lewis &amp; Bockius
LLP has rendered any legal advice to the Company in connection with the transactions contemplated hereby and that the Company has relied
for such matters on the advice of its own counsel. Except as specified above, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of the Transaction Documents. The Company shall pay all stamp and other taxes and duties levied in
connection with the sale of the Notes, the Warrants and the Investor Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.2
</b><span style="text-decoration: underline">Notices</span>. Any and all notices or other communications or deliveries required or permitted
to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission,
if such notice or communication is delivered via email at the email address specified in this Section prior to 5:00 p.m. (New York time)
on a Business Day, (b) the next Business Day after the date of transmission, if such notice or communication is delivered via email at
the email address specified in this Section on a day that is not a Business Day or later than 5:00 p.m. (New York time) on any date and
earlier than 11:59 p.m. (New York time) on such date, (c) the Business Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stardust
Power Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15
E. Putnam Ace, Suite 378</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greenwich,
CT 06830</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy (which shall not constitute notice) to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference Carmel LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31<sup>st</sup> Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Investor:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lind
Global Asset Management XIII LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
The Lind Partners LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">444
Madison Avenue, Floor 41</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy (which shall not constitute notice) to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fifth
Floor</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
NJ</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(732) 395-4400</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
such other address as may be designated in writing hereafter, in the same manner, by such Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.3</b>
<span style="text-decoration: underline">Severability</span>. If any provision of this Agreement is held by a court of competent jurisdiction
to be excessive in scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so
that it is enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Agreement
will not in any way be affected or impaired thereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.4</b>
<span style="text-decoration: underline">Governing Law</span>. This Agreement shall be governed by and construed in accordance with the
Laws of the State of Delaware, without reference to principles of conflict of laws or choice of laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.5</b>
<span style="text-decoration: underline">Jurisdiction and Venue</span>. Any action, proceeding or claim arising out of, or relating in
any way to this Agreement shall be brought and enforced in the New York Supreme Court, County of New York, or in the United States District
Court for the Southern District of New York. The Company and the Investor irrevocably submit to the jurisdiction of such courts, which
jurisdiction shall be exclusive, and hereby waive any objection to such exclusive jurisdiction or that such courts represent an inconvenient
forum. The prevailing party in any such action shall be entitled to recover its reasonable and documented attorneys&#8217; fees and out-of-pocket
expenses relating to such action or proceeding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.6</b>
<span style="text-decoration: underline">WAIVER OF RIGHT TO JURY TRIAL</span>. THE COMPANY AND THE INVESTOR HEREBY IRREVOCABLY WAIVE,
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE OTHER TRANSACTION DOCUMENTS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.7
</b><span style="text-decoration: underline">Survival</span>. The representations, warranties, agreements and covenants contained herein
shall survive the Closing and the delivery of the Securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.8</b>
<span style="text-decoration: underline">Entire Agreement</span>. The Transaction Documents, together with the Exhibits and Schedules
thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.9</b>
<span style="text-decoration: underline">Amendments; Waivers</span>. No provision of this Agreement may be waived or amended except in
a written instrument signed by the Company and the Investor. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner
impair the exercise of any such right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.10
</b><span style="text-decoration: underline">Construction</span>. The headings herein are for convenience only, do not constitute a part
of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be
deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against
any party. This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise
favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.11</b>
<span style="text-decoration: underline">Successors and Assigns</span>. This Agreement shall be binding upon, and inure to the benefit
of and be enforceable by, the Company and the Investor and their respective successors and assigns. The Company may not assign this Agreement
or any rights or obligations hereunder without the prior written consent of the Investor. The Investor may assign any or all of its rights
under this Agreement to any Person to whom the Investor assigns or transfers any Securities, provided such transferee agrees in writing
to be bound, with respect to the transferred Securities, by the provisions hereof that apply to the &#8220;Investor&#8221; and such transferee
is an accredited investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.12
</b><span style="text-decoration: underline">No Third-Party Beneficiaries</span>. This Agreement is intended for the benefit of the parties
hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.13</b>
<span style="text-decoration: underline">Further Assurances</span>. Each party hereto shall do and perform, or cause to be done and performed,
all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation
of the transactions contemplated hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.14</b>
<span style="text-decoration: underline">Counterparts</span>. This Agreement may be executed in two identical counterparts, both of which
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party. Signature pages delivered by facsimile or e-mail shall have the same force and effect as an original signature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.15
</b><span style="text-decoration: underline">Specific Performance</span>. The Company acknowledges that monetary damages alone would
not be adequate compensation to the Investor for a breach by the Company of this Agreement and the Investor may seek an injunction or
an order for specific performance from a court of competent jurisdiction if (a) the Company fails to comply or threatens not to comply
with this Agreement or (b) the Investor has reason to believe that the Company will not comply with this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[Signature
Page Follows]</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Securities Purchase Agreement as of the date first set forth above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"><b>COMPANY:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
  <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTOR:</b></span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="width: 43%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 45%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">STARDUST POWER INC.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">LIND GLOBAL ASSET MANAGEMENT XIII LLC</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
  <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif"><i>/s/ Roshan
  Pujari</i></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif"><i>/s/
    Jeff Easton</i></span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Roshan Pujari</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Jeff Easton</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">Title:</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Authorized Signatory</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Appendix
B</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF SENIOR SECURED CONVERTIBLE PROMISSORY NOTE</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT
BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">STARDUST
POWER INC.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
Secured Convertible Promissory Note</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">due
December 23, 2027</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font: normal 10pt Times New Roman, Times, Serif">Note
  No. 1</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,800,000.00</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
December 23, 2025 (the &#8220;<span style="text-decoration: underline">Issuance Date</span>&#8221;)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
value received, Stardust Power Inc., a Delaware corporation (the &#8220;<span style="text-decoration: underline">Maker</span>&#8221;
or the &#8220;<span style="text-decoration: underline">Company</span>&#8221;), hereby promises to pay to the order of Lind Global Asset
Management XIII LLC, a Delaware limited liability company (together with its successors and representatives, the &#8220;<span style="text-decoration: underline">Holder</span>&#8221;),
in accordance with the terms hereinafter provided, the principal amount of FOUR MILLION EIGHT HUNDRED THOUSAND ($4, 800,000) (the &#8220;<span style="text-decoration: underline">Principal
Amount</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
payments under or pursuant to this Senior Secured Convertible Promissory Note (this &#8220;Note&#8221;) shall be made in United States
Dollars in immediately available funds to the Holder at the address of the Holder set forth in the Purchase Agreement (as hereinafter
defined) or at such other place as the Holder may designate from time to time in writing to the Maker or by wire transfer of funds to
the Holder&#8217;s account, instructions for which are attached hereto as <span style="text-decoration: underline">Exhibit A</span>.
The outstanding principal balance of this Note shall be due and payable on December 23, 2027 (the &#8220;<span style="text-decoration: underline">Maturity
Date</span>&#8221;) or at such earlier time as provided herein; provided, that the Holder, in its sole discretion, may extend the Maturity
Date to any date after the original Maturity Date. In the event that the Maturity Date shall fall on Saturday or Sunday, such Maturity
Date shall be the next succeeding Business Day. All calculations made pursuant to this Note shall be rounded down to three decimal places.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<span style="text-decoration: underline">Purchase Agreement</span>. This Note has been executed and delivered pursuant to the Securities
Purchase Agreement, dated as of December 23, 2025 (as the same may be amended from time to time, the &#8220;<span style="text-decoration: underline">Purchase
Agreement</span>&#8221;), by and between the Maker and the Holder. Capitalized terms used and not otherwise defined herein shall have
the meanings set forth for such terms in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 73; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<span style="text-decoration: underline">Interest; Default Interest</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.1
Other than as set forth in <span style="text-decoration: underline">Section 1.2.2</span> herein, this Note shall not bear interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.2
If any amount payable by the Company under any Transaction Document is not paid when due, such amount shall thereafter bear interest
at the Past Due Rate (as hereinafter defined) to the fullest extent permitted by applicable law. In addition, following any Event of
Default, any Outstanding Principal Balance shall bear interest at the Past Due Rate. In either case, accrued and past due amounts (including
interest on past due interest) shall be due and payable on demand, at a rate per annum equal ten percent (10%) compounded annually and
computed on the basis of a 360-day year (the &#8220;<span style="text-decoration: underline">Past Due Rate</span>&#8221;), provided that,
in no event shall the rate of interest hereunder exceed the maximum rate permitted by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<span style="text-decoration: underline">Principal Installment Payments</span>. Commencing on the date that is one-hundred (120) days
from the Issuance Date and each one (1) month anniversary thereof (each, a &#8220;<span style="text-decoration: underline">Payment Date</span>&#8221;),
the Maker shall pay to the Holder the Outstanding Principal Amount hereunder in twenty (20) consecutive monthly installments, an amount
equal to Two Hundred Four Thousand and Zero/100 Dollars ($240,000.00) (each, a &#8220;<span style="text-decoration: underline">Monthly
Payment</span>&#8221;), until the Outstanding Principal Amount has been paid in full prior to or on the Maturity Date or, if earlier,
upon acceleration, repayment, conversion or redemption of this Note in accordance with the terms herein. The Monthly Payments shall,
at the Maker&#8217;s option, be made in (i) cash, (ii) Repayment Shares, or (iii) a combination of cash and Repayment Shares; provided
that the number of Repayment Shares shall be determined by dividing the Principal Amount being paid in shares of Common Stock by the
Repayment Share Price; and provided, further, that no portion of the Principal Amount may be paid in Repayment Shares unless such Repayment
Shares (A) may be immediately resold under Rule 144 without restriction on the number of shares to be sold or manner of sale, or (B)
are registered for resale under the 1933 Act and the registration statement is in effect and lawfully usable to effect immediate sales
of such Repayment Shares. The Company must provide advance written notice to the Holder of whether it will elect to pay a Monthly Payment
in cash, Repayment Shares or a combination thereof as follows: (i) with respect to the first Monthly Payment, at least ten (10) Business
Days before the Payment Date, and (ii) with respect to each Monthly Payment thereafter, within five (5) Business Days of the prior Payment
Date; provided, however, that if no such notice is provided within the timeframes set forth above, such Monthly Payments shall be made
in Repayment Shares. Any Monthly Payment made in cash shall also include an additional payment in cash of four percent (4%) which shall
be in addition to any other amounts owing under this Note and which shall not be applied towards the Outstanding Principal Amount. Notwithstanding
the foregoing, the Holder may elect with respect to no more than two of the Monthly Payments to increase the amount of such Monthly Payments
to an amount equal to up to Five Hundred Thousand dollars ($500,000.00) or a greater amount if consented to by the Company; provided
that in respect of any such increased Monthly Payment the Company elect to pay in cash up to 50% of the difference between the amount
of the regularly scheduled Monthly Payment and the amount of the increased Monthly Payment. In respect of any particular Monthly Payment
elected to be increased by the Holder, the Holder may provide one or more notices to the Maker of its election to increase such Monthly
Payment at any time prior to the applicable Payment Date; provided that such notices shall be provided to the Company prior to the next
succeeding Payment Date and that the amounts of the increases elected in such notices shall not cause the amount of such Monthly Payment
to exceed in the aggregate $500,000.00 unless the Company shall have consented to a higher amount. Following any such increased Monthly
Payment or conversion under this Note, the amount of such increase or conversion shall be deducted from the amount of the last Monthly
Payment owing hereunder until such Monthly Payment is reduced to zero and each Monthly Payment immediately preceding such Monthly Payment
in reverse chronological order until such preceding Monthly Payment is also reduced to zero.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
<span style="text-decoration: underline">Prepayment.</span> The Maker may repay all, but not less than all, of then the Prepayment Amount
on any date following the Prepayment Right Date; provided that the Maker shall have given no less than ten (10) Business Days written
notice to the Holder of such intended prepayment (the &#8220;<span style="text-decoration: underline">Prepayment Notice</span>&#8221;).
If the Maker elects to prepay this Note pursuant to this <span style="text-decoration: underline">Section 1.4</span>, the Holder shall
have the right (a &#8220;<span style="text-decoration: underline">Prepayment Conversion Notice</span>&#8221;) within five (5) Business
Days of the Holder&#8217;s receipt of a Prepayment Notice, to convert up to one third (1/3) of the amounts owing under this Note (the
&#8220;<span style="text-decoration: underline">Maximum Amount</span>&#8221;) at the lesser of the Repayment Share Price or the Conversion
Price (each as defined below), in accordance with the provisions of Article 3, specifying the Principal Amount (up to the Maximum Amount)
that the Holder will convert. Upon delivery of a Prepayment Notice, the Maker irrevocably and unconditionally agrees to, within five
(5) Business Days of receiving a Prepayment Conversion Notice, and if no Prepayment Conversion Notice is received, within ten (10) Business
Days of delivery of a Prepayment Notice: (i) repay the amount of the Prepayment Amount (as defined in the Purchase Agreement) <span style="text-decoration: underline">minus</span>
the amounts to be converted set forth in the Prepayment Conversion Notice and (ii) issue the applicable Conversion Shares to the Holder
in accordance with Article 3, as applicable. The foregoing notwithstanding, the Maker may not deliver a Prepayment Notice with respect
to any amounts that are subject to a Conversion Notice delivered by the Holder in accordance with Article 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
<span style="text-decoration: underline">Delisting from a Trading Market</span>. If at any time the Common Stock ceases to be listed
on a Trading Market, (i) the Holder may deliver a demand for payment to the Company and, if such a demand is delivered, the Company shall,
within ten (10) Business Days following receipt of the demand for payment from the Holder, pay all of the Outstanding Principal Amount
and any other amounts owing under this Note and the other Transaction Documents or (ii) the Holder may, at its election, at any time
following the Issuance Date, upon notice to the Company in accordance with <span style="text-decoration: underline">Section 5.1</span>,
convert all or a portion of the Outstanding Principal Amount plus any other amounts owing under this Note and the other Transaction Documents
and the Conversion Price shall be adjusted to the lower of (A) the then-current Conversion Price and (B) eighty percent (80%) of the
average of the three (3) lowest daily VWAPs during the twenty (20) Trading Days prior to delivery by the Holder of its notice of conversion
pursuant to this <span style="text-decoration: underline">Section 1.5</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
<span style="text-decoration: underline">Payment on Non-Business Days</span>. Whenever any payment to be made shall be due on a day which
is not a Business Day, such payment may be due on the next succeeding Business Day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7
<span style="text-decoration: underline">Transfer</span>. This Note may be transferred or sold, subject to the provisions of <span style="text-decoration: underline">Section
5.8</span> of this Note, or pledged, hypothecated or otherwise granted as security by the Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8
<span style="text-decoration: underline">Replacement</span>. Upon receipt of a duly executed and notarized written statement from the
Holder with respect to the loss, theft or destruction of this Note (or any replacement hereof), or, in the case of a mutilation of this
Note, upon surrender and cancellation of such Note, the Maker shall issue a new Note, of like tenor and amount, in lieu of such lost,
stolen, destroyed or mutilated Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9
<span style="text-decoration: underline">Use of Proceeds</span>. The Maker shall use the proceeds of this Note as set forth in the Purchase
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10
<span style="text-decoration: underline">Status of Note</span>. The obligations of the Maker under this Note shall be senior to all other
existing Indebtedness and equity of the Company other than Permitted Indebtedness and Permitted Senior Indebtedness secured by Permitted
Liens that may be issued after the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
2</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<span style="text-decoration: underline">Events of Default</span>. An &#8220;<span style="text-decoration: underline">Event of Default</span>&#8221;
under this Note shall mean the occurrence of any of the events defined in the Purchase Agreement, and any of the additional events described
below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any default in the payment of (i) the Principal Amount or any accrued and unpaid interest hereunder when due, or any principal or interest
owing under any other Note; or (ii) liquidated damages in respect of this Note or any other Note as and when the same shall become due
and payable (whether on the Maturity Date or by acceleration or otherwise);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the Maker shall fail to observe or perform any other covenant, condition or agreement contained in this Note or any Transaction Document;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
the Maker&#8217;s notice to the Holder, including by way of public announcement, at any time, of its inability to comply (including for
any of the reasons described in <span style="text-decoration: underline">Section 3.6(a)</span> hereof) or its intention not to comply
with proper requests for conversion of this Note into shares of Common Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
the Maker shall fail to (i) timely deliver the shares of Common Stock as and when required in <span style="text-decoration: underline">Section
3.2</span>; or (ii) make the payment of any fees and/or liquidated damages under any Note, the Purchase Agreement or the other Transaction
Documents;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
default shall be made in the performance or observance of any material covenant, condition or agreement contained in the Purchase Agreement
or any other Transaction Document that is not covered by any other provisions of this <span style="text-decoration: underline">Section
2.1</span>;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
at any time the Maker shall fail to have the Required Minimum of shares of Common Stock authorized, reserved and available for issuance
to satisfy the potential conversion in full (disregarding for this purpose any and all limitations of any kind on such conversion) of
this Note;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
any representation or warranty made by the Maker or any of its Subsidiaries herein or in the Purchase Agreement, any Note or any other
Transaction Document shall prove to have been false or incorrect or breached in a material respect on the date as of which made;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
unless otherwise approved in writing in advance by the Holder, the Maker shall, or shall announce an intention to pursue or consummate
a Change of Control, or a Change of Control shall be consummated, or the Maker shall negotiate, propose or enter into any agreement,
understanding or arrangement with respect to any Change of Control;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
except in regard to any Indebtedness as set forth on Schedule 3.17 to the Purchaser Agreement as of the Issuance Date, the Maker or any
of its Subsidiaries shall (A) default in any payment of any amount or amounts of principal of or interest (if any) on any Indebtedness
(other than the Indebtedness hereunder), the aggregate principal amount of which Indebtedness is in excess of $500,000 or (B) default
in the observance or performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument
or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default
or other event or condition is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such Indebtedness to cause
with the giving of notice if required, such Indebtedness to become due prior to its stated maturity;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
the Maker or any of its Subsidiaries shall: (i) apply for or consent to the appointment of, or the taking of possession by, a receiver,
custodian, trustee or liquidator of itself or of all or a substantial part of its property or assets; (ii) make a general assignment
for the benefit of its creditors; (iii) commence a voluntary case under the United States Bankruptcy Code (as now or hereafter in effect)
or under the comparable laws of any jurisdiction (foreign or domestic); (iv) file a petition seeking to take advantage of any bankruptcy,
insolvency, moratorium, reorganization or other similar law affecting the enforcement of creditors&#8217; rights generally; (v) acquiesce
in writing to any petition filed against it in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect)
or under the comparable laws of any jurisdiction (foreign or domestic); (vi) issue a notice of bankruptcy or winding down of its operations
or issue a press release regarding same; or (vii) take any action under the laws of any jurisdiction (foreign or domestic) analogous
to any of the foregoing;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
a proceeding or case shall be commenced in respect of the Maker or any of its Subsidiaries, without its application or consent, in any
court of competent jurisdiction, seeking: (i) the liquidation, reorganization, moratorium, dissolution, winding up, or composition or
readjustment of its debts; (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of all or any substantial
part of its assets in connection with the liquidation or dissolution of the Maker or any of its Subsidiaries; or (iii) similar relief
in respect of it under any law providing for the relief of debtors, and such proceeding or case described in clause (i), (ii) or (iii)
shall continue undismissed, or unstayed and in effect, for a period of forty-five (45) days or any order for relief shall be entered
in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction
(foreign or domestic) against the Maker or any of its Subsidiaries or action under the laws of any jurisdiction (foreign or domestic)
analogous to any of the foregoing shall be taken with respect to the Maker or any of its Subsidiaries and shall continue undismissed,
or unstayed and in effect for a period of forty-five (45) days;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
one or more final judgments or orders for the payment of money aggregating in excess of $500,000(or its equivalent in the relevant currency
of payment) are rendered against one or more of the Company and its Subsidiaries, except in connection with any current Proceedings as
set forth on Schedule 3.6 of the Purchase Agreement as of the Issuance Date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
the failure of the Maker to instruct the Transfer Agent to remove any legends from shares of Common Stock and issue such unlegended certificates
to the Holder within three (3) Trading Days of the Holder&#8217;s request so long as the Holder has provided reasonable assurances to
the Maker that such shares of Common Stock can be sold pursuant to Rule 144 or any other applicable exemption;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
the Maker&#8217;s shares of Common Stock are no longer publicly traded or cease to be listed on the Trading Market or, after the six
month anniversary of the Issuance Date, any Investor Shares may not be immediately resold under Rule 144 without restriction on the number
of shares to be sold or manner of sale, unless such Investor Shares have been registered for resale under the 1933 Act and may be sold
without restriction;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
the Maker proposes to or does consummate a &#8220;going private&#8221; transaction as a result of which the Common Stock will no longer
be registered under Sections 12(b) or 12(g) of the 1934 Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
there shall be any SEC or judicial stop trade order or trading suspension stop-order or any restriction in place with the Transfer Agent
restricting the trading of such Common Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
the Depository Trust Company places any restrictions on transactions in the Common Stock or the Common Stock is no longer tradeable through
the Depository Trust Company Fast Automated Securities Transfer program;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
the Maker challenges the enforceability of any provision of any Note or any other Transaction Document;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
the Company&#8217;s Market Capitalization is below $15,000,000 for ten (10) consecutive Days; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
the occurrence of a Material Adverse Effect in respect of the Maker, or the Maker and its Subsidiaries taken as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
For the avoidance of doubt, any default pursuant to clause (i) above shall not be subject to any cure periods pursuant to the instrument
governing such Indebtedness or this Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<span style="text-decoration: underline">Remedies Upon an Event of Default</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the occurrence of any Event of Default, subject to any applicable time period or cure period as set forth herein, the Maker shall
be obligated to pay to the Holder the Mandatory Default Amount, which Mandatory Default Amount shall be earned by the Holder on the date
the Event of Default giving rise thereto occurs and shall be due and payable on the earlier to occur of the Maturity Date, upon conversion,
redemption or prepayment of this Note or the date on which all amounts owing hereunder have been accelerated in accordance with the terms
hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon the occurrence of any Event of Default, the Maker shall, as promptly as possible but in any event within one (1) Business Day of
such Event of Default, notify the Holder of the occurrence of such Event of Default, describing the event or factual situation giving
rise to the Event of Default and specifying the relevant subsection or subsections of <span style="text-decoration: underline">Section
2.1</span> hereof under which such Event of Default has occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon the occurrence and during the continuance of an Event of Default<span style="text-decoration: underline">,</span> the Holder may
at any time at its option (1) declare the Mandatory Default Amount due and payable, and thereupon, the same shall be accelerated and
so due and payable, without presentment, demand, protest or notice, all of which are hereby expressly unconditionally and irrevocably
waived by the Maker and (2) exercise all other rights and remedies available to it under the Transaction Documents; provided, however,
that (x) upon the occurrence of an Event of Default described above, the Holder, in its sole and absolute discretion (without the obligation
to provide notice of such Event of Default), may: (a) from time-to-time demand that all or a portion of the Outstanding Principal Amount
be converted into shares of Common Stock at the lower of (i) the then-current Conversion Price and (ii) eighty-percent (80%) of the average
of the three (3) lowest daily VWAPs during the twenty (20) Trading Days prior to the delivery by the Holder of the applicable notice
of conversion or (b) exercise or otherwise enforce any one or more of the Holder&#8217;s rights, powers, privileges, remedies and interests
under this Note, the Purchase Agreement, the other Transaction Documents or applicable law and (y) upon the occurrence of an Event of
Default described in <span style="text-decoration: underline">Section 2.1(k)</span> or <span style="text-decoration: underline">Section
2.1(k)</span> above, the Mandatory Default Amount shall become immediately due and payable without presentment, demand, protest or other
notice of any kind, all of which are hereby waived by the Maker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
No course of delay on the part of the Holder shall operate as a waiver thereof or otherwise prejudice the rights of the Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
No remedy conferred hereby shall be exclusive of any other remedy referred to herein or now or hereafter available at law, in equity,
by statute or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
3</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<span style="text-decoration: underline">Conversion</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Conversion</span>. At any time following the Issuance Date, this Note shall be convertible (in
whole or in part), at the option of the Holder, into such number of fully paid and non-assessable shares of Common Stock as is determined
by dividing (x) that portion of the Outstanding Principal Amount and any other amounts owing hereunder or under the other Transaction
Documents that the Holder elects to convert (the &#8220;<span style="text-decoration: underline">Conversion Amount</span>&#8221;) by
(y) the Conversion Price then in effect on the date on which the Holder delivers a notice of conversion, in substantially the form attached
hereto as <span style="text-decoration: underline">Exhibit B</span> (the &#8220;<span style="text-decoration: underline">Conversion Notice</span>&#8221;),
in accordance with the instructions set forth in <span style="text-decoration: underline">Section 5.1</span> to the Maker. The Holder
shall deliver this Note to the Maker at the address designated in the Purchase Agreement at such time that this Note is fully converted.
With respect to partial conversions of this Note, the Maker shall keep written records of the amount of this Note converted as of the
date of such conversion (each, a &#8220;<span style="text-decoration: underline">Conversion Date</span>&#8221;). Any amounts of the Outstanding
Principal Amount converted pursuant to this Section 3.1(a) shall be credited to last Monthly Payment owing hereunder until such Monthly
Payment is reduced to zero and each Monthly Payment immediately preceding such Monthly Payment in reverse chronological order until such
preceding Monthly Payment is also reduced to zero as provided in Section 1.3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Conversion Price</span>. The &#8220;<span style="text-decoration: underline">Conversion Price</span>&#8221;
means, $5.837, and shall be subject to adjustment as provided herein; provided that no conversion under this Section 3.1 shall be effected
at a price per share below the Floor Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<span style="text-decoration: underline">Delivery of Conversion Shares</span>. As soon as practicable after the occurrence of any event
requiring the issuance of Common Stock issuable upon conversion of this Note (&#8220;<span style="text-decoration: underline">Conversion
Shares</span>&#8221;), and in any event within two (2) Business Days thereafter (such date, the &#8220;<span style="text-decoration: underline">Share
Delivery Date</span>&#8221;), the Maker shall, at its expense, cause to be issued in the name of and delivered to the Holder, or as the
Holder may direct, a certificate or certificates evidencing the number of fully paid and nonassessable shares of Common Stock to which
the Holder shall be entitled, in such denominations as may be requested by the Holder, which certificate or certificates shall be free
of restrictive and trading legends, except for any such legends as may be required under the Securities Act. In lieu of delivering physical
certificates for the shares of Common Stock issuable upon the occurrence of any event requiring the issuance of Conversion Shares in
accordance with this Note, provided the Transfer Agent is participating in the Depository Trust Company (&#8220;<span style="text-decoration: underline">DTC</span>&#8221;)
Fast Automated Securities Transfer program or a similar program, including the Transfer Agent&#8217;s direct registration system, upon
request of the Holder, the Company shall cause the Transfer Agent to electronically transmit such Conversion Shares so issuable to the
Holder (or its designee), by crediting the account of the Holder&#8217;s (or such designee&#8217;s) broker with DTC through its Deposit
and Withdrawal At Custodian (&#8220;<span style="text-decoration: underline">DWAC</span>&#8221;) system (provided that the same time
periods herein as for stock certificates shall apply) or through the Transfer Agent&#8217;s direct registration system, as instructed
by the Holder (or its designee); provided, that such issuance shall only be made through DTC&#8217;s DWAC system if such Conversion Shares
will be issued free of restrictive legends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<span style="text-decoration: underline">Ownership Cap</span>. Notwithstanding anything to the contrary contained herein, the Holder
shall not be entitled to receive shares representing Equity Interests upon conversion of this Note to the extent (but only to the extent)
that such exercise or receipt would cause the Holder Group (as defined below) to become, directly or indirectly, a &#8220;<span style="text-decoration: underline">beneficial
owner</span>&#8221; (within the meaning of Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder) of a number
of Equity Interests of a class that is registered under the 1934 Act which exceeds the Maximum Percentage (as defined in the Purchase
Agreement) of the Equity Interests of such class that are outstanding at such time. Any purported delivery of Equity Interests in connection
with the conversion of this Note prior to the termination of this restriction in accordance herewith shall be void and have no effect
to the extent (but only to the extent) that such delivery would result in the Holder Group becoming the beneficial owner of more than
the Maximum Percentage of the Equity Interests of a class that is registered under the 1934 Act that is outstanding at such time. If
any delivery of Equity Interests owed to the Holder following conversion of this Note is not made, in whole or in part, as a result of
this limitation, the Company&#8217;s obligation to make such delivery shall not be extinguished and the Company shall deliver such Equity
Interests as promptly as practicable after the Holder gives notice to the Company that such delivery would not result in such limitation
being triggered or upon termination of the restriction in accordance with the terms hereof. To the extent limitations contained in this
<span style="text-decoration: underline">Section 3.3</span> apply, the determination of whether this Note is convertible and of which
portion of this Note is convertible shall be the sole responsibility and in the sole determination of the Holder, and the submission
of a notice of conversion shall be deemed to constitute the Holder&#8217;s determination that the issuance of the full number of Conversion
Shares requested in the notice of conversion is permitted hereunder, and the Company shall not have any obligation to verify or confirm
the accuracy of such determination. For purposes of this <span style="text-decoration: underline">Section 3.2</span>, (i) the term &#8220;<span style="text-decoration: underline">Maximum
Percentage</span>&#8221; shall mean 4.99%; provided, that if at any time after the date hereof the Holder Group beneficially owns in
excess of 4.99% of any class of Equity Interests in the Company that is registered under the 1934 Act or exempt from the registration
and qualification requirements under the 1933 Act, then the Maximum Percentage shall automatically increase to 9.99% so long as the Holder
Group owns in excess of 4.99% of such class of Equity Interests (and shall, for the avoidance of doubt, automatically decrease to 4.99%
upon the Holder Group ceasing to own in excess of 4.99% of such class of Equity Interests); and (ii) the term &#8220;<span style="text-decoration: underline">Holder
Group</span>&#8221; shall mean the Holder plus any other Person with which the Holder is considered to be part of a group under Section
13 of the 1934 Act or with which the Holder otherwise files reports under Sections 13 and/or 16 of the 1934 Act. In determining the number
of Equity Interests of a particular class outstanding at any point in time, the Holder may rely on the number of outstanding Equity Interests
of such class as reflected in (x) the Company&#8217;s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission,
as the case may be, (y) a more recent public announcement by the Company or (z) a more recent notice by the Company or the Transfer Agent
to the Holder setting forth the number of Equity Interests of such class then outstanding. For any reason at any time, upon written or
oral request of the Holder, the Company shall, within one (1) Business Day of such request, confirm orally and in writing to the Holder
the number of Equity Interests of any class then outstanding. The provisions of this <span style="text-decoration: underline">Section
3.3</span> shall be construed, corrected and implemented in a manner so as to effectuate the intended beneficial ownership limitation
herein contained. Notwithstanding anything to the contrary contained in this Note or the other Transaction Documents, the Holder and
the Company agree that the total cumulative number of shares of Common issued to Holder hereunder together with all other Transaction
Documents may not exceed the requirements of rule Nasdaq Listing Rule 5635(d) (&#8220;Nasdaq 19.99% Cap&#8221;), except that such limitation
will not apply following Shareholder Approval or if the Common Stock is no longer listed on the Trading Market. If the Company is unable
to obtain Shareholder Approval to issue shares of Common Stock to the Holder in excess of the Nasdaq 19.99% Cap on or prior to the first
anniversary of the Issuance Date, any remaining outstanding balance of this Note must be repaid in cash at the request of the Holder
in accordance with the terms hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<span style="text-decoration: underline">Adjustment of Conversion Price</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Until the Note has been paid in full or converted in full, the Conversion Price shall be subject to adjustment from time to time as follows
(but shall not be increased, other than pursuant to <span style="text-decoration: underline">Section 3.4(a)(i)</span> hereof):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<span style="text-decoration: underline">Adjustments for Stock Splits and Combinations</span>. If the Maker shall at any time or from
time to time after the Closing Date (but whether before or after the Issuance Date) effect a split or other subdivision of the outstanding
Common Stock, the applicable Conversion Price in effect immediately prior to the stock split shall be proportionately decreased. Any
adjustments under this <span style="text-decoration: underline">Section 3.4(a)(i)</span> shall be effective at the close of business
on the date the stock split or combination occurs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<span style="text-decoration: underline">Adjustments for Certain Dividends and Distributions</span>. If the Maker shall at any time or
from time to time after the Closing Date (but whether before or after the Issuance Date) make or issue or set a record date for the determination
of holders of shares of Common Stock entitled to receive a dividend or other distribution payable in shares of Common Stock, then, and
in each event, the applicable Conversion Price in effect immediately prior to such event shall be decreased as of the time of such issuance
or, in the event such record date shall have been fixed, as of the close of business on such record date, by multiplying the applicable
Conversion Price then in effect by a fraction:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such
issuance or the close of business on such record date; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 58.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
the denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of
such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend
or distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 58.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<span style="text-decoration: underline">Adjustment for Other Dividends and Distributions</span>. If the Maker shall at any time or from
time to time after the Closing Date (but whether before or after the Issuance Date) make or issue or set a record date for the determination
of holders of shares of Common Stock entitled to receive a dividend or other distribution payable in other than shares of Common Stock,
then, and in each event, an appropriate revision to the applicable Conversion Price shall be made and provision shall be made (by adjustments
of the Conversion Price or otherwise) so that the Holder of this Note shall receive upon conversions thereof, in addition to the number
of shares of Common Stock receivable thereon, the number of securities of the Maker or other issuer (as applicable) or cash or other
property that it would have received had this Note been converted into shares of Common Stock in full (without regard to any conversion
limitations herein) on the date of such event and had thereafter, during the period from the date of such event to and including the
Conversion Date, retained such securities (together with any distributions payable thereon during such period) or assets, giving application
to all adjustments called for during such period under this <span style="text-decoration: underline">Section 3.4(a)(iii)</span> with
respect to the rights of the holders of this Note; provided, however, that if such record date shall have been fixed and such dividend
is not fully paid or if such distribution is not fully made on the date fixed therefor, the Conversion Price shall be adjusted pursuant
to this paragraph as of the time of actual payment of such dividends or distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 4.5pt"></p>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<span style="text-decoration: underline">Adjustments for Reclassification, Exchange or Substitution</span>. If the Common Stock at any
time or from time to time after the Closing Date (but whether before or after the Issuance Date) shall be changed to the same or different
number of shares or other securities of any class or classes of stock or other property, whether by reclassification, exchange, substitution
or otherwise (other than by way of a stock split or combination of shares or stock dividends provided for in <span style="text-decoration: underline">Sections
3.4(a)(i), (ii) and (iii)</span> hereof, or a reorganization, merger, consolidation, or sale of assets provided for in <span style="text-decoration: underline">Section
3.4(a)(vii)</span> hereof), then, and in each event, an appropriate revision to the Conversion Price shall be made and provisions shall
be made (by adjustments of the Conversion Price or otherwise) so that the Holder shall have the right thereafter to convert this Note
into the kind and amount of shares of stock or other securities or other property receivable upon reclassification, exchange, substitution
or other change, by holders of the number of shares of Common Stock into which such Note might have been converted immediately prior
to such reclassification, exchange, substitution or other change, all subject to further adjustment as provided herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 67.5pt; text-align: justify; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<span style="text-decoration: underline">Adjustments for Issuance of Additional Shares of Common Stock.</span> In the event the Maker
shall at any time or from time to time after the Closing Date (but whether before or after the Issuance Date) issue or sell any additional
shares of Common Stock (&#8220;<span style="text-decoration: underline">Additional Shares of Common Stock</span>&#8221;), other than
(A) as provided in this Note (including the foregoing subsections (i) through (iv) of this <span style="text-decoration: underline">Section
3.4(a)</span>), pursuant to any Equity Plan (including pursuant to shares of Common Stock Equivalents granted or issued under any Equity
Plan), (B) pursuant to Common Stock Equivalents (as defined below) granted or issued prior to the Closing Date, (C) Exempted Securities,
or (D) pursuant to the terms of this Note, in any case, at an effective price per share that is less than the Conversion Price then in
effect or without consideration, then the Conversion Price upon each such issuance shall be reduced to a price equal to 125% of the consideration
per share paid for such Additional Shares of Common Stock. For purposes of clarification, the amount of consideration received for such
Additional Shares of Common Stock shall not include the value of any additional securities or other rights received in connection with
such issuance of Additional Shares of Common Stock (i.e., warrants, rights of first refusal or other similar rights).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<span style="text-decoration: underline">Issuance, Amendment or Adjustment of Common Stock Equivalents</span>. Except for Exempted Securities,
if (x) the Maker, at any time after the Closing Date (but whether before or after the Issuance Date), shall issue any securities convertible
into or exercisable or exchangeable for, directly or indirectly, shares of Common Stock (&#8220;<span style="text-decoration: underline">Convertible
Securities</span>&#8221;), or any rights or warrants or options to purchase any such shares of Common Stock or Convertible Securities,
other than shares of Common Stock Equivalents granted or issued under any Equity Plan (collectively with the Convertible Securities,
the &#8220;<span style="text-decoration: underline">Common Stock Equivalents</span>&#8221;) and the price per share for which shares
of Common Stock may be issuable pursuant to any such Common Stock Equivalent shall be less than the applicable Conversion Price then
in effect, or (y) the price per share for which shares of Common Stock may be issuable under any Common Stock Equivalents is amended
or adjusted, pursuant to the terms of such Common Stock Equivalents or otherwise, and such price as so amended or adjusted shall be less
than the applicable Conversion Price in effect at the time of such amendment or adjustment, then, in each such case (x) or (y), the applicable
Conversion Price upon each such issuance or amendment or adjustment shall be adjusted as provided in subsection (vi) of this <span style="text-decoration: underline">Section
3.4(a)</span> as if the maximum number of shares of Common Stock issuable upon conversion, exercise or exchange of such Common Stock
Equivalents had been issued on the date of such issuance or amendment or adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 40.5pt"></p>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<span style="text-decoration: underline">Consideration for Stock</span>. In case any shares of Common Stock or any Common Stock Equivalents
shall be issued or sold:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
in connection with any merger or consolidation in which the Maker is the surviving corporation (other than any consolidation or merger
in which the previously outstanding shares of Common Stock of the Maker shall be changed to or exchanged for the stock or other securities
of another corporation), the amount of consideration therefor shall be deemed to be the fair value, as determined reasonably and in good
faith by the Board of Directors of the Maker and approved by the Holder, of such portion of the assets and business of the nonsurviving
corporation as such Board of Directors may determine to be attributable to such shares of Common Stock, Convertible Securities, rights
or warrants or options, as the case may be; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
in the event of any consolidation or merger of the Maker in which the Maker is not the surviving corporation or in which the previously
outstanding shares of Common Stock of the Maker shall be changed into or exchanged for the stock or other securities of another corporation
or other property, or in the event of any sale of all or substantially all of the assets of the Maker for stock or other securities or
other property of any corporation, the Maker shall be deemed to have issued shares of Common Stock, at a price per share equal to the
valuation of the Maker&#8217;s Common Stock based on the actual exchange ratio on which the transaction was predicated, as applicable,
and the fair market value on the date of such transaction of all such stock or securities or other property of the other corporation.
If any such calculation results in adjustment of the applicable Conversion Price, or the number of shares of Common Stock issuable upon
conversion of the Note, the determination of the applicable Conversion Price or the number of shares of Common Stock issuable upon conversion
of the Note immediately prior to such merger, consolidation or sale, shall be made after giving effect to such adjustment of the number
of shares of Common Stock issuable upon conversion of the Note. In the event shares of Common Stock are issued with other shares or securities
or other assets of the Maker for consideration which covers both, the consideration computed as provided in this <span style="text-decoration: underline">Section
3.4(a)(vii)</span> shall be allocated among such securities and assets as determined in good faith by the Board of Directors of the Maker,
and approved by the Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.5pt; text-align: justify; text-indent: 40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
<span style="text-decoration: underline">Record Date</span>. In case the Maker shall take record of the holders of its Common Stock for
the purpose of entitling them to subscribe for or purchase shares of Common Stock or Convertible Securities, then the date of the issue
or sale of the shares of Common Stock shall be deemed to be such record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">No Impairment</span>. The Maker shall not, by amendment of its Certificate of Incorporation
and Bylaws or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder
by the Maker, but will at all times in good faith assist in the carrying out of all the provisions of this <span style="text-decoration: underline">Section
3.4</span> and in the taking of all such action as may be necessary or appropriate in order to protect the conversion rights of the Holder
against impairment. In the event the Holder shall elect to convert this Note as provided herein, the Maker cannot refuse conversion based
on any claim that the Holder or anyone associated or affiliated with the Holder has been engaged in any violation of law, violation of
an agreement to which the Holder is a party or for any reason whatsoever, unless, an injunction from a court, or notice, restraining
and or adjoining conversion of this Note shall have issued and the Maker posts a surety bond for the benefit of the Holder in an amount
equal to one hundred fifty percent (150%) of the Principal Amount of the Note the Holder has elected to convert, which bond shall remain
in effect until the completion of arbitration/litigation of the dispute and the proceeds of which shall be payable to the Holder (as
liquidated damages) in the event it obtains judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Certificates as to Adjustments</span>. Upon occurrence of each adjustment or readjustment of
the Conversion Price or number of shares of Common Stock issuable upon conversion of this Note pursuant to this <span style="text-decoration: underline">Section
3.4</span>, the Maker at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish
to the Holder a certificate setting forth such adjustment and readjustment, showing in detail the facts upon which such adjustment or
readjustment is based. The Maker shall, upon written request of the Holder, at any time, furnish or cause to be furnished to the Holder
a like certificate setting forth such adjustments and readjustments, the applicable Conversion Price in effect at the time, and the number
of shares of Common Stock and the amount, if any, of other securities or property which at the time would be received upon the conversion
of this Note. Notwithstanding the foregoing, the Maker shall not be obligated to deliver a certificate unless such certificate would
reflect an increase or decrease of at least one percent (1%) of such adjusted amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Issue Taxes</span>. The Maker shall pay any and all issue and other taxes, excluding federal,
state or local income taxes, that may be payable in respect of any issue or delivery of shares of Common Stock on conversion of this
Note pursuant thereto; provided, however, that the Maker shall not be obligated to pay any transfer taxes resulting from any transfer
requested by the Holder in connection with any such conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Fractional Shares</span>. No fractional shares of Common Stock shall be issued upon conversion
of this Note. In lieu of any fractional shares to which the Holder would otherwise be entitled, the Maker shall pay cash equal such fractional
shares multiplied by the Conversion Price then in effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">Reservation of Shares of Common Stock</span>. The Maker shall at all times while this Note shall
be outstanding, reserve and keep available out of its authorized but unissued Common Stock, the Required Minimum of such number of shares
of Common Stock as shall from time to time be sufficient to effect the conversion of this Note (disregarding for this purpose any and
all limitations of any kind on such conversion). The Maker shall, from time to time, use all commercially reasonable efforts to increase
the authorized number of shares of Common Stock or take other effective action if at any time the unissued number of authorized shares
shall not be sufficient to satisfy the Maker&#8217;s obligations under this <span style="text-decoration: underline">Section 3.4(f)</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<span style="text-decoration: underline">Regulatory Compliance</span>. If any shares of Common Stock to be reserved for the purpose of
conversion of this Note require registration or listing with or approval of any governmental authority, stock exchange or other regulatory
body under any federal or state law or regulation or otherwise before such shares may be validly issued or delivered upon conversion,
the Maker shall, at its sole cost and expense, in good faith and as expeditiously as possible, secure such registration, listing or approval,
as the case may be.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<span style="text-decoration: underline">Effect of Events Prior to the Issuance Date</span>. If the Issuance Date of this Note is after
the Closing Date, then, if the Conversion Price or any other right of the Holder of this Note would have been adjusted or modified by
operation of any provision of this Note had this Note been issued on the Closing Date, such adjustment or modification shall be deemed
to apply to this Note as of the Issuance Date as if this Note had been issued on the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<span style="text-decoration: underline">Prepayment Following a Change of Control</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Mechanics of Prepayment at Option of Holder in Connection with a Change of Control</span>. No
sooner than fifteen (15) days prior to entry into an agreement for a Change of Control nor later than ten (10) days prior to the consummation
of a Change of Control, but not prior to the public announcement of such Change of Control, the Maker shall deliver written notice (&#8220;<span style="text-decoration: underline">Notice
of Change of Control</span>&#8221;) to the Holder. At any time after receipt of a Notice of Change of Control (or, in the event a Notice
of Change of Control is not delivered at least ten (10) days prior to a Change of Control, at any time within ten (10) days prior to
a Change of Control), the Holder may require the Maker to prepay, effective immediately prior to the consummation of such Change of Control,
an amount equal to the Outstanding Principal Amount <span style="text-decoration: underline">plus</span> five percent (5%) of the Outstanding
Principal Amount <span style="text-decoration: underline">plus</span> any other amounts owing under this Note (the &#8220;<span style="text-decoration: underline">COC
Repayment Price</span>&#8221;), by delivering written notice thereof (&#8220;<span style="text-decoration: underline">Notice of Prepayment
at Option of Holder Upon Change of Control</span>&#8221;) to the Maker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Payment of COC Repayment Price</span>. Upon the Maker&#8217;s receipt of a Notice(s) of Prepayment
at Option of Holder Upon Change of Control from the Holder, the Maker shall deliver the COC Repayment Price to the Holder immediately
prior to the consummation of the Change of Control; provided that the Holder&#8217;s original Note shall have been so delivered to the
Maker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<span style="text-decoration: underline">Inability to Fully Convert</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Holder&#8217;s Option if Maker Cannot Fully Convert</span>. If, upon the Maker&#8217;s receipt
of a Conversion Notice or as otherwise required under this Note, including with respect to repayment of principal in shares of Common
Stock as permitted under this Note, the Maker cannot issue shares of Common Stock for any reason, including, without limitation, because
the Maker (x) does not have a sufficient number of shares of Common Stock authorized and available or (y) is otherwise prohibited by
applicable law or by the rules or regulations of any stock exchange, interdealer quotation system or other self-regulatory organization
with jurisdiction over the Maker or any of its securities from issuing all of the shares of Common Stock which are to be issued to the
Holder pursuant to this Note, then the Maker shall issue as many shares of Common Stock as it is able to issue and, with respect to the
unconverted portion of this Note or with respect to any shares of Common Stock not timely issued in accordance with this Note, the Holder,
solely at Holder&#8217;s option, can elect to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
require the Maker to prepay that portion of this Note for which the Maker is unable to issue shares of Common Stock or for which shares
of Common Stock were not timely issued (the &#8220;<span style="text-decoration: underline">Mandatory Prepayment</span>&#8221;) at a
price equal to the number of shares of Common Stock that the Maker is unable to issue multiplied by the lesser of the Conversion Price
and the Repayment Share Price (the &#8220;<span style="text-decoration: underline">Mandatory Prepayment Price</span>&#8221;);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 166.5pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
void its Conversion Notice and retain or have returned, as the case may be, this Note that was to be converted pursuant to the Conversion
Notice (provided that the Holder&#8217;s voiding its Conversion Notice shall not affect the Maker&#8217;s obligations to make any payments
which have accrued prior to the date of such notice); or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 166.5pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
defer issuance of the applicable Conversion Shares until such time as the Maker can legally issue such shares; provided, that the Principal
Amount underlying such Conversion Shares shall remain outstanding until the delivery of such Conversion Shares; provided, further, that
if the Holder elects to defer the issuance of the Conversion Shares, it may exercise its rights under either clause (i) or (ii) above
at any time prior to the issuance of the Conversion Shares upon two (2) Business Days&#8217; notice to the Maker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 166.5pt; text-align: justify; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Mechanics of Fulfilling Holder&#8217;s Election</span>. The Maker shall immediately send to
the Holder, upon receipt of a Conversion Notice from the Holder, which cannot be fully satisfied as described in <span style="text-decoration: underline">Section
3.6(a)</span> above, a notice of the Maker&#8217;s inability to fully satisfy the Conversion Notice (the &#8220;<span style="text-decoration: underline">Inability
to Fully Convert Notice</span>&#8221;). Such Inability to Fully Convert Notice shall indicate (i) the reason why the Maker is unable
to fully satisfy the Holder&#8217;s Conversion Notice; and (ii) the amount of this Note which cannot be converted. The Holder shall notify
the Maker of its election pursuant to <span style="text-decoration: underline">Section 3.6(a)</span> above by delivering written notice
to the Maker (&#8220;<span style="text-decoration: underline">Notice in Response to Inability to Convert</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Payment of Mandatory Prepayment Price</span>. If the Holder shall elect to have its Note prepaid
pursuant to <span style="text-decoration: underline">Section 3.6(a)(i)</span> above, the Maker shall pay the Mandatory Prepayment Price
to the Holder within seven (7) Business Days of the Maker&#8217;s receipt of the Holder&#8217;s Notice in Response to Inability to Convert;
provided that prior to the Maker&#8217;s receipt of the Holder&#8217;s Notice in Response to Inability to Convert the Maker has not delivered
a notice to the Holder stating, to the satisfaction of the Holder, that the event or condition resulting in the Mandatory Prepayment
has been cured and all Conversion Shares issuable to the Holder can and will be delivered to the Holder in accordance with the terms
of this Note. If the Maker shall fail to pay the applicable Mandatory Prepayment Price to the Holder on the date that is one (1) Business
Day following the Maker&#8217;s receipt of the Holder&#8217;s Notice in Response to Inability to Convert, in addition to any remedy the
Holder may have under this Note and the Purchase Agreement, such unpaid amount shall bear interest at the rate of two percent (2%) per
month (prorated for partial months) until paid in full. Until the full Mandatory Prepayment Price is paid in full to the Holder, the
Holder may (i) void the Mandatory Prepayment with respect to that portion of the Note for which the full Mandatory Prepayment Price has
not been paid and (ii) receive back such Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">No Rights as Stockholder</span>. Nothing contained in this Note shall be construed as conferring
upon the Holder, prior to the conversion of this Note, the right to vote or to receive dividends or to consent or to receive notice as
a stockholder in respect of any meeting of stockholders for the election of directors of the Maker or of any other matter, or any other
rights as a stockholder of the Maker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<span style="text-decoration: underline">Compensation for Buy-In on Failure to Timely Deliver Conversion Shares</span>. In addition to
any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder Conversion Shares
or any other shares pursuant to a conversion on or before the Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Common Stock
to deliver in satisfaction of a sale by the Holder of the Conversion Shares which the Holder anticipated receiving upon such conversion
(a &#8220;<span style="text-decoration: underline">Buy-In</span>&#8221;), then the Company shall (a) pay in cash to the Holder the amount,
if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the Common Stock so purchased
exceeds (y) the amount obtained by multiplying (1) the number of Conversion Shares that the Company was required to deliver to the Holder
in connection with the conversion at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed,
and (b) at the option of the Holder, either reinstate the portion of the Note and equivalent number of Conversion Shares for which such
conversion was not honored (in which case such conversion shall be deemed rescinded) or deliver to the Holder the number of shares of
Common Stock that would have been issued had the Company timely complied with its conversion and delivery obligations hereunder. For
example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
conversion of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (a)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and evidence of the amount of such loss. Nothing herein
shall limit a Holder&#8217;s right to pursue a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s
failure to timely deliver shares of Common Stock upon conversion of the Note as required pursuant to the terms hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
4</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<span style="text-decoration: underline">Covenants</span>. For so long as any Note is outstanding, without the prior written consent
of the Holder:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Compliance with Transaction Documents</span>. The Maker shall, and shall cause its Subsidiaries
to, comply with its obligations under this Note and the other Transaction Documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Payment of Taxes, Etc</span>. The Maker shall, and shall cause each of its Subsidiaries to,
promptly pay and discharge, or cause to be paid and discharged, when due and payable, all lawful taxes, assessments and governmental
charges or levies imposed upon the income, profits, property or business of the Maker and the Subsidiaries, except for such failures
to pay that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect; provided,
however, that any such tax, assessment, charge or levy need not be paid if the validity thereof shall currently be contested in good
faith by appropriate proceedings and if the Maker or such Subsidiaries shall have set aside on its books reserves with respect thereto
in accordance with generally accepted accounting principles, and provided, further, that the Maker and such Subsidiaries will pay all
such taxes, assessments, charges or levies forthwith upon the commencement of proceedings to foreclose any lien which may have attached
as security therefor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<span style="text-decoration: underline">Corporate Existence</span>. The Maker shall, and shall cause each of its Subsidiaries to, maintain
in full force and effect its corporate existence, rights and franchises (other than the existence, rights and franchises of the Subsidiaries
of the Maker that the board of directors of the Maker determine are no longer necessary or useful to the operation of the Maker&#8217;s
business) and all licenses and other rights to use property owned or possessed by it and reasonably deemed to be necessary to the conduct
of its business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Investment Company Act</span>. The Maker shall conduct its businesses in a manner so that it
will not become subject to, or required to be registered under, the Investment Company Act of 1940, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<span style="text-decoration: underline">Prohibited Transactions; Equity and Indebtedness Issuances</span>. For the avoidance of doubt,
in addition to complying with its obligations under this Note and the other transaction documents, neither the Company nor any Subsidiary
shall enter into any Prohibited Transactions or issue equity or indebtedness in violation of Section 5.9 of the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<span style="text-decoration: underline">Repayment of This Note</span>. If the Company issues indebtedness, including but not limited
to, any subordinated indebtedness, indebtedness convertible into shares of Common Stock or preferred stock, which by its terms may be
redeemed by the Company, for aggregate proceeds of more than two million five hundred thousand dollars ($2,500,000), other than Permitted
Indebtedness, including, for the avoidance of doubt, Permitted Senior Indebtedness, in one or more transactions, unless otherwise waived
in writing by and at the discretion of the Holder, the Company will direct the proceeds from such transactions or transaction to repay
amounts due and owing under this Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<span style="text-decoration: underline">Set-Off</span>. This Note shall be subject to the set-off provisions set forth in the Purchase
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
5</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<span style="text-decoration: underline">Notices</span>. Any and all notices or other communications or deliveries required or permitted
to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission,
if such notice or communication is delivered via email at the email address specified in this Section prior to 5:00 p.m. (New York time)
on a Business Day, (b) the next Business Day after the date of transmission, if such notice or communication is delivered via email at
the email address specified in this Section on a day that is not a Business Day or later than 5:00 p.m. (New York time) on any date and
earlier than 11:59 p.m. (New York time) on such date, (c) the Business Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The addresses
for such notices and communications shall be as set forth in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<span style="text-decoration: underline">Governing Law</span>. This Agreement shall be governed by and construed in accordance with the
Laws of the State of Delaware, without reference to principles of conflict of laws or choice of laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<span style="text-decoration: underline">Headings</span>. The headings herein are for convenience only, do not constitute a part of this
Note and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Note will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.
This Note shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring
any party by virtue of the authorship of any provisions of this Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<span style="text-decoration: underline">Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief</span>. The remedies
provided in this Note shall be cumulative and in addition to all other remedies available under this Note, at law or in equity (including,
without limitation, a decree of specific performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver
of compliance with the provisions giving rise to such remedy and nothing herein shall limit the Holder&#8217;s right to pursue actual
damages for any failure by the Maker to comply with the terms of this Note. Amounts set forth or provided for herein with respect to
payments, conversion and the like (and the computation thereof) shall be the amounts to be received by the holder thereof and shall not,
except as expressly provided herein, be subject to any other obligation of the Maker (or the performance thereof). The Maker acknowledges
that a breach by it of its obligations hereunder will cause irreparable and material harm to the Holder and that the remedy at law for
any such breach would be inadequate. Therefore, the Maker agrees that, in the event of any such breach or threatened breach, the Holder
shall be entitled, in addition to all other available rights and remedies, at law or in equity, to equitable relief, including but not
limited to an injunction restraining any such breach or threatened breach, without the necessity of showing economic loss and without
any bond or other security being required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<span style="text-decoration: underline">Enforcement Expenses</span>. The Maker agrees to pay all costs and expenses of enforcement of
this Note, including, without limitation, attorneys&#8217; fees and expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<span style="text-decoration: underline">Binding Effect</span>. The obligations of the Maker and the Holder set forth herein shall be
binding upon the successors and assigns of each such party, whether or not such successors or assigns are permitted by the terms herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<span style="text-decoration: underline">Amendments; Waivers</span>. No provision of this Note may be waived or amended except in a written
instrument signed by the Company and the Holder. No waiver of any default with respect to any provision, condition or requirement of
this Note shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair
the exercise of any such right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<span style="text-decoration: underline">Compliance with Securities Laws</span>. The Holder of this Note acknowledges that this Note
is being acquired solely for the Holder&#8217;s own account and not as a nominee for any other party, and for investment, and that the
Holder shall not offer, sell or otherwise dispose of this Note in violation of securities laws. This Note and any Note issued in substitution
or replacement therefor shall be stamped or imprinted with a legend in substantially the following form:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;THIS
NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT
BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<span style="text-decoration: underline">Jurisdiction; Venue</span>. Any action, proceeding or claim arising out of, or relating in any
way to this Note shall be brought and enforced in the New York Supreme Court, County of New York, or in the United States District Court
for the Southern District of New York. The Company and the Holder irrevocably submit to the jurisdiction of such courts, which jurisdiction
shall be exclusive, and hereby waive any objection to such exclusive jurisdiction or that such courts represent an inconvenient forum.
The prevailing party in any such action shall be entitled to recover its reasonable and documented attorneys&#8217; fees and out-of-pocket
expenses relating to such action or proceeding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<span style="text-decoration: underline">Parties in Interest</span>. This Note shall be binding upon, inure to the benefit of and be
enforceable by the Maker, the Holder and their respective successors and permitted assigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<span style="text-decoration: underline">Failure or Indulgence Not Waiver</span>. No failure or delay on the part of the Holder in the
exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any
such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<span style="text-decoration: underline">Maker Waivers</span>. Except as otherwise specifically provided herein, the Maker and all others
that may become liable for all or any part of the obligations evidenced by this Note, hereby waive presentment, demand, notice of nonpayment,
protest and all other demands and notices in connection with the delivery, acceptance, performance and enforcement of this Note, and
do hereby consent to any number of renewals of extensions of the time or payment hereof and agree that any such renewals or extensions
may be made without notice to any such persons and without affecting their liability herein and do further consent to the release of
any person liable hereon, all without affecting the liability of the other persons, firms or Maker liable for the payment of this Note,
AND DO HEREBY WAIVE TRIAL BY JURY.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
No delay or omission on the part of the Holder in exercising its rights under this Note, or course of conduct relating hereto, shall
operate as a waiver of such rights or any other right of the Holder, nor shall any waiver by the Holder of any such right or rights on
any one occasion be deemed a waiver of the same right or rights on any future occasion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
THE MAKER ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE
LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS
MAY DESIRE TO USE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<span style="text-decoration: underline">Definitions</span>. Capitalized terms used herein and not defined shall have the meanings set
forth in the Purchase Agreement. For the purposes hereof, the following terms shall have the following meanings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&#8220;<span style="text-decoration: underline">Adjusted Floor Price</span>&#8221; means, as determined on each six month anniversary
of the Initial Issuance Date (each, an &#8220;<span style="text-decoration: underline">Adjustment Date</span>&#8221;), the lower of (i)
the Floor Price then in effect and (ii) 20% of the lower of (x) the Closing Sale Price of the Common Stock as of the Trading Day ended
immediately prior to such applicable Adjustment Date and (y) the quotient of (I) the sum of each Closing Sale Price of the Common Stock
on each Trading Day of the five (5) Trading Day period ended on, and including, the Trading Day ended immediately prior to such applicable
Adjustment Date, divided by (II) five (5). All such determinations to be appropriately adjusted for any stock split, stock dividend,
stock combination or other similar transaction during any such measuring period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&#8220;<span style="text-decoration: underline">Common Stock Equivalents</span>&#8221; means any rights or warrants or options to purchase
any shares of Common Stock or Convertible Securities, other than rights or warrants or options to purchase any shares of Common Stock
or Convertible Securities granted or issued under any Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&#8220;<span style="text-decoration: underline">Convertible Securities</span>&#8221; means any securities convertible into or exercisable
or exchangeable for, directly or indirectly, shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&#8220;<span style="text-decoration: underline">Exempted Securities</span>&#8221; means &#8220;Exempted Securities&#8221; means (a) Common
Stock or Preferred Stock or rights, warrants or options to purchase Common Stock issued to employees, officers or directors of, or consultants
or advisors to, the Company pursuant to a plan, agreement or arrangement approved by the Board of Directors (b) securities issued upon
the exercise or exchange of or conversion of any Securities issued hereunder, other securities exercisable or exchangeable for or convertible
into Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the
date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price
of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) securities
issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company; provided
that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities, (d) Common Stock issued
pursuant to the ATM Agreement, and (e) Common Stock or issuable in respect of any equity line of credit, stand-by equity distribution
agreements or similar transaction with the Investor or any affiliate thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&#8220;<span style="text-decoration: underline">Floor Price</span>&#8221; means $0.653 (as adjusted for stock splits, stock dividends,
stock combinations, recapitalizations and similar events), or, subject to the rules and regulations of the Principal Market, such lower
price as the Maker and the Holder may agree, from time to time; provided, that if on an Adjustment Date the Floor Price then in effect
is higher than the Adjusted Floor Price with respect to such Adjustment Date, on such Adjustment Date the Floor Price shall automatically
lower to such applicable Adjusted Floor Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&#8220;<span style="text-decoration: underline">Indebtedness</span>&#8221; means: (a) all obligations for borrowed money; (b) all obligations
evidenced by bonds, debentures, notes, or other similar instruments and all reimbursement or other obligations in respect of letters
of credit, bankers acceptances, current swap agreements, interest rate hedging agreements, interest rate swaps, or other financial products;
(c) all capital lease obligations that exceed $500,000 in the aggregate in any fiscal year; (d) all obligations or liabilities secured
by a lien or encumbrance on any asset of the Maker, irrespective of whether such obligation or liability is assumed; (e) all synthetic
leases; (f) any obligation guaranteeing or intended to guarantee (whether directly or indirectly guaranteed, endorsed, co-made, discounted
or sold with recourse) any of the foregoing obligations of any other person; (h) trade debt; and (i) endorsements for collection or deposit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&#8220;<span style="text-decoration: underline">Initial Issuance Date</span>&#8221; means the first date upon which a Note is issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&#8220;<span style="text-decoration: underline">Mandatory Default Amount</span>&#8221; means an amount equal to one hundred ten percent
(110%) of the Outstanding Principal Amount of this Note on the date on which the first Event of Default has occurred hereunder and any
other amounts owing under this Note or the other Transaction Documents; which for the avoidance of doubt is in addition to the Past Due
Rate payable in accordance with Section 1.2.2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&#8220;<span style="text-decoration: underline">Market Capitalization</span>&#8221; means, as of any date of determination, the product
of (a) the number of issued and outstanding shares of Common Stock as of such date (exclusive of any shares of Common Stock issuable
upon the exercise of options or warrants or conversion of any convertible securities), multiplied by (b) the closing price of the shares
of Common Stock on the Trading Market on the date of determination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&#8220;<span style="text-decoration: underline">Outstanding Principal Amount</span>&#8221; means, at the time of determination, the Principal
Amount outstanding after giving effect to any adjustments, conversions or prepayments pursuant to the terms hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&#8220;<span style="text-decoration: underline">Repayment Shares</span>&#8221; means shares of Common Stock issued to the Holder by the
Maker as payment for interest and/or the Principal Amount, pursuant to Section 1.3 of this Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&#8220;<span style="text-decoration: underline">Repayment Share Price</span>&#8221; means ninety percent (90%) of the average of such
five (5) consecutive daily VWAPs as may be selected by the Holder in its sole discretion during the twenty (20) Trading Days prior to
the issuance of the Repayment Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&#8220;<span style="text-decoration: underline">Trading Day</span>&#8221; means a day on which the Common Stock is traded on a Trading
Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&#8220;<span style="text-decoration: underline">VWAP</span>&#8221; means, as of any date, the price determined by the first of the following
clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of
one shares of Common Stock trading in the ordinary course of business on the applicable Trading Price for such date (or the nearest preceding
date) on such Trading Market as reported by Bloomberg Financial L.P.; (b) if the Common Stock is not then listed on a Trading Market
and if the shares of Common Stock are traded in the over-the-counter market, as reported by the OTCQX or OTCQB markets, the volume weighted
average price of one shares of Common Stock for such date (or the nearest preceding date) on the OTCQX or OTCQB markets, as reported
by Bloomberg Financial L.P.; (c) if the Common Stock is not then listed or quoted on a Trading Market or on the OTCQX or OTCQB markets
and if prices for the shares of Common Stock are then reported in the &#8220;Pink Sheets&#8221; published by the OTC Markets Group (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price of one shares of Common
Stock so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases, the fair market value of one shares of Common
Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Pages Follow]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Maker has caused this Note to be duly executed by its duly authorized officer as of the date first above indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STARDUST
  POWER INC.</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
  <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
  Roshan Pujari</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
  Pujari</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
  Executive Officer</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Appendix
C</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF WARRANT</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">THE
NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Warrant is issued pursuant to that certain Securities Purchase Agreement dated December 23, 2025, by and between the Company and the
Holder (as defined below) (the &#8220;<span style="text-decoration: underline">Purchase Agreement</span>&#8221;). Capitalized terms used
and not otherwise defined herein shall have the meanings set forth for such terms in the Purchase Agreement. Receipt of this Warrant
by the Holder shall constitute acceptance and agreement to all of the terms contained herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
2025-001</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>STARDUST
POWER INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMON
STOCK PURCHASE WARRANT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stardust
Power Inc., a Delaware corporation (together with any corporation which shall succeed to or assume the obligations of Stardust Power
Inc. hereunder, the &#8220;<span style="text-decoration: underline">Company</span>&#8221;), hereby certifies that, for value received,
Lind Global Asset Management XIII LLC (the &#8220;<span style="text-decoration: underline">Holder</span>&#8221;), is entitled, subject
to the terms set forth below, to purchase from the Company at any time during the Exercise Period (as defined in <span style="text-decoration: underline">Section
9</span>) up to Four Hundred Eleven Thousand Two Hundred Forty Five (411,245) fully paid and non-assessable shares of Common Stock (as
defined in <span style="text-decoration: underline">Section 9</span>), at a purchase price per share equal to the Exercise Price (as
defined in <span style="text-decoration: underline">Section 9</span>). The number of shares of Common Stock for which this Common Stock
Purchase Warrant (this &#8220;<span style="text-decoration: underline">Warrant</span>&#8221;) is exercisable and the Exercise Price are
subject to adjustment as provided herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<span style="text-decoration: underline">DEFINITIONS</span>. Certain terms are used in this Warrant as specifically defined in <span style="text-decoration: underline">Section
9</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<span style="text-decoration: underline">EXERCISE OF WARRANT</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<span style="text-decoration: underline">Exercise</span>. This Warrant may be exercised prior to its expiration pursuant to <span style="text-decoration: underline">Section
2.5</span> hereof by the Holder at any time or from time to time during the Exercise Period, by submitting the form of subscription attached
hereto (the &#8220;<span style="text-decoration: underline">Exercise Notice</span>&#8221;) duly executed by the Holder, to the Company
at its principal office, indicating whether the Holder is electing to purchase a specified number of shares by paying the Aggregate Exercise
Price as provided in <span style="text-decoration: underline">Section 2.2</span> or is electing to exercise this Warrant as to a specified
number of shares pursuant to the net exercise provisions of <span style="text-decoration: underline">Section 2.3</span>. On or before
the first Trading Day following the date on which the Company has received the Exercise Notice, the Company shall transmit by electronic
mail an acknowledgement of confirmation of receipt of the Exercise Notice. Subject to <span style="text-decoration: underline">Section
2.4</span>, this Warrant shall be deemed exercised for all purposes as of the close of business on the day on which the Holder has delivered
the Exercise Notice to the Company. The Aggregate Exercise Price, if any, shall be paid by wire transfer to the Company within five (5)
Business Days of the date of exercise and prior to the time the Company issues the certificates evidencing the shares issuable upon such
exercise. In the event this Warrant is not exercised in full, the Company may, at its expense, require the Holder, after such partial
exercise, to promptly return this Warrant to the Company and the Company will forthwith issue and deliver to or upon the order of the
Holder a new Warrant or Warrants of like tenor, in the name of the Holder or as the Holder (upon payment by the Holder of any applicable
transfer taxes) may request, calling in the aggregate on the face or faces thereof for the number of shares of Common Stock equal (without
giving effect to any adjustment therein) to the number of such shares called for on the face of this Warrant minus the number of such
shares (without giving effect to any adjustment therein) for which this Warrant shall have been exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 95; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<span style="text-decoration: underline">Payment of Exercise Price by Wire Transfer</span>. If the Holder elects to purchase a specified
number of shares by paying the Aggregate Exercise Price, the Holder shall pay such amount by wire transfer of immediately available funds
to the account designated by the Company in its acknowledgement of receipt of such Exercise Notice pursuant to <span style="text-decoration: underline">Section
2.1</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
<span style="text-decoration: underline">Net Exercise</span>. If a registration statement covering the Common Stock that is the subject
of the Notice of Exercise (the &#8220;<span style="text-decoration: underline">Unavailable Warrant Shares</span>&#8221;) is not available
for the resale of such Unavailable Warrant Shares to the public or upon exercise of this Warrant in connection with a Fundamental Transaction,
the Holder may elect to exercise this Warrant by receiving Common Stock equal to the number of shares determined pursuant to the following
formula:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
= <span style="text-decoration: underline">Y (A - B)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
    =</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares of Common Stock to be issued to Holder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y
    =</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares of Common Stock as to which this Warrant is to be exercised (as indicated on the Exercise Notice);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    =</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VWAP
    for the Trading Day immediately preceding the date of exercise; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B
    =</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Warrant will be exercised pursuant to this <span style="text-decoration: underline">Section 2.3</span> automatically and without further
action by any Person immediately prior to the time at which it expires in accordance with <span style="text-decoration: underline">Section
2.5</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
<span style="text-decoration: underline">Antitrust Notification</span>. If the Holder determines, in its sole judgment upon the advice
of counsel, that the issuance of any Warrant Shares pursuant to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the &#8220;<span style="text-decoration: underline">HSR Act</span>&#8221;), the Company
shall file as soon as practicable after the date on which the Company receives notice from the Holder of the applicability of the HSR
Act and a request to so file with the United States Federal Trade Commission and the United States Department of Justice the notification
and report form required to be filed by it pursuant to the HSR Act in connection with such issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.
<span style="text-decoration: underline">Termination</span>. This Warrant shall terminate upon the earlier to occur of (i) exercise in
full or (ii) the expiration of the Exercise Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<span style="text-decoration: underline">REGISTRATION RIGHTS</span>. The Holder of this Warrant has certain rights to require the Company
to register its resale of the Warrant Shares under the Securities Act and any blue sky or securities laws of any jurisdictions within
the United States at the time and in the manner specified in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<span style="text-decoration: underline">DELIVERY OF STOCK CERTIFICATES ON EXERCISE</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.
<span style="text-decoration: underline">Delivery of Exercise Shares</span>. As soon as practicable after any exercise of this Warrant
and in any event within one (1) Trading Day thereafter (such date, the &#8220;<span style="text-decoration: underline">Exercise Share
Delivery Date</span>&#8221;), the Company shall, at its expense (including the payment by it of any applicable issue or stamp taxes),
cause to be issued in the name of and delivered to the Holder, or as the Holder may direct, a certificate or certificates evidencing
the number of fully paid and non-assessable Common Stock (which number shall be rounded down to the nearest whole share in the event
any fractional share may otherwise be issuable upon such exercise and the Company shall pay a cash adjustment to the Holder in respect
of such final fraction in an amount equal to such fraction multiplied by the Exercise Price) to which the Holder shall be entitled on
such exercise, in such denominations as may be requested by the Holder, which certificate or certificates shall be free of restrictive
and trading legends (except for any such legends as may be required under the Securities Act). In lieu of delivering physical certificates
for the Common Stock issuable upon any exercise of this Warrant, provided the Warrant Shares are not restricted securities and the Company&#8217;s
transfer agent is participating in the Depository Trust Company (&#8220;<span style="text-decoration: underline">DTC</span>&#8221;) Fast
Automated Securities Transfer program or a similar program, upon request of the Holder, the Company shall cause its transfer agent to
electronically transmit such Common Stock issuable upon exercise of this Warrant to the Holder (or its designee), by crediting the account
of the Holder&#8217;s (or such designee&#8217;s) broker with DTC through its Deposit Withdrawal Agent Commission system (provided that
the same time periods herein as for stock certificates shall apply) as instructed by the Holder (or its designee).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.
<span style="text-decoration: underline">Compensation for Buy-In on Failure to Timely Deliver Exercise Shares</span>. In addition to
any other rights available to the Holder, if the Company fails to cause its transfer agent to transmit to the Holder Exercise Shares
pursuant to an exercise on or before the Exercise Share Delivery Date, and if after such date the Holder is required by its broker to
purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Common Stock to deliver
in satisfaction of a sale by the Holder of the Exercise Shares which the Holder anticipated receiving upon such exercise (a &#8220;<span style="text-decoration: underline">Buy-In</span>&#8221;),
then the Company shall (a) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including
brokerage commissions, if any) for the Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Exercise
Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the
sell order giving rise to such purchase obligation was executed, and (b) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent number of Exercise Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied
with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price
of $11,000 to cover a Buy-In with respect to an attempted exercise of Common Stock with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (a) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000.
The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and evidence
of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue a decree of specific performance and/or injunctive
relief with respect to the Company&#8217;s failure to timely deliver Common Stock upon exercise of the Warrant as required pursuant to
the terms hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
<span style="text-decoration: underline">Charges, Taxes and Expenses</span>. Issuance of Exercise Shares shall be made without charge
to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Exercise Shares, all of which
taxes and expenses shall be paid by the Company, and such Exercise Shares shall be issued in the name of the Holder or in such name or
names as may be directed by the Holder; <span style="text-decoration: underline">provided</span>, <span style="text-decoration: underline">however</span>,
that in the event Exercise Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto (the &#8220;<span style="text-decoration: underline">Assignment Form</span>&#8221;)
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<span style="text-decoration: underline">CERTAIN ADJUSTMENTS</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
<span style="text-decoration: underline">Stock Dividends and Splits</span>. If the Company, at any time while this Warrant is outstanding:
(a) pays a stock dividend or otherwise makes a distribution or distributions on Common Stock or any other equity or equity equivalent
securities payable in Common Stock (which, for avoidance of doubt, shall not include any Common Stock issued by the Company upon exercise
of this Warrant), (b) subdivides (including by way of share split) outstanding Common Stock into a larger number of shares, (c) combines
(including by way of reverse stock split) outstanding Common Stock into a smaller number of shares, or (d) issues by reclassification
of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of
which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this <span style="text-decoration: underline">Section 5.1</span> shall
become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<span style="text-decoration: underline">Pro Rata Distributions</span>. During such time as this Warrant is outstanding, if the Company
shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock ,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &#8220;<span style="text-decoration: underline">Distribution</span>&#8221;), at any time after the issuance of this Warrant, then,
in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated
therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the ownership limitations set forth in <span style="text-decoration: underline">Section
10</span> hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date
as of which the record holders of Common Stock is to be determined for the participation in such Distribution (provided, however, that,
to the extent that the Holder&#8217;s right to participate in any such Distribution would result in the Holder exceeding the beneficial
ownership limitation provided for in <span style="text-decoration: underline">Section 10</span>, then the Holder shall not be entitled
to participate in such Distribution to such extent (or in the beneficial ownership of any Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the beneficial ownership limitation).</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<span style="text-decoration: underline">Fundamental Transaction</span>. If, at any time while this Warrant is outstanding, (i) the Company
or any Subsidiary, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with
or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock is permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock , (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding Common Stock (not including any Common Stock held by the other Person
or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase
agreement or other business combination) (each a &#8220;<span style="text-decoration: underline">Fundamental Transaction</span>&#8221;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any ownership limitations set forth in <span style="text-decoration: underline">Section 10</span> hereof on the exercise of
this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the &#8220;<span style="text-decoration: underline">Alternate Consideration</span>&#8221;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any ownership limitations set forth in <span style="text-decoration: underline">Section
10</span> hereof on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock is given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined
below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within thirty (30) days after, the consummation
of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase
this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that, if the
Fundamental Transaction is not within the Company&#8217;s control, including not approved by the Company&#8217;s Board of Directors,
the Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental
Transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion
of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration is in the form of cash, shares or any combination thereof, or whether the holders of Common Stock is given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received Common Stock , as applicable, of the Successor Entity (which entity may be the Company
following such Fundamental Transaction) in such Fundamental Transaction. &#8220;<span style="text-decoration: underline">Black Scholes
Value</span>&#8221; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &#8220;OV&#8221;
function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting
(A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable contemplated Fundamental Transaction and the date that is sixty (60) months following the Issuance Date, (B) an expected
volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing
a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental
Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being
offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)
the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated
Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of
the Holder&#8217;s request pursuant to this Section 2(e) and (D) a remaining option time equal to the time between the date of the public
announcement of the applicable contemplated Fundamental Transaction and the date that is sixty (60) months following the Issuance Date
and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or
such other consideration) within the later of (i) five (5) Business Days of the Holder&#8217;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &#8220;<span style="text-decoration: underline">Successor Entity</span>&#8221;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 2(e) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of share capital or capital stock, as applicable, of such Successor Entity (or its parent entity)
equivalent to the Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise
of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of share capital or capital stock, as applicable (but taking into account the relative value of the Common Stock pursuant to such
Fundamental Transaction and the value of such shares of share capital or capital stock, as applicable, such number of shares of share
capital or capital stock, as applicable, and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if
such Successor Entity had been named as the Company herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<span style="text-decoration: underline">Adjustment to Exercise Price Upon Issuance of Common Stock</span>. In the event the Company
shall at any time or from time to time after the Closing Date (but whether before or after the Issue Date) issue or sell any additional
Common Stock (&#8220;<span style="text-decoration: underline">Additional Shares of Common Stock</span>&#8221;), other than (A) Exempted
Securities or (D) pursuant to the terms of this Warrant or the Notes, in any case, at an effective price per share that is <b><i>less</i></b>
than the Exercise Price then in effect or without consideration, then automatically and without further action by any Person the Exercise
Price upon each such issuance shall be reduced to a price equal to the consideration per share paid for such Additional Shares of Common
Stock . For purposes of clarification, the amount of consideration received for such Additional Shares of Common Stock shall not include
the value of any additional securities or other rights received in connection with such issuance of Additional Shares of Common Stock
(i.e., warrants, rights of first refusal or other similar rights).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<span style="text-decoration: underline">Calculations</span>. All calculations under this <span style="text-decoration: underline">Section
5</span> shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this <span style="text-decoration: underline">Section
5</span>, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number
of shares of Common Stock (excluding treasury shares, if any) issued and outstanding at the close of the Trading Day on or, if not applicable,
most recently preceding, such given date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<span style="text-decoration: underline">Notice to Holder</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<span style="text-decoration: underline">Adjustment to Exercise Price</span>. Whenever the Exercise Price is adjusted pursuant to any
provision of this <span style="text-decoration: underline">Section 5</span>, the Company shall promptly mail to the Holder a notice setting
forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<span style="text-decoration: underline">Notice to Allow Exercise by Holder</span>. If (i) the Company shall declare a dividend (or any
other distribution in whatever form) on the Common Stock; (ii) the Company shall declare a special nonrecurring cash dividend on or a
redemption of the Common Stock; (iii) the Company shall authorize the granting to all holders of the Common Stock rights or warrants
to subscribe for or purchase any shares of capital stock of any class or of any rights; (iv) the approval of any stockholders of the
Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company
is a party, any sale or transfer of all or substantially all of the assets of the Company, of any compulsory share exchange whereby the
Common Stock is converted into other securities, cash or property; or (v) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company; then, in each case, the Company shall cause to be mailed to the Holder at its
last address as it shall appear upon the Warrant Register of the Company, at least twenty (20) calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate
action required to be specified in such notice. Subject to applicable law, the Holder is entitled to exercise this Warrant during the
period commencing on the date of such notice to the effective date of the event triggering such notice. Notwithstanding the foregoing,
the delivery of the notice described in this <span style="text-decoration: underline">Section 5.6</span> is not intended to and shall
not bestow upon the Holder any voting rights whatsoever with respect to outstanding unexercised Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<span style="text-decoration: underline">NO IMPAIRMENT</span>. The Company will not, by amendment of the Certificate of Incorporation
or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith
assist in the carrying out of all such terms and in taking all such action as may be necessary or appropriate in order to protect the
rights of the Holder against impairment. Without limiting the generality of the foregoing, the Company (a) will not increase the par
value of any Common Stock receivable on the exercise of this Warrant above the amount payable therefor on such exercise and (b) will
take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable
shares of stock on the exercise of this Warrant from time to time outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<span style="text-decoration: underline">NOTICES OF RECORD DATE</span>. In the event of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who
are entitled to receive any dividend or other distribution, or any right to subscribe for, purchase or otherwise acquire any shares of
stock of any class or any other securities or property, or to receive any other right;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.6in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any transfer
of all or substantially all the assets of the Company to or any consolidation or merger of the Company with or into any other Person
or any other Change of Control; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.6in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
any voluntary or involuntary dissolution, liquidation or winding-up of the Company; then, and in each such event, the Company will mail
or cause to be mailed to the Holder a notice specifying (i) the date on which any such record is to be taken for the purpose of such
dividend, distribution or right, and stating the amount and character of such dividend, distribution or right, or (ii) the date on which
any such reorganization, reclassification, recapitalization, transfer, consolidation, merger, dissolution, liquidation or winding-up
is anticipated to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock shall be entitled
to exchange their Common Stock for securities or other property deliverable on such reorganization, reclassification, recapitalization,
transfer, consolidation, merger, dissolution, liquidation or winding-up. Such notice shall be mailed at least fifteen (15) days prior
to the date specified in such notice on which any such action is to be taken.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.6in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<span style="text-decoration: underline">RESERVATION OF STOCK ISSUABLE ON EXERCISE OF WARRANT; REGULATORY COMPLIANCE</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.
<span style="text-decoration: underline">Reservation of Stock Issuable on Exercise of Warrant</span>. The Company shall at all times
while this Warrant shall be outstanding, reserve and keep available out of its authorized but unissued Common Stock, such number of shares
of Common Stock as shall from time to time be sufficient to effect the exercise of all or any portion of the Warrant Shares (disregarding
for this purpose any and all limitations of any kind on such exercise). The Company shall, from time to time in accordance with the Delaware
General Corporation Law, increase the authorized number of shares of Common Stock or take other effective action if at any time the unissued
number of authorized shares shall not be sufficient to satisfy the Company&#8217;s obligations under this <span style="text-decoration: underline">Section
8</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.
<span style="text-decoration: underline">Regulatory Compliance</span>. If any Common Stock to be reserved for the purpose of exercise
of the Warrant Shares require registration or listing with or approval of any Governmental Authority, stock exchange or other regulatory
body under any federal or state law or regulation or otherwise before such shares may be validly issued or delivered upon exercise, the
Company shall, at its sole cost and expense, in good faith and as expeditiously as possible, secure such registration, listing or approval,
as the case may be.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<span style="text-decoration: underline">DEFINITIONS</span>. As used herein the following terms, unless the context otherwise requires,
have the following respective meanings:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Affiliate</span>&#8221;
means a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control
with, the Person specified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Aggregate
Exercise Price</span>&#8221; means, in connection with the exercise of this Warrant at any time, an amount equal to the product obtained
by multiplying (i) the Exercise Price times (ii) the number of shares of Common Stock for which this Warrant is being exercised at such
time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Business
Day</span>&#8221; means any day other than a Saturday, Sunday or any other day on which banks are permitted or required to be closed
in New York City.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Change
of Control</span>&#8221; has the meaning set forth in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Common
Stock</span>&#8221; means (i) the Company&#8217;s common stock, par value $0.0001 per share, and (ii) any other securities into which
or for which any of the securities described in clause (i) above have been converted or exchanged pursuant to a plan of recapitalization,
reorganization, merger, sale of assets or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Convertible
Securities</span>&#8221; means any debt, equity or other securities that are, directly or indirectly, convertible into or exchangeable
for Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Exchange
Act</span>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder from time
to time in effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Exercise
Period</span>&#8221; means the period commencing on the date that is six (6) months after the Issue Date (&#8220;Exercise Period Commencement&#8221;)
and ending 11:59 P.M. (New York City time) on the date that is sixty (60) months from the Exercise Period Commencement or earlier closing
of a Fundamental Transaction (other than a Fundamental Transaction of the type described in clause (d) of the definition thereof resulting
in the conversion into or exchange for another security of the Company).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Exercise
Price</span>&#8221; means $5.837 per share, as may be adjusted pursuant to the terms hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Exercise
Shares</span>&#8221; means the Common Stock for which this Warrant is then being exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Fair
Market Value</span>&#8221; means, with respect to any security or other property, the fair market value of such security or other property
as determined by the Board of Directors, acting in good faith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Governmental
Authority</span>&#8221; means the government of the United States or any other nation, or of any political subdivision thereof, whether
state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive,
legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national
bodies such as the European Union or the European Central Bank).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Issue
Date</span>&#8221; means December 23, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Note</span>&#8221;
means the senior secured convertible promissory note issued by the Company to the Holder pursuant to the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Person</span>&#8221;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Securities
Act</span>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder from time to time
in effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Subsidiary</span>&#8221;
means, as of any time of determination and with respect to any Person, any United States corporation, partnership, limited liability
company or limited liability partnership, all of the stock (or other equity interest) of every class of which, except directors&#8217;
qualifying shares (or any equivalent), shall, at such time, be owned by such Person either directly or through Subsidiaries and of which
such Person or a Subsidiary shall have 100% control thereof, except directors&#8217; qualifying shares. Unless the context otherwise
clearly requires, any reference to a &#8220;Subsidiary&#8221; is a reference to a Subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Trading
Day</span>&#8221; means a day on which the Common Stock is traded on a Trading Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Trading
Market</span>&#8221; means whichever of the New York Stock Exchange, NYSE: Amex Exchange, or the Nasdaq Stock Market (including the Nasdaq
Capital Market), on which the Common Stock is listed or quoted for trading on the date in question.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">VWAP</span>&#8221;
means, as of any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of one share of Common Stock trading in the ordinary course of
business on the applicable Trading Price for such date (or the nearest preceding date) on such Trading Market as reported by Bloomberg
Financial L.P.; (b) if the Common Stock is not then listed on a Trading Market and if the Common Stock is traded in the over-the-counter
market, as reported by the OTC Bulletin Board, the volume weighted average price of one share of Common Stock for such date (or the nearest
preceding date) on the OTC Bulletin Board, as reported by Bloomberg Financial L.P.; (c) if the Common Stock is not then listed or quoted
on the OTC Bulletin Board and if prices for the Common Stock is then reported in the &#8220;Pink Sheets&#8221; published by the Pink
OTC Markets Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price of
one share of Common Stock so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases, the Fair Market Value of one
share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the
Company (in each case rounded to four decimal places).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<span style="text-decoration: underline">Warrant
Shares</span>&#8221; means collectively the Common Stock of the Company issuable upon exercise of the Warrant in accordance with its
terms, as such number may be adjusted pursuant to the provisions thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<span style="text-decoration: underline">LIMITATION ON BENEFICIAL OWNERSHIP</span>. Notwithstanding anything to the contrary contained
herein, the Holder shall not be entitled to receive Common Stock or other securities (together with Common Stock, &#8220;<span style="text-decoration: underline">Equity
Interests</span>&#8221;) upon exercise of this Warrant to the extent (but only to the extent) that such exercise or receipt would cause
the Holder Group to become, directly or indirectly, a &#8220;beneficial owner&#8221; (within the meaning of Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder) of a number of Equity Interests of a class that is registered under the Exchange
Act which exceeds the Maximum Percentage (as defined in the Purchase Agreement) of the Equity Interests of such class that are outstanding
at such time. Any purported delivery of Equity Interests in connection with the exercise of the Warrant prior to the termination of this
restriction in accordance herewith shall be void and have no effect to the extent (but only to the extent) that such delivery would result
in the Holder Group becoming the beneficial owner of more than the Maximum Percentage of the Equity Interests of a class that is registered
under the Exchange Act that is outstanding at such time. If any delivery of Equity Interests owed to the Holder following exercise of
this Warrant is not made, in whole or in part, as a result of this limitation, the Company&#8217;s obligation to make such delivery shall
not be extinguished and the Company shall deliver such Equity Interests as promptly as practicable after the Holder gives notice to the
Company that such delivery would not result in such limitation being triggered or upon termination of the restriction in accordance with
the terms hereof. To the extent limitations contained in this <span style="text-decoration: underline">Section 10</span> apply, the determination
of whether this Warrant is exercisable and of which portion of this Warrant is exercisable shall be the sole responsibility and in the
sole determination of the Holder, and the submission of an Exercise Notice shall be deemed to constitute the Holder&#8217;s determination
that the issuance of the full number of Warrant Shares requested in the Exercise Notice is permitted hereunder, and neither the Company
nor any Warrant agent shall have any obligation to verify or confirm the accuracy of such determination. For purposes of this <span style="text-decoration: underline">Section
10</span>, (i) the term &#8220;<span style="text-decoration: underline">Maximum Percentage</span>&#8221; shall have the definition set
forth in the Purchase Agreement; and (ii) the term &#8220;<span style="text-decoration: underline">Holder Group</span>&#8221; shall mean
the Holder plus any other Person with which the Holder is considered to be part of a group under Section 13 of the Exchange Act or with
which the Holder otherwise files reports under Sections 13 and/or 16 of the Exchange Act. In determining the number of Equity Interests
of a particular class outstanding at any point in time, the Holder may rely on the number of outstanding Equity Interests of such class
as reflected in (x) the Company&#8217;s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the Securities
and Exchange Commission, as the case may be, (y) a more recent public announcement by the Company or (z) a more recent notice by the
Company or its transfer agent to the Holder setting forth the number of Equity Interests of such class then outstanding. For any reason
at any time, upon written or oral request of the Holder, the Company shall, within one (1) Trading Day of such request, confirm orally
and in writing to the Holder the number of Equity Interests of any class then outstanding. The provisions of this <span style="text-decoration: underline">Section
10</span> shall be construed, corrected and implemented in a manner so as to effectuate the intended beneficial ownership limitation
herein contained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<span style="text-decoration: underline">REGISTRATION AND TRANSFER OF WARRANT</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.
<span style="text-decoration: underline">Registration of Warrant</span>. The Company shall register and record transfers, exchanges,
reissuances and cancellations of this Warrant, upon the records to be maintained by the Company for that purpose, in the name of the
record holder hereof from time to time. The Company may deem and treat the registered holder of this Warrant as the absolute owner hereof
for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
The Company shall be entitled to rely, and held harmless in acting or refraining from acting in reliance upon, any notices, instructions
or documents it believes in good faith to be from an authorized representative of the Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2
<span style="text-decoration: underline">Transferability</span>. This Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form of assignment (the &#8220;<span style="text-decoration: underline">Assignment
Notice</span>&#8221;) attached hereto duly executed by the Holder or its agent or attorney. The Company may require the transferor thereof
to provide to the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of the transferred Warrant under the 1933
Act. Upon such surrender, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as
applicable, and in the denomination or denominations specified in such Assignment Notice, and shall issue to the assignor a new Warrant
evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. This Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Exercise Shares without having a new Warrant issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.3.
<span style="text-decoration: underline">New Warrants</span>. This Warrant may be divided or combined with other Warrants upon presentation
hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants
are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with <span style="text-decoration: underline">Section
11.2</span>, as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant
or Warrants in exchange for this Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on
transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Exercise
Shares issuable pursuant thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<span style="text-decoration: underline">LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT</span>. The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Exercise Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of this Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock
certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or share certificate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<span style="text-decoration: underline">REMEDIES</span>. The Company stipulates that the remedies at law of the Holder in the event
of any default or threatened default by the Company in the performance of or compliance with any of the terms of this Warrant are not
and will not be adequate, and that such terms may be specifically enforced by a decree for the specific performance of any agreement
contained herein or by an injunction against a violation of any of the terms hereof or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<span style="text-decoration: underline">NO RIGHTS AS A STOCKHOLDER</span>. Except as otherwise specifically provided herein, the Holder,
solely in such Person&#8217;s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the
holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the
Holder, solely in such Person&#8217;s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any
right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock,
consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise,
prior to the issuance to the Holder of the Exercise Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<span style="text-decoration: underline">NOTICES</span>. All notices, requests, demands and other communications that are required or
may be given pursuant to the terms of this Warrant shall be in writing and shall be deemed delivered (i) on the date of delivery when
delivered by hand on a Business Day during normal business hours or, if delivered on a day that is not a Business Day or after normal
business hours, then on the next Business Day, (ii) on the date of transmission when sent by facsimile transmission or email during normal
business hours on a Business Day with telephone confirmation of receipt or, if transmitted on a day that is not a Business Day or after
normal business hours, then on the next Business Day, or (iii) on the second Business Day after the date of dispatch when sent by a reputable
courier service that maintains records of receipt. The addresses for notice shall be as set forth in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<span style="text-decoration: underline">CONSENT TO AMENDMENTS</span>. Any term of this Warrant may be amended, and the Company may take
any action herein prohibited, or compliance therewith may be waived, only if the Company shall have obtained the written consent (and
not without such written consent) to such amendment, action or waiver from the Holder. No course of dealing between the Company and the
Holder nor any delay in exercising any rights hereunder shall operate as a waiver of any rights of the Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<span style="text-decoration: underline">MISCELLANEOUS</span>. In case any provision of this Warrant shall be invalid, illegal or unenforceable,
or partially invalid, illegal or unenforceable, the provision shall be enforced to the extent, if any, that it may legally be enforced
and the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. If any
provision of this Warrant is found to conflict with the Purchase Agreement, the provisions of this Warrant shall prevail. If any provision
of this Warrant is found to conflict with the Note, the provisions of the Note shall prevail. THIS WARRANT SHALL BE CONSTRUED AND ENFORCED
IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE INTERNAL LAW OF THE STATE OF NEW YORK EXCLUDING CHOICE-OF-LAW
PRINCIPLES OF THE LAW OF SUCH STATE THAT WOULD PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE. The headings
in this Warrant are for purposes of reference only, and shall not limit or otherwise affect any of the terms hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[Remainder
of Page Intentionally Left Blank]</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
as of December 23, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STARDUST
    POWER INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Roshan Pujari</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Appendix
D</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATE
OF AMENDMENT</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
THE CERTIFICATE OF INCORPORATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF
<span style="text-transform: uppercase">Stardust Power INC.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stardust
Power Inc., a corporation organized and existing under the laws of the State of Delaware (the &#8220;<b><i>Corporation</i></b>&#8221;),
DOES HEREBY CERTIFY AS FOLLOWS:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    the Board of Directors of the Corporation (the &#8220;<b><i>Board</i></b>&#8221;) has duly adopted resolutions (a) authorizing the
    Corporation to execute and file with the Secretary of State of the State of Delaware this Certificate of Amendment (the &#8220;<b><i>Certificate
    of Amendment</i></b>&#8221;) to the Certificate of Incorporation of the Corporation, as amended (the &#8220;<b><i>Certificate of
    Incorporation</i></b>&#8221;), setting forth the amendment to the Certificate of Incorporation and (b) declaring the Certificate
    of Amendment to be advisable and in the best interests of the Corporation and its stockholders in accordance with Section 242 of
    the Delaware General Corporation Law.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    pursuant to a resolution of the Board, this Certificate of Amendment was submitted to the stockholders of the Corporation for their
    approval, and was duly adopted and approved in accordance with Section 242 of the Delaware General Corporation Law.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    pursuant to this Certificate of Amendment, Article V, Section 4 of the Certificate of Incorporation is hereby amended and restated
    in its entirety as follows:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Section
4. Each director shall hold office until the annual meeting at which such director&#8217;s term expires and until such director&#8217;s
successor is duly elected and qualified, or until such director&#8217;s earlier death, resignation, disqualification or removal. Any
director may resign at any time upon notice to the Corporation given in writing or by any electronic transmission permitted by the Bylaws.
</span>Subject to the special rights of the holders of any series of Preferred Stock, <span style="text-decoration: line-through">no</span> director<span style="text-decoration: underline double">s</span> may be removed
from the Board <span style="text-decoration: line-through">except for cause</span> <span style="text-decoration: underline double">with or without cause</span> and only by the affirmative vote of the holders of at least two-thirds
(2/3) of the voting power of the then-outstanding shares of capital stock of the Corporation entitled to vote generally in the election
of directors voting together as a single class. In the event of any increase or decrease in the authorized number of directors, (a) each
director then serving as such shall nevertheless continue as a director of the class of which the director is a member and (b) the newly
created or eliminated directorships resulting from such increase or decrease shall be apportioned by the Board among the classes of directors
so as to ensure that no one class has more than one (1) director more than any other class. To the extent possible, consistent with the
foregoing rule, any newly created directorships shall be added to those classes whose terms of office are to expire at the latest dates
following such allocation, and any newly eliminated directorships shall be subtracted from those classes whose terms of office are to
expire at the earliest dates following such allocation, unless otherwise provided from time to time by resolution adopted by the Board.
No decrease in the authorized number of directors constituting the Board shall shorten the term of any incumbent director.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    except as amended hereby, the provisions of the Corporation&#8217;s Certificate of Incorporation shall remain in full force and effect.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">IN
WITNESS WHEREOF,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stardust Power Inc. has caused this
Certificate of Amendment to be duly executed and acknowledged in its name and on its behalf by the following duly authorized officer
of the Corporation this ____ day of ____.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STARDUST
    POWER INC.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roshan
    Pujari</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 106; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Appendix
E</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05in; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Stardust
Power Inc</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Amended
and Restated 2024 Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
Purpose of this Plan</b>. The purpose of this Plan is to advance the interests of the Company&#8217;s shareholders by enhancing the ability
of the Company Group to attract, retain, and motivate persons who make (or are expected to make) important contributions to the Company
Group by providing such persons with incentive compensation and equity ownership opportunities and thereby better aligning the interests
of such persons with those of the Company&#8217;s shareholders. This Plan permits the grant of Incentive Stock Options, Nonstatutory
Share Options, Share Appreciation Rights, Restricted Shares, Restricted Share Units, Other Share or Cash Based Awards, and Dividend Equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
Definitions</b>. As used herein, the following definitions will apply:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
&#8220;<b>Administrator</b>&#8221; means the Board or any of its Committees as will be administering this Plan, in accordance with Section
4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
&#8220;<b>Applicable Laws</b>&#8221; means any applicable law, including the requirements relating to the administration of equity-based
awards under corporate, securities, tax, and employment laws, and any share exchange or quotation system on which the Shares are listed
or quoted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
&#8220;<b>Award</b>&#8221; means, individually or collectively, a grant under this Plan of Options, Share Appreciation Rights, Restricted
Shares, Restricted Share Units, an Other Share or Cash Based Award, or a Dividend Equivalent award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
&#8220;<b>Award Agreement</b>&#8221; means the written or electronic agreement, terms and conditions, contract, or other instrument or
document setting forth the terms and provisions applicable to each Award granted under this Plan. The Award Agreement is subject to the
terms and conditions of this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
&#8220;<b>Board</b>&#8221; means the Board of Directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
&#8220;<b>Cause</b>&#8221; has the meaning given to such term in any written agreement between the Participant and any member of the
Company Group defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence
of any of the following actions or events by such Participant: (i) the Participant&#8217;s commission of any felony or any crime involving
fraud, dishonesty, or moral turpitude&#894; (ii) the Participant&#8217;s commission of or attempted commission of, or participation in,
a fraud or act of dishonesty against the Company Group&#894; (iii) the Participant&#8217;s material violation of any contract or agreement
between any member of the Company Group and the Participant or of any statutory duty owed to the Company Group&#894; (iv) the Participant&#8217;s
material failure to comply with the written polices or rules of the Company Group&#894; (v) the Participant&#8217;s unauthorized use
or disclosure of the Company Group&#8217;s confidential information or trade secrets&#894; (vi) the Participant&#8217;s material failure
or neglect to perform assigned job duties or services for the Company Group after receiving written notification of the failure&#894;
(vii) the Participant&#8217;s willful disregard of any material lawful written instruction from the Company Group&#894; or (viii) the
Participant&#8217;s willful misconduct or insubordination with respect to the Company Group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
&#8220;<b>Change in Control</b>&#8221; means the occurrence of any of the following events:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
any &#8220;person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any trustee or
other fiduciary holding securities under any employee benefit plan of the Company, or any company owned, or immediately after the transaction
would be owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of
the combined voting power or economic interests of the Company, as applicable, as of immediately prior to such transaction), becoming
the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing
more than 50% of the combined voting power or economic interests of the Company&#8217;s then outstanding securities&#894; provided that
the provisions of this clause (i) are not intended to apply to or include as a Change in Control any transaction that is specifically
excepted from the definition of Change in Control under clause (iii) below&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 107; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
during any period of 12 months, individuals who at the beginning of such 12-month period constitute the Board, and any new director (other
than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in clause
(i), (iii), or (iv) of this definition or a director whose initial assumption of office occurs as a result of either an actual or threatened
election contest (as such term is used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened
solicitation of proxies or consents by or on behalf of a person other than the Board) whose election by the Board or nomination for election
by the Company&#8217;s shareholders was approved by a vote of at least a majority of the directors then still in office who either were
directors at the beginning of such 12-month period or whose election or nomination for election was previously so approved, cease for
any reason to constitute at least a majority of the Board&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
a merger or consolidation of the Company with any other corporation or other entity, other than a merger or consolidation that would
result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding
or by being converted into voting securities of the surviving entity or parent company thereof) more than 50% of (i) the combined voting
power of the voting securities and (ii) the economic interests of the surviving entity or the ultimate parent company thereof (within
the meaning of Section 424(e) of the Code), provided that a merger or consolidation effected to implement an internal recapitalization
of the Company (or similar transaction) in which no &#8220;person&#8221; is or becomes the beneficial owner, directly or indirectly,
of securities of the Company representing more than 50% of either the combined voting power of the Company&#8217;s then-outstanding voting
securities or the then-outstanding economic interests shall not be considered a Change in Control&#894; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
a complete winding up, liquidation, or dissolution of the Company or the consummation of a sale or disposition by the Company of all
or substantially all of the Company&#8217;s assets in which any &#8220;person,&#8221; other than a person or persons who beneficially
own, directly or indirectly, 50% or more of the combined voting power and economic interests of the outstanding voting securities of
the Company immediately prior to the sale, acquires (or has acquired during the 12-month period ending on the most recent acquisition
by such &#8220;person&#8221;) assets from the Company that have a total gross fair market value equal to 50% or more of the total gross
fair market value of all of the assets of the Company as of immediately prior to such sale or disposition of the Company&#8217;s assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if a Change in Control constitutes a payment event with respect to any Award (or any portion of an Award) that provides
for the deferral of compensation that is subject to Code Section 409A, then, to the extent required to avoid the imposition of additional
taxes under Code Section 409A, such transaction or event described in subsection (i), (ii), (iii), or (iv) above with respect to such
Award (or portion thereof) will not be deemed a Change in Control unless the transaction qualifies as a &#8220;change in control event&#8221;
within the meaning of Code Section 409A. Further and for the avoidance of doubt, a transaction will not constitute a Change in Control
if: (i) its sole purpose is to change the jurisdiction of the Company&#8217;s incorporation&#894; or (ii) its sole purpose is to create
a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately
before such transaction. The Administrator shall have full and final authority, which shall be exercised in its sole discretion, to determine
conclusively whether a Change in Control has occurred pursuant to the above definition, the date of the occurrence of such Change in
Control, and any incidental matters relating thereto, provided that any exercise of authority in conjunction with a determination of
whether a Change in Control is a &#8220;change in control event&#8221; as defined in Treasury Regulation Section 1.409A-3(i)(5) shall
be consistent with such regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
&#8220;<b>Code</b>&#8221; means the Internal Revenue Code of 1986, as amended. Any reference to a section of the Code herein will be
a reference to any successor or amended section of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
&#8220;<b>Code Section 409A</b>&#8221; shall mean Section 409A of the Code and the Department of Treasury regulations and other interpretive
guidance issued thereunder, including, without limitation, any such regulations or other guidance that may be issued after the Effective
Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.
&#8220;<b>Committee</b>&#8221; means the Compensation Committee of the Board, or another committee or subcommittee of the Board that
may be comprised of one or more Directors and/or executive officers of the Company as appointed by the Board, to the extent permitted
in accordance with Applicable Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.
&#8220;<b>Company</b>&#8221; means Stardust Power Inc., a Delaware Corporation, or any successor thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l.
&#8220;<b>Company Group</b>&#8221; means the Company and its Parents and Subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m.
&#8220;<b>Consultant</b>&#8221; means any consultant or advisor if: (i) the consultant or advisor renders bona fide services to the Company
Group&#894; (ii) the services rendered by the consultant or advisor are not in connection with the offer or sale of securities in a capital-raising
transaction and do not directly or indirectly promote or maintain a market for the Company&#8217;s securities&#894; and (iii) the consultant
or advisor is a natural person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.
&#8220;<b>Director</b>&#8221; means a member of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o.
&#8220;<b>Disability</b>&#8221; means that the Participant is unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for
a continuous period of not less than 12 months in accordance with the definition of &#8220;total and permanent disability&#8221; as defined
in Code Section 22(e)(3), provided that, in the case of Awards other than Incentive Stock Options, the Administrator in its discretion
may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by
the Administrator from time to time. Notwithstanding the foregoing, if &#8220;Disability&#8221; constitutes a payment event with respect
to any Award (or any portion of an Award) that provides for the deferral of compensation that is subject to Code Section 409A, then,
to the extent required to avoid the imposition of additional taxes under Code Section 409A, &#8220;Disability&#8221; shall mean a disability
within the meaning of Code Section 409A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p.
&#8220;<b>Dividend Equivalent</b>&#8221; means a right to receive the equivalent value (in cash or Shares) of dividends paid on Shares,
awarded under Section 10(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q.
&#8220;<b>DRO</b>&#8221; means a &#8220;domestic relations order,&#8221; as defined by the Code or Title I of the Employee Retirement
Income Security Act of 1974, as amended from time to time, or the rules thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">r.
&#8220;<b>Effective Date</b>&#8221; shall mean April 8, 2026, subject to approval of this Plan by the Company&#8217;s shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">s.
&#8220;<b>Employee</b>&#8221; means any officer or employee (as determined in accordance with Code Section 3401(c) and the Treasury Regulations
thereunder) of the Company or any Parent or Subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t.
&#8220;<b>Equity Restructuring</b>&#8221; shall mean a nonreciprocal transaction between the Company and its shareholders, such as a
share dividend, share split, spin-off, rights offering, or recapitalization through a large, nonrecurring cash dividend, that affects
the number or kind of Shares (or other securities of the Company) or the share price of Shares (or other securities) and causes a change
in the per-share value of the Shares underlying outstanding Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">u.
&#8220;<b>Exchange Act</b>&#8221; means the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
&#8220;<b>Exchange Program</b>&#8221; means a program under which (i) outstanding Awards are surrendered or cancelled in exchange for
Awards of the same type (which may have higher or lower exercise prices and different terms), Awards of a different type, and/or cash,
(ii) Participants would have the opportunity to transfer any outstanding Awards to a financial institution or other person or entity
selected by the Administrator, and/or (iii) the exercise price of an outstanding Award is reduced or increased. The Administrator will
determine the terms and conditions of any Exchange Program in its sole discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">w.
&#8220;<b>Fair Market Value</b>&#8221; means, as of any date, the value of a Share determined as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
If the Shares are listed on any established stock or share exchange or national market system, or quoted or traded on any automated quotation
system, including without limitation the Nasdaq Stock Market, then the Fair Market Value will be the closing sales price for a Share
(or the closing bid, if no sales were reported) as quoted on such exchange or system on the trading day immediately preceding the date
of determination, as reported in <i>The Wall Street Journal </i>or such other source as the Administrator deems reliable&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
If the Shares are not listed on an established stock or share exchange or national market system, and not quoted or traded on an automated
quotation system, but the Shares are regularly quoted by a recognized securities dealer, then the Fair Market Value will be the mean
of the high bid and low asked prices for such date or, if no high bids and low asks were reported on such date, the high bid and low
asked prices for a Share on the last preceding date such bids and asks were reported, as reported in <i>The Wall Street Journal </i>or
such other source as the Administrator deems reliable&#894; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
In the absence of an established market for the Shares, the Fair Market Value will be determined in good faith by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, for income tax reporting purposes under applicable law and for such other purposes as the Committee deems appropriate,
including, without limitation, where Fair Market Value is used in reference to exercise, vesting, settlement, or payout of an Award,
the Fair Market Value shall be determined by the Administrator in accordance with uniform and nondiscriminatory standards adopted by
it from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x.
&#8220;<b>Greater Than 10% Shareholder</b>&#8221; shall mean an individual then owning (within the meaning of Code Section 424(d)) more
than 10% of the total combined voting power of all classes of shares of the Company or any subsidiary corporation (as defined in Code
Section 424(f)) or parent corporation (as defined in Code Section 424(e)) of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">y.
&#8220;<b>Incentive Stock Option</b>&#8221; means an Option that by its terms qualifies and is otherwise intended to qualify as an incentive
stock option within the meaning of Code Section 422 and the regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">z.
&#8220;<b>Nonstatutory Share Option</b>&#8221; means an Option that by its terms does not qualify or is not intended to qualify as an
Incentive Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">aa.
&#8220;<b>Non-Employee Director</b>&#8221; shall mean a Director of the Company who is not an Employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bb.
&#8220;<b>Option</b>&#8221; means a right to purchase Shares at a specified exercise price, granted under Section 6. An Option shall
be either a Nonstatutory Share Option or an Incentive Stock Option, provided that Options granted to Non-Employee Directors and Consultants
shall only be Nonstatutory Share Options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc.
&#8220;<b>Other Share or Cash Based Award</b>&#8221; shall mean a cash payment, cash bonus award, share payment, share bonus award, performance
award, or incentive award that is paid in cash, Shares, or a combination of both, awarded under Section 10, which may include, without
limitation, deferred shares, deferred share units, performance awards, retainers, committee fees, and meeting-based fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dd.
&#8220;<b>Parent</b>&#8221; means any entity (other than the Company) in an unbroken chain of entities ending with the Company if, at
the time of determination, each of the entities other than the Company owns securities or interests possessing fifty percent (50%) or
more of the total combined voting power of all classes of shares in one of the other entities in such chain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ee.
&#8220;<b>Participant</b>&#8221; means the holder of an outstanding Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ff.
&#8220;<b>Performance Criteria</b>&#8221; means the criteria (and adjustments) that the Administrator selects for an Award for purposes
of establishing the Performance Goals for a Performance Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">gg.
&#8220;<b>Performance Goals</b>&#8221; shall mean one or more goals established in writing by the Administrator for the Performance Period
based upon one or more Performance Criteria. Depending on the Performance Criteria used to establish such Performance Goals, the Performance
Goals may be expressed in terms of overall Company performance or the performance of a Subsidiary, division, business unit, or an individual.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">hh.
&#8220;<b>Performance Period</b>&#8221; means one or more periods of time, which may be of varying and overlapping durations, as the
Administrator may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining
a Participant&#8217;s right to, vesting of, and/or payment in respect of an Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
&#8220;<b>Period of Restriction</b>&#8221; means the period during which the transfer of Restricted Shares is subject to restrictions
and, therefore, the Restricted Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage
of time, the achievement of levels of performance, or the occurrence of other events as determined by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">jj.
&#8220;<b>Permitted Transferee</b>&#8221; means, with respect to a Participant, any &#8220;family member&#8221; of the Participant, as
defined in the General Instructions to Form S-8 Registration Statement under the Securities Act (or any successor form thereto), or any
other transferee specifically approved by the Administrator after taking into account Applicable Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">kk.
&#8220;<b>Plan</b>&#8221; means this Stardust Power, Inc. Amended and Restated 2024 Equity Incentive Plan, as may be amended from time
to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ll.
&#8220;<b>Program</b>&#8221; means any program adopted by the Administrator pursuant to this Plan containing the terms and conditions
intended to govern a specified type of Award granted under this Plan and pursuant to which such type of Award may be granted under this
Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">mm.
&#8220;<b>Restricted Shares</b>&#8221; means Shares issued pursuant to Section 8 that are subject to certain restrictions and may be
subject to risk of forfeiture or repurchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">nn.
&#8220;<b>Restricted Share Unit</b>&#8221; means a bookkeeping entry representing an amount equal to the Fair Market Value of one Share,
granted pursuant to Section 9. Each Restricted Share Unit represents an unfunded and unsecured obligation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">oo.
&#8220;<b>Securities Act</b>&#8221; means the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pp.
&#8220;<b>Service Provider</b>&#8221; means an Employee, Director, or Consultant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">qq.
&#8220;<b>Share</b>&#8221; means a share of the Company&#8217;s common stock, with a par value of $0.00001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rr.
&#8220;<b>Share Appreciation Right</b>&#8221; means an Award, granted alone or in connection with an Option, that pursuant to Section
7 is designated as a Share Appreciation Right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ss.
&#8220;<b>Subsidiary</b>&#8221; means any entity (other than the Company) in an unbroken chain of entities beginning with the Company
if each of the entities other than the last entity in the unbroken chain beneficially owns, at the time of the determination, securities
or interests representing at least fifty percent (50%) of the total combined voting power of all classes of securities or interests in
one of the other entities in such chain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tt.
&#8220;<b>Substitute Award</b>&#8221; means an Award granted under this Plan in connection with a corporate transaction, such as a merger,
combination, consolidation, or acquisition of property or shares, in any case, upon the assumption of, or in substitution for, outstanding
equity awards previously granted by another company or other entity other than the Company or any Parent or Subsidiary, provided that
in no event shall the term &#8220;Substitute Award&#8221; be construed to refer to an award made in connection with the cancellation
and repricing of an Option or Share Appreciation Right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">uu.
&#8220;<b>Termination of Service</b>&#8221; means the date that the Participant ceases to be a Service Provider. The Administrator, in
its sole discretion, shall determine the effect of all matters and questions relating to any Termination of Service for purposes of this
Plan. For the avoidance of doubt, unless the Administrator determines otherwise, and subject to Section 29, the cessation of employee
status but the continuation of the performance of services for the Company or a Parent or Subsidiary as a Director or Consultant, or
vice versa, shall not be deemed a cessation of service that would constitute a Termination of Service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
Shares Subject to this Plan</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Shares Subject to this Plan</i></b>. Subject to the provisions of Section 14, the maximum aggregate number of Shares that may be
subject to Awards and sold under this Plan is 3,799,526<sup>1</sup> (the &#8220;<b>Share Pool</b>&#8221;). The Share Pool will be increased
on the first day of each Company fiscal year during the term of the Plan, beginning January 1, 2027 and ending with a final increase
on January 1, 2034, in an amount equal to 5% of the number of outstanding Shares on the last day of the immediately preceding fiscal
year. Notwithstanding the foregoing, and subject to the provisions of Section 14, the maximum number of Shares that may be issued upon
the exercise of Incentive Stock Options shall equal the Share Pool. The Shares may be authorized but unissued, or reacquired Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Lapsed Awards</i></b>. If an Award expires or becomes unexercisable without having been exercised in full, or is surrendered pursuant
to an Exchange Program, then the unpurchased Shares, or for Awards other than Options the forfeited or repurchased Shares, that were
subject thereto will become available for future grant or sale under this Plan (unless this Plan has terminated). With respect to Share
Appreciation Rights, only Shares actually issued pursuant to a Share Appreciation Right will cease to be available under this Plan&#894;
all remaining Shares under Share Appreciation Rights will remain available for future grant or sale under this Plan (unless this Plan
has terminated). Shares that have actually been issued under this Plan under any Award will not be returned to this Plan and will not
become available for future distribution under this Plan, provided that, if Shares issued pursuant to Awards of Restricted Shares or
Restricted Share Units are repurchased by the Company or are forfeited to the Company due to the failure to vest, then such Shares will
become available for future grant under this Plan. Shares used to pay the exercise price of an Award or to satisfy the tax withholding
obligations related to an Award will become available for future grant or sale under this Plan. To the extent that an Award under this
Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance
under this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
The Share Pool has been adjusted to reflect the Company&#8217;s 1-for-10 reverse stock split on September 8, 2025 and is inclusive of
(i) the automatic increases to the Share Pool on January 1, 2025 of 238,681 shares (adjusted to reflect the reverse stock split) and
on January 1, 2026 of 493,478 shares and (ii) the additional 2,600,000 shares approved on the Effective Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Substitute Awards</i></b>. Substitute Awards may be granted on such terms as the Administrator deems appropriate, notwithstanding
limitations on Awards in this Plan. Substitute Awards shall not reduce the Shares authorized for grant under this Plan, except as may
be required by reason of Code Section 422, and Shares subject to such Substitute Awards shall not be added to the Shares available for
Awards under this Plan. Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company
or any Subsidiary combines has shares available under a pre-existing plan approved by its shareholders and not adopted in contemplation
of such acquisition or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the
extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination
to determine the consideration payable to the holders of common shares of the entities party to such acquisition or combination) may
be used for Awards under this Plan and shall not reduce the Shares authorized for grant under this Plan (and Shares subject to such Awards
shall not be added to the Shares available for Awards under this Plan), provided that Awards using such available Shares shall (i) not
be made after the date that awards or grants could have been made under the terms of the pre-existing plan, absent the acquisition or
combination, and shall only be made to individuals who were not employed by or providing services to the Company or its Parents or Subsidiaries
immediately prior to such acquisition or combination, and (ii) be made in respect of Incentive Stock Options only to the extent allowable
under Code Section 422 and the Treasury Regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
Administration of this Plan</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Administrator</i></b>. The Committee shall administer this Plan (except as otherwise permitted herein). To the extent required
to comply with the provisions of Rule 16b-3 under the Exchange Act, it is intended that each member of the Committee will be, at the
time the Committee takes any action with respect to an Award that is subject to Rule 16b-3, a &#8220;non-employee director&#8221; within
the meaning of Rule 16b-3. Additionally, to the extent required by Applicable Law, each of the individuals constituting the Committee
shall be an &#8220;independent director&#8221; under the rules of any securities exchange or automated quotation system on which the
Shares are listed, quoted, or traded. Notwithstanding the foregoing, any action taken by the Committee shall be valid and effective,
whether or not members of the Committee at the time of such action are later determined not to have satisfied the requirements for membership
set forth in this Section 4(a). Notwithstanding the foregoing, (i) the Board shall conduct the general administration of this Plan with
respect to Awards granted to Non-Employee Directors and, with respect to such Awards, the term &#8220;Administrator&#8221; as used in
this Plan shall be deemed to refer to the Board, and (ii) the Board or Committee may delegate its authority hereunder to the extent permitted
by Section 4(e).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Duties of the Administrator</i></b>. It shall be the duty of the Administrator to conduct the general administration of this Plan
in accordance with its provisions. The Administrator shall have the power: to interpret this Plan and all Programs and Award Agreements&#894;
to adopt such rules for the administration, interpretation, and application of this Plan and any Program as are not inconsistent with
this Plan or Applicable Law&#894; to interpret, amend, or revoke any such rules&#894; and to amend this Plan or any Program or Award
Agreement, provided that the rights or obligations of the Participant holding such Award that is the subject of any such Program or Award
Agreement are not materially and adversely affected by such amendment, unless the consent of the Participant is obtained or such amendment
is otherwise permitted under Section 19 or Section 29. In its sole discretion, the Board may at any time and from time to time exercise
any and all rights and duties of the Committee in its capacity as the Administrator under this Plan except with respect to matters which
under Rule 16b-3 under the Exchange Act or any successor rule, or any regulations or rules issued thereunder, or the rules of any securities
exchange or automated quotation system on which the Shares are listed, quoted, or traded are required to be determined in the sole discretion
of the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Powers of the Administrator</i></b>. Subject to the provisions of this Plan, including, in the case of the Committee, subject to
the specific duties delegated by the Board to the Committee, and Applicable Law, the Administrator will have the authority, in its discretion:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
to determine the Fair Market Value&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
to select the Service Providers to whom Awards may be granted hereunder&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
to determine the type or types of Awards to be granted to each Service Provider (including, without limitation, any Awards granted in
tandem with another Award granted pursuant to this Plan)&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
to determine the number of Awards to be granted and the number of Shares to be covered by each Award granted hereunder&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
to approve forms of Award Agreements for use under this Plan&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
to determine the terms and conditions, not inconsistent with the terms of this Plan, of any Award granted hereunder. Such terms and conditions
include, but are not limited to, the exercise price, the time or times when Awards may be exercised or vest (which may be based on one
or more Performance Criteria or the achievement of one or more Performance Goals), any vesting acceleration or waiver of forfeiture restrictions,
and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator
will determine&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
to institute and determine the terms and conditions of an Exchange Program&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii.
to determine whether, to what extent, and under what circumstances an Award may be settled, or the exercise price of an Award may be
paid, in cash, Shares, other Awards, or other property, or an Award may be canceled, forfeited, or surrendered&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ix.
to construe and interpret the terms of this Plan and Awards&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">x.
to prescribe, amend, and rescind rules and regulations relating to this Plan, including rules and regulations relating to sub-plans established
for the purpose of satisfying applicable foreign laws or for qualifying for favorable tax treatment under applicable foreign laws&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">xi.
to modify or amend each Award (subject to Section 19), including but not limited to the discretionary authority to extend the post-termination
exercisability period of Awards and to extend the maximum term of an Option (subject to Section 6(d))&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">xii.
to make all determinations in respect of adjustments and treatment of Awards as provided in Section 14&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">xiii.
to allow Participants to satisfy withholding tax obligations in a manner prescribed in Section 15&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">xiv.
to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously authorized
by the Administrator&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">xv.
to allow a Participant to defer the receipt of the payment of cash or the delivery of Shares that otherwise would be due to such Participant
under an Award&#894;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">xvi.
to take all steps reasonably necessary to ensure that the Company Group complies with Applicable Law in connection with this Plan and
any Award&#894; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">xvii.
to make all other determinations deemed necessary or advisable for administering this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Effect of Administrator&#8217;s Decision</i></b>. The Administrator&#8217;s decisions, determinations, and interpretations will
be final and binding on all Participants and any other holders of Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<b><i>Delegation of Authority</i></b>. The Board or the Committee may from time to time delegate to a committee of one or more Directors
or one or more officers of the Company the authority to grant or amend Awards or to take other administrative actions pursuant to this
Section 4, provided that in no event shall an officer of the Company be delegated the authority to grant Awards to, or amend Awards held
by, the following individuals: (i) individuals who are subject to Section 16 of the Exchange Act&#894; or (ii) officers of the Company
(or Directors) to whom authority to grant or amend Awards has been delegated hereunder&#894; provided further that any delegation of
administrative authority shall only be permitted to the extent that it is permissible under any Applicable Law. Any delegation hereunder
shall be subject to the restrictions and limits that the Board or the Committee specifies at the time of such delegation, and the Board
or the Committee, as applicable, may at any time rescind the authority so delegated or appoint a new delegatee. At all times, the delegatee
appointed under this Section 4(e) shall serve in such capacity at the pleasure of the Board or the Committee, as applicable, and the
Board or the Committee may abolish any committee at any time and re-vest in itself any previously delegated authority. Neither the Administrator
nor any member or delegate thereof shall have any liability to any person (including any Participant) for any action taken or omitted
to be taken or any determination made in good faith with respect to this Plan or any Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
Eligibility</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Participation</i></b>. The Administrator may, from time to time, select from among all Service Providers those to whom an Award
shall be granted and shall determine the nature and amount of each Award, which shall not be inconsistent with the requirements of this
Plan or any Applicable Law as may apply to such Service Provider. No Service Provider or other person shall have any right to be granted
an Award pursuant to this Plan and neither the Company nor the Administrator is obligated to treat Service Providers, Participants, or
any other persons uniformly. Participation by each Participant in this Plan shall be voluntary and nothing in this Plan or any Program
shall be construed as mandating that any Service Provider or other person shall participate in this Plan. Nonstatutory Share Options,
Share Appreciation Rights, Restricted Shares, Restricted Share Units, and Other Share or Cash Based Awards may be granted to Service
Providers. Incentive Stock Options may be granted only to employees of the Company or any &#8220;parent corporation&#8221; or &#8220;subsidiary
corporation&#8221; (in each case, within the meaning of Section 424 of the Code) and who are US taxpayers. Nonstatutory Share Options
and Share Appreciation Rights may not be granted to Service Providers who are subject to Code Section 409A unless the Shares underlying
such Awards is treated as &#8220;service recipient stock&#8221; under Code Section 409A or unless such Awards otherwise comply with the
requirements of Code Section 409A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Limitations Applicable to Section 16 Persons</i></b>. Notwithstanding any other provision of this Plan, any Award granted or awarded
to any individual who is then subject to Section 16 of the Exchange Act shall be subject to any additional limitations set forth in any
applicable exemptive rule under Section 16 of the Exchange Act (including Rule 16b-3 of the Exchange Act and any amendments thereto)
that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Plan and Awards granted
or awarded hereunder shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Foreign Holders</i></b>. Notwithstanding any provision of this Plan or applicable Program to the contrary, in order to comply with
the laws in countries other than the United States in which the Company and its Parents and Subsidiaries operate or have Employees, Non-Employee
Directors, or Consultants, or in order to comply with the requirements of any foreign securities exchange or other Applicable Law, the
Administrator, in its sole discretion, shall have the power and authority to: (i) determine which Parents and Subsidiaries shall be covered
by this Plan&#894; (ii) determine which Service Providers outside the United States are eligible to participate in this Plan&#894; (iii)
modify the terms and conditions of any Award granted to Service Providers outside the United States to comply with Applicable Law (including,
without limitation, applicable foreign laws or listing requirements of any foreign securities exchange)&#894; (iv) establish subplans
and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable&#894; and (v)
take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local governmental
regulatory exemptions or approvals or listing requirements of any foreign securities exchange (including directing the applicable member
of the Company Group operating in such jurisdiction to file any necessary reporting with, or make necessary submissions to, the local
governmental authorities and to comply with any other obligation as may be applicable under the laws of such jurisdiction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Non-Employee Director Award Limit</i></b>. Notwithstanding any provision to the contrary in this Plan, the sum of the grant date
fair value of equity-based Awards (as determined in accordance with ASC 718 or successor provision but excluding the impact of estimated
forfeitures related to service-based vesting provisions) granted under this Plan to an individual Non-Employee Director as compensation
for services to the Board during any one Company fiscal year during the term of the Plan, taken together with any cash fees paid to such
Non-Employee Director during such Company fiscal year in respect of the Non-Employee Director&#8217;s services as a member of the Board
during such Company fiscal year, may not exceed $750,000. The Administrator may make exceptions to this limit for individual Non-Employee
Directors in extraordinary circumstances, as the Administrator may determine in its discretion, provided that the Non-Employee Director
receiving such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation
decisions involving Non-Employee Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<b><i>Limit on Number of Shares Subject to Awards</i></b>. Notwithstanding any provision in this Plan to the contrary, and subject to
Section 14, the maximum number of Shares with respect to one or more Awards that may be granted to any one Participant during any calendar
year shall be 3,799,526<sup>2</sup> Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
Share Options</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Grant of Options</i></b>. Subject to the terms and provisions of this Plan, including any limitations in this Plan that apply to
Incentive Stock Options, the Administrator, at any time, and from time to time, may grant Options in such amounts as the Administrator,
in its sole discretion, will determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Option Agreement</i></b>. Each Award of an Option will be evidenced by an Award Agreement that will specify the exercise price,
the term of the Option, the number of Shares subject to the Option, the exercise restrictions, if any, applicable to the Option, and
such other terms and conditions as the Administrator, in its sole discretion, will determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
This limit has been adjusted to reflect the Company&#8217;s 1-for-10 reverse stock split on September 8, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Limitations</i></b>. Each Option will be designated in the Award Agreement as either an Incentive Stock Option or a Nonstatutory
Share Option. Notwithstanding such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which
Incentive Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans of the Company
and any parent corporation or subsidiary corporation thereof (as defined in Sections 424(e) and 424(f) of the Code, respectively)) exceeds
$100,000, such Options will be treated as Nonstatutory Share Options to the extent required by Code Section 422. For purposes of this
Section 6(c), Incentive Stock Options will be taken into account in the order in which they were granted, the Fair Market Value of the
Shares will be determined as of the time the Option with respect to such Shares is granted, and calculation will be performed in accordance
with Code Section 422 and Treasury Regulations promulgated thereunder. Neither the Company nor the Administrator shall have any liability
to a Participant or any other person (i) if an Option (or any part thereof) that is intended to qualify as an Incentive Stock Option
fails to qualify as an Incentive Stock Option or (ii) for any action or omission by the Company or the Administrator that causes an Option
not to qualify as an Incentive Stock Option, including, without limitation, the conversion of an Incentive Stock Option to a Nonstatutory
Share Option or the grant of an Option intended as an Incentive Stock Option that fails to satisfy the requirements under the Code applicable
to an Incentive Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Term of Option</i></b>. The term of each Option will be stated in the Award Agreement, provided that the term will be no more than
ten years from the date of grant thereof. In the case of an Incentive Stock Option granted to a Greater Than 10% Shareholder, the term
of the Incentive Stock Option will be five years from the date of grant or such shorter term as may be provided in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<b><i>Option Exercise Price and Consideration</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<b><i>Exercise Price</i></b>. The per Share exercise price for the Shares to be issued pursuant to the exercise of an Option will be
determined by the Administrator (which exercise price may be the Fair Market Value per Share, the par value per Share, or another amount),
but, with respect to Incentive Stock Options, will be no less than 100% of the Fair Market Value per Share on the date of grant (and,
if applicable, on the date that the Incentive Stock Option is modified, extended, or renewed for purposes of Section 424(h) of the Code).
In addition, in the case of an Incentive Stock Option granted to a Greater Than 10% Shareholder, the per Share exercise price will be
no less than 110% of the Fair Market Value per Share on the date of grant (and on the date that the Option is modified, extended, or
renewed for purposes of Section 424(h) of the Code). Options that are a Substitute Award may be granted with a per Share exercise price
of less than 100% of the Fair Market Value per Share on the date of grant, provided that the exercise price of any Substitute Award shall
be determined in accordance with the applicable requirements of Code Section 424 and Code Section 409A. Other than pursuant to Sections
14(a) and 14(c), the Administrator shall not be permitted to (A) lower the per Share exercise price of an Option after it is granted,
(B) cancel an Option when the per Share exercise price exceeds the Fair Market Value of the underlying Shares in exchange for cash or
another Award (other than in connection with Substitute Awards), (C) cancel an outstanding Option in exchange for an Option with a per
Share exercise price that is less than the per Share exercise price of the original Option, or (D) take any other action with respect
to an Option that may be treated as a repricing pursuant to the applicable rules of the securities exchange on which any securities of
the Company are then listed for trading, without approval of the Company&#8217;s shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<b><i>Waiting Period and Exercise Dates</i></b>. At the time that an Option is granted, the Administrator will fix the period within
which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised. Except
as limited by the requirements of Section 6(d), Code Section 409A, or Code Section 422 and regulations and rulings thereunder, and without
limiting the Company&#8217;s rights under Section 19, the Administrator may extend the term of any outstanding Option, and may extend
the time period during which vested Options may be exercised, in connection with any Termination of Service of the Participant, and may
amend, subject to Section 19, any other term or condition of such Option relating to such Termination of Service of the Participant or
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<b><i>Form of Consideration</i></b>. The Administrator will determine the acceptable form of consideration for exercising an Option,
including the method of payment. In the case of an Incentive Stock Option, the Administrator will determine the acceptable form of consideration
at the time of grant. Such consideration may consist entirely of: (A) cash, (B) check, (C) other Shares, provided that such Shares have
a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such Option will be exercised,
and provided further that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator
determines in its sole discretion, (D) consideration received by the Company under a cashless exercise program (whether through a broker
or otherwise) implemented by the Company in connection with this Plan, (E) a net exercise, (F) such other consideration and method of
payment for the issuance of Shares to the extent permitted by Applicable Laws, or (G) any combination of the foregoing methods of payment.
In making its determination as to the type of consideration to accept, the Administrator will consider if acceptance of such consideration
may be reasonably expected to benefit the Company. Notwithstanding any other provision of this Plan to the contrary, no Participant who
is a Director or an &#8220;executive officer&#8221; of the Company within the meaning of Section 13(k) of the Exchange Act shall be permitted
to pay the exercise price of an Option, or continue any extension of credit with respect to the exercise price of an Option, with a loan
from the Company or a loan arranged by the Company in violation of Section 13(k) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
<b><i>Exercise of Option</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
Procedure for Exercise&#894; Rights as a Shareholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Any Option granted hereunder will be exercisable according to the terms of this Plan and at such times and under such conditions as determined
by the Administrator and set forth in the Award Agreement. An exercisable Option may be exercised in whole or in part, but may not be
exercised for a fraction of a Share and the Administrator may require that, by the terms of the Option, a partial exercise must be with
respect to a minimum number of Shares. Except as explicitly set forth in Section 3(b), exercising an Option in any manner will decrease
the number of Shares thereafter available, both for purposes of this Plan and for sale under the Option, by the number of Shares as to
which the Option is exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
An Option will be deemed exercised when the Company receives: (i) notice of exercise (in such form as the Administrator may specify from
time to time) from the person entitled to exercise the Option, which shall be signed or otherwise acknowledged electronically by the
Participant or other person then entitled to exercise the Option or such portion thereof&#894; (ii) full payment for the Shares with
respect to which the Option is exercised (together with applicable tax withholding)&#894; (iii) such representations and documents as
the Administrator, in its sole discretion, deems necessary or advisable to effect compliance with Applicable Law&#894; and (iv) in the
event that the Option shall be exercised pursuant to the terms of this Plan by any person or persons other than the Participant, appropriate
proof of the right of such person or persons to exercise the Option, as determined in the sole discretion of the Administrator. The Administrator
may provide in any Award Agreement for the automatic exercise of an Option upon such terms and conditions as established by the Administrator,
provided that the Fair Market Value per Share is greater than the exercise price at the time of exercise. Full payment may consist of
any consideration and method of payment authorized by the Administrator and permitted by the Award Agreement and this Plan. Shares issued
upon exercise of an Option will be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant
and their spouse (or, to the extent applicable, to the person other than the Participant who is entitled to exercise the Option and who
does so exercise the Option as permitted herein).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
During a Participant&#8217;s lifetime, an Incentive Stock Option may be exercised only by the Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent
of the Company), no right to vote or receive dividends or any other rights as a shareholder will exist with respect to the Shares subject
to an Option, notwithstanding the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the
Option is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares
are issued, except as provided in Section 14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<b><i>Termination of Service of Participant</i></b>. If a Participant ceases to be a Service Provider, other than upon the Participant&#8217;s
Termination of Service as a result of the Participant&#8217;s death or Disability, then the Participant may exercise their Option within
such period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set
forth in the Award Agreement) to the extent that the Option is vested on the date of Termination of Service. In the absence of a specified
time in the Award Agreement, the Option shall remain exercisable for three months following the Participant&#8217;s Termination of Service.
Unless otherwise provided by the Administrator, if, on the date of Termination of Service, the Participant is not vested as to their
entire Option, then the Participant shall forfeit the unvested portion of the Option and the Shares covered by such unvested portion
of the Option will revert to this Plan. If, after Termination of Service, the Participant does not exercise their Option within the time
specified by the Administrator, then the Option will terminate, and the Shares covered by such Option will revert to this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<b><i>Disability of Participant</i></b>. If a Participant ceases to be a Service Provider as a result of the Participant&#8217;s Disability,
then the Participant may exercise their Option within such period of time as is specified in the Award Agreement (but in no event later
than the expiration of the term of such Option as set forth in the Award Agreement) to the extent that the Option is vested on the date
of Termination of Service. In the absence of a specified time in the Award Agreement, the Option shall remain exercisable for 12 months
following the Participant&#8217;s Termination of Service. Unless otherwise provided by the Administrator, if, on the date of Termination
of Service, the Participant is not vested as to their entire Option, then the Shares covered by the unvested portion of the Option will
revert to this Plan. If, after Termination of Service, the Participant does not exercise their Option within the time specified herein,
then the Option will terminate, and the Shares covered by such Option will revert to this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<b><i>Death of Participant</i></b>. If a Participant dies while a Service Provider, then the Option may be exercised within such period
of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set forth in
the Award Agreement), to the extent that the Option is vested on the date of death, by the Participant&#8217;s designated beneficiary,
provided that such beneficiary has been designated prior to the Participant&#8217;s death in a form acceptable to the Administrator.
If no such beneficiary has been designated by the Participant, then such Option may be exercised by the personal representative of the
Participant&#8217;s estate or by the person(s) to whom the Option is transferred pursuant to the Participant&#8217;s will or in accordance
with the laws of descent and distribution. In the absence of a specified time in the Award Agreement, the Option shall remain exercisable
for 12 months following the Participant&#8217;s Termination of Service. Unless otherwise provided by the Administrator, if, at the time
of death, the Participant is not vested as to their entire Option, then the Shares covered by the unvested portion of the Option will
immediately revert to this Plan. If the Option is not so exercised within the time specified herein, then the Option will terminate,
and the Shares covered by such Option will revert to this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<b><i>Incentive Stock Options</i></b>. Notwithstanding the foregoing, Incentive Stock Options may not be exercised after the first to
occur of (A) ten years from the date it is granted, unless an earlier time is set in the Award Agreement, (B) subject to the following
subclause (C), three months after the Participant&#8217;s termination of employment as an employee (as described in Section 5(a)), and
(C) one year after the date of the Participant&#8217;s termination of employment on account of death or Disability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<b><i>Notification Regarding Disposition</i></b>. If requested by the Company, then the Participant shall give the Company prompt written
or electronic notice of any disposition or other transfers (other than in connection with a Change in Control) of Shares acquired by
exercise of an Incentive Stock Option that occurs within (A) two years from the date of granting (including the date that the Option
is modified, extended, or renewed for purposes of Code Section 424(h)) such Option to such Participant, or (B) one year after the date
of transfer of such Shares to such Participant. Such notice shall specify the date of such disposition or other transfer and the amount
realized, in cash, other property, assumption of indebtedness, or other consideration, by the Participant in such disposition or other
transfer. The Company may require that Shares acquired by exercise of an Incentive Stock Option be retained with a broker or agent designated
by the Company for a designated period of time and/or may establish other procedures to permit tracking of disqualifying dispositions
of such Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
Share Appreciation Rights</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Grant of Share Appreciation Rights</i></b>. Subject to the terms and conditions of this Plan, a Share Appreciation Right may be
granted to Service Providers at any time, and from time to time, as will be determined by the Administrator, in its sole discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Number of Shares</i></b>. The Administrator will have complete discretion to determine the number of Shares subject to any Award
of Share Appreciation Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Exercise Price and Other Terms</i></b>. The per Share exercise price for the Shares that will determine the amount of the payment
to be received upon exercise of a Share Appreciation Right as set forth in Section 7(f) will be determined by the Administrator. The
Administrator, subject to the provisions of this Plan, will have complete discretion to determine the terms and conditions of Share Appreciation
Rights granted under this Plan. In the case of a Share Appreciation Right that is a Substitute Award, the exercise price per share of
the Shares subject to such Share Appreciation Right, as applicable, may be less than the Fair Market Value per share on the date of grant,
provided that the exercise price of any Substitute Award shall be determined in accordance with the applicable requirements of Code Section
409A. Other than pursuant to Section 14(a) and 14(c), the Administrator shall not be permitted to (A) lower the exercise price per Share
of a Share Appreciation Right after it is granted, (B) cancel a Share Appreciation Right when the exercise price per Share exceeds the
Fair Market Value of the underlying Shares in exchange for another Award (other than in connection with Substitute Awards), (C) cancel
an outstanding Share Appreciation Right in exchange for a Share Appreciation Right with an exercise price per Share that is less than
the exercise price per Share of the original Share Appreciation Right, or (D) take any other action with respect to a Share Appreciation
Right that may be treated as a repricing pursuant to the applicable rules of the securities exchange on which any securities of the Company
are then listed for trading, without approval of the Company&#8217;s shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Share Appreciation Right Agreement</i></b>. Each Share Appreciation Right grant will be evidenced by an Award Agreement that will
specify the number of Shares, exercise price, the term of the Share Appreciation Right, the conditions of exercise, and such other terms
and conditions as the Administrator, in its sole discretion, will determine. The Administrator may provide in any Award Agreement for
the automatic exercise of a Share Appreciation Right upon such terms and conditions as established by the Administrator, provided that
the Fair Market Value per Share is greater than the exercise price at the time of exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<b><i>Expiration of Share Appreciation Rights</i></b>. A Share Appreciation Right granted under this Plan will expire upon the date determined
by the Administrator, in its sole discretion, and set forth in the Award Agreement. Notwithstanding the foregoing, the rules of Section
6(d) relating to the maximum term and Section 6(f) relating to exercise also will apply to Share Appreciation Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
<b><i>Payment of Share Appreciation Right Amount&#894; Rights as a Shareholder</i></b>. Upon exercise of a Share Appreciation Right,
a Participant will be entitled to receive payment from the Company in an amount determined by multiplying:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
the difference between the Fair Market Value of a Share on the date of exercise over the exercise price per Share of such Award&#894;
times</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
the number of Shares with respect to which the Share Appreciation Right is exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the discretion of the Administrator, the payment upon exercise of a Share Appreciation Right may be in cash, in Shares of equivalent
value, or in some combination thereof. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company
or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a shareholder will
exist with respect to the Shares subject to a Share Appreciation Right, notwithstanding the exercise of the Share Appreciation Right.
The Company will issue (or cause to be issued) such Shares promptly after the Share Appreciation Right is exercised. No adjustment will
be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section
14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
Restricted Shares</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Grant of Restricted Shares</i></b>. Subject to the terms and provisions of this Plan, the Administrator, at any time, and from
time to time, may grant Restricted Shares to Service Providers in such amounts as the Administrator, in its sole discretion, will determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Restricted Share Agreement</i></b>. Each Award of Restricted Shares will be evidenced by an Award Agreement that will specify the
number of Shares, Period of Restriction, and such other terms and conditions as the Administrator, in its sole discretion, will determine.
The Administrator shall establish the purchase price, if any, and form of payment for the Restricted Shares, provided that, if a purchase
price is charged, then such purchase price shall be no less than the par value, if any, of the Shares to be purchased, unless otherwise
permitted by Applicable Law. Unless the Administrator determines otherwise, the Company, as escrow agent, will hold Restricted Shares
until the restrictions on such Restricted Shares have lapsed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Transferability</i></b>. Except as provided in this Section 8 or as the Administrator determines, Restricted Shares may not be
sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Other Restrictions</i></b>. The Administrator, in its sole discretion, may impose such other restrictions on Restricted Shares
as it may deem advisable or appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<b><i>Removal of Restrictions</i></b>. Except as otherwise provided in this Section 8, Restricted Shares covered by each Restricted Share
grant made under this Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction or at
such other time as the Administrator may determine. The Administrator, in its discretion, may accelerate the time at which any restrictions
will lapse or be removed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
<b><i>Voting Rights</i></b>. During the Period of Restriction, Participants holding Restricted Shares granted hereunder may exercise
full voting rights with respect to those Shares, unless the Administrator determines otherwise, and subject to the restrictions in this
Plan, any applicable Program, and/or the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
<b><i>Dividends and Other Distributions</i></b>. During the Period of Restriction, Participants holding Restricted Shares will be entitled
to receive all dividends and other distributions paid or made with respect to such Shares to the extent that such dividends and other
distributions have a record date that is on or after the date on which the Participant to whom such Restricted Shares are granted becomes
the record holder of such Restricted Shares, unless the Administrator provides otherwise. The Administrator may, at or after the date
of grant, authorize the payment of dividends or dividend equivalents on Awards granted under this Section 8 on either a current, deferred,
or contingent basis, either in cash or in additional Shares. If any such dividends or distributions are paid in Shares, then the Shares
will be subject to the same restrictions on transferability and forfeitability as the Restricted Shares with respect to which they were
paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
<b><i>Return of Restricted Shares to the Company</i></b>. Except as otherwise determined by the Administrator and provided in the Award
Agreement, if no price was paid by the Participant for the Restricted Shares, then, upon a Termination of Service during the applicable
Period of Restriction, the Participant&#8217;s rights in unvested Restricted Shares then subject to restrictions shall lapse, and such
Restricted Shares shall be surrendered to the Company and cancelled without consideration on the date of such Termination of Service.
If a price was paid by the Participant for the Restricted Shares, then, except as otherwise determined by the Administrator and provided
in the Award Agreement, upon a Termination of Service during the applicable Period of Restriction, the Company shall have the right to
timely repurchase from the Participant the unvested Restricted Shares then subject to restrictions at a cash price per share equal to
the price paid by the Participant for such Restricted Share or such other amount as may be specified in the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
Restricted Share Units</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Grant</i></b>. Restricted Share Units may be granted at any time, and from time to time, as determined by the Administrator. After
the Administrator determines that it will grant Restricted Share Units, it will evidence the Award in an Award Agreement providing for
the terms, conditions, and restrictions related to the grant, including the number of Restricted Share Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Vesting Criteria and Other Terms</i></b>. The Administrator will set vesting criteria in its discretion, which, depending on the
extent to which the criteria are met, will determine the number of Restricted Share Units that will be paid out to the Participant. The
Administrator may set vesting criteria based upon the achievement of one or more Performance Goals or Performance Criteria, or any other
basis determined by the Administrator in its discretion. An Award of Restricted Share Units shall only be eligible to vest while the
Participant is a Service Provider, provided that the Administrator, in its sole discretion, may provide (in an Award Agreement or otherwise)
that a Restricted Share Unit award may become vested subsequent to a Termination of Service in the event of the occurrence of certain
events, including a Change in Control, the Participant&#8217;s death, retirement, or disability, or any other specified Termination of
Service in accordance with the applicable requirements of Code Section 409A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Earning Restricted Share Units</i></b>. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive
a payout as determined by the Administrator. Notwithstanding the foregoing, at any time after the grant of Restricted Share Units, the
Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be met to receive a payout. A Participant will
have no rights of a shareholder with respect to Shares subject to any Restricted Share Unit unless and until the Shares are delivered
in settlement of the Restricted Share Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Form and Timing of Payment</i></b>. At the time of grant, the Administrator shall specify the payment date applicable to each grant
of Restricted Share Units, which shall be no earlier than the vesting date or dates of the Award, and may be determined at the election
of the Participant (if permitted by the applicable Award Agreement and Code Section 409A), provided that, except as otherwise determined
by the Administrator, and subject to compliance with Code Section 409A, in no event shall the payment date relating to each Restricted
Share Unit occur following the later of (i) the 15th day of the third month following the end of the calendar year in which the applicable
portion of the Restricted Share Unit vests&#894; and (ii) the 15th day of the third month following the end of the Company&#8217;s fiscal
year in which the applicable portion of the Restricted Share Unit vests. On the payment date, the Company shall, in accordance with the
applicable Award Agreement and subject to Sections 15 and 20, transfer to the Participant one unrestricted, fully-transferable Share
for each Restricted Share Unit scheduled to be paid out on such date and not previously forfeited, or, in the sole discretion of the
Administrator, an amount in cash equal to the Fair Market Value of such Shares on the maturity date, or a combination of cash and Shares
as determined by the Administrator, provided that, in the sole discretion of the Administrator, the Participant may be required to pay
the par value of a Share, if any, for each Restricted Share Unit that is paid out in Shares or cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<b><i>Cancellation</i></b>. On the date set forth in the Award Agreement, all unearned Restricted Share Units will be forfeited to the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
Other Share or Cash Based Awards and Dividend Equivalents</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Other Share or Cash Based Awards</i></b>. The Administrator is authorized to grant Other Share or Cash Based Awards, including
awards entitling a Participant to receive Shares or cash to be delivered immediately or in the future, to any Service Provider. Subject
to the provisions of this Plan and any applicable Program, the Administrator shall determine the terms and conditions of each Other Share
or Cash Based Award, including the term of the Award, any exercise or purchase price, Performance Criteria and Performance Goals, transfer
restrictions, vesting conditions, and other terms and conditions applicable thereto, which shall be set forth in the applicable Award
Agreement. Other Share or Cash Based Awards may be paid in cash, Shares, or a combination of cash and Shares, as determined by the Administrator,
and may be available as a form of payment in the settlement of other Awards granted under this Plan, as stand-alone payments, as a part
of a bonus, deferred bonus, deferred compensation, or other arrangement, and/or as payment in lieu of compensation to which a Service
Provider is otherwise entitled. Any Other Share or Cash Based Award shall either be exempt from, or comply with, the provisions of Code
Section 409A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Dividend Equivalents</i></b>. Dividend Equivalents may be granted by the Administrator, either alone or in tandem with another
Award, based on dividends declared on the Shares underlying the Award, to be credited as of dividend payment dates during the period
between the date that the Dividend Equivalents are granted to a Participant and the date that such Dividend Equivalents terminate or
expire, as determined by the Administrator. Such Dividend Equivalents shall be converted to cash or additional Shares by such formula
and at such time and subject to such restrictions and limitations as may be determined by the Administrator. In addition, Dividend Equivalents
with respect to an Award that are based on dividends paid prior to the vesting of such Award shall only be paid out to the Participant
to the extent that the vesting conditions are subsequently satisfied and the Award vests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
Acceleration</b>. The Administrator has the exclusive power, authority, and sole discretion to accelerate, wholly or partially, the vesting
or lapse of restrictions of (and, if applicable, the Company shall cease to have a right of repurchase) any Award or portion thereof
at any time after the grant of an Award, subject to whatever terms and conditions it selects and, as applicable, in accordance with Section
14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
Leaves of Absence/Transfer Between Locations</b>. The Administrator shall in its discretion determine the circumstances under which vesting
of Awards granted hereunder will be suspended during any unpaid leave of absence. Except as provided otherwise by the Administrator in
an Award Agreement or as required pursuant to Applicable Law, a Participant will not cease to be an Employee in the case of (a) any leave
of absence approved by the Company or (b) transfers between locations of the Company or between the Company or any Parent or Subsidiary.
For purposes of Incentive Stock Options, no such leave may exceed three months, unless reemployment upon expiration of such leave is
guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed,
then, six months following the first day of such leave, any Incentive Stock Option held by the Participant will cease to be treated as
an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Share Option. For purposes of this Plan, unless the
Administrator determines otherwise, and subject to Section 29, a Participant&#8217;s employee-employer relationship or consultancy relationship
shall be deemed to be terminated in the event that the Parent or Subsidiary employing or contracting with such Participant ceases to
remain a Subsidiary or Parent following any merger, sale of shares, or other corporate transaction or event (including, without limitation,
a spin-off). In all cases, the Administrator shall treat a Participant&#8217;s leave of absence or employment transfer in compliance
with Applicable Law where required to do so pursuant to the Code or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
Limited Transferability of Awards</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
Unless determined otherwise by the Administrator, Awards may not be sold, pledged, assigned, hypothecated, or otherwise transferred in
any manner other than (i) by will or by the laws of descent and distribution or (ii) subject to the consent of the Administrator, pursuant
to a DRO, unless and until such Award has been exercised or the Shares underlying such Award have been issued, and all restrictions applicable
to such Shares have lapsed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
No Award or interest or right therein shall be liable for or otherwise subject to the debts, contracts, or engagements of the Participant
or the Participant&#8217;s successors in interest, or shall be subject to disposition by transfer, alienation, anticipation, pledge,
hypothecation, encumbrance, assignment, or any other means whether such disposition be voluntary or involuntary or by operation of law
by judgment, levy, attachment, garnishment, or any other legal or equitable proceedings (including bankruptcy) unless and until such
Award has been exercised, or the Shares underlying such Award have been issued, and all restrictions applicable to such Shares have lapsed,
and any attempted disposition of an Award prior to satisfaction of these conditions shall be null and void and of no effect, except to
the extent that such disposition is permitted by Section 13(a). During the lifetime of the Participant, only the Participant may exercise
any exercisable portion of an Award granted to such Participant under this Plan, unless it has been disposed of pursuant to a DRO. After
the death of the Participant, any exercisable portion of an Award may, prior to the time when such portion becomes unexercisable under
this Plan or the applicable Program or Award Agreement, be exercised by the Participant&#8217;s personal representative or by any person
empowered to do so under the deceased Participant&#8217;s will or under the then-applicable laws of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
Notwithstanding Sections 13(a) and 13(b), the Administrator, in its sole discretion, may determine to permit a Participant or a Permitted
Transferee of such Participant to transfer an Award, other than an Incentive Stock Option (unless such Incentive Stock Option is intended
to become a Nonstatutory Share Option), to any one or more Permitted Transferees of such Participant, subject to the following terms
and conditions: (i) an Award transferred to a Permitted Transferee shall not be assignable or transferable by the Permitted Transferee
other than (A) to another Permitted Transferee of the applicable Participant or (B) by will or the laws of descent and distribution or,
subject to the consent of the Administrator, pursuant to a DRO&#894; (ii) an Award transferred to a Permitted Transferee shall continue
to be subject to all the terms and conditions of the Award as applicable to the original Participant (other than the ability to further
transfer the Award to any person other than another Permitted Transferee of the applicable Participant)&#894; (iii) the Participant (or
transferring Permitted Transferee) and the receiving Permitted Transferee shall execute any and all documents requested by the Administrator,
including, without limitation, documents to (A) confirm the status of the transferee as a Permitted Transferee, (B) satisfy any requirements
for an exemption for the transfer under Applicable Law, and (C) evidence the transfer&#894; and (iv) the transfer of an Award to a Permitted
Transferee shall be without consideration. In addition, and further notwithstanding Section 13(a), the Administrator, in its sole discretion,
may determine to permit a Participant to transfer Incentive Stock Options to a trust that constitutes a Permitted Transferee if, under
Code Section 671 and other Applicable Law, the Participant is considered the sole beneficial owner of the Incentive Stock Option while
it is held in the trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
Notwithstanding Section 13(a), a Participant may, in the manner determined by the Administrator, designate a beneficiary to exercise
the rights of the Participant and to receive any distribution with respect to any Award upon the Participant&#8217;s death. A beneficiary,
legal guardian, legal representative, or other person claiming any rights pursuant to this Plan is subject to all terms and conditions
of this Plan, any Program or Award Agreement applicable to the Participant, and any additional restrictions deemed necessary or appropriate
by the Administrator. If the Participant is married or a domestic partner in a domestic partnership qualified under Applicable Law and
resides in a community property state, then a designation of a person other than the Participant&#8217;s spouse or domestic partner,
as applicable, as the Participant&#8217;s beneficiary with respect to more than 50% of the Participant&#8217;s interest in the Award
shall not be effective without the prior written or electronic consent of the Participant&#8217;s spouse or domestic partner. If no beneficiary
has been designated or survives the Participant, then payment shall be made to the person entitled thereto pursuant to the Participant&#8217;s
will or the laws of descent and distribution. Subject to the foregoing, a beneficiary designation may be changed or revoked by a Participant
at any time, provided that the change or revocation is delivered in writing to the Administrator prior to the Participant&#8217;s death.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
Adjustments&#894; Dissolution or Liquidation&#894; Change in Control</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Adjustments</i></b>. In the event that any share dividend or other distribution (whether in the form of cash, Shares, other securities,
or other property), recapitalization, share split, reverse share split, reorganization, merger, consolidation, split-up, spin-off, combination,
repurchase, or exchange of Shares or other securities of the Company, or other Equity Restructuring or change in the corporate structure
of the Company affecting Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential
benefits intended to be made available under this Plan, shall make equitable adjustments to (i) the aggregate number of Shares that may
be delivered under this Plan as set forth in the limitation in Section 3(a), (ii) the number and grant or exercise price of Shares covered
by each outstanding Award, and (iii) the terms and conditions of any outstanding Awards (including, without limitation, any applicable
Performance Criteria and Performance Goals with respect thereto).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Dissolution or Liquidation</i></b>. In the event of the proposed winding up, dissolution, or liquidation of the Company, the Administrator
will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent that it has
not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Merger or other Reorganization</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
In the event of any transaction or event described in Section 14(a), including a Change in Control, each outstanding Award will be treated
as the Administrator determines in its sole discretion and on such terms and conditions as the Administrator deems appropriate, including,
without limitation: (A) that Awards will be assumed, or substantially equivalent Awards will be substituted, by the acquiring or succeeding
corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and applicable exercise or purchase
prices, in all cases, as determined by the Administrator&#894; (B) upon written notice to a Participant, that the Participant&#8217;s
Awards will terminate upon or immediately prior to the consummation of such transaction&#894; (C) that outstanding Awards will vest and
become exercisable, realizable, or payable, or restrictions applicable to an Award will lapse, in whole or in part, prior to or upon
consummation of such transaction or event, notwithstanding anything to the contrary in this Plan or the applicable Program or Award Agreement&#894;
(D) that an Award will be terminated in exchange for an amount of cash and/or property, if any, equal to the amount that would have been
attained upon the exercise of such Award or realization of the Participant&#8217;s rights as of the date of the occurrence of the transaction
(and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the Administrator determines in good faith that
no amount would have been attained upon the exercise of such Award or realization of the Participant&#8217;s rights, then such Award
may be terminated by the Company without payment)&#894; (E) that the Award will be replaced with other rights or property selected by
the Administrator in its sole discretion&#894; (F) providing that the Award cannot vest, be exercised, or become payable after such event&#894;
or (G) any combination of the foregoing. In taking any of the actions permitted under this Section 14(c), the Administrator will not
be obligated to treat all Awards, all Awards held by a Participant, or all Awards of the same type, similarly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
In the event that the successor corporation in a Change in Control does not assume or substitute for the Award (or portion thereof),
the Administrator will (A) cause any or all of such Award (or portion thereof) to terminate in exchange for cash, rights, or other property
pursuant to this Section 14(c), or (B) cause the Participant to fully vest in and have the right to exercise all of their outstanding
Options and Share Appreciation Rights, including Shares as to which such Awards would not otherwise be vested or exercisable, all restrictions
on Restricted Shares and Restricted Share Units will lapse, and, with respect to Awards with Performance Criteria, all Performance Goals
will be deemed achieved at the greater of actual performance or 100% of target levels and all other terms and conditions met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
For the purposes of this Section 14(c), an Award will be considered assumed if, following the Change in Control, the Award confers the
right to purchase or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether
shares, cash, or other securities or property) received in the Change in Control by holders of Shares for each Share held on the effective
date of the transaction (and, if holders were offered a choice of consideration, the type of consideration chosen by the holders of a
majority of the outstanding Shares), provided that, if such consideration received in the Change in Control is not solely common shares
of the successor corporation or its parent, then the Administrator may, with the consent of the successor corporation, provide for the
consideration to be received upon the exercise of an Option or Share Appreciation Right or upon the payout of a Restricted Share Unit,
for each Share subject to such Award, to be solely common shares of the successor corporation or its parent equal in fair market value
to the per share consideration received by holders of Shares in the Change in Control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
Notwithstanding anything in this Section 14(c) to the contrary, an Award that vests, is earned, or paid-out upon the satisfaction of
one or more Performance Goals will not be considered assumed if the Company or its successor modifies any of such Performance Goals without
the Participant&#8217;s consent, provided that a modification to such Performance Goals only to reflect the successor corporation&#8217;s
post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
Notwithstanding anything in this Section 14(c) to the contrary, if a payment under an Award Agreement is subject to Code Section 409A,
and if the change in control definition contained in the Award Agreement does not comply with the definition of &#8220;change of control&#8221;
for purposes of a distribution under Code Section 409A, then any payment of an amount that is otherwise accelerated under this Section
will be delayed until the earliest time that such payment would be permissible under Code Section 409A without triggering any penalties
applicable under Code Section 409A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Limitations</i></b>. The Administrator, in its sole discretion, may include such further provisions and limitations in any Award,
agreement, or certificate as it may deem equitable and in the best interests of the Company that are not inconsistent with the provisions
of this Plan or Applicable Law. The existence of this Plan, any Program, any Award Agreement, and/or the Awards granted hereunder shall
not affect or restrict in any way the right or power of the Company or the shareholders of the Company to make or authorize any adjustment,
recapitalization, reorganization, or other change in the Company&#8217;s capital structure or its business, any merger or consolidation
of the Company, any issue of shares or of options, warrants, or rights to purchase shares, or of bonds, debentures, preferred, or prior
preference shares whose rights are superior to or affect the Shares or the rights thereof, or which are convertible into or exchangeable
for Shares, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or
any other corporate act or proceeding, whether of a similar character or otherwise. In the event of any pending share dividend, share
split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets
to shareholders, or any other change affecting the Shares or the price of a Share, for reasons of administrative convenience, the Company,
in its sole discretion, may refuse to permit the exercise of any Award during a period of up to 30 days prior to the consummation of
any such transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.
Tax Withholding</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Withholding Requirements</i></b>. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof), the Company
and each other applicable member of the Company Group will have the power and the right to deduct or withhold, or require a Participant
to remit to the Company or such other member, an amount sufficient to satisfy federal, state, local, foreign, or other taxes (including
the Participant&#8217;s FICA, employment tax, Medicare, or social security contribution obligations) required to be withheld with respect
to any taxable event concerning a Participant arising as a result of this Plan or any Award under the tax laws and rules of the Participant&#8217;s
country of residence or under any other applicable tax law or rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Withholding Arrangements</i></b>. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from
time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation): (i) paying
cash&#894; (ii) electing to have the Company withhold otherwise deliverable Shares having a Fair Market Value no greater than the aggregate
amount of such obligations based on the maximum statutory withholding rates in such Participant&#8217;s applicable jurisdictions for
federal, state, local, and foreign income tax and payroll tax purposes that are applicable to such taxable income&#894; (iii) delivering
to the Company already-owned Shares having a Fair Market Value equal to the statutory amount required to be withheld, provided that the
delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion&#894;
(iv) selling a sufficient number of Shares otherwise deliverable to the Participant through such means as the Administrator may determine
in its sole discretion (whether through a broker or otherwise) equal to the amount required to be withheld&#894; or (v) any combination
of the above permitted forms of payment. The amount of the withholding requirement will be deemed to include any amount that the Administrator
determines may be withheld at the time the election is made, not to exceed the amount determined by using the maximum federal, state,
or local marginal income tax rates applicable to the Participant with respect to the Award on the date that the amount of tax to be withheld
is to be determined. The Fair Market Value of the Shares to be withheld or delivered will be determined as of the date that the taxes
are required to be withheld.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.
No Effect on Employment or Service</b>. Neither this Plan nor any Award will confer upon a Participant any right with respect to continuing
the Participant&#8217;s relationship as a Service Provider with the Company, any Parent, any Subsidiary, or any of their affiliates,
nor will they interfere in any way with the Participant&#8217;s right or the right of the Company, any Parent, any Subsidiary, or any
of their affiliates to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
Date of Grant</b>. The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination
granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to
each Participant within a reasonable time after the date of such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.
Term of Plan</b>. The Stardust Power, Inc. 2024 Equity Incentive Plan originally became effective on July 8, 2024 and is being amended
and restated by this Plan. Subject to Section 22, this Plan will become effective on the Effective Date and, unless earlier terminated
by the Board under Section 19, will remain in effect until the earlier of (i) the earliest date as of which all Awards granted under
this Plan have been satisfied in full or terminated, and no Shares approved for issuance under this Plan remain available to be granted
under new Awards, or (ii) the Expiration Date (as defined in Section 19(d)), but Awards previously granted may extend beyond that date
in accordance with this Plan. If this Plan is not approved by the Company&#8217;s shareholders, then this Plan will not become effective,
and no Awards will be granted under this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.
Amendment and Termination</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Amendment and Termination of Awards</i></b>. Subject to Applicable Law, the Administrator may amend, modify, or terminate any outstanding
Award, including, but not limited to, substituting therefor another Award of the same or a different type, changing the date of exercise
or settlement, and converting an Incentive Stock Option to a Nonstatutory Share Option, provided that the Participant&#8217;s consent
to such action shall be required unless (i) the Administrator determines that the action, taking into account any related action, would
not materially and adversely affect the Participant, or (ii) the change is otherwise permitted under this Plan (including, without limitation,
under Section 14 or Section 29).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Amendment and Termination of this Plan</i></b>. Except as otherwise provided in Section 19(c), the Board may at any time amend,
alter, suspend, or terminate this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Shareholder Approval</i></b>. Notwithstanding Section 19(b), the Company will obtain shareholder approval of any Plan amendment
to the extent necessary to comply with Applicable Laws, including, without limitation, with respect to any increase to the limits imposed
in Section 3(a) on the maximum number of Shares that may be issued under this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Expiration</i></b>. No Awards may be granted or awarded during any period of suspension or after termination of this Plan, and
notwithstanding anything herein to the contrary, in no event may any Award be granted under this Plan after April 8, 2036 (such anniversary,
the &#8220;<b>Expiration Date</b>&#8221;). Any Awards that are outstanding on the Expiration Date shall remain in force according to
the terms of this Plan, the applicable Program, and the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<b><i>Effect of Amendment or Termination</i></b>. No amendment, alteration, suspension, or termination of this Plan will impair the rights
of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing
and signed by the Participant and the Company. Termination of this Plan will not affect the Administrator&#8217;s ability to exercise
the powers granted to it hereunder with respect to Awards granted under this Plan prior to the date of such termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.
Conditions Upon Issuance of Shares</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<b><i>Legal Compliance</i></b>. The Administrator shall determine the methods by which Shares shall be delivered or deemed to be delivered
to Participants. Shares will not be issued pursuant to the exercise of an Award unless the Administrator has determined that the exercise
of such Award and the issuance and delivery of such Shares will comply with Applicable Laws and may be further subject to the approval
of counsel for the Company with respect to such compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<b><i>Representations</i></b>. In addition to the terms and conditions provided herein, the Company may require a Participant to make
such reasonable covenants, agreements, and representations as the Administrator, in its sole discretion, deems advisable in order to
comply with Applicable Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>


<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<b><i>Restrictions</i></b>. All share certificates delivered pursuant to this Plan and all Shares issued pursuant to book entry procedures
are subject to any stop-transfer orders and other restrictions as the Administrator deems necessary or advisable to comply with Applicable
Law. The Administrator may place legends on any share certificate or book entry to reference restrictions applicable to the Shares (including,
without limitation, restrictions applicable to Restricted Shares). The Administrator shall have the right to require any Participant
to comply with any timing or other restrictions with respect to the settlement, distribution, or exercise of any Award, including a window-period
limitation, as may be imposed in the sole discretion of the Administrator. The Company, in its sole discretion, may (i) retain physical
possession of any share certificate evidencing Shares until any restrictions thereon shall have lapsed and/or (ii) require that the share
certificates evidencing such Shares be held in custody by a designated escrow agent (which may be, but need not be, the Company) until
the restrictions thereon shall have lapsed, and that the Participant deliver a share power, endorsed in blank, relating to such Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<b><i>Certificates&#894; Book-Entry Procedures</i></b>. Notwithstanding anything herein to the contrary, the Company shall not be required
to issue or deliver any certificates evidencing Shares pursuant to the exercise of any Award, unless and until the Administrator has
determined, with advice of counsel, that the issuance and delivery of such certificates is in compliance with all Applicable Laws, regulations
of governmental authorities, and, if applicable, the requirements of any exchange on which the Shares are listed or traded. Notwithstanding
any other provision of this Plan, unless otherwise determined by the Administrator or required by any Applicable Law, the Company shall
not deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares shall be recorded
in the books of the Company (or, as applicable, its transfer agent or share plan administrator).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21.
Inability to Obtain Authority</b>. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which
authority is deemed by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, will relieve
the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority will not have
been obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>22.
Shareholder Approval</b>. This Plan will be submitted for approval by the shareholders of the Company within 12 months after the date
that this Plan is adopted by the Board. Such shareholder approval will be obtained in the manner and to the degree required under Applicable
Laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23.
Forfeiture and Claw-Back Provisions</b>. All Awards (including any proceeds, gains, or other economic benefit actually or constructively
received by a Participant upon any receipt or exercise of any Award or upon the receipt or resale of any Shares underlying the Award
and any payments of a portion of an incentive-based bonus pool allocated to a Participant) shall be subject to the provisions of any
claw-back policy implemented by the Company, including, without limitation, any claw-back policy adopted to comply with the requirements
of Applicable Law, including, without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations
promulgated thereunder, whether or not such claw-back policy was in place at the time of grant of an Award, to the extent set forth in
such claw-back policy and/or in the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>24.
Data Privacy</b>. As a condition of receipt of any Award, each Participant explicitly and unambiguously consents to the collection, use,
and transfer, in electronic or other form, of personal data as described in this Section 24 by and among, as applicable, the Company
and its Parents and Subsidiaries for the exclusive purpose of implementing, administering, and managing the Participant&#8217;s participation
in this Plan. The Company and its Parents and Subsidiaries may hold certain personal information about a Participant, including, but
not limited to, the Participant&#8217;s name, home address, telephone number, date of birth, social security or insurance number or other
identification number, salary, nationality, job title(s), any shares held in the Company or any of its Parents and Subsidiaries, and
details of all Awards, in each case, for the purpose of implementing, managing, and administering this Plan and Awards (the &#8220;<b>Data</b>&#8221;).
The Company and its Parents and Subsidiaries may transfer the Data amongst themselves as necessary for the purpose of implementation,
administration, and management of a Participant&#8217;s participation in this Plan, and the Company and its Parents and Subsidiaries
may each further transfer the Data to any third parties assisting the Company and its Parents and Subsidiaries in the implementation,
administration, and management of this Plan. These recipients may be located in the Participant&#8217;s country, or elsewhere, and the
Participant&#8217;s country may have different data privacy laws and protections than the recipient&#8217;s country. Through acceptance
of an Award, each Participant authorizes such recipients to receive, possess, use, retain, and transfer the Data, in electronic or other
form, for the purposes of implementing, administering, and managing the Participant&#8217;s participation in this Plan, including any
requisite transfer of such Data as may be required to a broker or other third party with whom the Company or any of its Parents or Subsidiaries
or the Participant may elect to deposit any Shares. The Data related to a Participant will be held only as long as is necessary to implement,
administer, and manage the Participant&#8217;s participation in this Plan, unless Applicable Law permits such Data to be held longer,
in which case such Data may be held longer in the Administrator&#8217;s discretion. A Participant may, at any time, view the Data held
by the Company with respect to such Participant, request additional information about the storage and processing of the Data with respect
to such Participant, recommend any necessary corrections to the Data with respect to the Participant, or refuse or withdraw the consents
herein in writing, in any case without cost, by contacting their local human resources representative. The Company may cancel the Participant&#8217;s
ability to participate in this Plan and, in the Administrator&#8217;s discretion, the Participant may forfeit any outstanding Awards
if the Participant refuses or withdraws their consents as described herein. For more information on the consequences of refusal to consent
or withdrawal of consent, Participants may contact their local human resources representative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>25.
Paperless Administration</b>. In the event that the Company establishes, for itself or using the services of a third party, an automated
system for the documentation, granting, or exercise of Awards, such as a system using an internet website or interactive voice response,
then the paperless documentation, granting, or exercise of Awards by a Participant may be permitted through the use of such an automated
system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>26.
Effect of Plan upon Other Compensation Plans</b>. The adoption of this Plan shall not affect any other compensation or incentive plans
in effect for the Company or any Parent or Subsidiary. Nothing in this Plan shall be construed to limit the right of the Company or any
Parent or Subsidiary: (a) to establish any other forms of incentives or compensation for Employees, Directors, or Consultants of the
Company or any Parent or Subsidiary&#894; or (b) to grant or assume options or other rights or awards otherwise than under this Plan
in connection with any proper corporate purpose, including, without limitation, the grant or assumption of options or other rights or
awards in connection with the acquisition by purchase, lease, merger, consolidation, or otherwise of the business, shares, or assets
of any corporation, partnership, limited liability company, firm, association, or entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>27.
Titles and Headings, References to Sections of the Code or Exchange Act</b>. The titles and headings of the Sections in this Plan are
for convenience of reference only and, in the event of any conflict, the text of this Plan, rather than such titles or headings, shall
control. References to sections of the Code or the Exchange Act shall include any amendment or successor thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>28.
Governing Law</b>. This Plan shall be administered, interpreted, and enforced under the internal laws of the State of Delaware without
regard to conflicts of laws thereof or of any other jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>29.
Code Section 409A</b>. To the extent that the Administrator determines that any Award granted under this Plan is subject to Code Section
409A, this Plan, the Program pursuant to which such Award is granted, and the Award Agreement evidencing such Award shall incorporate
the terms and conditions required by Code Section 409A. In that regard, to the extent that any Award under this Plan or any other compensatory
plan or arrangement of the Company or any of its Parents or Subsidiaries is subject to Code Section 409A, and such Award or other amount
is payable on account of a Participant&#8217;s Termination of Service (or any similarly defined term), then (a) such Award or amount
shall only be paid to the extent such Termination of Service qualifies as a &#8220;separation from service&#8221; as defined in Code
Section 409A, and (b) if such Award or amount is payable to a &#8220;specified employee,&#8221; as defined in Code Section 409A, then,
to the extent required in order to avoid a distribution subject to taxes under Code Section 409A, such Award or other compensatory payment
shall not be payable prior to the earlier of (i) the expiration of the six-month period measured from the date of the Participant&#8217;s
Termination of Service, or (ii) the date of the Participant&#8217;s death. To the extent applicable, this Plan, the Program, and any
Award Agreements shall be interpreted in accordance with Code Section 409A. Notwithstanding any provision of this Plan to the contrary,
in the event that the Administrator determines that any Award may be subject to Code Section 409A, the Administrator may (but is not
obligated to), without a Participant&#8217;s consent, adopt such amendments to this Plan and the applicable Program and Award Agreement
or adopt other policies and procedures (including amendments, policies, and procedures with retroactive effect), or take any other actions,
that the Administrator determines are necessary or appropriate to (A) exempt the Award from Code Section 409A and/or preserve the intended
tax treatment of the benefits provided with respect to the Award, or (B) comply with the requirements of Code Section 409A and thereby
avoid the application of any penalty taxes under Section Code 409A. The Company makes no representations or warranties as to the tax
treatment of any Award under Code Section 409A or otherwise. The Company shall have no obligation under this Section 29 or otherwise
to take any action (whether or not described herein) to avoid the imposition of taxes, penalties, or interest under Code Section 409A
with respect to any Award, and shall have no liability to any Participant or any other person if any Award, compensation, or other benefits
under this Plan are determined to constitute non-compliant, &#8220;nonqualified deferred compensation&#8221; subject to the imposition
of taxes, penalties, and/or interest under Code Section 409A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>30.
Unfunded Status of Awards</b>. This Plan is intended to be an &#8220;unfunded&#8221; plan for incentive compensation. With respect to
any payments not yet made to a Participant pursuant to an Award, nothing contained in this Plan or any Program or Award Agreement shall
give the Participant any rights that are greater than those of a general creditor of the Company or any Parent or Subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31.
Indemnification</b>. To the extent permitted under Applicable Law, each member of the Administrator (and each delegate thereof pursuant
to Section 4(f)) shall be indemnified and held harmless by the Company from any loss, cost, liability, or expense that may be imposed
upon or reasonably incurred by such member in connection with or resulting from any claim, action, suit, or proceeding to which they
may be a party or in which they may be involved by reason of any action or failure to act pursuant to this Plan or any Award Agreement,
and against and from any and all amounts paid by them, with the Board&#8217;s approval, in satisfaction of judgment in such action, suit,
or proceeding against them, provided that they give the Company an opportunity, at its own expense, to handle and defend the same before
they undertake to handle and defend it on their own behalf and, once the Company gives notice of its intent to assume such defense, the
Company shall have sole control over such defense with counsel of the Company&#8217;s choosing. The foregoing right of indemnification
shall not be available to the extent that a court of competent jurisdiction in a final judgment or other final adjudication, in either
case not subject to further appeal, determines that the acts or omissions of the person seeking indemnity giving rise to the indemnification
claim resulted from such person&#8217;s bad faith, fraud, or willful criminal act or omission. The foregoing right of indemnification
shall not be exclusive of any other rights of indemnification to which such persons may be entitled as a matter of law, or otherwise,
or any power that the Company may have to indemnify them or hold them harmless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>32.
Relationship to Other Benefits</b>. No payment pursuant to this Plan shall be taken into account in determining any benefits under any
pension, retirement, savings, profit sharing, group insurance, welfare, or other benefit plan of the Company or any Parent or Subsidiary,
except to the extent otherwise expressly provided in writing in such other plan or an agreement thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="text-align: center"><div style="width: 8.5in; text-align: left; margin-left: auto; margin-right: auto">

<div style="font: 8pt Arial, Helvetica, Sans-Serif; width: 46%; float: left"><br/>
<br/>
<br/>
<br/>
<span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><br/></span><p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><i>STARDUST
POWER INC.<br/>15 E. PUTNAM AVE, SUITE 378<br/>GREENWICH, CT 06830</i></span></p></div>
<div style="width: 50%; float: right">
<img src="proxy_001.jpg" alt=""/><br/>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>VOTE BY INTERNET<br/></b><i>Before
The Meeting </i>- Go to <b><span style="text-decoration: underline">www.proxyvote.com</span> or scan the QR Barcode above</b></span></p>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Use the Internet to transmit your
voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on June 1, 2026. Have your proxy card
in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction
form.</span></p>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><i>During The Meeting </i>- Go
to <b><span style="text-decoration: underline">www.virtualshareholdermeeting.com/SDST2026</span></b></span></p>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">You may attend the meeting via
the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the
instructions.</span></p>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>VOTE BY PHONE - 1-800-690-6903<br/></b>Use
any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time on June 1, 2026. Have your proxy card
in hand when you call and then follow the instructions.</span></p>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>VOTE BY MAIL<br/></b>Mark, sign
and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge,
51 Mercedes Way, Edgewood, NY 11717.</span></p></div><br/><br/><br/><br/>
<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">

<tr style="vertical-align: bottom">
   <td colspan="2" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">TO VOTE, MARK
   BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="border-bottom: #000000 1pt dashed; font: 8pt Arial, Helvetica, Sans-Serif; width: 70%; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">V94800-P50674&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
   <td style="border-bottom: #000000 1pt dashed; font: 8pt Arial, Helvetica, Sans-Serif; width: 30%; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">KEEP
   THIS PORTION FOR YOUR RECORDS</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 70%; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 30%; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">DETACH AND RETURN THIS
   PORTION ONLY</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td colspan="2" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>THIS PROXY
   CARD IS VALID ONLY WHEN SIGNED AND DATED.</b></span></td></tr></table>
<div style="border: #000000 2pt solid; padding: 4pt">

<div style="width: 70%; float: left">

<table cellspacing="0" cellpadding="0" border="0" style="font: 8pt/normal Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><td colspan="3" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>STARDUST
   POWER INC.</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td colspan="3" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td colspan="3" style="font: 8pt Arial, Helvetica, Sans-Serif; padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>The
   Board of Directors recommends you vote FOR each director nominee in Proposal 1 and FOR Proposals 2, 3, 4 and 5:</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif">
   <td colspan="3" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: center"/>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1.&#160;&#160;&#160;&#160;&#160;</span></td>
   <td colspan="5" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Election of Director Nominees: <i>To be elected for terms expiring at the 2027 Annual Meeting of Stockholders:</i></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 4pt"><i>&#160;</i></span></p></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
   <td colspan="2" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>For</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Withhold</b></span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; padding-left: 10pt"/>
   <td colspan="2" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: center"/>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt; width: 1%"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; width: 5%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1a.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; width: 45%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Roshan
   Pujari</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center; width: 8%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center; width: 20%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 21%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1b.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Anupam
   Agarwal</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1c.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Charlotte
   Nangolo</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1d.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Mark
   Rankin</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1e.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Michael
   Earl Cornett Sr.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1f.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Sudhindra
   Kankanwadi</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
    <td style="font: 8pt Arial, Helvetica, Sans-Serif"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
</table></div>

<br/>
<br/>

<div style="width: 28%; float: right">

<table cellspacing="0" cellpadding="0" border="0" style="line-height: normal; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
   <td style="width: 50%; text-align: left; text-align: justify"><span style="font-size: xx-small; font-family: Arial">&#160;</span></td>
   <td style="width: 50%; text-align: right">
   <div style="border-top-style: solid; border-top-width: 2pt; height: 25pt; border-right-style: solid; border-right-width: 2pt; width: 25pt"></div></td></tr></table></div><br/>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: normal; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
   <td colspan="2" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 91%; text-align: left; padding-left: 10pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>For</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Against</b></span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Abstain</b></span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2.&#160;&#160;&#160;&#160;&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Ratification
   of the selection of KNAV CPA LLP as the Company's independent registered public accounting firm for the fiscal year ending December
   31, 2026.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3.
   </span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Approval
   of, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of shares of Common Stock to Lind Global Asset Management
   XIII LLC.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4.
   </span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Approval
   of an amendment of the Company&#8217;s Certificate of Incorporation to clarify the director removal provision.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.
   </span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Approval
   of an amendment and restatement of the Company&#8217;s 2024 Equity Incentive Plan.</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#9744;</span></td></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 90%; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td colspan="2" style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 91%; text-align: left; padding-left: 10pt"><p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>NOTE: </b>To transact such
   other business as may properly come before the meeting or any adjournments or postponements thereof.</span></p></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 10pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 3%; white-space: nowrap; text-align: center; padding-right: 3pt; padding-left: 3pt"/></tr></table>
<br/>

<table cellspacing="0" cellpadding="0" border="0" style="font: 8pt/14pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="font: 8pt/normal Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"/>
   <td colspan="5" style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: left"><p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Please
                                            sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator,
                                            or other fiduciary, please give full title as such. Joint owners should each sign personally.
                                            All holders must sign. If a corporation or partnership, please sign in full corporate or
                                            partnership name by authorized officer.</span></p>

 </td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 1%; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 20%; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 10%; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 20%; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 20%; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 10%; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; width: 19%; white-space: nowrap; text-align: left"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left; padding-top: 4pt; padding-bottom: 4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;&#160;&#160;</span></td>
   <td style="border-top: #000000 1pt solid; border-right: #000000 1pt solid; border-bottom: #000000 1.5pt solid; border-left: #000000 1pt solid; font: 8pt Arial, Helvetica, Sans-Serif; padding-top: 4pt; white-space: nowrap; text-align: left; padding-bottom: 4pt"/>
   <td style="border-top: #000000 1pt solid; border-right: #000000 1pt solid; border-bottom: #000000 1.5pt solid; font: 8pt Arial, Helvetica, Sans-Serif; padding-top: 4pt; white-space: nowrap; text-align: left; padding-bottom: 4pt"/>
   <td style="border-right: #000000 1pt solid; font: 8pt Arial, Helvetica, Sans-Serif; padding-top: 4pt; white-space: nowrap; text-align: left; padding-bottom: 4pt"/>
   <td style="border-top: #000000 1pt solid; border-right: #000000 1pt solid; border-bottom: #000000 1.5pt solid; font: 8pt Arial, Helvetica, Sans-Serif; padding-top: 4pt; white-space: nowrap; text-align: left; padding-bottom: 4pt"/>
   <td style="border-top: #000000 1pt solid; border-right: #000000 1pt solid; border-bottom: #000000 1.5pt solid; font: 8pt Arial, Helvetica, Sans-Serif; padding-top: 4pt; white-space: nowrap; text-align: left; padding-bottom: 4pt"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left; padding-top: 4pt; padding-bottom: 4pt"/></tr>
<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Signature
   [PLEASE SIGN WITHIN BOX]&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Date</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"/>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Signature
   (Joint Owners)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Date</span></td>
   <td style="font: 8pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: left"/></tr></table></div>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div></div>

<!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always"></div><div style="margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center">&#160;</p>

<div style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center"><div style="font: 8pt Arial, Helvetica, Sans-Serif; width: 8.5in; text-align: left; margin-left: auto; margin-right: auto">

<br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center"><b><span style="font-size: x-small; font-family: Arial">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders To Be<br/>Held on June 2, 2026:<br/></span></b><span style="font-size: x-small; font-family: Arial">The Notice, Proxy Statement and our 2025 Annual Report are available at www.proxyvote.com.</span></p><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/><br/>
<table cellspacing="0" cellpadding="0" border="0" style="font: 8pt/14pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">

<tr style="font: 8pt Arial, Helvetica, Sans-Serif; vertical-align: bottom">
   <td style="border-top: #000000 1pt dashed; font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; white-space: nowrap; text-align: right"><span style="font-size: xx-small; font-family: Arial">V94801-P50674&#160;&#160;&#160;&#160;&#160;</span></td></tr></table>
<div style="border: #000000 2pt solid; font: 8pt Arial, Helvetica, Sans-Serif; padding: 4pt 10pt">
<br/>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center"><b><span style="font-size: small; font-family: Arial">STARDUST POWER INC.<br/></span></b><b><span style="font-size: small; font-family: Arial">Annual Meeting of Stockholders<br/>June 2, 2026 at 11:00 AM Eastern Time<br/>This proxy is solicited by the Board of Directors<br/>
<br/>
</span></b></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Arial; font-size: x-small">The undersigned stockholder of Stardust Power Inc. (herein, the "Company") hereby appoints Roshan Pujari and Bruce Czachor, and each of them, with power to act without the other and with power of substitution, as proxies and attorneys-in-fact, and hereby authorizes them to represent and vote, as provided on the reverse side, all the shares of the Company's Common Stock which the undersigned is entitled to vote at the Annual Meeting of Stockholders of the Company to be held live via the internet at www.virtualshareholdermeeting.com/SDST2026 at 11:00 AM Eastern Time on June 2, 2026, or at any adjournments or postponements thereof.<br/>
<br/>
<b>THIS PROXY CARD, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED. IF NO DIRECTION IS MADE BUT
THE CARD IS SIGNED, THIS PROXY WILL BE VOTED FOR THE ELECTION OF ALL NOMINEES UNDER PROPOSAL 1, FOR PROPOSALS 2, 3, 4 AND 5 AND IN THE
DISCRETION OF THE PROXIES WITH RESPECT TO SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENTS OR POSTPONEMENTS
THEREOF. IN THE EVENT THAT ANY OF THE NOMINEES NAMED ON THE REVERSE SIDE ARE UNAVAILABLE FOR ELECTION OR UNABLE TO SERVE, THE SHARES
REPRESENTED BY THE PROXY MAY BE VOTED FOR A SUBSTITUTE NOMINEE SELECTED BY THE BOARD OF DIRECTORS.</b><br/>
<br/>
<br/>
<br/>
<br/>
</span></p>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin-bottom: 0pt; text-align: center"><b><span style="font-size: x-small; font-family: Arial">(Continued and to be marked, dated and signed, on the other side)</span></b></p></div>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: center">&#160;</p>

</div>


<!-- Field: Page; Sequence: 133; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

</div>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdsKgkAQhp/Adxj2OnKV6MK7EovIIkSi2y2nWNIdmd0OPlJv2apEw8Cc/m9+ISZiTStdI8NpWeRQYtPWyiEUeEVGc0GvSDfbBHwt8KatY2XcMP7AlDyDnplPZ2e/H5RPbbFKQM7CSIbx3DeJlLDYiaC/p2SuukLjtKpBmQoOTC1rdIq78UOp3mSo6QanI7LVZBKIpnI8fyCWUQx7eqoX8d1CnqcimAwRiDXTo/Wq7O3Q9CRkNTbezo70P4MvvvZKRg== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>proxy_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !( 2$# 2(  A$! Q$!_\0
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M:1:S8Q>&-9O;JRTZS\1>(_$%GXVUNUOS!83V&F:;#::3H3:DLM]+?_G?=_\
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MJ6L:5:67C_P\\B_\)98:_KNAZ+H%K/::AKFN:-H]WI&K7P3S-W7<_&.\TO\
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M->N[S7=-DC@5P=W;7;S[^1^2O_!N5_P35_;D_8;_ &A/VP_&O[6'P#U'X/\
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M^":?Q@_9A^,]AXF^"G@7XJWO[+/_  BGP^^*WQ)^'7Q3\ _&+PWK6KV?PN^
MWQ(C\":?9?&'4_ ?B6W-DUAX;LDU^^A\5Z;Y?AY+VSUR.R_L<6VFW[WD)..!
MYCLL?'W5X5G4OE\NV]0=F]D4 Q_8Y2ZEF3;&6*8>3>'D:)FE4X"1, )U9(TW
M2+,RK- A9"#YGMI_3N?R[_M?_ ;XZ:__ ,&O7P?_ &?_  Y\$?BYXC^/.G?L
M<?L=>%;_ .!VE_"_QUK7Q:L?$WAW2?AS;^(/#FK_  PT[0KGQQ9ZKH5QI]];
M:]I5UH<-]ICV=W#?0P20R*OS[X,\,:AXL_8W_;_^%'@+2?\ @X9^(_Q4\:_\
M$Q?VA?"NA_#_ /X*$?#'XZ3_  -N/%<O@;1K-/"OP3TG7OA]X;EUOXRZSXDN
M;70/ V@:7#J^M:EX9N?$^DZ)IATII[4?V&1VDJ.6$H4-O)0!L*9/]:4*&(9E
M?,[%T9O.=F9G.&IQMIW9=\H*HZ,!N+*=B,JY1D).'<3JS2O(LL$),C8R .9_
MBW]^I_$3^R!^Q'^T5^R-\=/^"''[3?Q$^$_[8_[2WPYU[X(Q_"[XB_"SXJ>'
M/CK\3-=_X)L_&KQAI-M:WOC/PO\ #O1_#EO>?!'X53Z;=Z#X:?P[XS\'OH_@
M2P\%ZS)=:O;WNJZ;?6/E/_"FOV\XO^"6G[0G[$'PN_97_:8T_P"*?[=/_!6S
MXQ>%M7N=4^ WQD\(^&_#_P"SYJOBOPCXKO?B?XR\>7O@HZ=X#^$?C_6AH&B0
M_$/5L^%+WP-%XUMK6YN8--O%3^\,:?-DG?&OSGE"R.8GD22X0LL84&ZEC6>7
M9&NT@PDR*[25,]EOE:4I 9"=HD=5>0H+=XPTA,.Z3)<QM"LD:F)G;S<NT9 Y
MGY?TV_U/Y"_@A\%/V^OV*?\ @J?^SY\:/%G[$FF?#[X!?M,_L]VW[%WQDTG]
MCWQ'\5OVL_"7A"+X1>'_  YIOPI^+/Q?UG3_ (+>![SX:S+=_P#"/Z=%XFUF
MWU&SO-'TOXAW5WJ\.JZM<R7._P#\$3_VK/&'[#?[*NG?LO\ QN_8#_X*CQ_$
M"^_:-^,_B%-?\*?L _M ZY\-(=%^(WQ$^U>']<N/&EWX?T:SBT?[+(-1OM3O
M$N(=/TTR2OJ$MB \O]:J6<@D$A*#*A9 CR!V*\(QG(W21QJTVRWD1D#3O\^$
M2GK;3H5*SMCS&D<,S,'8X^8@C<H/*^3&\<*@Y"LV<A+UU/XA/CM^SW\:/A3^
MVBOC_P#X)(_LS?\ !4_]DG]J#QE^U*%^,?P^USX9:Q)_P3F^(/@F7Q7K+>-_
MB%=_%?47UGX1)X.\6/#%XNMO"VJ:[JFE6-GJQA\$:!X$UVVL+4?MQ_P7FT;]
MI#QG^Q+H7PH^$'P?\:_%OX=?%GXM> ?!'[7MO\&OA39?'3XQ>$?V=+A6O_%_
MB#X*?"O5[+5I/&'BT:_9Z19Z7/!H.JZKH<-S/K-LNFS:;_:EC^XOV=\;2$*^
M6T>-\FPKN.R,PL'CP%()D&&R/+">6>&?9'R&#*K"-8@RLPD"^8[2L9-N'$BL
MI$1C"QN"ROD@@ _C!_X(P:5^WO\  S]JSP=^SEXC^%O[5OP0_8WUKQC\7_BT
MOQY\?_L.>-4^+'[9LL]AHWA/X1>"/VM?B)XY\-?%.Y_9I_X0/PMITEQIL=UJ
M_P -=7U%;&[\-)KB6^K6>K7/N'_!;W_@F7^TI\8?VM?@M\4_V-AXTT+0_P!O
M;PYI?[#_ .WIJ'@'0)-6M['X7Z9XAT?QQX<^*'C*^BM]1ET73(O#OAJY\.:K
MXPN9M-MM*G\%>#]!34FC\;Z[:ZW_ %H&WG 0B0,R-DKN94= RA49G%Q)PH\P
MDLQ,H(X5R0V2VE=@<QXRQ9LN&(W JJG#LH8[7<>8T6ZWC'DNLK>4%<SO?0_F
M0\9_LY_$3_@E_P#\%-K3]L;X5_LK?%W]HS]B_P ;_L<?"C]E(>&?V9?!=]\5
MOB]^S0WP5T30?"W@[3M*^#>G7$_B_P 3_#S7?#GAG2%DD\+0W-[9W]UJ5QK
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MWPOX9\.^&]+M]%\.>&]$MK_0=3OWL]*TRVBB:]U"^NM1U"Y:>]O9Y)YV(**
M4Y)W3UVV3_-'RM_Q"V?\%<O^A-_9]_\ #\67_P R5?V9_P#!#O\ 8-^*W_!.
MC]B'2_@=\;-0\+ZA\3M>^*'C7XC>*;'P7J%SK/A_P^?$AL[.Q\/1Z[):VO\
M;%W!I^E-=SWUK:0V)OF73482_.2B@)3E*W,[VVT2_)(_:.BBB@D**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>formdef14a_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14a_001.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Y 5X# 2(  A$! Q$!_\0
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M/:EJ&#/E)N 5L'<HS@')R!DDD \ YY SA0=HFK);*[3=E=K:]E?_ ('E8T_
M**0D $^GIUIN\#'!YP1P<X(ZGT[@@\CO3$VDKO1=Q]% .0#ZC-,\Q?<\XZ'^
MN./?I[TKJZC?5W:75I;OY=0;25V]._J/HI@D4G&#]2./\_3/Y4^BZO:^J2=N
MMGL_1@FFKIW044S>,;L-CZ<\^W4?B*56##(SC..01GZ9[4P335T[KOT[#J*:
M6"]<_@"?\]>W^-,69&W8S\OWN.@SC/O^&:/Z_3\Q]WOR_%;IZ]MR6BF+(K'
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M]786]L^OS>'=(U:71]-N7E6V?5]12UTJUFEABN;V-YHE;^%/XG_\%Z_VCO\
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M(ZJDY>Q]I1JQ3<'4Y^1232IN=DFXZ3:3U>B=E=V9^4WP!_X.??\ @F9^T?\
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M65&8?O?^UU\W[*7[3I'&?V>OC;D<_>/PR\4\C!],8YQ@X!Z5_F2_L#?\%/\
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M;.W@M+6VMUM;:UMH8[>UMK:W0)!;6]O $BAAA0*D<:($1 J1@*"*]#/L#EF
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MBTSQE#J'A;498+^RUBQO?"NL):Z=<O;O=Q?8)TD2&\B<X_\ P3T_X*(_ ?\
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MV_>;OD@EL9_B')R37^7'_P $O_\ @J%^R)_P3SM?^"E/@;]J7]FCQ9^TO/\
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MY(U$T[V6BM*/1$1=HU1\L<! L>-I+,0H4A@ H?."6.(SDD@*:_C/_P"">_\
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M .E%%% !COZ4444 %'^?\_YY[T44 %%%% !2  9([\GK_GO2T4 '^?RHHHH
M*/\ /^?7\:** #'^/4_Y[].GY"C&?\_A110 8Q_.C'?U]S_+H/PZ]Z**/^&
B3 SGOC'X?3I2T44 )@=.?S/8YZYS_G'2EHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sdst-20251231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayHqbP9z5Z8mekhvWB7bckqHyghwTCDwSWpgxR28UoI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:SDST="http://stardust-power.com/20251231" elementFormDefault="qualified" targetNamespace="http://stardust-power.com/20251231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://stardust-power.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="sdst-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sdst-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sdst-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>sdst-20251231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="sdst-20251231.xsd#Cover" roleURI="http://stardust-power.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://stardust-power.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>sdst-20251231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="ecd_AwardTmgDiscLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgDiscLineItems" xlink:to="ecd_AwardTmgDiscLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgDiscLineItems_lbl" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>sdst-20251231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="sdst-20251231.xsd#Cover" roleURI="http://stardust-power.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpPensionBenefitsAdjustments" roleURI="http://xbrl.sec.gov/ecd/role/PvpPensionBenefitsAdjustments" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:presentationLink xlink:type="extended" xlink:role="http://stardust-power.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STARDUST
POWER INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any program, plan or obligation that requires us to grant equity awards on specified dates. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20250101__20251231_zTx7MiLM4c7g">We
also do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_z76eRhlGWiV8">no</span>t
have any program, plan or practice to time award dates of stock option grants to our executive officers in coordination with the release
of material nonpublic information and typically aim to make equity grants during an open trading window.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
awards may occasionally be granted following a significant change in job responsibilities or to meet special retention or performance
objectives. During 2025, we did </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--MnpiDiscTimedForCompValFlag_dbF_c20250101__20251231_zUHKmKOhzhKj">no</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t
time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation, and no stock
options were granted to any named executive officer.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered [Text Block]</a></td>
<td class="text">We
also do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_z76eRhlGWiV8">no</span>t
have any program, plan or practice to time award dates of stock option grants to our executive officers in coordination with the release
of material nonpublic information and typically aim to make equity grants during an open trading window.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>9</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://stardust-power.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="formdef14a.htm">formdef14a.htm</File>
    <File>sdst-20251231.xsd</File>
    <File>sdst-20251231_def.xml</File>
    <File>sdst-20251231_lab.xml</File>
    <File>sdst-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>formdef14a_001.jpg</File>
    <File>proxy_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "formdef14a.htm": {
   "nsprefix": "SDST",
   "nsuri": "http://stardust-power.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "formdef14a.htm"
     ]
    },
    "schema": {
     "local": [
      "sdst-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "sdst-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sdst-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sdst-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 9,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 95,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://stardust-power.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r15",
      "r25",
      "r50"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r18",
      "r28",
      "r53"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r46"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r46",
      "r54",
      "r58",
      "r66"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r64"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://stardust-power.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://stardust-power.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://stardust-power.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://stardust-power.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://stardust-power.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://stardust-power.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r15",
      "r25",
      "r50"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r12",
      "r22",
      "r47"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r54"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r54"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r54"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r54"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r54"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r46",
      "r54",
      "r58",
      "r66"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r70"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r70"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r70"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r17",
      "r27",
      "r52"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r20",
      "r30",
      "r55"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r20",
      "r30",
      "r55"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r33"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r2",
      "r12",
      "r22",
      "r47"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r13",
      "r23",
      "r48"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r14",
      "r24",
      "r49"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r21",
      "r31",
      "r56"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r16",
      "r26",
      "r51"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-26-018351-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-26-018351-xbrl.zip
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M]V0-%BMZ:,GH.05:FX2?08S'%_PHX>0A2XIPO_7F*6B^SXTIE'4#Z"=) R_
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M<5[),7ERY*UM8N<F@@W9*FISQ 3MR0%9<2VKW9D$<**PNKGR.%=H- >^5PH
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M\A.+W&Z=JU[=P2MNT<%K#'=C6 LN0U(NPR;F'5F_)I<*0#=HJF1&V<D$6T)
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M&<62TP.D*SAD0 ^"<G[2A.QA\.>2.P@MIDI2%K()=#>%U7V0MU36;6<DP"T
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MTJ&M8&4BWAQ[D^?P,#A,+%:PAWQI,$9Y-%+'4A!<7M%UW%&9RV!2P+2Y13(
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MTBP/K;K!4U"XG'-DOR W:LCGTSCW=7T1N^[.@CLU5=PS.-)7Q?:.V9)1^<[
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M'AT,\(/=T!';"!Y2 08M8T8UU* #.&33CP,UPP2ME-(ERB(A;89"@>1*S44
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M;;/E;]PMQ_%4D2DKI97I=+_M=<A.1-B<1;99XEZV.[08IN2<@>K*FBW(M-M
M'RA[V>_LUA:#<-&IH!:%#+9;$@[(TJ$ IJPN&]E8E\358*13Y*X@W,S(]K<
M)G'FR-$3$-W)#,CVU*]0&S(6@1SFQ$<6!&",2$5AD"UT%%GKA[9(SQOI3U64
M5#X/%-:C9"->^Z$,2ILK]:!9O!B PI+,0C\KJXA^05(#730I@)WI"=4L/$W5
MYJW2>JNE.&ROUZDR\W)=9>;FJLP\7\4J,RZY/'B<TULS^553C[YKLL^]RRJZ
MC3HXC;Z$JI[0QI< -]5EO@0M]7;,!5I>F74OFN-+*&U$I=VL8B6JR7 DUW5O
M% ER[5NX3U3\4*/UK@%]<Q\V^[Z'ZMEEO.X/+_<]=':D73.VTL; ZB&/$$U
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M&_M9$08ZR1]7-(6'XZ(=A:1%A.@=:!D*J32Y@W^Q1#(NK@1C*1CMWD!5,")
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MQG46R\=BS:#N8O##V#/&"HI[NE 4!A\H+M&IYG)!H>P-Y..02ADH12G4E"'
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MIL]_?<E>=8K3" S'_"</;LCC"R]B+KL*A+'Z4TQ/HR^L%"3F![_/L,@]^'C
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M0:<OZL'M#*/42'<*-L1&&>VFY"8H(APGQBEA@Z<JEG@/^S15!?C-4R$R66&
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M+;>9G*;(03"F1 ,-^@;7,"!,%[58."=)W'5U^S3<6 .&?@$VW\;R4B\Z_F
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M?.&@Q5[4!G5GJD+S1"N!WBA*6E,8 0N+;RG7WT\GLH$3//XS1B6YW9#5N=6
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MHS(:]_9P #V:-5=)&GDUS"?PZH*&S9<6=X/T^(%]#7@#<.1_7)Q^1/@(C]U
M*&KP>L85TL',R1->Z[)8]D%#'V"#G:%S?-%UMT  #?#8O605%Q3E.(G0:<)J
MKGH8 P4):^5R-;01A52CPAQD.>/1U#U*LN\$F*%/8M32=_L^+4RMQAM/@<L#
M1^$ESJ=]/[!M/GB$/_DL5+AGIXURBE<AO<M5VFB3,EK-C&E21J7/03;[J>JB
M<D#R,0NP[RP%4A^U? 8\'T6S<M)(OPS+;[P6J0H$#.1MLU5&PQ%3Z61BF15D
M!5<]G?A9Z,]3QR?M!HDD(9V *:8TUQ)IMMXD<"E09T355SN6\"T4;4 OVK P
MSSD%!4 YW?X/FKQP0ZS( D8RV/^.<X[&\#HI-@FL$\UG$H"13TKK -8ZGBKE
M"KCV%S&)PR&6'5-D@G3/HKM<BPU8EJ) T=Y^A;@U"VZP,8=#[K_JQ(%'CK=)
M*(#.AZN.!R3(V!&!S Z[>[GCA$NL04,F=1V%;A)0I@;Z+U'Z2!U6G@-T*8_3
MBC[NF# VJCLP15@&:VX>,J$^JX ^:B- 72&ZB1RUP>KPE$HDN7B>R"9C688X
M["SYE8'N2-7Q% 0E<,0<<<G2(E\UNI;<!F*$PE)0\ +S;2H(;T]O@F?;_21&
M@"HCM@?29T5]<LB_@Y7JN"-\,&CC0X&.4VUS2 '(.A]'X?((]5<XEP+4\MF,
MNH#181=-!>Y&S2N$<^"4C&/82:7ZT!77^XQ!+5&R#?47\8!D$TO^-BGREELQ
M-7[CNA"X8[&DDU]/W-[_\Z>SGX]AD^R0AJ5Z>!1\LQPMY34V+OL^3#Z*9#S0
ML+:]5[A)<@:TQ$Z!7IDUI#*&9%X0*0-%/SC2_$XE<W2'Z.*G-4<B"F-;KMN]
M_;*J)A5IF+SG6'?+T%,:%,FID)BYOP-[0$R>]XHU*&P]J4KAX+NO+8_L'K%0
M8$1)QEJ#.P"S$!1=^!AN/H;FT$))W?.0FKY]@ \)]U]P6=(O<U:9/B;^!#@]
M[1FL, HT^#U[#4,1Q:,1VF%IBLD0_-#58(*,&O&Z;$XRH3M?5EL<H[8(V.)X
M&@Q2G@_,%OA*/PBSHI?._6WG_0X_\BX&AHM::PB7"T:$Z>#@<4@GZ-.G4WX,
M!? ?P 9M'8B?P^V%MQQ6VAI=B+5.O\4XSC+UDB=1K):O7BV>//9H SWB2'=#
MK!VU$&M+A%C;;R'65@H&P/:*FB9;*,_($.-$>IE$?X<)5A+5B^8?+V*B'6D3
MS;%,-$E1-7'KKF@!ZY\Z9X4)>WBLP%DD5N#6Q0IH;!TN(-7$MB[V#XVWWZ:5
MU4)1,"[0'+/VP0Q]PUY^?M^R3'#QT()0?B+C:>1<)%L3U5K1_5JP8V^'.11F
M<4J*'>D6>S_+ _*)J&P\&Q>!&$[A9.J<#I6 @/D(:B*<=$(*#"A64U+P!S8$
M;)!1I'I(;:.!2AU+U5IT-4JU][J0:^)G)77?<L=SD"0>!&B+P3Y,_3\IB%Z[
MH+A12AF#.QB#58A]CFGF <P&=#F0?J&0&NW>F]>OM?.84QOL]4;;&FGY#8R<
MU'T?H\F&5$B]K:CZ%75#U/;>24V4T&8P6\OH>Q<@3-E6NAJPJ<[J)JPTZ,*H
M<AI-<J=\):G)M^^HKLSX^=^#*,1!RQM9.(SH=2"P;0E3?7WUO[];(?=T/NV#
MPBJ3?7__]%YF\[9.O#6;"LB.\]][E[^?]/[UG.3A,T,<_)=PL*)CD">8\A?.
MR;\ 3!K=[VC)\C43&"U%OL]N$3O%#*Z>PK2GN);P24"HI!OCMNH..' ZRT&2
MI4)+VJO>L3:"C?0JX'$/@Q11[7,@-,E#E)E=2I6!@4)@[[>"JE(2=!<E["V2
MI0$8ELFG4Q0DA0[&UV0)R$27\SRC!&0DF_L_.]U;RD8&.?F!6\7_@:WB>Y@*
MAF\6PYS!E') (S]). )GR$VM%O<-<\,EP4J*$(QNE45+.0$XKH.:@!7"PP=-
M3"P&KCF6.@7E(2//A"V$^<M]0[#(84VIC:=W;A+3VG'4&93S8)BCP\QJ<N^G
M#@X[ Q5E$,PHH%G^G,18%VX$9+C9;>Q.8YB-S'/0TZTEQ94^&**>3P2]C!CM
M&"+B]<=U>+[U0<\$J'*)_0W00K.:_# T^Z-7>:X;U6^.7KU9$=G+)+2"_^8]
MO$YL$SH2/3Y88DOG]]'9GJ1UHW-#6%H-3)W75(#8'KCUW<?-I;,]2>M&YX:P
MK@:D+*\I8VJ5O:7,?W>H;>>WMVEJ/6ZUWJFKSZ>GW<L_G$+GF.ONNT^]9^.Q
M>GX^N'NZ?@015I+[,N$G@BL:J5A6P9/4D,G4Y /2]:(<;<)"X:&C@Q_[>]0-
M\Y"C!.5?'SQ?;_N#D@06G^[]Z01O$+)>AM11!JCFQF7_S#+;@VS?"L1/8!BD
M)8JA%[]@#@)W2(3C<Z%]AQ>R+KC4I[TP0I$FN0MZ'GO?T4;[3NT"\27@MW]_
MT2GG@'SK$GYG1XT7OZ#7N6&E:I:EAIZEKE2[3TW47ODAEJ\CA5M_>=GNV/KO
MV#ML"=UNV*9L6(.RB]VLN1<PQ>NH'=@6M<J!'WAG+16QW=V-VMVS.-J6X5BD
M_$2W<[\ \[40SN5][[3[_BSVO1LRBNDYAKQK]GE_$_9YG3>U=@<?KSE:R:6S
MNUQW#AR@:RH/<Q_PGY(GX3%;Q:U\-<JW9/;H9[7&<UUOPWX;^KCJ9+?4CF\J
MB%W3P*PZ=.>OJ[G;Q5'VECN_.]F7ZJ)7&C)!QOD=8Z)#Z>X1GV"2[>XM..;1
MP2OOX+#3;N"F;N!VNW7MUK5;]\A;=_CFT#O:?]5NX,9N8+MW&[MW>U[G8-_;
M.SAZZBU<K0W$AA_^_-8-P/K%*N ESL=TGKH[3Q?_N[I3^5A'<<D6S\$"PZQB
M.NU6% <ZV ?SI;/?[L9:[$:30MONP^/N ^BFG3WO\$V3CM/NQ^/NQ]'AKK>[
MN]ONQEKLQMZ!=]CHLFPWXY&OAO>JL^\='CS-?GR/ M_06OF1"U;:X_6MP8GV
MIC^RJO[FM;=_N-?NQEKL1JNJM_O0[H,9:+^S"YI(:S"MQVXT>N?;C7C<C7B]
M]\;;VW\VROFCN=3OKA]OSUGK4E_;K3@XZ'B[^ZU+?3UVH_4<KM%F['F'>_O>
MX6[+JM9C/_9WC[PW1ZVNN!Z[L==IG3OKL1,=;W^OXQT]D>MSM5DQ3X"JPB5*
M![)$J3U[K<=],[9B_^"-=_BJ9<KKL1NMIW<]]F'O3<=[=?"ZW8VUV(U.YP ,
MJG8WUF,W#EO1O1X;\>KHR'O]NJDL;Y/U]T=SP=^-@=@>N6\>J+W_[6:TF]%N
M1KL9[6:TF]%N1KL9Z[4997COI2'Y=E[M[!\NU ^XC/#]AEZ$:2X567@)]"PM
M=%#:AP>@#C.RUQ*:0=F=>VDA2OV2B4[G[D[&C4A,WXG1WG#-&^Z$WK7E#%ZS
M70PHN3@IRQR[BR$FW=>N/W?]V0S,8#HL5[UC[H;G45]<1(++IQ$\/0K%(...
MO/YXC WH,N&.$S_*W"'^./*#Q+W![MH$&0X4;/?]%+Y_>?49/C;*PW#NW@CJ
MP9E._$0@$3'U\9W&D4NHFP3K#%8S(9-C8]"4?IM'V&9U2W:?X^[!%_!5U3-8
MMIU[R>1PJSYL+M>(42Z["III RF(5VXU!,5\,,*$] @./<^X$:Y/'0*)-FQ/
MZ'X((OA'X(?4.S"/,MG&-AI2JS]N2%7[I^-X&  Y/G<.C&?! (AXM?>Z-$_Z
M"_Z^/-D=]WIRUP; 'W&-W%L_=7DC9.?361+W::OC/(.IZ:<+JV%OPB".AH'L
M,:S[*]*0\#,1L.-^B!/7IQ:%>9I:L/%^FN;3&;^,K6ZQJV*>\A8QK?A4Z;0P
MNC?\ (0@G/Q(+[)O5E(U?/3<62C@53RB(K&Z%)[%0.%KU9)0;GD$OTS5^<"F
ME A>Z'-K1#5(FL$OIL"G\?1'F1]$8@B4P!?PI6X4Y?#0)?5+Q#6%J4_A8FW_
MHP!]S\CW%8C[PYVJI%R8(SXJ[WM<3KL"!>1YK6J=".D\G0A!WN-/\2ZFLG4H
M7J$X 2+T#<#CCG\$5H\]-P,-M=M'F&P8#AZ"JX4W.<V1C<EK2>_1,W"UD9;;
M23"8 .=(@'GY 3&R4S\98-=JNE1'>#=M 0-4$!]ACA.$H=NGWA=9R%R<Y4]%
M^A1;7:C^LT>[P.SFL!;8!]V'40? ;3QF_[[-@(F?P= @6(%!4&]OM4@P8GS+
M75GI$V>]<_A,.,A#OT&P:+Y?9-[8 9:X7X*MSPW!UB3H02"CP*'=K;]T=@X.
M7S*GGL:)L!N >+ X0O--W7'VO6F0"[-I;GE+34$Z/QL4EZL)'(CM:Y%,'1MB
MF>#12:@JKMP787S;LL26)2Z+)>X_'4N\E"HR:D_^'/4'5*UMA@*7,0Q&>//@
M3M%5!]XX#?(I=\VI*JKMS6AOQK)NQL'3W8S39 ?&XU1&8/EC^"R:EF(Z"V.^
M*"  ?_-!KP;QTJ D&V?2$KTWW^2ZV=WI/'JO. 257Q9>^#))/^M>7G:O3W[O
M.>]/KHX_G5]]ONRYU^>N;!CGUC6,V\!I+K!#JVQ.MEHT=^P3IR34! S\ *XE
MF;\"6VE;4JG0%FZ6Q*!83EG%ALL\%"F0S(8]44^2KR+2=/^XPL=(X\T,'?JI
M?@[:KDA!5>__";(5/L3. 5*%$^&K#G7D)YK Z1'2!4)&0P@$1, U5%\[-4LD
M,<L2?Y!Y8)^@@>]IZP06QL$1$D'YU[#F\+LA*/0I?#$FAT 2]/-,* 4_C*/Q
M=@:JKIOF@P'16C CGJZGW6J/S5/="1FNJ!V0TWE6S4;>NA$:3N$"0[SXI:>%
MG-,=)X(N%I_W^E8 &S*M9\T1SR/G2LPR=MQU.N1CV/<*+(2Z;)#ECLPD<KO9
M]K_0SV"VVX-GHU& !*)3\<2VMD^B&_PU\*YNBFR3#@5RG6[2#[*$V9H^+D[U
MN "_RE+9:K<"GNIN(:5%;SF]93Y9=B8K'PMP=>!V[,H!'KE-OA.CIWG &F'*
M <W(9T<HNB?<E%K5L?O>1_4YF/$D0+'KBTB,D%PI,H"#W_A!2"YH6+S/.U<[
M<@@AR,-LB$CB*?F&B=?"_^ZXO=&(Y8"U0WM'W#VTN$-("RB><L$J&V8IGW#8
M1#3,IZZO+ZCD[>5E*ZX266VX(C4K 3+@+Q)TS\-_\(OY#+_\E[U=^@.<_CDZ
MIL!:I,4H.;'8A16D:0X_UP0FL/&.@*=!_J+HC&<U[5HY2%"9!DBS6/FV8<G=
M =RJF)P[ ^O,!AG\._1S]';Y]!?@0MEV/()[AXN99KP2*9UI']A'M$UB/1..
M_@/M0QR);7()SN(T(V$91'P^\!WTP0^ QW$K6AHP?=Y2<QVY)U/Q_VUONQ\"
M$0[?NA?^6/P,0_TG%Z ;O05SZ6?W=]2M@#AW>UN:Q* >*<+OZQ!5B@8?D11Z
M4&/<^]O=<B"ZLNQWF_>U"D:]=:S:*UG#P;/6JJGU^MF]GL]@_&[B]S'#&#O7
M\IJ>Q;AZG0/[K9_4:_@G8_4JH_=O/\$RURPX:,!?MOL"V!!\>T;[9<?@>87U
MP;*.BQ'@L\+';9*05MKGIS^;&Z^TWG_QUE_E:]9D"16R!A%R0R:VCH=BF;KL
M!]%/R+6V=UBG*#6HLMX*==G2@;&UV0IN48TVJU]L5FAWW/=HV(>6-5YYQ_$3
M3%" -0O#^/:9JQQ-B6&VE"U+X>_+!FL4UN76\XM_?Z%\L<4_5Y;Z*TSWNC_'
M=$W)?G/TZLT*Z%Y!E $8 W=,WV$2@2.@_:<OOG8JUIAK0>K^Y7!7FFLRLH]&
M"QF?R-4PK,XI"6C9*<-.)B:@S8IY"6# (7NMB5ZLYWG?E .^"72NX$ O5!G9
M'J8GI7.CV.,[Z8E#ULA,LL @D0M:WKMH3'E)88@QDB 16K&[%>$(52?IV*,D
M+4S#E.X]S\4$HF@L4R@YF#(0%+N)J?NV]@AB\(CHP,\I)U2 /BW;0YB**+#3
M(\H1%@^5./@WL',B!9X,4B:U+RC#U1_&LTP,/3?-*8Z$7Q6PTD$_("^7S(4F
M@NNYMXH^+TTMW %)_6W!YR6+>#@7ZKJA"OTL56 .<58,@-7Y0:4;U*UW@SKH
M!G5;-^BF.0J:/2"$VZ7 NC9L5L_=_:$2BSA*=.AA#48RA,'=B_A6)$_A_["/
MB^W\J"!&U#D_.(WJ 9Z/T@LH;)W6[=&Z/5JWQS/1ZVO='G3K[_-Y[+,GH_58
MK+61V7HLVL/T8W*V!H\%:S2MNZ)U5SQ+U97<%16M_3M\%7@"6U_%CU>>H5-#
M'5.165N/N9&S>]:.BW)5AI0)<&53VDJJ.)!:?:FRFL0*9?"BT*JI*J2DT!I8
M#!1K+&=8DDDYZ"CC099M%PJ2JY^1-H?K#R:!N&'F!?SGBY@74"6PLF+@9W%2
M1O;XQ\5)+=:%HX5]E&F[)H/-$\ <N5@#^2*,@:N!R6M8&))COF[-BW79RUI2
M"V2 _*--,OP<Q$/TG0S)Q<*5VP1@0<*?JYG=:RQRJUM(H(XWR&3S DFLOQ2
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MA39N-6:,5ALU%8-(]"5;4Q_9IF-WJ[.MB:R8;I"_SN_#3#WC9[A9D<K.)NG
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M:#*H_8<D#"@<^B"K@F)XI$\*GU1_^,#W6AB1\#D/@"D3DW@ LT_1>Y.;B[Q
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MEA[A+<_IF?!CWL*X$71U;B7[\O QHVV?JIU7&BN6>D'O'<%YZ0CI\ @^R!&
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M1@P%P2Y$Y%^Z9J./H2?X FD78\=*!"0O-]J%4>NX8&&0]UNRS(E'<.2/J#K
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M93]/T"5]3![I@ZI#NGI]>[WK7H>1&+M7JEJ=<^:/\![IGI][TI,LJT_Z.OO
M7":M-!]=WZY49D<US(R#7(F>F)3L)'D?;B#W8@=6YI/ HW! K!A.KYS77<X
MWR@YV%C!?AT5PKGY-'8[?,E!F;#E>Z8BF_/6^<.O"M)_NHN8?CF1C82L]8!*
MWG%GBG=\MGPPH2I[O9K57NL!Z=66Y,#.&W\\><ZAE@_\L<T/Z+LW/NA[^!2S
MK&+Z-K68_.@#54&UY\>?.+F+J:!R(2LT24)I6:( F8K1 >3@"/Y,TD_N69B/
M&PE:ZP'IN#B;)PX90E\VE>3=1]-@L?VD3!J6H7[D9YE@YQKF.FJRF;XTA2CS
ML!*H:\1EK0>DQ86Y=] GZU JL VY( N8B,.G")+YL3OQX[(XV(X;!3O1,!0;
M=N)(V$ERQW4I*>T5LR1?2W)X%;D%&11,2BW#>VC@NTPOV@C?\@?$+<]"]1[^
M[%Y2_<7L)^R'M#H;J&\]U+>S\S5@W^\3Z_L=;[M5Z'QRJZ.Z/V,OZ(1V]^IJ
MEQI5SMGMI@)(( ^ <L!PT\-N"RFA^0==TDGVOFQ-*,-624?-WT1]XM.WI$?S
MA/_XZ[>_8XF+9GP=K!O7,*G+7RB32<;#E/4-VS')0MO8JLEQJL#G_-PPQ5K$
M)0MU0Y4^>D1C"UXW]/_B\BJR+8S=/(1!092<7*)8\XG4="D<4B GQT))BW2C
M5 P'26-R'?ZW1F8JH1$3J^)/+55UXME4%4L632Z3\ 59Y4@1KW#O%+VFI'55
M0U>(H,ET,)T+MC2%V4:L_9=5YDZC,QN="3JSMY$Z<\%]Z<VA8Q?JQ51]7%)B
M7&#*NC[;YM0T=;M0/[ZDFGW=P7J;#K8JX6P34^*3![50+[YN IY"61ZW=D^G
M),PV^K+1ES7ZLK_V^I*<N ON3XHLV%84\Q'"OU6)"%?K16E U2L,#XG6%,YG
M,<6=#!G=+RL$:(+YY#&&M]V'(PW[P=LH*R-2',@8;PI6#L(!Z$H$[5)6W&'K
M;]M?0Q\@:PE2?3\T&G._?R_+1H 6(Q<Y/BH?RPR,K:SP&R76*+'U4V+!VBNQ
M10T=-.R*X5";$F VB10N?J0SR+5,7Q$VL Z7DXH,RSRHLMW"527G%U0=-=IG
M"1KEJZTMZZYM+"]Y@5UD>M ,1 C20OU(:!)7,24_+[8L::.$&R6\=DI8;)P2
MSOR((-L2BA)FVF:L0!<59&5 D=Z;HI>%JB!9&!N'I:6!O 5WO'R/2)5)9EX%
M \8#(B(S,H.V<U^5^:(/5=%V&0U!DBC$0^06INK[42,O/(JC0V!1@C(U-V9\
M8:CEWNZ><:4U<(2U'E!%*)PWY625)8-P&\EX.0.RR&:&88[^#.>M$)-@J##6
ML7(\2N HD[)$91"'20&&+J6SJF*85#,A%COW?C0PIO#>[J&QA:VTU[<%)YYW
M^$UA[%BMD?4NFVO$::T'9(M3$L^":,HLM3I@I8=I(NX#8JI0<MA+Y[YJ[;9:
MK78C &L]H.GD54W*VH8,R"QQ#!=7PA/<$&AZCK0U(C)"A4_E6CB9BZ\E%"G#
M[# _XF+#]&:;Y*@1B[4>D!*+-V&&^15%*ISW(L]%NCI#<[^Q,9\1#'W4X)Z7
MB7O>:W#/W]<.6X'N[5*Z2/@@*,/N"IY/@E4FV^XUR;8O9$!:0OY3A/G8(=K8
M28/M)W<KW"93C)_CPHE8-1V=R_"QI!"1R9:"$0R^\6=7B_\IV!.,CBI!HI6O
MF N2@4,W^VI3CR"D(S\,4#)-3<!1FO2%"#(.=5[I[,Y.'WXN?>X=9$-D'ERJ
MJ;X5RM'<I4DQHE_2N%V_+_-!V4OOZ-[* JBP*'F!!1P5B6=/9JVJV<)NR5N+
MVDOP]NL"SJYV>Z?5QGIRS,9R+9#(B[IWL_,O=TLMQ;R;3>?+JB4CH=2$P!,3
M[(/\8%F[RE1+3 L/_ZMGV"G-,+IXMGK;*H9@MT!E,<TD,X7$/9PC<N:0G3@6
MC]%XIP]GEB1J!K&"\WN\@_"78+I,-9IFK0=4T31J6]?<#IESLA\5 311RK3U
MX GDU48,%#,AX1NL.L,J8B]8=Y@XN>3;(\X^/\H2U8#SJ*E24S?A'+X2L>H\
M[>M GVQ6?].(Y%H/2(OD0X5%R9 .B >"\BDL=0!_1\F(\7V<A.L93EWX9YCV
MBR'&4?OP]-#'>Z[G)GVNY=VGF#"E_A)"QN\W(K+F RJ)")&1B(%?1/GJK.?C
MW79C.K^$ 6G1^"R&(S!5K*H4DV<:FEXECV?YN($W1,E8"$)D4!FNS$![ZY(G
M3-EB4E-9^9W.*()A!@4".8)D1$P#!/% JJTB'269X(H4$QEL<1+OJ,ZHPVY6
MCEU:\P[Y,X?LQ3X%$',N_5QZNQD<LB'THC"[K^DG?R#2!Y@4K*R,&X:!<?9\
M;%7M"_<*9J!<(@--4@M+B"YG>)%V.(O/(NV'&:EHH0@XH<])6O$[8WLW$^_!
M%!7:S9XR1<PC\M7HHG&LMY-+:\ %O[F)/,2/J)#(A'M<VL))D>/Q0E%1F_ZA
M!G]N2J3C]873 W6G' *7QTD.US41:X(*N%3TQ:PTF)Q,IY2385!@"BITHO,/
M+; F02P#83VLYWB4AGA JIEPZ._*5,O/)E^\9;$ ,?MY+'4GW5EX+V2C*&33
M#"2P)U-KLFW9*[H6!3KS1K7BV ;C5K].7DH[S]R ,C[90:^+N[!? EEA/!M6
M@F^5D[LE@#=(>Q$>T9O"J:#G9Z\F7:R4E.BJ-?A.F$1\KWE4Z:4MJP8$S"+?
M40\.MKE, %C%8Y .A[GX)+&)1*=2!R1U$@Z;*94X:D/%S=4N*?V8S!X2H?*:
MX5H*)B,E4NO2,$FWX<+H2A=LPB<QJ+8>I6-I*M4MDTW%=K@$+NM[*SRT+5T4
M(:POB(>(!M5J]9D%P<,>@48E8GT8E:R-XU!4BI,Q>*1\NV6@G?((N-D8OL?Q
M@SCHN[3^MIJ<K"\G<OQ5!6=1+')"2)XYV)[\6#T>4AK?4";V#4 AP2!Z12Y?
MCMM=7GR@JS:L.53.FQ)FFJ6^ L*&?0G',!R:J+L<Z4\@50U-IGY(Z ]U;>(U
M@2F"+J'0PU6>M_\0+_!Z.K EZKK$G9?V8;!=JPW9CX+MET@R68RV1/V/B!!7
MQAHGL2OR_H8&&7X$F@NFUW-)X>[T]/<!2G4(TTI)0*9\ DQ''61<K[XIT<)Q
M35\1!/,F:-A[UGI O_24T?<V28?.R<X_I"I%,V/)EX##W7:KN06L_X LF6"D
MFL-(-5LRE#-A @Y7C/#_O@T'.5I@'\(H4M1C_RO2Y,=VJ^5^C*D^VPV>G9G[
M!L.86$;J5?O0:[5:^+^[K593O&F]!Z1N)N\ZG:M)+U-YB>_@<$\9@=_O"[JY
MP3]0;E"IC)B+.1*-V^A9H W'#;1AF="&_0;:L((=MCX;:@4Z]+>;ZVH)E:5;
M7H>-Y?42!F1JTP:B!P<E7B07PA4WX-&U']",^L,-;GQ#!E1=8^<=HG)L#<_.
M*USGLAME%!69Q=:M0$CH;C'.+/TT5T>B0IF:\7TDN?-\"05BGY(\"YSVOO+3
M804NKL:53GT_=>(1O=N#,*)8Q0BD,2N_,W/AI9(%NGU4?7TCJ6L]H E)O0+Q
M&:_4%K'RFC9H(C=?,F9GON@8%S_&I0ADT6;Y6:42@2H_,.G%EIY_HQ1-@,JI
M1@3Q?6CU* >T;+)1.VL]("U<5\XU1>!6F#G3^)U?R("44+SW'^N1:Y'_Z+EI
M$0D/X[ 2:XRT1H11^*L([CA,F'*(7G@R,ECB\HW"89C+7^)+!P++C$<<KR0<
MFQ48A*XT?LGU'I"6&G$GXL"Y%L/D 9:SROM0J6V]-&O&<$8V<K+6 ])R$HJX
M1KV 7A QH6)31,6.(A'@_Y>ZP "@/5?$_6+82QD/2_@1YH9+,X20#(K,CQ"H
M)!!"A_Q"\A$%J%8(%I"?1F+6>D!*8CZ *DE#/W(Z 1JYPN7<L_J2;D/YL.O+
MATU=(TPXLA$SV/HH13".A/-30@E]1A .1$XR4H=XK9C%D%!4YF.4JT$8@S#*
M;/*@Q&]MJGRD$^ <_/NF! W*_4^(F\/=@/DIPM.91<1AT@LCBZG:2GO2_(RL
M6TM(,61U17PD9;Y0#E()>\=@&A@.*.$AH962'BRS')Q&(.)S!AQSHS:EN0<X
MRONI1BKO 3^[OX2_*@"6Y]XGC^(!\[3#7SV&8\5)+-1L#9(H2A[I6*#3 FFQ
M\?V!*T+:NWXDZU83WDMC\-0<<"J5Y^#L?N&]/-4$BY3!4'QG()@T6Q9DD)A
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MU,\4>BM%N2B^.P%0P56]P] W1Z#H^U*7<'.WCW_.U$S1.LPMF>;7)D[O4/Z
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ME*>?C$)JRI"?(S Z8X>#_K[(7>+4@WZ'/;::)2K,V0H?F%AOZT&7N2/R/0U
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M!K^]3XJ,N3/G,-(.O!/+1B.S*X0.J8L'MC4R=Q6K'U-,D2G./:?.UI!6MVE
M!UU*PYMS'):MZ4E#*O<_P4OAO$3ZK6&"+CWG(?2I;YK^GNH]Z'+EN# @+CXR
M!LD_Z564X0]6L1M9R;=@$6^U6Y7<6RN:S.U0"J\<A\1AC9T).J]M(M6G'#40
M,%/#EJ\\$]<9PGF1/PHAPY2\Q:@&R9!*7)@;M*TV3T\H4ONBEY&-DFM584N<
M+H0P+'+<6903/DE#-R$?N+-0JVQEVQ:Y;EF=X'>D*$J"A_F.M&6^502?\R:Q
M<>*W O-G?T'S!\FN<LHY?RN$-H(Z><DCQ$386N^7'3<LV"-_7/77."HP8QK
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MBE&'8WIJ@E5?'3U&O%B%> ?\)"19Y']L$7!C@:R+?CK6^JU\U=/>IX$?1E0
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M,F[L^O$;@T".?]?IED>O$4:U8"IW'C!5),%4V(T2: @^HQ@._6$ 2?H=SER
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M^CD!K4NYB$3UK)@D:BQ%F N?P0?Z<%34#/\_>^^ZW#:2I8O^SZ= S.[904;
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MG%NC;#7.GT>'U3^E7J!%(KHUZ#![I,AKA84TQ;D%MA_')&! $D\(B;$R1U'
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MBL?CQ84X(^.#&+$9N!*P)>N@#!<=WJFK0G=LA;]OG-R2:YU15 ,-9H9S2+5
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M[K#\U1&CGW81HXU&C YV$:/OYWAM^"Y:EY4RG3\['8UVA%%/G8X$.7<N?16
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M61POC*XDK.RH^1*,]0E.HIA;2D)/I!41Z?\HC]@;5:;SN4U,1C1"GI8A\E8
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MY1O\G,R:G'7L?E)F9)TDT<L?]IZAA^4.9^'+?-[^5-7L#.N#0H</N?2GN;B
M[&[BX2&IKTZ7(Q#&T@E<@M96Q]7)6+I/MN9L/[:H^A/4EI=KF.[VP/:F<(K'
M8Y)29^*VMV8\2#?X8$!<[E/'T,"5EDND27MV#:VB'=_:?['7AJ_O2L.6-I(?
M^;%;)B!#%BADDFKMMY%D"ND=IE.J!()L4W-AU&SA<QA'6__ T B:@L6Q<88X
M'P\OPB?.=_QGLUSCF%-8V@+,>ZR@V,*!$^6V9"O1N,9WY%:7J2UC(HRF1HR(
MF#RZO,VC]S)_;_-%$5U>YXN2J!+A?_]O6N1_!Q,HTC!&ZV\O#A0GT/[R.?K
MW3,R5S6Q EW,Q@^8"G7LT*4&TX&WC1"1P]B0MGS:X(7."ZK<+?[TV" S.\K\
M=)QR7V.,>W+78JX&492V9 E([IG6A71ZU0."F4QX)D.W&YTW0FRLO_R3%Q[)
M9]P=+[S4RMIX2\&TMS+XY[EV-+JX3@H\G,C\E>%72#LVZ</%K+W%G]&R5G_D
M0@?&.N[A(NIS_*;ZM%]%!L>7":L@V)@9K1/=L-6UZJ=<DI(7JN26H'4\WQ@+
MF.>#3Z+1F,H;L3&TMND*M3$.(2658 >6AP"=V:Y+0P_$&:==J UK,1UC(($T
M(ONED2];G;8VX,?QX"MTE?-Y/%_ #;5_<."5O^;"&=2K:65:90J8?I5:(:XY
M+%-#7R=8&1X7\TW;X"04Z556SLEA.:*-B$]$RHZ?$@@\Z@P<@1W_0% /)88C
M'9VQI6&$9^%.Q7,#"F2IU>KE6SM2ZDUIM!)J=>HJE040B"'K! K=#9\(J0L
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M*@OY8'B_-&O&=/37;.NLOX0)[>[L/EU?;)!;:$E"H A#66J*$8P[J:W5[2V
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M^OZN<#%).6\U)5)EFG3O-B=N,>=EQLRD"+7G]=) #^D=H*FDY,'PTCSC3(S
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MVT[*NL(56Y%2AVF67 <L/-(;KV!K#<\I/"Q'_, JN[5I,,:VJ1R8:HM"S.2
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MB9GVG*W1E%A/^1?DU(RJM+RT"3[P=^ $S2R4B4B;IRK)S'<1?X>CR?(-W4[
M=N,2F E!2#)!?N(%3EL<6H4(6:Y<(Y5Q4I;7PI)JW34.#]P%L?$+EX#U72#
MJ)!>0,XU%&_1]QV<I\@-2P2O98"JQR+FDGE\<8@U^28706N;L/!1Z%J3\P1;
MF"%]LLCD3ALZ&X#DJ7==)R"^ YRMHP%C9/ 67%DP,/+0D6Y*2D&R60N?S[*%
M1->P2\4X2P1NDDRG6<X_.3B)I3:V''OI_#PY3UT[T,NLR)T;"F<E#GYC,!QM
MFQ2Y!I;ZN8B((/IVV@/;)U+8O:]@W%7!%:/+.:(5J/XAF_^YG/->$M8X@>DO
M2T9S,$UYS'U3F)F7#C)GMPNFZNWK;:/J%A1-A5]S,#?1%\+05PH#'A5S'X)B
MXNL&?R^ODD2SC0NZX,I?@"0C!?\TF\*C%MQ@(1KL[CW]J^OF!,[['+M"YM'^
M3#<=Y!9?X>:D0CWO1<EV]*1AVN)T9"OV !A85<NDB&YGGKIP2CG*I('$=SDH
MI/,@U !*#%U4!?LIN(=5T6(&<57/ 2_S(*E,GOUKB>H1NTPE,Y"I:A@&X' Q
MB0FZ@HMG<GY_L(2'N.6^MDM[O$F25#>19#IY5:7@;O$/"\N%YUJS$@Q(!X>P
M65T0+#*=N&E4#+>-?84J(D1J?=YUI=5YV+-8SH_K424QH79PK#'_->C"Z=!.
ME^4\JRX:C1K"7L9AVX;FF[EIGL9Z51=,&)]1^XY$U,H4+EWI5:B*H8(IF' *
M%=]@+2NNT=^AIZ]#T!!"ILD<%[X'M/RZV?S,)%&>?4S77X2JM0K5)I1S"DGG
MVS7=&.>T'^0[):9^1?-K2CYVE<2YB#>OOD;O,:_'2+%ZN+XXS<BO2'^[64.M
M"UG:R0IAQ)5&4[S@MC-;*&U\O4O87?V>!FFDLPI?_M+-!\MC;6>?@IHVY2DV
M-<;+U5^G?)FJC4MM7>'V+GFDTQE,-D3:I]%9\BFM>MT_L$&X,@0#T K+/K&E
M6_AM*JN4&JAIBM'X/#8@Y]QA! /E.<I>@65M_'FRJL634.Q'EB!%G"WGX^E6
MC'TQR*Y[QS3N'53C=='/JK+.&;0KXAQ7FI+DN&@%R*Y6GS ];>,[ZF=4_LQ-
M9GO8'NET!ND&A^V5D(2Z.BC5&-DQB&+=U0UA<%O6T)5D=%<-^,UYEB[M.6H_
MOLN=Y#O-DQ.H!LOMVPE/ 7%?L6-&(NM?8RM*A5DU\Y)_ Z'J5M8?Z70&TXT2
M6!1%LV[OREK@]I43!,9 2HGW*P@S(.N"0L10Q )#<'0O?4S3191<@A'-=51+
M%[%,EO5%4<*D)A2%6\[E++6)UD^X@]0D>I/-J1;!VD%-3ZA5E),(,41')3>E
MK:;8X$L".C9Q?]'?]WDPR2IF>1-+FO]FTW=R,QM\H>9\DW-/;!#%O'FA##O\
M@]9PP66H*,V-#M0,RRD(M>-P@$3<3@T*L:V4&);<]M0O\XV.(TZ(^!C)F%!4
M\-*U-VPHBD]WN^:?K5XHNQ+<WN&B5[!$U52%9#OZ*'\^U?W4(@:V"NUNIW-S
M.O+%-AUYI^G(9]]>.O+;/5YW9R^<;V0OG"-4L"BI= /L10S!:9*Q%24?')82
M \"G%#S I84&M'>KM(D,.CZ3ORHM(AG )LDMZMS( SE'#-H<0U9);N\>!,$R
M>C)5G&G"FN!F9T;%Y%K5NHJOS$Q>Z"WGR17')<\M=#*@"Y.2<XU0%Q\:AI=-
M\FM5UR(N<]M5X&KFX/*7 "HU?Q]CCUVTHR2<&C=SDP1LH[\2L0.50&"ZK:@J
M1/_$'$1S$!V_MK%;6;6H7:UWMW?F(YW.X&*#0WTD5"W3Z.B2 K[O->U,P)30
MY!,,_A@>6LQY(OB5<Q4!=TW-!=/]Q&N^S3>SJH7IQN UBK>9,K<N_HEP_V*2
M3=FE-1@@=GX.=<IVM-G!\SHXG\,BXW J';D*?JMTH6^ XHC=F'K/VLR*38(7
M70MJ2ZWUX&X8TO9(WM5T[J&)X][ZA_(]-M!E*N57KDUQ$AVX"GDX-W59Y _O
MO6RA7C?HXF0#7?PF1:,D&Y-"4#( %_^[A55?/BA]T Q*]PL(:!!3%<7<%E B
M) -5R6!W;QA-DNO*ESG "\' HT*D -I"P)7V&\!]!ULLJ>V3:WKJT^93;1'
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MN)<;Y3X(04R+JRJPF_% &Y;Y[]'?_CO[6PY7Z7]_EX&4C_YF'#=18]-K2WC
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MW%<TKY)3QLZYT&>'\M"&YN8\-_2]J$DQ>^Z=PTLPR:X)"%4NBIKJXK0,=OK
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MBC4V5UD4-KPF<2_V1.=YH_>!JO+.J>&DEW?+C(,(#?_.G?)_M]F5UTC5]*,
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MB6_>??B@G_C3\>NS-'EU_.'L])<C@L^=)C__<G;RQG04#@)3GATYJR[SDDX
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M2&JA;U@E3"D8U0"2A[TA&Y'L@6?9HX,#>.YI?MYQ7.3@V2'<G:MN>9ZY(??
M7+ A_^A(0+W.BM8XS_J)G]@=AYV6P!8\I)1"7/!09-<"JQ3%8<+K9F;I<9-
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ML!+ADE(ACT"<;>32#$=Q5YAH0XW44;0TO=I*A2EAX*WWV[_HW]]X,'"!&8*
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M@R H:D5P&Q?XTQ<T6@SF[\6_=B4_2@)FWK5AHOE\$S"W/4P+I2/\MO*_C5<
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MA85\37L7DXEG'PKA@^=*0>WD#X-: 3UGR;6+?VLK-,/'<<DQ[QMMN=O^P]8
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MZL,%W1R*"?[BX+D>AH,V:R\*,.NU[%T$7W40MS-(&<ZSF@C/"S>?ZJ05@IY
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MFXKZW#9#QXDDM0>7"GRU65'/NA58WS.Q MCJ-<=E$=KOMJ38%ODT:VSO*E8
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MQ3CS9B:H()?[ "U[0$@%M 9@^SCHY!"_PM>GPK#FJ]-W:1_^[ 30(! R!4_
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M=I>3XR9RF\9 3#$A8@JD;O!,_12G\)?L>.DE6'8,*L6QX5,*+XN5O#HJJ**
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MJC/>)BR201+/I46>)!&8MLE0L=LYD]@R=E0N^6,!Y]( O2'LP0#V8)K(J[.
M0 +%*@KZ[MJ"-O0E\L]3(B 72,F;T6"(YRW3:UX'CSA)1J/M-]+>^RH^8_1M
M)J7"3'0A9#NA0X:8D?)\R#,V8VNT,:3Z!=QG0F1*':] KM-D'C%WH*V8%=1H
M2M0@Z(7D9WSEHRM"(3,;?J*L-S??AYW)T<NQRQ4*8Z_\^1P18=&X615&/[O5
MZU651%EK$F6_2J(\CB3*^O7Y 0(1^("A>.D/V35K "*'SBD3BAVK1B=85.C:
M#[Z!& MGW%\RC_W)(#R?4S\N-\1D)N@5,8I/30"6!:I2Y?5C)!M1?M(DEN:
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M:Q];5C!ERBQ'U-J.O;=80T<EF'L[>R]$(X[G4AFKI"2TS\Z2X5>F0'J=*UW
M>[/._W[L AYP-E8=F5Q91G4-O]_1_XY W]WG7 4RKIW5FR1];%."SCJ04YL6
MG5EZAK[;'KTG&_39/=W>!VPB/MR15\;MC]*J)L?Q'W?/#W[/D%35Z'^LT<SV
MZS]-13B3.ECGK+I)=N''F'^9_^FGX4_6@GJ2+]<XQ__\QZL7!P<_.\"DI[:W
M<_]S^XY\_-[N6H?W]Q!X#T4K_F"?H9K,YKH)?XOI5,;>#Y!]/\'"6Z-9-_BY
M9MWZ9M*(YU-_ A-HG/OI%?"\/YJ[O0D&W 8:;96PJ@RU:C(;-IG*4*L,M<V4
M?0_;4!L^%D/M^,)/(WDPL'"L[<?G290\HNM=V6J5O*ILM4=KWCRJR52V6F6K
M;:;L>]BVVNBQV&J 2P##[_KQUS!^1!>[LM(J2559:8_6L'E4DZFLM,I*VTS9
M]["MM.#16&GA\,(/(IA!TT\C<9P )MI,]-*?-\/*9*M,MDT56X]%DSXJ*^=1
M3:8RV2J3;3-EW\,VV<:/Q63KS4<783Q*?9C#>S_^ZL=7_NAG]Q]4YMIC,-=<
M5@8'GK\,)F[O91%;?DVHK005=S<TN!N*41L@OR@ ;PCF2ZOZ[=MV)H<;\5([
MNW(#%;QL)&I-12DAB3S.V_C):X7L9_U [1"TE*DUW3NTD'#QV>6_3S^RGZ#^
M?H@F,"'V+N'R4*=EXT_!VKO*:2"O=DN/4UFKWWWC1?^ KG-&(KTYBJ99">88
MV9_>/[S ?3>JW\LJ[*]Y$1K$;E@M1&.0 3W$FCKI?Y#5KKJ"-\B 9WE7ICX?
MC/MZ?_+K7A;['F[6PQGGX[^@:[LU>W= MKIOF7#/]D[7GQF64CDEYE?, @O;
MZGV[\4D<GS7$Z>D9L(Q:!(S_-T.JT&F K(0B#<Y#(!T)1F(Z'T3A4'%'(@-S
MF$X( PLX4\-,KH)8!'XJY"_#ST^"(5(YPS#V%4_) Q1A#\:EWWRSHUJ!DA5X
M_ *]LK@JBZNRN#;X@J[MUNS7<6Z/SZYJ3($*S(_(IJJAW3.=I],D"Y#B?2CM
MIV@!9L]5.+L0;3\;^7^)4VD]P6?=>12(P^?[AS4B6\N J7N(?/%(-(B/D";8
M1!IH"!(*%&.GTA(3;Z-D %PA61;,Q <_]L^1JQJ&\4>KU9(FW'%E4U461;4"
ME4U5V5253?5@QOGX+^C:;LW!W\.F C)J'^A.P+Y1<2L.2_WG/U[N[;[X)1/'
M, 6,;Z'QU(J'B;3!4B8D3L0P\N6KB'984Z2DP01>0V2NF?QF93%5]D*U I7%
M5%E,E<7T8,;Y^"_HVF[-X=_18B)V^VPF3:-5%M3>SMZ!:/XU#V<+,)_D-\/+
M0)Q%?F45539!M0*555191955]'#&>6\7]&?71=L,>#=]\7U74K<[_>9K 16C
M_43,4OEE?S@3V7QX@0:)-#=2,9AG81QD&1063?P%!%VF01HM($,6B$$P3M(
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MFZ+<3F0CIRU%*KD*TABT983=_#%XX;.C/;S78BDL]&G8%8#P2/CH;;O->YP
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MYQY@S+N*MI/Z4/7WE@?IZ["9G%6M44 'E*SP@.-:T%F(&FSX;N>?K/'S6LS
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MT0<L*CS',8W+J"0X"L]QJTC&H62M!NH*Z4=:TT(J.2PR<9F6'$'?0F)ZBRT
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MF^.J</MMY<^%).<=CPGU0@<)0ZI-4/6 )329M FFP%JQEI[P%E!# ?YTGC4
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M.8U':(JS,:'?B].45;847_^O7AC9V/\ 4$L#!!0    (  :*E5QG'#Z04@,
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MYDS+A CPM4S9[ "/,YH0$QM=H8^$TS<JRS:U*B@\I-;,>>889Q0ED*,"OHI
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M!/A."KA6H%"<8?*P!3P.K5&RBE)/9U34E5 <3]$5N$=#=BA%^VI@.&B.HI"
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MT?^![1(*=%/"3--M-Y:6CB;N6V:F_(QG_O18^2F!3-9M;Y86?;6+!;R9W3.
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M+FAT;5!+ 0(4 Q0    (  :*E5Q]$'$Q\3@  %$Z   2              "
M <KK @!F;W)M9&5F,31A7S P,2YJ<&=02P$"% ,4    "  &BI5<88-3'=4Q
M  #'-   #0              @ 'K) , <')O>'E?,# Q+FIP9U!+ 0(4 Q0
M   (  :*E5QG'#Z04@,  (@-   1              "  >M6 P!S9'-T+3(P
M,C4Q,C,Q+GAS9%!+ 0(4 Q0    (  :*E5S_0Z#8F@(  $D-   5
M      "  6Q: P!S9'-T+3(P,C4Q,C,Q7V1E9BYX;6Q02P$"% ,4    "  &
MBI5<\/EY:>D/  "NT   %0              @ $Y70, <V1S="TR,#(U,3(S
M,5]L86(N>&UL4$L! A0#%     @ !HJ57*-CM2?"#   ZJ0  !4
M     ( !56T# '-D<W0M,C R-3$R,S%?<')E+GAM;%!+!08     !P ' +\!
(  !*>@,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>formdef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sdst-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831979</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000004">0001831979</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000011">STARDUST POWER INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000012">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000013">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
do not have any program, plan or obligation that requires us to grant equity awards on specified dates. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20250101__20251231_zTx7MiLM4c7g"&gt;We
also do &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_z76eRhlGWiV8"&gt;no&lt;/span&gt;t
have any program, plan or practice to time award dates of stock option grants to our executive officers in coordination with the release
of material nonpublic information and typically aim to make equity grants during an open trading window.&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
awards may occasionally be granted following a significant change in job responsibilities or to meet special retention or performance
objectives. During 2025, we did &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--MnpiDiscTimedForCompValFlag_dbF_c20250101__20251231_zUHKmKOhzhKj"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;t
time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation, and no stock
options were granted to any named executive officer.&lt;/span&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000014">We
also do &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_z76eRhlGWiV8"&gt;no&lt;/span&gt;t
have any program, plan or practice to time award dates of stock option grants to our executive officers in coordination with the release
of material nonpublic information and typically aim to make equity grants during an open trading window.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="From2025-01-01to2025-12-31" id="Fact000015">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="From2025-01-01to2025-12-31" id="Fact000016">false</ecd:MnpiDiscTimedForCompValFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
